EnLink Midstream LLC29336T100US29336T100701/30/2025To approve the Agreement and Plan of Merger, dated as of November 24, 2024 (the "Merger Agreement"), by and among EnLink Midstream, LLC ("EnLink"), ONEOK, Inc. ("ONEOK"), Elk Merger Sub I, L.L.C., a direct, wholly-owned subsidiary of ONEOK, Elk Merger Sub II, L.L.C., a direct, wholly-owned subsidiary of ONEOK, and EnLink Midstream Manager, LLC, the managing member of EnLink, as it may be amended from time to time, a copy of which is attached as Annex A to the proxy statement/prospectus, and the Mergers (as defined in the Merger Agreement) contemplated by the Merger Agreement.EXTRAORDINARY TRANSACTIONSISSUER761678.0000000.000000FOR761678.000000FORS000045418EnLink Midstream LLC29336T100US29336T100701/30/2025To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to EnLink's named executive officers that is based on or otherwise relates to the Mergers.SECTION 14A SAY-ON-PAY VOTESISSUER761678.0000000.000000FOR761678.000000FORS000045418EnLink Midstream LLC29336T100US29336T100701/30/2025To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to EnLink's named executive officers that is based on or otherwise relates to the Mergers.SECTION 14A SAY-ON-PAY VOTESISSUER761678.0000000.000000FOR761678.000000FOR1S000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Alan S. ArmstrongDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Stephen W. BergstromDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Michael A. CreelDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Stacey H. DoreDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Carri A. LockhartDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Richard E. MuncriefDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Peter A. RagaussDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Rose M. RobesonDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Scott D. SheffieldDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: William H. SpenceDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Elect 11 Director Nominees for a One-Year Term: Jesse J. TysonDIRECTOR ELECTIONSISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Approve, on an Advisory Basis, the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER234975.0000000.000000FOR234975.000000FORS000045418The Williams Companies, Inc.969457100US969457100404/29/2025Approve, on an Advisory Basis, the Compensation of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER234975.0000000.000000FOR234975.000000FOR1S000045418The Williams Companies, Inc.969457100US969457100404/29/2025Ratify the Selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2025.AUDIT-RELATEDISSUER234975.0000000.000000FOR234975.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Election of Class II Directors: Evan BayhDIRECTOR ELECTIONSISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Election of Class II Directors: Jeffrey C. CampbellDIRECTOR ELECTIONSISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Election of Class II Directors: Kimberly N. Ellison-TaylorDIRECTOR ELECTIONSISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Election of Class II Directors: Kim K.W. RuckerDIRECTOR ELECTIONSISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent auditor for 2025.AUDIT-RELATEDISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Approval, on an advisory basis, of the company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Approval, on an advisory basis, of the company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER51747.0000000.000000FOR51747.000000FOR1S000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Approval of an amendment to the company's Restated Certificate of Incorporation to declassify the Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Approval of an amendment to the company's Restated Certificate of Incorporation to eliminate supermajority provisions.CORPORATE GOVERNANCEISSUER51747.0000000.000000FOR51747.000000FORS000045418Marathon Petroleum Corporation56585A102US56585A102504/30/2025Shareholder proposal to support a simple majority vote.CORPORATE GOVERNANCESECURITY HOLDER51747.0000000.000000ABSTAIN51747.000000AGAINSTS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: Robert Skaggs, Jr.DIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: David SlaterDIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: Angela ArchonDIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: Stephen BakerDIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: Elaine PickleDIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: Peter TumminelloDIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To elect seven directors from the nominees described in the proxy statement: Dwayne WilsonDIRECTOR ELECTIONSISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To approve, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers;SECTION 14A SAY-ON-PAY VOTESISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To approve, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers;SECTION 14A SAY-ON-PAY VOTESISSUER115.0000000.000000FOR115.000000FOR1S000045418DT Midstream, Inc.23345M107US23345M107105/06/2025To approve the Stockholder Rights Proposal; andCORPORATE GOVERNANCEISSUER115.0000000.000000FOR115.000000FORS000045418DT Midstream, Inc.23345M107US23345M107105/06/2025Stockholder Proposal to Support Shareholder Ability to Call for a Special Shareholder Meeting.CORPORATE GOVERNANCESECURITY HOLDER115.0000000.000000ABSTAIN115.000000AGAINSTS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Fred M. DiazDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: H. Paulett EberhartDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Marie A. FfolkesDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Kimberly S. GreeneDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Deborah P. MajorasDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Eric D. MullinsDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: R. Lane RiggsDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Randall J. WeisenburgerDIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Elect directors to serve until the 2026 Annual Meeting of Stockholders: Rayford Wilkins, Jr.DIRECTOR ELECTIONSISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Advisory vote to approve the 2024 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER40976.0000000.000000FOR40976.000000FORS000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Advisory vote to approve the 2024 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER40976.0000000.000000FOR40976.000000FOR1S000045418Valero Energy Corporation91913Y100US91913Y100105/06/2025Ratify the appointment of KPMG LLP as Valero's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER40976.0000000.000000FOR40976.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Mayank (Mike) M. AsharDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Gaurdie E. Banister, Jr.DIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Susan M. CunninghamDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Gregory L. EbelDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Jason B. FewDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Douglas L. FosheeDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Theresa B.Y. JangDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Teresa S. MaddenDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Manjit MinhasDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Stephen S. PolozDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director S. Jane RoweDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Elect Director Steven W. WilliamsDIRECTOR ELECTIONSISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER1494.0000000.000000FOR1494.000000FORS000045418Enbridge Inc.29250N105CA29250N105005/07/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER1494.0000000.000000FOR1494.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Scott BonhamDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Cheryl F. CampbellDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Michael R. CulbertDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director William D. JohnsonDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Susan C. JonesDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director John E. LoweDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Dawn Madahbee LeachDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Francois L. PoirierDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Una PowerDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Mary Pat SalomoneDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Siim A. VanaseljaDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Thierry VandalDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Elect Director Dheeraj "D" VermaDIRECTOR ELECTIONSISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Approve KPMG LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER338.0000000.000000FOR338.000000FORS000045418TC Energy Corporation87807B107CA87807B107605/08/2025Amend Shareholder Rights PlanSHAREHOLDER RIGHTS AND DEFENSESISSUER338.0000000.000000FOR338.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Anne-Marie N. AinsworthDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Anna C. CatalanoDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Leldon E. EcholsDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Manuel J. FernandezDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Timothy GoDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Rhoman J. HardyDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Jeanne M. JohnsDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: R. Craig KnockeDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Robert J. KostelnikDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Ross B. MatthewsDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Franklin MyersDIRECTOR ELECTIONSISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER837.0000000.000000FOR837.000000FOR1S000045418HF Sinclair Corporation403949100US403949100005/14/2025Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2025 fiscal year.AUDIT-RELATEDISSUER837.0000000.000000FOR837.000000FORS000045418HF Sinclair Corporation403949100US403949100005/14/2025Approval of HF Sinclair's Second Amended and Restated Certificate of Incorporation to provide for officer exculpation.CORPORATE GOVERNANCEISSUER837.0000000.000000FOR837.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: G. Andrea BottaDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Jack A. FuscoDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Patricia K. CollawnDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Brian E. EdwardsDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Denise GrayDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Lorraine MitchelmoreDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: W. Benjamin MorelandDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Donald F. Robillard, Jr.DIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Matthew RunkleDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Election of Directors: Neal A. ShearDIRECTOR ELECTIONSISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2024.SECTION 14A SAY-ON-PAY VOTESISSUER65997.0000000.000000FOR65997.000000FORS000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers for 2024.SECTION 14A SAY-ON-PAY VOTESISSUER65997.0000000.000000FOR65997.000000FOR1S000045418Cheniere Energy, Inc.16411R208US16411R208505/15/2025Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER65997.0000000.000000FOR65997.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Richard D. KinderDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Kimberly A. DangDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Amy W. ChronisDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Ted A. GardnerDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Anthony W. Hall, Jr.DIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 13 nominated directors, each for a one year term expiring in 2026: Steven J. KeanDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Michael C. MorganDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Arthur C. ReichstetterDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: C. Park ShaperDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: William A. SmithDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Election of Directors: Election of 11 nominated directors, each for a one year term expiring in 2026: Robert F. VagtDIRECTOR ELECTIONSISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025AUDIT-RELATEDISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy StatementSECTION 14A SAY-ON-PAY VOTESISSUER287855.0000000.000000FOR287855.000000FORS000045418Kinder Morgan, Inc.49456B101US49456B101705/15/2025Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy StatementSECTION 14A SAY-ON-PAY VOTESISSUER287855.0000000.000000FOR287855.000000FOR1S000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Hal KvisleDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Chansoo JoungDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director George LewisDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Leonard MallettDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Robert (Bob) G. PhillipsDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Sonya ReedDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Shannon RyhorchukDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Mary Pat SalomoneDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Frances M. VallejoDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Don WishartDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Elect Director Bevin WirzbaDIRECTOR ELECTIONSISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Approve KPMG LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER22427.0000000.000000FOR22427.000000FORS000045418South Bow Corporation83671M105CA83671M105905/15/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER22427.0000000.000000FOR22427.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To elect the four Class III Directors named in the proxy statement, each to serve until the 2028 annual meeting of stockholders: Waters S. Davis, IVDIRECTOR ELECTIONSISSUER36690.0000000.000000FOR36690.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To elect the four Class III Directors named in the proxy statement, each to serve until the 2028 annual meeting of stockholders: Rene R. JoyceDIRECTOR ELECTIONSISSUER36690.0000000.000000FOR36690.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To elect the four Class III Directors named in the proxy statement, each to serve until the 2028 annual meeting of stockholders: Caron A. LawhomDIRECTOR ELECTIONSISSUER36690.0000000.000000FOR36690.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To elect the four Class III Directors named in the proxy statement, each to serve until the 2028 annual meeting of stockholders: Matthew J. MeloyDIRECTOR ELECTIONSISSUER36690.0000000.000000FOR36690.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2025.AUDIT-RELATEDISSUER36690.0000000.000000FOR36690.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024.SECTION 14A SAY-ON-PAY VOTESISSUER36690.0000000.000000FOR36690.000000FORS000045418Targa Resources Corp.87612G101US87612G101305/20/2025To approve, on an advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2024.SECTION 14A SAY-ON-PAY VOTESISSUER36690.0000000.000000FOR36690.000000FOR1S000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Brian L. DerksenDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Julie H. EdwardsDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Lori A. GobillotDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Mark W. HeldermanDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Randall J. LarsonDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Pattye L. MooreDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Pierce H. Norton IIDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Eduardo A. RodriguezDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Gerald D. SmithDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Election of 10 Directors: Wayne T. SmithDIRECTOR ELECTIONSISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm of ONEOK, Inc. for the year ending December 31, 2025.AUDIT-RELATEDISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Approval of the ONEOK, Inc. 2025 Equity Incentive Plan.COMPENSATIONISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025Approval of the ONEOK, Inc. 2025 Employee Stock Award Program.COMPENSATIONISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025An advisory vote to approve ONEOK, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER118919.0000000.000000FOR118919.000000FORS000045418ONEOK, Inc.682680103US682680103605/21/2025An advisory vote to approve ONEOK, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER118919.0000000.000000FOR118919.000000FOR1S000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Company Nominees RECOMMENDED by the Company: A. Nigel HearneDIRECTOR ELECTIONSISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Company Nominees RECOMMENDED by the Company: John E. LoweDIRECTOR ELECTIONSISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Company Nominees RECOMMENDED by the Company: Robert W. PeaseDIRECTOR ELECTIONSISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Company Nominees RECOMMENDED by the Company: Howard I. UngerleiderDIRECTOR ELECTIONSISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Elliot Nominees OPPOSED by the Company: Brian S. CoffmanDIRECTOR ELECTIONSSECURITY HOLDER39061.0000000.000000WITHHOLD39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Elliot Nominees OPPOSED by the Company: Sigmund L. CorneliusDIRECTOR ELECTIONSSECURITY HOLDER39061.0000000.000000WITHHOLD39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Elliot Nominees OPPOSED by the Company: Michael A. HeimDIRECTOR ELECTIONSSECURITY HOLDER39061.0000000.000000WITHHOLD39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Election of 4 Class I Directors to Hold Office Until the 2028 Annual Meeting: Elliot Nominees OPPOSED by the Company: Stacy D. NieuwoudtDIRECTOR ELECTIONSSECURITY HOLDER39061.0000000.000000WITHHOLD39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Management Proposal to Approve the Declassification of the Board of DirectorsSHAREHOLDER RIGHTS AND DEFENSESISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Advisory Approval of Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Advisory Approval of Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER39061.0000000.000000FOR39061.000000FOR1S000045418Phillips 66718546104US718546104005/21/2025Advisory Approval of Frequency of Future Advisory Approvals of Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER39061.0000000.000000ONE YEAR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Advisory Approval of Frequency of Future Advisory Approvals of Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER39061.0000000.000000ONE YEAR39061.000000FOR1S000045418Phillips 66718546104US718546104005/21/2025Ratification of the Appointment of Emst & YoungAUDIT-RELATEDISSUER39061.0000000.000000FOR39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Elliott Proposal Requiring Annual Director ResignationsSHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER39061.0000000.000000AGAINST39061.000000FORS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: ELLIOTT NOMINEES: Brian S. CoffmanDIRECTOR ELECTIONSSECURITY HOLDER78122.0000000.000000WITHHOLD78122.000000AGAINSTS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: ELLIOTT NOMINEES: Sigmund L. CorneliusDIRECTOR ELECTIONSSECURITY HOLDER78122.0000000.000000WITHHOLD78122.000000AGAINSTS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: ELLIOTT NOMINEES: Michael A. HeimDIRECTOR ELECTIONSSECURITY HOLDER78122.0000000.000000WITHHOLD78122.000000AGAINSTS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: ELLIOTT NOMINEES: Stacy D. NieuwoudtDIRECTOR ELECTIONSSECURITY HOLDER78122.0000000.000000WITHHOLD78122.000000AGAINSTS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: COMPANY NOMINEES OPPOSED BY ELLIOTT: A. Nigel HearneDIRECTOR ELECTIONSISSUER78122.0000000.000000WITHHOLD78122.000000FORS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: COMPANY NOMINEES OPPOSED BY ELLIOTT: John E. LoweDIRECTOR ELECTIONSISSUER78122.0000000.000000WITHHOLD78122.000000FORS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: COMPANY NOMINEES OPPOSED BY ELLIOTT: Robert W. PeaseDIRECTOR ELECTIONSISSUER78122.0000000.000000WITHHOLD78122.000000FORS000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to elect Brian S. Coffman, Sigmund L. Cornelius, Michael A. Heim and Stacy D. Nieuwoudt as Class I Directors to hold office until the Company's 2028 Annual Meeting of Stockholders: COMPANY NOMINEES OPPOSED BY ELLIOTT: Howard I. UngerleiderDIRECTOR ELECTIONSISSUER78122.0000000.000000WITHHOLD78122.000000FORS000045418Phillips 66718546104US718546104005/21/2025The Company's proposal to approve the declassification of the Board of Directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER78122.0000000.000000FOR78122.000000FORS000045418Phillips 66718546104US718546104005/21/2025The Company's proposal to approve, on an advisory basis, the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER78122.0000000.000000AGAINST78122.000000NONES000045418Phillips 66718546104US718546104005/21/2025The Company's proposal to approve, on an advisory basis, the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER78122.0000000.000000AGAINST78122.000000NONE1S000045418Phillips 66718546104US718546104005/21/2025The Company's proposal to approve, on an advisory basis, the frequency of future shareholder advisory votes to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER78122.0000000.000000ONE YEAR78122.000000NONES000045418Phillips 66718546104US718546104005/21/2025The Company's proposal to approve, on an advisory basis, the frequency of future shareholder advisory votes to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER78122.0000000.000000ONE YEAR78122.000000NONE1S000045418Phillips 66718546104US718546104005/21/2025The Company's proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm.AUDIT-RELATEDISSUER78122.0000000.000000FOR78122.000000NONES000045418Phillips 66718546104US718546104005/21/2025Elliott's proposal to approve, on an advisory basis, a resolution requesting that the Board of Directors adopt a policy to implement the annual election of all directors.SHAREHOLDER RIGHTS AND DEFENSESSECURITY HOLDER78122.0000000.000000FOR78122.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Victor BurkDIRECTOR ELECTIONSISSUER3762802.0000000.000000FOR3762802.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Kevin McCarthyDIRECTOR ELECTIONSISSUER3762802.0000000.000000FOR3762802.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Harry PefanisDIRECTOR ELECTIONSISSUER3762802.0000000.000000FOR3762802.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Gary PetersenDIRECTOR ELECTIONSISSUER3762802.0000000.000000FOR3762802.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER3762802.0000000.000000FOR3762802.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025The approval, on a non-binding advisory basis, of our 2024 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3762802.0000000.000000FOR3762802.000000FORS000045418Plains All American Pipeline, L.P.726503105US726503105105/21/2025The approval, on a non-binding advisory basis, of our 2024 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3762802.0000000.000000FOR3762802.000000FOR1S000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Robert PenderDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Michael SabelDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Andrew OrekarDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Sari GranatDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Jimmy StatonDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Thomas ReidDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Election of the 7 director nominees named in this proxy statement: Roderick ChristieDIRECTOR ELECTIONSISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Ratification of selection of Ernst & Young LLP ("EY") as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER539680.0000000.000000FOR539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER539680.0000000.000000FOR539680.000000FOR1S000045418Venture Global, Inc.92333F101US92333F101205/21/2025Advisory vote on "say-on-pay" frequency.SECTION 14A SAY-ON-PAY VOTESISSUER539680.0000000.000000THREE YEARS539680.000000FORS000045418Venture Global, Inc.92333F101US92333F101205/21/2025Advisory vote on "say-on-pay" frequency.SECTION 14A SAY-ON-PAY VOTESISSUER539680.0000000.000000THREE YEARS539680.000000FOR1S000045418Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Randal KirkDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Cesar AlvarezDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Steven FrankDIRECTOR ELECTIONSISSUER68764.0000000AGAINST68764.000000AGAINSTS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Vinita GuptaDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Fred HassanDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Jeffrey KindlerDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Nancy Howell AgeeDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: Helen SabzevariDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Election of Directors: James TurleyDIRECTOR ELECTIONSISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024.AUDIT-RELATEDISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER68764.0000000FOR68764.000000FORS000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER68764.0000000FOR68764.000000FOR2S000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER68764.0000000FOR68764.000000FOR5S000047353Precigen, Inc.74017N105US74017N105407/05/2024Company Proposal - Approval of an Amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan.COMPENSATIONISSUER68764.0000000FOR68764.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/12/2024To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Peter Salzmann, M.D., M.B.A.DIRECTOR ELECTIONSISSUER3403.0000000WITHHOLD3403.000000AGAINSTS000047353Immunovant, Inc.45258J102US45258J102508/12/2024To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: George MigauskyDIRECTOR ELECTIONSISSUER3403.0000000WITHHOLD3403.000000AGAINSTS000047353Immunovant, Inc.45258J102US45258J102508/12/2024To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesDIRECTOR ELECTIONSISSUER3403.0000000WITHHOLD3403.000000AGAINSTS000047353Immunovant, Inc.45258J102US45258J102508/12/2024To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025.AUDIT-RELATEDISSUER3403.0000000FOR3403.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/12/2024To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3403.0000000FOR3403.000000FORS000047353Immunovant, Inc.45258J102US45258J102508/12/2024To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3403.0000000FOR3403.000000FOR2S000047353Immunovant, Inc.45258J102US45258J102508/12/2024To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3403.0000000FOR3403.000000FOR5S000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024Election of Director: Min Cui, Ph.D.DIRECTOR ELECTIONSISSUER30276.0000000FOR30276.000000FORS000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024Ratification of the appointment of KPMG LLP as the independent registered public accounting firm.AUDIT-RELATEDISSUER30276.0000000FOR30276.000000FORS000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER30276.0000000FOR30276.000000FORS000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER30276.0000000FOR30276.000000FOR2S000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER30276.0000000FOR30276.000000FOR5S000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the Company's Class A Common Stock.CAPITAL STRUCTUREISSUER30276.0000000FOR30276.000000FORS000047353Nuvation Bio Inc.67080N101US67080N101909/03/2024To approve adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies.CORPORATE GOVERNANCEISSUER30276.0000000FOR30276.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024Election of Directors: Sushil PatelDIRECTOR ELECTIONSISSUER9569.0000000FOR9569.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024Election of Directors: Dieter WeinandDIRECTOR ELECTIONSISSUER9569.0000000WITHHOLD9569.000000AGAINSTS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024Election of Directors: Madhavan BalachandranDIRECTOR ELECTIONSISSUER9569.0000000FOR9569.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2025.AUDIT-RELATEDISSUER9569.0000000FOR9569.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9569.0000000FOR9569.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9569.0000000FOR9569.000000FOR2S000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9569.0000000FOR9569.000000FOR5S000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9569.0000000ONE YEAR9569.000000FORS000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9569.0000000ONE YEAR9569.000000FOR2S000047353Replimune Group, Inc.76029N106US76029N106309/04/2024To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9569.0000000ONE YEAR9569.000000FOR5S000047353Celcuity Inc.15102K100US15102K100710/07/2024To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock available for issuance from 65,000,000 shares to 95,000,000 shares.CAPITAL STRUCTUREISSUER5901.0000000FOR5901.000000FORS000047353Celcuity Inc.15102K100US15102K100710/07/2024To approve, if necessary, adjournment of the Special Meeting to solicit additional proxies in favor of the authorized share increase described in proposal 1.CORPORATE GOVERNANCEISSUER5901.0000000FOR5901.000000FORS000047353Exscientia Plc30223G102US30223G102211/12/2024Approve Scheme of ArrangementEXTRAORDINARY TRANSACTIONSISSUER12668.0000006691.000000FOR12668.000000FORS000047353Exscientia Plc30223G102US30223G102211/12/2024Approve Matters Relating to the Proposed Business Combination of Exscientia plc and Recursion Pharmaceuticals Inc.EXTRAORDINARY TRANSACTIONSISSUER12668.0000006691.000000FOR12668.000000FORS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104411/12/2024To approve the issuance of shares of Class A Common Stock of Recursion Pharmaceuticals, Inc. ("Recursion") in connection with Recursion's acquisition of the entire issued and to be issued share capital of Exscientia plc pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, for purposes of complying with the applicable provisions of the Nasdaq Listing Rules (the "Recursion Share Issuance Proposal").EXTRAORDINARY TRANSACTIONSISSUER1.0000009762.000000FOR1.000000FORS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104411/12/2024To approve any motion to adjourn the special meeting of stockholders of Recursion (the "Recursion Special Meeting") to another time or place, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Recursion Special Meeting to approve the Recursion Share Issuance Proposal.CORPORATE GOVERNANCEISSUER1.0000009762.000000FOR1.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Election of Directors: Kenneth GalbraithDIRECTOR ELECTIONSISSUER10114.0000000WITHHOLD10114.000000AGAINSTS000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Election of Directors: Susan MahonyDIRECTOR ELECTIONSISSUER10114.0000000WITHHOLD10114.000000AGAINSTS000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Election of Directors: Kelvin NeuDIRECTOR ELECTIONSISSUER10114.0000000WITHHOLD10114.000000AGAINSTS000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Election of Directors: Scott PlatshonDIRECTOR ELECTIONSISSUER10114.0000000FOR10114.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Advisory Vote on the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER10114.0000000FOR10114.000000FORS000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Advisory Vote on the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER10114.0000000FOR10114.000000FOR2S000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Advisory Vote on the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER10114.0000000FOR10114.000000FOR5S000047353Zymeworks Inc.98985Y108US98985Y108212/10/2024Appointment of Auditors Ratification of the appointment of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2024AUDIT-RELATEDISSUER10114.0000000FOR10114.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Hongbo LuDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Michael S. PerryDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Christopher AnzaloneDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Mauro FerrariDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Adeoye OlukotunDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: William WaddillDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Victoria VakienerDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Election of Directors: Douglas IngramDIRECTOR ELECTIONSISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3211.0000000FOR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3211.0000000FOR3211.000000FOR2S000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3211.0000000FOR3211.000000FOR5S000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Advisory Vote on Frequency of Executive Compensation Advisory Votes.SECTION 14A SAY-ON-PAY VOTESISSUER3211.0000000ONE YEAR3211.000000FORS000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Advisory Vote on Frequency of Executive Compensation Advisory Votes.SECTION 14A SAY-ON-PAY VOTESISSUER3211.0000000ONE YEAR3211.000000FOR2S000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025Advisory Vote on Frequency of Executive Compensation Advisory Votes.SECTION 14A SAY-ON-PAY VOTESISSUER3211.0000000ONE YEAR3211.000000FOR5S000047353Arrowhead Pharmaceuticals, Inc.04280A100US04280A100703/12/2025To ratify the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER3211.0000000FOR3211.000000FORS000047353Scilex Holding Company03/19/2025Proposal to approve any amendment to the Company's Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock, $0.0001 par value per share (the "Common Stock"), within a range of 1-for-14 to 1-for-50 (or any number in between), without reducing the authorized number of shares of the Common Stock, and the filing of a final amendment with the ratio within such range to be determined in the sole discretion of the Board of Directors of the Company (the "Board") at any time on or before March 19, 2026, without further approval or authorization of our stockholders (the "Reverse Stock Split Proposal").CAPITAL STRUCTUREISSUER17635.0000000FOR17635.000000FORS000047353Scilex Holding Company03/19/2025Proposal to consider and vote upon an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal.CORPORATE GOVERNANCEISSUER17635.0000000FOR17635.000000FORS000047353Scilex Holding Company80880W205US80880W205203/19/2025Proposal to approve any amendment to the Company's Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock, $0.0001 par value per share (the "Common Stock"), within a range of 1-for-14 to 1-for-50 (or any number in between), without reducing the authorized number of shares of the Common Stock, and the filing of a final amendment with the ratio within such range to be determined in the sole discretion of the Board of Directors of the Company (the "Board") at any time on or before March 19, 2026, without further approval or authorization of our stockholders (the "Reverse Stock Split Proposal").CAPITAL STRUCTUREISSUER320.0000000FOR320.000000FORS000047353Scilex Holding Company80880W205US80880W205203/19/2025Proposal to consider and vote upon an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal.CORPORATE GOVERNANCEISSUER320.0000000FOR320.000000FORS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director Yu-Hsin LinDIRECTOR ELECTIONSISSUER1285.0000000AGAINST1285.000000AGAINSTS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director Hao-Yuan ChuangDIRECTOR ELECTIONSISSUER1285.0000000AGAINST1285.000000AGAINSTS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director Wan-Shan ChenDIRECTOR ELECTIONSISSUER1285.0000000AGAINST1285.000000AGAINSTS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director John M. LongoDIRECTOR ELECTIONSISSUER1285.0000000FOR1285.000000FORS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director Ita LuDIRECTOR ELECTIONSISSUER1285.0000000FOR1285.000000FORS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director Gary C. BiddleDIRECTOR ELECTIONSISSUER1285.0000000FOR1285.000000FORS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Approve Removal of Hung-Wei Chen as DirectorDIRECTOR ELECTIONSAUDIT-RELATEDCORPORATE GOVERNANCEISSUER1285.0000000AGAINST1285.000000AGAINSTS000047353Belite Bio, Inc.07782B104US07782B104404/15/2025Elect Director Xiao-Hui ChenDIRECTOR ELECTIONSISSUER1285.0000000AGAINST1285.000000AGAINSTS000047353Biohaven Ltd.G1110E107VGG1110E107905/05/2025Election of Directors for a term expiring at the 2028 Annual Meeting of shareholders: Vlad Coric, M.D.DIRECTOR ELECTIONSISSUER1513.0000000AGAINST1513.000000AGAINSTS000047353Biohaven Ltd.G1110E107VGG1110E107905/05/2025Election of Directors for a term expiring at the 2028 Annual Meeting of shareholders: Kishan MehtaDIRECTOR ELECTIONSISSUER1513.0000000AGAINST1513.000000AGAINSTS000047353Biohaven Ltd.G1110E107VGG1110E107905/05/2025Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2025.AUDIT-RELATEDISSUER1513.0000000FOR1513.000000FORS000047353Biohaven Ltd.G1110E107VGG1110E107905/05/2025A non-binding advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1513.0000000FOR1513.000000FORS000047353Biohaven Ltd.G1110E107VGG1110E107905/05/2025A non-binding advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1513.0000000FOR1513.000000FOR2S000047353Biohaven Ltd.G1110E107VGG1110E107905/05/2025A non-binding advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1513.0000000FOR1513.000000FOR5S000047353ACELYRIN, Inc.00445A100US00445A100705/13/2025To adopt the Agreement and Plan of Merger, dated February 6, 2025, among Alumis Inc., Arrow Merger Sub, Inc. and ACELYRIN, Inc., as may be amended from time to time. We refer to this proposal as the "ACELYRIN merger proposal."EXTRAORDINARY TRANSACTIONSISSUER25918.0000000FOR25918.000000FORS000047353ACELYRIN, Inc.00445A100US00445A100705/13/2025To approve the adjournment from time to time of the ACELYRIN virtual special meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the ACELYRIN merger proposal. We refer to this proposal as the "ACELYRIN adjournment proposal."CORPORATE GOVERNANCEISSUER25918.0000000FOR25918.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: Richard E. BullerDIRECTOR ELECTIONSISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: David F. DalveyDIRECTOR ELECTIONSISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: Leo T. FurchtDIRECTOR ELECTIONSISSUER6460.0000000WITHHOLD6460.000000AGAINSTS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: Lance G. LaingDIRECTOR ELECTIONSISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: Polly A. MurphyDIRECTOR ELECTIONSISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: Richard J. NigonDIRECTOR ELECTIONSISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025Elect seven directors: Brian F. SullivanDIRECTOR ELECTIONSISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the fiscal year December 31, 2025.AUDIT-RELATEDISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025To approve, by a non-binding and advisory vote, compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6460.0000000FOR6460.000000FORS000047353Celcuity Inc.15102K100US15102K100705/13/2025To approve, by a non-binding and advisory vote, compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6460.0000000FOR6460.000000FOR2S000047353Celcuity Inc.15102K100US15102K100705/13/2025To approve, by a non-binding and advisory vote, compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6460.0000000FOR6460.000000FOR5S000047353Celcuity Inc.15102K100US15102K100705/13/2025To approve an amendment to the Company's Amended and Restated 2017 Stock Incentive Plan increasing the number of shares available for issuance under the plan by 3,000,000.COMPENSATIONISSUER6460.0000000AGAINST6460.000000AGAINSTS000047353Larimar Therapeutics, Inc.517125100US517125100305/13/2025Election of Class II Director for a Three-Year Term Expiring in 2028: Thomas E. HamiltonDIRECTOR ELECTIONSISSUER26869.0000000WITHHOLD26869.000000AGAINSTS000047353Larimar Therapeutics, Inc.517125100US517125100305/13/2025Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2024SECTION 14A SAY-ON-PAY VOTESISSUER26869.0000000FOR26869.000000FORS000047353Larimar Therapeutics, Inc.517125100US517125100305/13/2025Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2024SECTION 14A SAY-ON-PAY VOTESISSUER26869.0000000FOR26869.000000FOR2S000047353Larimar Therapeutics, Inc.517125100US517125100305/13/2025Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers in 2024SECTION 14A SAY-ON-PAY VOTESISSUER26869.0000000FOR26869.000000FOR5S000047353Larimar Therapeutics, Inc.517125100US517125100305/13/2025Ratification of Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for the 2025 Fiscal YearAUDIT-RELATEDISSUER26869.0000000FOR26869.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the annual report and accounts for the year ended December 31, 2024, together with the directors' report and independent auditor's report thereon, be received and adopted.CORPORATE GOVERNANCEISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That PricewaterhouseCoopers LLP ("PwC") be re-appointed as auditors to hold office from the conclusion of the annual general meeting until the conclusion of the next annual general meeting at which the Company's annual report and accounts are presented.AUDIT-RELATEDISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the Audit and Risk Committee be authorized to determine PwC's remuneration.AUDIT-RELATEDISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the directors' remuneration report (excluding the directors' remuneration policy), as set out in the Company's annual report and accounts for the year ended December 31, 2024, be approved.COMPENSATIONISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER27369.0000000FOR27369.000000FOR2S000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER27369.0000000FOR27369.000000FOR5S000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER27369.0000000ONE YEAR27369.000000AGAINSTS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER27369.0000000ONE YEAR27369.000000AGAINST2S000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.SECTION 14A SAY-ON-PAY VOTESISSUER27369.0000000ONE YEAR27369.000000AGAINST5S000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That Dr. Deepika Pakianathan be re-appointed as a director of the Company.DIRECTOR ELECTIONSISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That Dr. Pierre Jacquet be re-appointed as a director of the Company.DIRECTOR ELECTIONSISSUER27369.0000000FOR27369.000000FORS000047353Mereo BioPharma Group Plc589492107US589492107205/13/2025That Michael Wyzga be re-appointed as a director of the Company.DIRECTOR ELECTIONSISSUER27369.0000000AGAINST27369.000000AGAINSTS000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To elect, by separate resolution, three directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2028, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Paula K. CobbDIRECTOR ELECTIONSISSUER4401.0000000FOR4401.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To elect, by separate resolution, three directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2028, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Lars G. EkmanDIRECTOR ELECTIONSISSUER4401.0000000FOR4401.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To elect, by separate resolution, three directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2028, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Gene G. KinneyDIRECTOR ELECTIONSISSUER4401.0000000FOR4401.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To ratify, on a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2025, and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve remuneration of that auditor.AUDIT-RELATEDISSUER4401.0000000FOR4401.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER4401.0000000FOR4401.000000FORS000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER4401.0000000FOR4401.000000FOR2S000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER4401.0000000FOR4401.000000FOR5S000047353Prothena Corporation plcG72800108IE00B91XRN2005/13/2025To approve an amendment to the Company's 2018 Long Term Incentive Plan to increase the number of ordinary shares available for issuance under that Plan by 2,000,000 ordinary shares.COMPENSATIONISSUER4401.0000000AGAINST4401.000000AGAINSTS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: John T. HendersonDIRECTOR ELECTIONSISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: B. Lynne ParshallDIRECTOR ELECTIONSISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: Muna BhanjiDIRECTOR ELECTIONSISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To approve the amendment and restatement of the Cytokinetics Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under such plan by 5,000,000 shares of common stock and (ii) provide for limitations on the maximum grant value that non-executive directors may receive under such plan of $1,000,000 for annual grants to continuing directors and $1,250,000 for the initial grant to new directors.COMPENSATIONISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To approve an amendment to Cytokinetics, Incorporated's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common available for issuance by Cytokinetics, Incorporated from 163,000,000 to 326,000,000 shares of common stock.CAPITAL STRUCTUREISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Cytokinetics, Incorporated's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3064.0000000FOR3064.000000FORS000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3064.0000000FOR3064.000000FOR2S000047353Cytokinetics, Incorporated23282W605US23282W605705/14/2025To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3064.0000000FOR3064.000000FOR5S000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025Election of Directors: Keith A. KatkinDIRECTOR ELECTIONSISSUER6048.0000000WITHHOLD6048.000000AGAINSTS000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025Election of Directors: Dennis G. PodlesakDIRECTOR ELECTIONSISSUER6048.0000000WITHHOLD6048.000000AGAINSTS000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025Election of Directors: Aleksandra Rizo, M.D., Ph.D.DIRECTOR ELECTIONSISSUER6048.0000000FOR6048.000000FORS000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER6048.0000000FOR6048.000000FORS000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER6048.0000000FOR6048.000000FOR2S000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER6048.0000000FOR6048.000000FOR5S000047353Syndax Pharmaceuticals, Inc.87164F105US87164F105705/14/2025To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER6048.0000000FOR6048.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Marshall Fordyce, M.D.DIRECTOR ELECTIONSISSUER1805.0000000WITHHOLD1805.000000AGAINSTS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Beth Seidenberg, M.D.DIRECTOR ELECTIONSISSUER1805.0000000WITHHOLD1805.000000AGAINSTS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To elect the three Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Kimball HallDIRECTOR ELECTIONSISSUER1805.0000000WITHHOLD1805.000000AGAINSTS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1805.0000000FOR1805.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1805.0000000FOR1805.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1805.0000000FOR1805.000000FOR2S000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1805.0000000FOR1805.000000FOR5S000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1805.0000000ONE YEAR1805.000000FORS000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1805.0000000ONE YEAR1805.000000FOR2S000047353Vera Therapeutics, Inc.92337R101US92337R101405/14/2025To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1805.0000000ONE YEAR1805.000000FOR5S000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025Election of Directors: Judith A. ReinsdorfDIRECTOR ELECTIONSISSUER4528.0000002955.000000WITHHOLD4528.000000AGAINSTS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025Election of Directors: Edward C. SaltzmanDIRECTOR ELECTIONSISSUER4528.0000002955.000000FOR4528.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025Election of Directors: Roy D. BaynesDIRECTOR ELECTIONSISSUER4528.0000002955.000000FOR4528.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2025.AUDIT-RELATEDISSUER4528.0000002955.000000FOR4528.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4528.0000002955.000000FOR4528.000000FORS000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4528.0000002955.000000FOR4528.000000FOR2S000047353Nurix Therapeutics, Inc.67080M103US67080M103605/19/2025To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4528.0000002955.000000FOR4528.000000FOR5S000047353Viking Therapeutics, Inc.92686J106US92686J106005/20/2025ELECTION OF DIRECTOR NOMINEES FOR CLASS I (term to expire in 2028): Matthew W. FoehrDIRECTOR ELECTIONSISSUER1.0000003429.000000WITHHOLD1.000000AGAINSTS000047353Viking Therapeutics, Inc.92686J106US92686J106005/20/2025ELECTION OF DIRECTOR NOMINEES FOR CLASS I (term to expire in 2028): Charles A. Rowland, Jr.DIRECTOR ELECTIONSISSUER1.0000003429.000000WITHHOLD1.000000AGAINSTS000047353Viking Therapeutics, Inc.92686J106US92686J106005/20/2025RATIFICATION OF THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.AUDIT-RELATEDISSUER1.0000003429.000000FOR1.000000FORS000047353Viking Therapeutics, Inc.92686J106US92686J106005/20/2025TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000003429.000000AGAINST1.000000AGAINSTS000047353Viking Therapeutics, Inc.92686J106US92686J106005/20/2025TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000003429.000000AGAINST1.000000AGAINST2S000047353Viking Therapeutics, Inc.92686J106US92686J106005/20/2025TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000003429.000000AGAINST1.000000AGAINST5S000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Lindsay Androski, JD, MBA, CFADIRECTOR ELECTIONSISSUER43209.0000000FOR43209.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Robert Alan BeardsleyDIRECTOR ELECTIONSISSUER43209.0000000FOR43209.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Joseph BishopDIRECTOR ELECTIONSISSUER43209.0000000FOR43209.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew GlineDIRECTOR ELECTIONSISSUER43209.0000000FOR43209.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Anuj HasijaDIRECTOR ELECTIONSISSUER43209.0000000FOR43209.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; andSECTION 14A SAY-ON-PAY VOTESISSUER43209.0000000FOR43209.000000FORS000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; andSECTION 14A SAY-ON-PAY VOTESISSUER43209.0000000FOR43209.000000FOR2S000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; andSECTION 14A SAY-ON-PAY VOTESISSUER43209.0000000FOR43209.000000FOR5S000047353Arbutus Biopharma Corporation03879J100CA03879J100305/21/2025To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER43209.0000000FOR43209.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Adoption of Merus N.V.'s Dutch statutory annual accounts for the financial year 2024.CORPORATE GOVERNANCEISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2025 for purposes of Dutch law.AUDIT-RELATEDISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2024.CORPORATE GOVERNANCEISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors.CORPORATE GOVERNANCEISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Re-appointment of Anand Mehra, M.D. as non-executive director.DIRECTOR ELECTIONSISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors.CORPORATE GOVERNANCEISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Re-appointment of Maxine Gowen, Ph.D. as non-executive director.DIRECTOR ELECTIONSISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Granting authorization to Merus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital.CAPITAL STRUCTUREISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3469.0000000FOR3469.000000FORS000047353Merus N.V.N5749R100NL001160626405/21/2025Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3469.0000000FOR3469.000000FOR2S000047353Merus N.V.N5749R100NL001160626405/21/2025Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3469.0000000FOR3469.000000FOR5S000047353Nuvation Bio Inc.67080N101US67080N101905/21/2025Election of Director: Kathryn E. FalbergDIRECTOR ELECTIONSISSUER62421.0000000WITHHOLD62421.000000AGAINSTS000047353Nuvation Bio Inc.67080N101US67080N101905/21/2025Ratification of the appointment of KPMG LLP as the independent registered public accounting firm.AUDIT-RELATEDISSUER62421.0000000FOR62421.000000FORS000047353Nuvation Bio Inc.67080N101US67080N101905/21/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER62421.0000000FOR62421.000000FORS000047353Nuvation Bio Inc.67080N101US67080N101905/21/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER62421.0000000FOR62421.000000FOR2S000047353Nuvation Bio Inc.67080N101US67080N101905/21/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER62421.0000000FOR62421.000000FOR5S000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: Frank LitvackDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: Linda MarbanDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: David MusketDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: George DunbarDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: Karimah Es SabarDIRECTOR ELECTIONSISSUER11448.0000000WITHHOLD11448.000000AGAINSTS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: Paul AuwaerterDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: Philip GotwalsDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025ELECTION OF DIRECTORS: Michael KelliherDIRECTOR ELECTIONSISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025RATIFICATION OF THE SELECTION OF ROSE, SNYDER & JACOBS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.AUDIT-RELATEDISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025APPROVAL OF THE CAPRICOR THERAPEUTICS 2025 EQUITY INCENTIVE PLAN.COMPENSATIONISSUER11448.0000000AGAINST11448.000000AGAINSTS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER11448.0000000FOR11448.000000FORS000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER11448.0000000FOR11448.000000FOR2S000047353Capricor Therapeutics, Inc.14070B309US14070B309605/22/2025APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASISSECTION 14A SAY-ON-PAY VOTESISSUER11448.0000000FOR11448.000000FOR5S000047353Dianthus Therapeutics, Inc.252828108US252828108005/22/2025To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Marino GarciaDIRECTOR ELECTIONSISSUER2186.0000004800.000000WITHHOLD2186.000000AGAINSTS000047353Dianthus Therapeutics, Inc.252828108US252828108005/22/2025To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Paula SoteropoulosDIRECTOR ELECTIONSISSUER2186.0000004800.000000WITHHOLD2186.000000AGAINSTS000047353Dianthus Therapeutics, Inc.252828108US252828108005/22/2025To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER2186.0000004800.000000AGAINST2186.000000AGAINSTS000047353Dianthus Therapeutics, Inc.252828108US252828108005/22/2025To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER2186.0000004800.000000AGAINST2186.000000AGAINST2S000047353Dianthus Therapeutics, Inc.252828108US252828108005/22/2025To approve, on an advisory basis, the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER2186.0000004800.000000AGAINST2186.000000AGAINST5S000047353Dianthus Therapeutics, Inc.252828108US252828108005/22/2025To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2186.0000004800.000000FOR2186.000000FORS000047353Mineralys Therapeutics, Inc.603170101US603170101305/22/2025Election of Class II directors for a three-year term to expire at the 2028 annual meeting of stockholders: Glenn P. SblendorioDIRECTOR ELECTIONSISSUER13494.0000000WITHHOLD13494.000000AGAINSTS000047353Mineralys Therapeutics, Inc.603170101US603170101305/22/2025Election of Class II directors for a three-year term to expire at the 2028 annual meeting of stockholders: Derek DiRocco, Ph.D.DIRECTOR ELECTIONSISSUER13494.0000000WITHHOLD13494.000000AGAINSTS000047353Mineralys Therapeutics, Inc.603170101US603170101305/22/2025Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER13494.0000000FOR13494.000000FORS000047353SCHOLAR ROCK HOLDING CORPORATION80706P103US80706P103005/22/2025To elect three Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: Srinivas Akkaraju, M.D., Ph.D.DIRECTOR ELECTIONSISSUER3939.0000000WITHHOLD3939.000000AGAINSTS000047353SCHOLAR ROCK HOLDING CORPORATION80706P103US80706P103005/22/2025To elect three Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: Joshua ReedDIRECTOR ELECTIONSISSUER3939.0000000WITHHOLD3939.000000AGAINSTS000047353SCHOLAR ROCK HOLDING CORPORATION80706P103US80706P103005/22/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3939.0000000FOR3939.000000FORS000047353SCHOLAR ROCK HOLDING CORPORATION80706P103US80706P103005/22/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3939.0000000FOR3939.000000FOR2S000047353SCHOLAR ROCK HOLDING CORPORATION80706P103US80706P103005/22/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3939.0000000FOR3939.000000FOR5S00004735389bio, Inc.282559103US282559103305/28/2025Election of Directors: To be elected for terms expiring in 2028: Martin BablerDIRECTOR ELECTIONSISSUER11686.0000000FOR11686.000000FORS00004735389bio, Inc.282559103US282559103305/28/2025Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D.DIRECTOR ELECTIONSISSUER11686.0000000WITHHOLD11686.000000AGAINSTS00004735389bio, Inc.282559103US282559103305/28/2025Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A.DIRECTOR ELECTIONSISSUER11686.0000000FOR11686.000000FORS00004735389bio, Inc.282559103US282559103305/28/2025Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER11686.0000000FOR11686.000000FORS00004735389bio, Inc.282559103US282559103305/28/2025Approval of, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER11686.0000000FOR11686.000000FORS00004735389bio, Inc.282559103US282559103305/28/2025Approval of, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER11686.0000000FOR11686.000000FOR2S00004735389bio, Inc.282559103US282559103305/28/2025Approval of, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER11686.0000000FOR11686.000000FOR5S000047353Arcellx, Inc.03940C100US03940C100905/28/2025To elect three Class III directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Rami ElghandourDIRECTOR ELECTIONSISSUER170.0000001054.000000FOR170.000000FORS000047353Arcellx, Inc.03940C100US03940C100905/28/2025To elect three Class III directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: David LubnerDIRECTOR ELECTIONSISSUER170.0000001054.000000FOR170.000000FORS000047353Arcellx, Inc.03940C100US03940C100905/28/2025To elect three Class III directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Kristin MyersDIRECTOR ELECTIONSISSUER170.0000001054.000000FOR170.000000FORS000047353Arcellx, Inc.03940C100US03940C100905/28/2025To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER170.0000001054.000000FOR170.000000FORS000047353Arcellx, Inc.03940C100US03940C100905/28/2025To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER170.0000001054.000000FOR170.000000FOR2S000047353Arcellx, Inc.03940C100US03940C100905/28/2025To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER170.0000001054.000000FOR170.000000FOR5S000047353Arcellx, Inc.03940C100US03940C100905/28/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER170.0000001054.000000FOR170.000000FORS000047353Neumora Therapeutics, Inc.640979100US640979100005/28/2025To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Alaa HalawaDIRECTOR ELECTIONSISSUER15518.0000000WITHHOLD15518.000000AGAINSTS000047353Neumora Therapeutics, Inc.640979100US640979100005/28/2025To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Maykin Ho, Ph.D.DIRECTOR ELECTIONSISSUER15518.0000000WITHHOLD15518.000000AGAINSTS000047353Neumora Therapeutics, Inc.640979100US640979100005/28/2025To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2025.AUDIT-RELATEDISSUER15518.0000000FOR15518.000000FORS000047353Neumora Therapeutics, Inc.640979100US640979100005/28/2025To approve the repricing of certain stock options outstanding under the 2023 Incentive Award Plan and the 2020 Equity Incentive Plan.COMPENSATIONISSUER15518.0000000AGAINST15518.000000AGAINSTS000047353Neumora Therapeutics, Inc.640979100US640979100005/28/2025To approve amendments to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-5 and 1-for-30, as determined by the Company's Board of Directors in its discretion.CAPITAL STRUCTUREISSUER15518.0000000FOR15518.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Lori A. WoodsDIRECTOR ELECTIONSISSUER26440.0000000FOR26440.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Heidi HensonDIRECTOR ELECTIONSISSUER26440.0000000FOR26440.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Robert Froman Williamson, IIIDIRECTOR ELECTIONSISSUER26440.0000000FOR26440.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Frank Morich, M.D., Ph.D.DIRECTOR ELECTIONSISSUER26440.0000000FOR26440.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to elect five directors named in the Proxy Statement, each to hold office until the Company's 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified: Johan (Thijs) SpoorDIRECTOR ELECTIONSISSUER26440.0000000FOR26440.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER26440.0000000FOR26440.000000FORS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000AGAINST26440.000000AGAINSTS000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000AGAINST26440.000000AGAINST2S000047353Perspective Therapeutics, Inc.46489V302US46489V302405/28/2025To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER26440.0000000AGAINST26440.000000AGAINST5S000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025Election of Class III Directors for terms expiring in 2028: Peter HarwinDIRECTOR ELECTIONSISSUER4270.0000000WITHHOLD4270.000000AGAINSTS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025Election of Class III Directors for terms expiring in 2028: Michael Henderson, M.D.DIRECTOR ELECTIONSISSUER4270.0000000FOR4270.000000FORS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025Election of Class III Directors for terms expiring in 2028: Sandra Milligan, M.D., J.D.DIRECTOR ELECTIONSISSUER4270.0000000WITHHOLD4270.000000AGAINSTS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4270.0000000FOR4270.000000FORS000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4270.0000000FOR4270.000000FOR2S000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4270.0000000FOR4270.000000FOR5S000047353Spyre Therapeutics, Inc.00773J202US00773J202405/29/2025To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER4270.0000000FOR4270.000000FORS000047353Tyra Biosciences, Inc.90240B106US90240B106105/29/2025To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Todd Harris, Ph.D.DIRECTOR ELECTIONSISSUER683.0000006043.000000WITHHOLD683.000000AGAINSTS000047353Tyra Biosciences, Inc.90240B106US90240B106105/29/2025To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Adele M. GulfoDIRECTOR ELECTIONSISSUER683.0000006043.000000FOR683.000000FORS000047353Tyra Biosciences, Inc.90240B106US90240B106105/29/2025To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: S. Michael Rothenberg, M.D., Ph.D.DIRECTOR ELECTIONSISSUER683.0000006043.000000WITHHOLD683.000000AGAINSTS000047353Tyra Biosciences, Inc.90240B106US90240B106105/29/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER683.0000006043.000000FOR683.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/29/2025To elect the following two nominees for director to hold office until the 2028 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Jeffrey S. HatfieldDIRECTOR ELECTIONSISSUER12349.0000000WITHHOLD12349.000000AGAINSTS000047353Vir Biotechnology, Inc.92764N102US92764N102805/29/2025To elect the following two nominees for director to hold office until the 2028 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Saira RamasastryDIRECTOR ELECTIONSISSUER12349.0000000FOR12349.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12349.0000000FOR12349.000000FORS000047353Vir Biotechnology, Inc.92764N102US92764N102805/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12349.0000000FOR12349.000000FOR2S000047353Vir Biotechnology, Inc.92764N102US92764N102805/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER12349.0000000FOR12349.000000FOR5S000047353Vir Biotechnology, Inc.92764N102US92764N102805/29/2025To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER12349.0000000FOR12349.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To elect two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Edward HurwitzDIRECTOR ELECTIONSISSUER3989.0000000WITHHOLD3989.000000AGAINSTS000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To elect two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Dirk KerstenDIRECTOR ELECTIONSISSUER3989.0000000WITHHOLD3989.000000AGAINSTS000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3989.0000000FOR3989.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3989.0000000FOR3989.000000FOR2S000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3989.0000000FOR3989.000000FOR5S000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3989.0000000ONE YEAR3989.000000FORS000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3989.0000000ONE YEAR3989.000000FOR2S000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3989.0000000ONE YEAR3989.000000FOR5S000047353Dyne Therapeutics, Inc.26818M108US26818M108005/30/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3989.0000000FOR3989.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Election of Four Class I Directors: Allan M. FoxDIRECTOR ELECTIONSISSUER10528.0000000WITHHOLD10528.000000AGAINSTS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Election of Four Class I Directors: Alexandra Glucksmann, Ph.D.DIRECTOR ELECTIONSISSUER10528.0000000WITHHOLD10528.000000AGAINSTS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Election of Four Class I Directors: Curran SimpsonDIRECTOR ELECTIONSISSUER10528.0000000FOR10528.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Election of Four Class I Directors: Jennifer ZacharyDIRECTOR ELECTIONSISSUER10528.0000000WITHHOLD10528.000000AGAINSTS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER10528.0000000FOR10528.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Advisory vote on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10528.0000000FOR10528.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Advisory vote on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10528.0000000FOR10528.000000FOR2S000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Advisory vote on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10528.0000000FOR10528.000000FOR5S000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10528.0000000ONE YEAR10528.000000FORS000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10528.0000000ONE YEAR10528.000000FOR2S000047353REGENXBIO Inc.75901B107US75901B107005/30/2025Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10528.0000000ONE YEAR10528.000000FOR5S000047353REGENXBIO Inc.75901B107US75901B107005/30/2025To approve the REGENXBIO Inc. 2025 Equity Incentive Plan.COMPENSATIONISSUER10528.0000000AGAINST10528.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/02/2025To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Phillip B. Donenberg, CPADIRECTOR ELECTIONSISSUER5730.00000035048.000000WITHHOLD5730.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/02/2025To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Sukumar Nagendran, MDDIRECTOR ELECTIONSISSUER5730.00000035048.000000WITHHOLD5730.000000AGAINSTS000047353Taysha Gene Therapies, Inc.877619106US877619106106/02/2025To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025.AUDIT-RELATEDISSUER5730.00000035048.000000FOR5730.000000FORS000047353Taysha Gene Therapies, Inc.877619106US877619106106/02/2025To approve a proposed amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of common stock from 400,000,000 to 700,000,000 shares.CAPITAL STRUCTUREISSUER5730.00000035048.000000FOR5730.000000FORS000047353Akero Therapeutics, Inc.00973Y108US00973Y108206/03/2025To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Judy Chou, Ph.D.DIRECTOR ELECTIONSISSUER4234.0000000WITHHOLD4234.000000AGAINSTS000047353Akero Therapeutics, Inc.00973Y108US00973Y108206/03/2025To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Tomas HeymanDIRECTOR ELECTIONSISSUER4234.0000000WITHHOLD4234.000000AGAINSTS000047353Akero Therapeutics, Inc.00973Y108US00973Y108206/03/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER4234.0000000FOR4234.000000FORS000047353Akero Therapeutics, Inc.00973Y108US00973Y108206/03/2025To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4234.0000000FOR4234.000000FORS000047353Akero Therapeutics, Inc.00973Y108US00973Y108206/03/2025To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4234.0000000FOR4234.000000FOR2S000047353Akero Therapeutics, Inc.00973Y108US00973Y108206/03/2025To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4234.0000000FOR4234.000000FOR5S000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025ELECTION OF DIRECTORS: Julian BakerDIRECTOR ELECTIONSISSUER4794.0000000FOR4794.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025ELECTION OF DIRECTORS: Peter KleinDIRECTOR ELECTIONSISSUER4794.0000000FOR4794.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025ELECTION OF DIRECTORS: Steve KrognesDIRECTOR ELECTIONSISSUER4794.0000000WITHHOLD4794.000000AGAINSTS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025AUDIT-RELATEDISSUER4794.0000000FOR4794.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025Advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER4794.0000000FOR4794.000000FORS000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025Advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER4794.0000000FOR4794.000000FOR2S000047353Denali Therapeutics Inc.24823R105US24823R105906/03/2025Advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER4794.0000000FOR4794.000000FOR5S000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Edward M. Kaye, M.D.DIRECTOR ELECTIONSISSUER8290.0000000WITHHOLD8290.000000AGAINSTS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Seth L. Harrison, M.D.DIRECTOR ELECTIONSISSUER8290.0000000WITHHOLD8290.000000AGAINSTS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Arthur O. Tzianabos, Ph.D.DIRECTOR ELECTIONSISSUER8290.0000000WITHHOLD8290.000000AGAINSTS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8290.0000000FOR8290.000000FORS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8290.0000000FOR8290.000000FORS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8290.0000000FOR8290.000000FOR2S000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8290.0000000FOR8290.000000FOR5S000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8290.0000000ONE YEAR8290.000000FORS000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8290.0000000ONE YEAR8290.000000FOR2S000047353Stoke Therapeutics, Inc.86150R107US86150R107706/03/2025To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8290.0000000ONE YEAR8290.000000FOR5S000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Election of the following nominees as Class II directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Mark Fishman, M.D.DIRECTOR ELECTIONSISSUER3642.0000000AGAINST3642.000000AGAINSTS000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Election of the following nominees as Class II directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Carole Ho, M.D.DIRECTOR ELECTIONSISSUER3642.0000000FOR3642.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Election of the following nominees as Class II directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Kathleen WalshDIRECTOR ELECTIONSISSUER3642.0000000FOR3642.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3642.0000000FOR3642.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3642.0000000FOR3642.000000FORS000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3642.0000000FOR3642.000000FOR2S000047353Beam Therapeutics Inc.07373V105US07373V105206/04/2025Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3642.0000000FOR3642.000000FOR5S000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Karen FerranteDIRECTOR ELECTIONSISSUER14737.0000000WITHHOLD14737.000000AGAINSTS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Matthew E. RosDIRECTOR ELECTIONSISSUER14737.0000000WITHHOLD14737.000000AGAINSTS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER14737.0000000FOR14737.000000FORS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER14737.0000000FOR14737.000000FORS000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER14737.0000000FOR14737.000000FOR2S000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER14737.0000000FOR14737.000000FOR5S000047353Cogent Biosciences, Inc.19240Q201US19240Q201206/04/2025Approval of an amendment of the Company's Certificate of Incorporation to provide for officer exculpation.CORPORATE GOVERNANCEISSUER14737.0000000FOR14737.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To elect the three (3) nominees for Class II director named below to hold office until the 2028 Annual Meeting of Stockholders: Mary Ann Gray, Ph.D.DIRECTOR ELECTIONSISSUER5542.0000000WITHHOLD5542.000000AGAINSTS000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To elect the three (3) nominees for Class II director named below to hold office until the 2028 Annual Meeting of Stockholders: Ran NussbaumDIRECTOR ELECTIONSISSUER5542.0000000WITHHOLD5542.000000AGAINSTS000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To elect the three (3) nominees for Class II director named below to hold office until the 2028 Annual Meeting of Stockholders: Alpna Seth, Ph.D.DIRECTOR ELECTIONSISSUER5542.0000000WITHHOLD5542.000000AGAINSTS000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER5542.0000000FOR5542.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5542.0000000FOR5542.000000FORS000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5542.0000000FOR5542.000000FOR2S000047353Keros Therapeutics, Inc.492327101US492327101306/04/2025To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5542.0000000FOR5542.000000FOR5S000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2024.CORPORATE GOVERNANCEISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2024.CORPORATE GOVERNANCEISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025 by the audit committee of the Company's Board of Directors.AUDIT-RELATEDISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Appointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Wouter JoustraDIRECTOR ELECTIONSISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Appointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Mark McKennaDIRECTOR ELECTIONSISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Appointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Adele GulfoDIRECTOR ELECTIONSISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Reappointment of Michael Davidson M.D. as executive director and Dr. James N. Topper as non-executive director of the Company until the 2029 annual general meeting: Michael DavidsonDIRECTOR ELECTIONSISSUER6140.0000000AGAINST6140.000000AGAINSTS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Reappointment of Michael Davidson M.D. as executive director and Dr. James N. Topper as non-executive director of the Company until the 2029 annual general meeting: James N. TopperDIRECTOR ELECTIONSISSUER6140.0000000AGAINST6140.000000AGAINSTS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Extension of authorization for the Board of Directors to acquire ordinary shares and depository receipts for ordinary shares in the Company's capital.CAPITAL STRUCTUREISSUER6140.0000000AGAINST6140.000000AGAINSTS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Non-binding, advisory vote to approve the 2024 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6140.0000000FOR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Non-binding, advisory vote to approve the 2024 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6140.0000000FOR6140.000000FOR2S000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Non-binding, advisory vote to approve the 2024 compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6140.0000000FOR6140.000000FOR5S000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6140.0000000ONE YEAR6140.000000FORS000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6140.0000000ONE YEAR6140.000000FOR2S000047353NewAmsterdam Pharma Company N.V.N62509109NL00150012L706/04/2025Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6140.0000000ONE YEAR6140.000000FOR5S000047353Prime Medicine, Inc.74168J101US74168J101606/04/2025To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Thomas Cahill, M.D., Ph.D.DIRECTOR ELECTIONSISSUER13123.00000020797.000000WITHHOLD13123.000000AGAINSTS000047353Prime Medicine, Inc.74168J101US74168J101606/04/2025To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Robert NelsenDIRECTOR ELECTIONSISSUER13123.00000020797.000000WITHHOLD13123.000000AGAINSTS000047353Prime Medicine, Inc.74168J101US74168J101606/04/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER13123.00000020797.000000FOR13123.000000FORS000047353Tourmaline Bio, Inc.89157D105US89157D105406/04/2025To elect two Class I directors, each to serve until the 2028 Annual Meeting of Stockholders: Dr. Caley CasteleinDIRECTOR ELECTIONSISSUER5458.0000000WITHHOLD5458.000000AGAINSTS000047353Tourmaline Bio, Inc.89157D105US89157D105406/04/2025To elect two Class I directors, each to serve until the 2028 Annual Meeting of Stockholders: Aaron KantoffDIRECTOR ELECTIONSISSUER5458.0000000WITHHOLD5458.000000AGAINSTS000047353Tourmaline Bio, Inc.89157D105US89157D105406/04/2025To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as Tourmaline's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER5458.0000000FOR5458.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn SvoronosDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian CannonDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven GannonDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth GarofaloDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin GoverDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick MachadoDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian MortimerDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary PatouDIRECTOR ELECTIONSISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2589.0000000FOR2589.000000FOR2S000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2589.0000000FOR2589.000000FOR5S000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To appoint PricewaterhouseCoopers LLP ("PwC") as the Corporation's auditor to hold office until the next annual meeting of the Corporation;AUDIT-RELATEDISSUER2589.0000000FOR2589.000000FORS000047353Xenon Pharmaceuticals Inc.98420N105CA98420N105006/04/2025To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation;AUDIT-RELATEDISSUER2589.0000000FOR2589.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To elect three Class I directors to our board of directors to serve until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: BJ BormannDIRECTOR ELECTIONSISSUER36133.0000000WITHHOLD36133.000000AGAINSTS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To elect three Class I directors to our board of directors to serve until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: James BradyDIRECTOR ELECTIONSISSUER36133.0000000FOR36133.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To elect three Class I directors to our board of directors to serve until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Garheng KongDIRECTOR ELECTIONSISSUER36133.0000000FOR36133.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER36133.0000000FOR36133.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER36133.0000000FOR36133.000000FORS000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER36133.0000000FOR36133.000000FOR2S000047353Xeris Biopharma Holdings, Inc.98422E103US98422E103806/04/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER36133.0000000FOR36133.000000FOR5S000047353Annexon, Inc.03589W102US03589W102706/05/2025To elect the two nominees for director to serve as Class II directors to hold office until the 2028 annual meeting of stockholders: Jung E. ChoiDIRECTOR ELECTIONSISSUER22642.0000000FOR22642.000000FORS000047353Annexon, Inc.03589W102US03589W102706/05/2025To elect the two nominees for director to serve as Class II directors to hold office until the 2028 annual meeting of stockholders: William D. WaddillDIRECTOR ELECTIONSISSUER22642.0000000WITHHOLD22642.000000AGAINSTS000047353Annexon, Inc.03589W102US03589W102706/05/2025To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER22642.0000000FOR22642.000000FORS000047353Annexon, Inc.03589W102US03589W102706/05/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22642.0000000FOR22642.000000FORS000047353Annexon, Inc.03589W102US03589W102706/05/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22642.0000000FOR22642.000000FOR2S000047353Annexon, Inc.03589W102US03589W102706/05/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER22642.0000000FOR22642.000000FOR5S000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Anthony S. MarucciDIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Keith L. BrownlieDIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Cheryl L. CohenDIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Herbert J. ConradDIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Rita I. Jain, M.D.DIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: James J. MarinoDIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Garry Neil, M.D.DIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Harry H. Penner, Jr.DIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025Election of Directors: Denice TorresDIRECTOR ELECTIONSISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares.COMPENSATIONISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4254.0000000FOR4254.000000FORS000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4254.0000000FOR4254.000000FOR2S000047353Celldex Therapeutics, Inc.15117B202US15117B202506/05/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER4254.0000000FOR4254.000000FOR5S000047353CG Oncology, Inc.156944100US156944100906/05/2025To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Arthur KuanDIRECTOR ELECTIONSISSUER3539.0000000FOR3539.000000FORS000047353CG Oncology, Inc.156944100US156944100906/05/2025To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James J. MuleDIRECTOR ELECTIONSISSUER3539.0000000WITHHOLD3539.000000AGAINSTS000047353CG Oncology, Inc.156944100US156944100906/05/2025To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Leonard PostDIRECTOR ELECTIONSISSUER3539.0000000WITHHOLD3539.000000AGAINSTS000047353CG Oncology, Inc.156944100US156944100906/05/2025To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3539.0000000FOR3539.000000FORS000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Election of three Class II directors for three-year terms: Helen Collins, M.D.DIRECTOR ELECTIONSISSUER10541.0000000WITHHOLD10541.000000AGAINSTS000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Election of three Class II directors for three-year terms: Thomas MalleyDIRECTOR ELECTIONSISSUER10541.0000000WITHHOLD10541.000000AGAINSTS000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Election of three Class II directors for three-year terms: Carol SchaferDIRECTOR ELECTIONSISSUER10541.0000000WITHHOLD10541.000000AGAINSTS000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER10541.0000000FOR10541.000000FORS000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10541.0000000FOR10541.000000FORS000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10541.0000000FOR10541.000000FOR2S000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER10541.0000000FOR10541.000000FOR5S000047353Kura Oncology, Inc.50127T109US50127T109706/05/2025Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan.COMPENSATIONISSUER10541.0000000AGAINST10541.000000AGAINSTS000047353MBX Biosciences, Inc.55287L101US55287L101706/05/2025Election of two Class I Directors, each to serve until the Company's 2028 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Tiba Aynechi, Ph.D.DIRECTOR ELECTIONSISSUER508.0000005488.000000WITHHOLD508.000000AGAINSTS000047353MBX Biosciences, Inc.55287L101US55287L101706/05/2025Election of two Class I Directors, each to serve until the Company's 2028 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: P. Kent HawrylukDIRECTOR ELECTIONSISSUER508.0000005488.000000WITHHOLD508.000000AGAINSTS000047353MBX Biosciences, Inc.55287L101US55287L101706/05/2025Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2025.AUDIT-RELATEDISSUER508.0000005488.000000FOR508.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Jorge Santos da SilvaDIRECTOR ELECTIONSISSUER1.0000002283.000000FOR1.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Simon SturgeDIRECTOR ELECTIONSISSUER1.0000002283.000000FOR1.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Andrew PhillipsDIRECTOR ELECTIONSISSUER1.0000002283.000000FOR1.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER1.0000002283.000000FOR1.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002283.000000FOR1.000000FORS000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002283.000000FOR1.000000FOR2S000047353MoonLake Immunotherapeutics61559X104KY61559X104506/05/2025Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000002283.000000FOR1.000000FOR5S000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To elect three class II directors named in the proxy statement to our Board of Directors: John Curnutte, M.D., Ph.D.DIRECTOR ELECTIONSISSUER8116.0000000FOR8116.000000FORS000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To elect three class II directors named in the proxy statement to our Board of Directors: Katharine Knobil, M.D.DIRECTOR ELECTIONSISSUER8116.0000000WITHHOLD8116.000000AGAINSTS000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To elect three class II directors named in the proxy statement to our Board of Directors: Thomas McCourtDIRECTOR ELECTIONSISSUER8116.0000000WITHHOLD8116.000000AGAINSTS000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8116.0000000AGAINST8116.000000AGAINSTS000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8116.0000000AGAINST8116.000000AGAINST2S000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8116.0000000AGAINST8116.000000AGAINST5S000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To approve an amendment to our Amended and Restated Certificate of Incorporation to limit the liability of certain officers of Pliant Therapeutics, Inc. as permitted by Delaware law.CORPORATE GOVERNANCEISSUER8116.0000000FOR8116.000000FORS000047353Pliant Therapeutics, Inc.729139105US729139105706/05/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8116.0000000FOR8116.000000FORS000047353Sana Biotechnology, Inc.799566104US799566104506/05/2025To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Steven D. Harr, M.D.DIRECTOR ELECTIONSISSUER8987.00000041062.000000FOR8987.000000FORS000047353Sana Biotechnology, Inc.799566104US799566104506/05/2025To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert L. RosielloDIRECTOR ELECTIONSISSUER8987.00000041062.000000FOR8987.000000FORS000047353Sana Biotechnology, Inc.799566104US799566104506/05/2025To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Michelle Seitz, CFADIRECTOR ELECTIONSISSUER8987.00000041062.000000FOR8987.000000FORS000047353Sana Biotechnology, Inc.799566104US799566104506/05/2025To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Patrick Y. Yang, Ph.D.DIRECTOR ELECTIONSISSUER8987.00000041062.000000WITHHOLD8987.000000AGAINSTS000047353Sana Biotechnology, Inc.799566104US799566104506/05/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8987.00000041062.000000FOR8987.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To elect six directors to hold office until the next Annual Meeting of Stockholders: Matthew PaulsDIRECTOR ELECTIONSISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To elect six directors to hold office until the next Annual Meeting of Stockholders: Nevan ElamDIRECTOR ELECTIONSISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To elect six directors to hold office until the next Annual Meeting of Stockholders: Richard J. HawkinsDIRECTOR ELECTIONSISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To elect six directors to hold office until the next Annual Meeting of Stockholders: Joseph S. McCrackenDIRECTOR ELECTIONSISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To elect six directors to hold office until the next Annual Meeting of Stockholders: David A. RamsayDIRECTOR ELECTIONSISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To elect six directors to hold office until the next Annual Meeting of Stockholders: An van Es-JohanssonDIRECTOR ELECTIONSISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To approve, on an advisory basis, the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER30479.0000000FOR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To approve, on an advisory basis, the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER30479.0000000FOR30479.000000FOR2S000047353Savara Inc.805111101US805111101606/05/2025To approve, on an advisory basis, the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER30479.0000000FOR30479.000000FOR5S000047353Savara Inc.805111101US805111101606/05/2025To indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER30479.0000000ONE YEAR30479.000000FORS000047353Savara Inc.805111101US805111101606/05/2025To indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER30479.0000000ONE YEAR30479.000000FOR2S000047353Savara Inc.805111101US805111101606/05/2025To indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTESISSUER30479.0000000ONE YEAR30479.000000FOR5S000047353Soleno Therapeutics, Inc.834203309US834203309406/05/2025To elect two Class II directors to each serve until the 2028 Annual Meeting of stockholders or until his successor is duly elected and qualified: Anish Bhatnagar, M.D.DIRECTOR ELECTIONSISSUER2653.0000000FOR2653.000000FORS000047353Soleno Therapeutics, Inc.834203309US834203309406/05/2025To elect two Class II directors to each serve until the 2028 Annual Meeting of stockholders or until his successor is duly elected and qualified: William G. HarrisDIRECTOR ELECTIONSISSUER2653.0000000WITHHOLD2653.000000AGAINSTS000047353Soleno Therapeutics, Inc.834203309US834203309406/05/2025To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2653.0000000FOR2653.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025Election of Class I Director: Lesley Ann CalhounDIRECTOR ELECTIONSISSUER35826.0000000WITHHOLD35826.000000AGAINSTS000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER35826.0000000FOR35826.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025To approve an amendment to our Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000.CAPITAL STRUCTUREISSUER35826.0000000FOR35826.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35826.0000000FOR35826.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35826.0000000FOR35826.000000FOR2S000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35826.0000000FOR35826.000000FOR5S000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35826.0000000ONE YEAR35826.000000FORS000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35826.0000000ONE YEAR35826.000000FOR2S000047353Tango Therapeutics, Inc.87583X109US87583X109006/05/2025Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35826.0000000ONE YEAR35826.000000FOR5S000047353Third Harmonic Bio, Inc.88427A107US88427A107906/05/2025Election of Class III Directors: Thomas M. SolowayDIRECTOR ELECTIONSISSUER946.0000009979.000000WITHHOLD946.000000AGAINSTS000047353Third Harmonic Bio, Inc.88427A107US88427A107906/05/2025Election of Class III Directors: David P. Bonita, M.D.DIRECTOR ELECTIONSISSUER946.0000009979.000000FOR946.000000FORS000047353Third Harmonic Bio, Inc.88427A107US88427A107906/05/2025Election of Class III Directors: Geoff McDonough, M.D.DIRECTOR ELECTIONSISSUER946.0000009979.000000WITHHOLD946.000000AGAINSTS000047353Third Harmonic Bio, Inc.88427A107US88427A107906/05/2025To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER946.0000009979.000000FOR946.000000FORS000047353Third Harmonic Bio, Inc.88427A107US88427A107906/05/2025To approve the liquidation and dissolution of the company pursuant to the Dissolution and the Plan of Dissolution, which, if approved, will authorize the Board of Directors to liquidate and dissolve the company in accordance with the Dissolution and the Plan of Dissolution.EXTRAORDINARY TRANSACTIONSISSUER946.0000009979.000000FOR946.000000FORS000047353Third Harmonic Bio, Inc.88427A107US88427A107906/05/2025To grant discretionary authority to our Board of Directors to adjourn the Annual Meeting, even if a quorum is present, to solicit additional proxies in the event that there are insufficient shares present in person or by proxy voting in favor of the liquidation and dissolution of the company pursuant to the Dissolution and the Plan of Dissolution.CORPORATE GOVERNANCEISSUER946.0000009979.000000FOR946.000000FORS000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Election of three Class I directors to our board of directors, each to serve until the 2028 annual meeting of stockholders: Lonnel CoatsDIRECTOR ELECTIONSISSUER19719.0000000FOR19719.000000FORS000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Election of three Class I directors to our board of directors, each to serve until the 2028 annual meeting of stockholders: Jodie MorrisonDIRECTOR ELECTIONSISSUER19719.0000000FOR19719.000000FORS000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Election of three Class I directors to our board of directors, each to serve until the 2028 annual meeting of stockholders: Krishna Yeshwant, M.D.DIRECTOR ELECTIONSISSUER19719.0000000WITHHOLD19719.000000AGAINSTS000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER19719.0000000FOR19719.000000FORS000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Approval, on an advisory basis, of the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19719.0000000FOR19719.000000FORS000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Approval, on an advisory basis, of the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19719.0000000FOR19719.000000FOR2S000047353Verve Therapeutics, Inc.92539P101US92539P101206/05/2025Approval, on an advisory basis, of the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19719.0000000FOR19719.000000FOR5S000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter FarrellDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. PayneDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy SassineDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James BarlowDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. HolmesDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda MarquetDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. MarantzDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John MarkelsDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef SlaouiDIRECTOR ELECTIONSISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER7003.0000000FOR7003.000000FORS000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER7003.0000000FOR7003.000000FOR2S000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER7003.0000000FOR7003.000000FOR5S000047353Arcturus Therapeutics Holdings Inc.03969T109US03969T109706/06/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7003.0000000FOR7003.000000FORS000047353Relay Therapeutics, Inc.75943R102US75943R102306/06/2025To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Alexis BorisyDIRECTOR ELECTIONSISSUER21362.0000000WITHHOLD21362.000000AGAINSTS000047353Relay Therapeutics, Inc.75943R102US75943R102306/06/2025To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Mark Murcko, Ph.D.DIRECTOR ELECTIONSISSUER21362.0000000WITHHOLD21362.000000AGAINSTS000047353Relay Therapeutics, Inc.75943R102US75943R102306/06/2025To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER21362.0000000AGAINST21362.000000AGAINSTS000047353Relay Therapeutics, Inc.75943R102US75943R102306/06/2025To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER21362.0000000AGAINST21362.000000AGAINST2S000047353Relay Therapeutics, Inc.75943R102US75943R102306/06/2025To consider and act upon an advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER21362.0000000AGAINST21362.000000AGAINST5S000047353Relay Therapeutics, Inc.75943R102US75943R102306/06/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; andAUDIT-RELATEDISSUER21362.0000000FOR21362.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Election of Directors: Alise Reicin, M.D.DIRECTOR ELECTIONSISSUER2651.0000000WITHHOLD2651.000000AGAINSTS000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Election of Directors: Praveen Tipirneni, M.D.DIRECTOR ELECTIONSISSUER2651.0000000WITHHOLD2651.000000AGAINSTS000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2651.0000000FOR2651.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2651.0000000FOR2651.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2651.0000000FOR2651.000000FOR2S000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER2651.0000000FOR2651.000000FOR5S000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Advisory vote on the frequency of stockholder advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2651.0000000ONE YEAR2651.000000FORS000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Advisory vote on the frequency of stockholder advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2651.0000000ONE YEAR2651.000000FOR2S000047353Tectonic Therapeutic, Inc.878972108US878972108606/06/2025Advisory vote on the frequency of stockholder advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2651.0000000ONE YEAR2651.000000FOR5S000047353Bicara Therapeutics Inc.055477103US055477103206/09/2025To elect three class I directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Kiran Mazumdar-ShawDIRECTOR ELECTIONSISSUER1.0000006808.000000WITHHOLD1.000000AGAINSTS000047353Bicara Therapeutics Inc.055477103US055477103206/09/2025To elect three class I directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Jake Simson, Ph.D.DIRECTOR ELECTIONSISSUER1.0000006808.000000WITHHOLD1.000000AGAINSTS000047353Bicara Therapeutics Inc.055477103US055477103206/09/2025To elect three class I directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Ryan Cohlhepp, Pharm D.DIRECTOR ELECTIONSISSUER1.0000006808.000000FOR1.000000FORS000047353Bicara Therapeutics Inc.055477103US055477103206/09/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; andAUDIT-RELATEDISSUER1.0000006808.000000FOR1.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025Election of Directors: Yasunori Kaneko, M.D.DIRECTOR ELECTIONSISSUER6560.0000000FOR6560.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025Election of Directors: Patrick Machado, J.D.DIRECTOR ELECTIONSISSUER6560.0000000WITHHOLD6560.000000AGAINSTS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025Election of Directors: Andrew Perlman, M.D., Ph.D.DIRECTOR ELECTIONSISSUER6560.0000000FOR6560.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025Election of Directors: Antoni Ribas, M.D., Ph.D.DIRECTOR ELECTIONSISSUER6560.0000000WITHHOLD6560.000000AGAINSTS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER6560.0000000FOR6560.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6560.0000000FOR6560.000000FORS000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6560.0000000FOR6560.000000FOR2S000047353Arcus Biosciences, Inc.03969F109US03969F109306/10/2025To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6560.0000000FOR6560.000000FOR5S000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Arthur Levin, Ph.D.DIRECTOR ELECTIONSISSUER1.0000003637.000000FOR1.000000FORS000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Simona SkerjanecDIRECTOR ELECTIONSISSUER1.0000003637.000000FOR1.000000FORS000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To elect Class II directors for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Tamar ThompsonDIRECTOR ELECTIONSISSUER1.0000003637.000000WITHHOLD1.000000AGAINSTS000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To ratify the appointment of Deloitte & Touche LLP as our independent public accounting firm for the fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER1.0000003637.000000FOR1.000000FORS000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003637.000000AGAINST1.000000AGAINSTS000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003637.000000AGAINST1.000000AGAINST2S000047353Avidity Biosciences, Inc.05370A108US05370A108806/10/2025To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003637.000000AGAINST1.000000AGAINST5S000047353Immunome, Inc.45257U108US45257U108806/10/2025To elect the two nominees named in this Proxy Statement to serve as Class II directors, to hold office until the 2028 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Isaac BarchasDIRECTOR ELECTIONSISSUER8612.0000000WITHHOLD8612.000000AGAINSTS000047353Immunome, Inc.45257U108US45257U108806/10/2025To elect the two nominees named in this Proxy Statement to serve as Class II directors, to hold office until the 2028 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Jean-Jacques BienaimeDIRECTOR ELECTIONSISSUER8612.0000000WITHHOLD8612.000000AGAINSTS000047353Immunome, Inc.45257U108US45257U108806/10/2025To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as Immunome, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8612.0000000FOR8612.000000FORS000047353LENZ Therapeutics, Inc.52635N103US52635N103706/10/2025To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028 annual meeting of stockholders, each until their respective successors are elected and qualified: Class III: Kimberlee C. DrapkinDIRECTOR ELECTIONSISSUER2892.0000001100.000000WITHHOLD2892.000000AGAINSTS000047353LENZ Therapeutics, Inc.52635N103US52635N103706/10/2025To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028 annual meeting of stockholders, each until their respective successors are elected and qualified: Class III: Zach ScheinerDIRECTOR ELECTIONSISSUER2892.0000001100.000000WITHHOLD2892.000000AGAINSTS000047353LENZ Therapeutics, Inc.52635N103US52635N103706/10/2025To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028 annual meeting of stockholders, each until their respective successors are elected and qualified: Class I: Frederic GuerardDIRECTOR ELECTIONSISSUER2892.0000001100.000000FOR2892.000000FORS000047353LENZ Therapeutics, Inc.52635N103US52635N103706/10/2025To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028 annual meeting of stockholders, each until their respective successors are elected and qualified: Class I: James McCollumDIRECTOR ELECTIONSISSUER2892.0000001100.000000FOR2892.000000FORS000047353LENZ Therapeutics, Inc.52635N103US52635N103706/10/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2892.0000001100.000000FOR2892.000000FORS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Cynthia ButittaDIRECTOR ELECTIONSISSUER16740.0000000WITHHOLD16740.000000AGAINSTS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Cyrus Harmon, Ph.D.DIRECTOR ELECTIONSISSUER16740.0000000WITHHOLD16740.000000AGAINSTS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Graham Walmsley, M.D., Ph.D.DIRECTOR ELECTIONSISSUER16740.0000000WITHHOLD16740.000000AGAINSTS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER16740.0000000FOR16740.000000FORS000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER16740.0000000FOR16740.000000FOR2S000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER16740.0000000FOR16740.000000FOR5S000047353Olema Pharmaceuticals, Inc.68062P106US68062P106606/10/2025Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER16740.0000000FOR16740.000000FORS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Fred CalloriDIRECTOR ELECTIONSISSUER12527.0000000WITHHOLD12527.000000AGAINSTS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Michael KishbauchDIRECTOR ELECTIONSISSUER12527.0000000WITHHOLD12527.000000AGAINSTS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Jill C. MilneDIRECTOR ELECTIONSISSUER12527.0000000FOR12527.000000FORS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The approval of the first amendment to our Second Amended and Restated 2015 Stock Incentive Plan, to increase the number of shares of our common stock available for grant under the plan by 5,500,000 shares.COMPENSATIONISSUER12527.0000000AGAINST12527.000000AGAINSTS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER12527.0000000FOR12527.000000FORS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The approval, by non-binding advisory vote, of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER12527.0000000AGAINST12527.000000AGAINSTS000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The approval, by non-binding advisory vote, of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER12527.0000000AGAINST12527.000000AGAINST2S000047353Astria Therapeutics, Inc.04635X102US04635X102806/11/2025The approval, by non-binding advisory vote, of our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER12527.0000000AGAINST12527.000000AGAINST5S000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Matthew K. FustDIRECTOR ELECTIONSISSUER2211.0000000WITHHOLD2211.000000AGAINSTS000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: R. Scott Struthers, Ph.D.DIRECTOR ELECTIONSISSUER2211.0000000WITHHOLD2211.000000AGAINSTS000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To elect three directors to serve as Class I directors for a three-year term to expire at the 2028 annual meeting of stockholders: Rogerio Vivaldi Coelho, M.D.DIRECTOR ELECTIONSISSUER2211.0000000WITHHOLD2211.000000AGAINSTS000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER2211.0000000FOR2211.000000FORS000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;SECTION 14A SAY-ON-PAY VOTESISSUER2211.0000000FOR2211.000000FORS000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;SECTION 14A SAY-ON-PAY VOTESISSUER2211.0000000FOR2211.000000FOR2S000047353Crinetics Pharmaceuticals, Inc.22663K107US22663K107906/11/2025To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;SECTION 14A SAY-ON-PAY VOTESISSUER2211.0000000FOR2211.000000FOR5S000047353Disc Medicine, Inc.254604101US254604101106/11/2025To elect each of the following Class II nominees to the Board of Directors as set forth below: Georges Gemayel, Ph.D.DIRECTOR ELECTIONSISSUER1913.0000000FOR1913.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/11/2025To elect each of the following Class II nominees to the Board of Directors as set forth below: Mark Chin, M.S., M.B.A.DIRECTOR ELECTIONSISSUER1913.0000000FOR1913.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/11/2025To elect each of the following Class II nominees to the Board of Directors as set forth below: Liam Ratcliffe, M.D., Ph.D.DIRECTOR ELECTIONSISSUER1913.0000000WITHHOLD1913.000000AGAINSTS000047353Disc Medicine, Inc.254604101US254604101106/11/2025To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1913.0000000FOR1913.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/11/2025To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1913.0000000FOR1913.000000FOR2S000047353Disc Medicine, Inc.254604101US254604101106/11/2025To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1913.0000000FOR1913.000000FOR5S000047353Disc Medicine, Inc.254604101US254604101106/11/2025To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1913.0000000ONE YEAR1913.000000FORS000047353Disc Medicine, Inc.254604101US254604101106/11/2025To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1913.0000000ONE YEAR1913.000000FOR2S000047353Disc Medicine, Inc.254604101US254604101106/11/2025To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1913.0000000ONE YEAR1913.000000FOR5S000047353Disc Medicine, Inc.254604101US254604101106/11/2025To ratify the appointment of Emst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1913.0000000FOR1913.000000FORS000047353Entrada Therapeutics, Inc.29384C108US29384C108006/11/2025Election of Directors: Dipal DoshiDIRECTOR ELECTIONSISSUER6785.0000000FOR6785.000000FORS000047353Entrada Therapeutics, Inc.29384C108US29384C108006/11/2025Election of Directors: Kush M. Parmar, M.D., Ph.D.DIRECTOR ELECTIONSISSUER6785.0000000WITHHOLD6785.000000AGAINSTS000047353Entrada Therapeutics, Inc.29384C108US29384C108006/11/2025Election of Directors: Mary ThistleDIRECTOR ELECTIONSISSUER6785.0000000FOR6785.000000FORS000047353Entrada Therapeutics, Inc.29384C108US29384C108006/11/2025Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER6785.0000000FOR6785.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: William ChaseDIRECTOR ELECTIONSISSUER9060.0000000FOR9060.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Georgia Keresty, Ph.D., M.P.H.DIRECTOR ELECTIONSISSUER9060.0000000AGAINST9060.000000AGAINSTS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: John M. Leonard, M.D.DIRECTOR ELECTIONSISSUER9060.0000000FOR9060.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER9060.0000000FOR9060.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOS").SECTION 14A SAY-ON-PAY VOTESISSUER9060.0000000AGAINST9060.000000AGAINSTS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOS").SECTION 14A SAY-ON-PAY VOTESISSUER9060.0000000AGAINST9060.000000AGAINST2S000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOS").SECTION 14A SAY-ON-PAY VOTESISSUER9060.0000000AGAINST9060.000000AGAINST5S000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOS.SECTION 14A SAY-ON-PAY VOTESISSUER9060.0000000ONE YEAR9060.000000FORS000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOS.SECTION 14A SAY-ON-PAY VOTESISSUER9060.0000000ONE YEAR9060.000000FOR2S000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOS.SECTION 14A SAY-ON-PAY VOTESISSUER9060.0000000ONE YEAR9060.000000FOR5S000047353Intellia Therapeutics, Inc.45826J105US45826J105106/11/2025Approval of the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan.COMPENSATIONISSUER9060.0000000AGAINST9060.000000AGAINSTS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Ronald Barrett, Ph.D.DIRECTOR ELECTIONSISSUER1998.0000000WITHHOLD1998.000000AGAINSTS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: David Campbell, Ph.D.DIRECTOR ELECTIONSISSUER1998.0000000WITHHOLD1998.000000AGAINSTS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Winston KungDIRECTOR ELECTIONSISSUER1998.0000000WITHHOLD1998.000000AGAINSTS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1998.0000000FOR1998.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1998.0000000FOR1998.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1998.0000000FOR1998.000000FOR2S000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1998.0000000FOR1998.000000FOR5S000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1998.0000000ONE YEAR1998.000000FORS000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1998.0000000ONE YEAR1998.000000FOR2S000047353Janux Therapeutics, Inc.47103J105US47103J105106/11/2025Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1998.0000000ONE YEAR1998.000000FOR5S000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/11/2025Election of Directors: Steven L. HoerterDIRECTOR ELECTIONSISSUER2462.00000012110.000000FOR2462.000000FORS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/11/2025Election of Directors: Angie You, Ph.D.DIRECTOR ELECTIONSISSUER2462.00000012110.000000WITHHOLD2462.000000AGAINSTS000047353ORIC Pharmaceuticals, Inc.68622P109US68622P109306/11/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2462.00000012110.000000FOR2462.000000FORS000047353Terns Pharmaceuticals, Inc.880881107US880881107406/11/2025Election of Class I Directors for a three-year term: Robert AzelbyDIRECTOR ELECTIONSISSUER18641.0000000FOR18641.000000FORS000047353Terns Pharmaceuticals, Inc.880881107US880881107406/11/2025Election of Class I Directors for a three-year term: Hongbo LuDIRECTOR ELECTIONSISSUER18641.0000000WITHHOLD18641.000000AGAINSTS000047353Terns Pharmaceuticals, Inc.880881107US880881107406/11/2025Election of Class I Directors for a three-year term: Heather TurnerDIRECTOR ELECTIONSISSUER18641.0000000FOR18641.000000FORS000047353Terns Pharmaceuticals, Inc.880881107US880881107406/11/2025To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER18641.0000000FOR18641.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Adoption of the 2024 Dutch statutory annual accounts for the fiscal year ended December 31, 2024.CORPORATE GOVERNANCEISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2024.CORPORATE GOVERNANCEISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Reappointment of Robert Gut, M.D., Ph.D. as non-executive director.DIRECTOR ELECTIONSISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Reappointment of Matthew Kapusta as executive director.DIRECTOR ELECTIONSISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Reappointment of Jeremy Springhorn, Ph.D. as non-executive director.DIRECTOR ELECTIONSISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Authorization of the Board to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares.CAPITAL STRUCTUREISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Authorization of the Board to exclude or limit preemptive rights upon the issuance of Ordinary Shares.CAPITAL STRUCTUREISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Authorization of the Board to repurchase Ordinary Shares.CAPITAL STRUCTUREISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Appointment of KPMG as external auditor of the Company for the financial year 2025.AUDIT-RELATEDISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER8163.0000000FOR8163.000000FORS000047353uniQure N.V.N90064101NL001069665406/11/2025Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER8163.0000000FOR8163.000000FOR2S000047353uniQure N.V.N90064101NL001069665406/11/2025Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER8163.0000000FOR8163.000000FOR5S000047353uniQure N.V.N90064101NL001069665406/11/2025Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan.COMPENSATIONISSUER8163.0000000FOR8163.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/12/2025To elect two class II directors to our Board of Directors, to serve until the 2028 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carl L.G. HansenDIRECTOR ELECTIONSISSUER21643.00000020000.000000FOR21643.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/12/2025To elect two class II directors to our Board of Directors, to serve until the 2028 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Michael HaydenDIRECTOR ELECTIONSISSUER21643.00000020000.000000WITHHOLD21643.000000AGAINSTS000047353AbCellera Biologics Inc.00288U106CA00288U106606/12/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER21643.00000020000.000000FOR21643.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/12/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay;SECTION 14A SAY-ON-PAY VOTESISSUER21643.00000020000.000000FOR21643.000000FORS000047353AbCellera Biologics Inc.00288U106CA00288U106606/12/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay;SECTION 14A SAY-ON-PAY VOTESISSUER21643.00000020000.000000FOR21643.000000FOR2S000047353AbCellera Biologics Inc.00288U106CA00288U106606/12/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay;SECTION 14A SAY-ON-PAY VOTESISSUER21643.00000020000.000000FOR21643.000000FOR5S000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Bhaskar Chaudhuri, Ph.D.DIRECTOR ELECTIONSISSUER10033.0000000WITHHOLD10033.000000AGAINSTS000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Sue-Jean LinDIRECTOR ELECTIONSISSUER10033.0000000WITHHOLD10033.000000AGAINSTS000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Howard G. Welgus, M.D.DIRECTOR ELECTIONSISSUER10033.0000000WITHHOLD10033.000000AGAINSTS000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER10033.0000000FOR10033.000000FORS000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10033.0000000AGAINST10033.000000AGAINSTS000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10033.0000000AGAINST10033.000000AGAINST2S000047353Arcutis Biotherapeutics, Inc.03969K108US03969K108806/12/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER10033.0000000AGAINST10033.000000AGAINST5S000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To re-elect as a director Thomas LonngrenDIRECTOR ELECTIONSISSUER27863.0000000AGAINST27863.000000AGAINSTS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To re-elect as a director Robert McQuadeDIRECTOR ELECTIONSISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To re-elect as a director Kabir NathDIRECTOR ELECTIONSISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To re-elect as a director Gino SantiniDIRECTOR ELECTIONSISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To re-appoint PricewaterhouseCoopers LLP (UK) as UK statutory auditors of the CompanyAUDIT-RELATEDISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To ratify the appointment of PricewaterhouseCoopers LLP (US) as the Company's independent registered public accounting firmAUDIT-RELATEDISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To authorise the Audit and Risk Committee to determine the auditors' remuneration for the fiscal year ending 31 December 2025AUDIT-RELATEDISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To receive the UK statutory annual accounts and reports for the fiscal year ended 31 December 2024 and to note that the Directors do not recommend the payment of any dividend for the year ended 31 December 2024CORPORATE GOVERNANCEISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To receive and approve on an advisory basis the Company's UK statutory directors' remuneration report for the year ended 31 December 2024COMPENSATIONISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended 31 December 2024SECTION 14A SAY-ON-PAY VOTESISSUER27863.0000000FOR27863.000000FORS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended 31 December 2024SECTION 14A SAY-ON-PAY VOTESISSUER27863.0000000FOR27863.000000FOR2S000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended 31 December 2024SECTION 14A SAY-ON-PAY VOTESISSUER27863.0000000FOR27863.000000FOR5S000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To authorise the directors to allot shares in the companyCAPITAL STRUCTUREISSUER27863.0000000AGAINST27863.000000AGAINSTS000047353COMPASS Pathways plc20451W101US20451W101806/12/2025To disapply statutory pre-emption rightsCAPITAL STRUCTUREISSUER27863.0000000AGAINST27863.000000AGAINSTS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/12/2025To elect two Class III Directors with terms to expire at the 2028 annual meeting of stockholders: lan T. ClarkDIRECTOR ELECTIONSISSUER15202.0000000WITHHOLD15202.000000AGAINSTS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/12/2025To elect two Class III Directors with terms to expire at the 2028 annual meeting of stockholders: Peter A. Thompson, M.D.DIRECTOR ELECTIONSISSUER15202.0000000FOR15202.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/12/2025To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER15202.0000000FOR15202.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/12/2025To approve, on a non-binding advisory basis, the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER15202.0000000FOR15202.000000FORS000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/12/2025To approve, on a non-binding advisory basis, the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER15202.0000000FOR15202.000000FOR2S000047353Corvus Pharmaceuticals, Inc.221015100US221015100506/12/2025To approve, on a non-binding advisory basis, the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER15202.0000000FOR15202.000000FOR5S000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2028: Anthony RosenbergDIRECTOR ELECTIONSISSUER10068.0000000FOR10068.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2028: David P. Ryan, M.D.DIRECTOR ELECTIONSISSUER10068.0000000FOR10068.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2028: Mary ThistleDIRECTOR ELECTIONSISSUER10068.0000000FOR10068.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER10068.0000000FOR10068.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to vote, on an advisory basis, to approve our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10068.0000000FOR10068.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to vote, on an advisory basis, to approve our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10068.0000000FOR10068.000000FOR2S000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to vote, on an advisory basis, to approve our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10068.0000000FOR10068.000000FOR5S000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10068.0000000ONE YEAR10068.000000FORS000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10068.0000000ONE YEAR10068.000000FOR2S000047353Cullinan Therapeutics, Inc.230031106US230031106306/12/2025Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER10068.0000000ONE YEAR10068.000000FOR5S000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025Election of Directors to hold office until the 2026 annual general meeting of shareholders: Robert BarrowDIRECTOR ELECTIONSISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025Election of Directors to hold office until the 2026 annual general meeting of shareholders: Suzanne Bruhn, Ph.D.DIRECTOR ELECTIONSISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025Election of Directors to hold office until the 2026 annual general meeting of shareholders: Roger Crystal, M.D.DIRECTOR ELECTIONSISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025Election of Directors to hold office until the 2026 annual general meeting of shareholders: David GryskaDIRECTOR ELECTIONSISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025Election of Directors to hold office until the 2026 annual general meeting of shareholders: Andreas KrebsDIRECTOR ELECTIONSISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025Election of Directors to hold office until the 2026 annual general meeting of shareholders: Carol A. ValloneDIRECTOR ELECTIONSISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2026 annual general meeting of shareholders.AUDIT-RELATEDISSUER17499.0000000FOR17499.000000FORS000047353Mind Medicine (MindMed) Inc.60255C885CA60255C885006/12/2025To consider, and if deemed advisable, approve, the Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan.COMPENSATIONISSUER17499.0000000FOR17499.000000FORS000047353Neurogene, Inc.64135M105US64135M105306/12/2025Election of Class II Directors for terms expiring in 2028: Sarah B. NoonbergDIRECTOR ELECTIONSISSUER4159.0000001343.000000FOR4159.000000FORS000047353Neurogene, Inc.64135M105US64135M105306/12/2025Election of Class II Directors for terms expiring in 2028: Robert Keith WoodsDIRECTOR ELECTIONSISSUER4159.0000001343.000000WITHHOLD4159.000000AGAINSTS000047353Neurogene, Inc.64135M105US64135M105306/12/2025To approve an amendment to our 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock.COMPENSATIONISSUER4159.0000001343.000000AGAINST4159.000000AGAINSTS000047353Neurogene, Inc.64135M105US64135M105306/12/2025To approve an amendment to our 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock.COMPENSATIONISSUER4159.0000001343.000000AGAINST4159.000000AGAINSTS000047353Neurogene, Inc.64135M105US64135M105306/12/2025To approve on an an (non-binding) basis the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4159.0000001343.000000FOR4159.000000FORS000047353Neurogene, Inc.64135M105US64135M105306/12/2025To approve on an an (non-binding) basis the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4159.0000001343.000000FOR4159.000000FOR2S000047353Neurogene, Inc.64135M105US64135M105306/12/2025To approve on an an (non-binding) basis the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4159.0000001343.000000FOR4159.000000FOR5S000047353Neurogene, Inc.64135M105US64135M105306/12/2025To ratify on an advisory (non-binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER4159.0000001343.000000FOR4159.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Robert W. DugganDIRECTOR ELECTIONSISSUER1.0000006879.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Mahkam ZanganehDIRECTOR ELECTIONSISSUER1.0000006879.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Manmeet S. SoniDIRECTOR ELECTIONSISSUER1.0000006879.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Kenneth A. ClarkDIRECTOR ELECTIONSISSUER1.0000006879.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Robert BoothDIRECTOR ELECTIONSISSUER1.0000006879.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Alessandra CesanoDIRECTOR ELECTIONSISSUER1.0000006879.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Yu (Michelle) XiaDIRECTOR ELECTIONSISSUER1.0000006879.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Mostafa RonaghiDIRECTOR ELECTIONSISSUER1.0000006879.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025ELECTION OF DIRECTORS: Jeff HuberDIRECTOR ELECTIONSISSUER1.0000006879.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1.0000006879.000000FOR1.000000FORS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025Approval, by a non-binding advisory vote, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006879.000000AGAINST1.000000AGAINSTS000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025Approval, by a non-binding advisory vote, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006879.000000AGAINST1.000000AGAINST2S000047353Summit Therapeutics Inc.86627T108US86627T108806/12/2025Approval, by a non-binding advisory vote, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000006879.000000AGAINST1.000000AGAINST5S000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: John FureyDIRECTOR ELECTIONSISSUER1400.0000000FOR1400.000000FORS000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Jacks LeeDIRECTOR ELECTIONSISSUER1400.0000000WITHHOLD1400.000000AGAINSTS000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Heath Lukatch, Ph.D.DIRECTOR ELECTIONSISSUER1400.0000000WITHHOLD1400.000000AGAINSTS000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1400.0000000FOR1400.000000FORS000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1400.0000000AGAINST1400.000000AGAINSTS000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1400.0000000AGAINST1400.000000AGAINST2S000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1400.0000000AGAINST1400.000000AGAINST5S000047353Vaxcyte, Inc.92243G108US92243G108506/12/2025Approval of the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by recent amendments to the Delaware General Corporation Law.CORPORATE GOVERNANCEISSUER1400.0000000FOR1400.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. DahiyatDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. FeigalDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. GormanDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. GustafsonDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara KlenckeDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce MontgomeryDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. RanieriDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To elect the eight nominees to the Board of Directors named in the accompanying Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Todd E. SimpsonDIRECTOR ELECTIONSISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares;COMPENSATIONISSUER4964.0000000AGAINST4964.000000AGAINSTS000047353Xencor, Inc.98401F105US98401F105706/12/2025To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement;SECTION 14A SAY-ON-PAY VOTESISSUER4964.0000000FOR4964.000000FORS000047353Xencor, Inc.98401F105US98401F105706/12/2025To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement;SECTION 14A SAY-ON-PAY VOTESISSUER4964.0000000FOR4964.000000FOR2S000047353Xencor, Inc.98401F105US98401F105706/12/2025To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement;SECTION 14A SAY-ON-PAY VOTESISSUER4964.0000000FOR4964.000000FOR5S000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025Election of Directors: Timothy C. Barabe, MBADIRECTOR ELECTIONSISSUER32.0000006075.000000WITHHOLD32.000000AGAINSTS000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025Election of Directors: Carsten Brunn, Ph.D.DIRECTOR ELECTIONSISSUER32.0000006075.000000FOR32.000000FORS000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025Election of Directors: Nishan de Silva, MD MBADIRECTOR ELECTIONSISSUER32.0000006075.000000FOR32.000000FORS000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER32.0000006075.000000FOR32.000000FORS000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER32.0000006075.000000FOR32.000000FOR2S000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER32.0000006075.000000FOR32.000000FOR5S000047353Cartesian Therapeutics, Inc.816212302US816212302506/13/2025To ratify the appointment of Ernst & Young LLP as Cartesian Therapeutics, Inc. 's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER32.0000006075.000000FOR32.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Alan Russell, Ph.D.DIRECTOR ELECTIONSISSUER4365.0000000WITHHOLD4365.000000AGAINSTS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Elect the directors named in the attached Proxy Statement to serve until the 2028 Annual Meeting of Stockholders: Arlene MorrisDIRECTOR ELECTIONSISSUER4365.0000000WITHHOLD4365.000000AGAINSTS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER4365.0000000FOR4365.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Conduct an advisory vote on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4365.0000000FOR4365.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Conduct an advisory vote on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4365.0000000FOR4365.000000FOR2S000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Conduct an advisory vote on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4365.0000000FOR4365.000000FOR5S000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4365.0000000ONE YEAR4365.000000FORS000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4365.0000000ONE YEAR4365.000000FOR2S000047353Edgewise Therapeutics, Inc.28036F105US28036F105706/13/2025Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4365.0000000ONE YEAR4365.000000FOR5S000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/13/2025To elect three Class I director nominees to our board of directors, to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Christine Siu, MBADIRECTOR ELECTIONSISSUER15768.0000000FOR15768.000000FORS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/13/2025To elect three Class I director nominees to our board of directors, to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Kimberly L. Blackwell, M.D.DIRECTOR ELECTIONSISSUER15768.0000000FOR15768.000000FORS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/13/2025To elect three Class I director nominees to our board of directors, to serve until the Company's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jan Skvarka, Ph.D., MBADIRECTOR ELECTIONSISSUER15768.0000000WITHHOLD15768.000000AGAINSTS000047353Monte Rosa Therapeutics, Inc.61225M102US61225M102706/13/2025To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; andAUDIT-RELATEDISSUER15768.0000000FOR15768.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jacob Chacko, M.D., MBADIRECTOR ELECTIONSISSUER16350.0000000WITHHOLD16350.000000AGAINSTS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Susannah Gray, MBADIRECTOR ELECTIONSISSUER16350.0000000FOR16350.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Charles Theuer, M.D., Ph.D.DIRECTOR ELECTIONSISSUER16350.0000000WITHHOLD16350.000000AGAINSTS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Ratification of the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER16350.0000000FOR16350.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER16350.0000000FOR16350.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER16350.0000000FOR16350.000000FOR2S0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER16350.0000000FOR16350.000000FOR5S0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes.SECTION 14A SAY-ON-PAY VOTESISSUER16350.0000000ONE YEAR16350.000000FORS0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes.SECTION 14A SAY-ON-PAY VOTESISSUER16350.0000000ONE YEAR16350.000000FOR2S0000473534D Molecular Therapeutics, Inc.35104E100US35104E100106/17/2025Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes.SECTION 14A SAY-ON-PAY VOTESISSUER16350.0000000ONE YEAR16350.000000FOR5S000047353AnaptysBio, Inc.032724106US032724106506/17/2025To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D.DIRECTOR ELECTIONSISSUER7490.0000000FOR7490.000000FORS000047353AnaptysBio, Inc.032724106US032724106506/17/2025To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: John OrwinDIRECTOR ELECTIONSISSUER7490.0000000WITHHOLD7490.000000AGAINSTS000047353AnaptysBio, Inc.032724106US032724106506/17/2025To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: J. Anthony Ware, M.D.DIRECTOR ELECTIONSISSUER7490.0000000WITHHOLD7490.000000AGAINSTS000047353AnaptysBio, Inc.032724106US032724106506/17/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7490.0000000FOR7490.000000FORS000047353AnaptysBio, Inc.032724106US032724106506/17/2025To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.SECTION 14A SAY-ON-PAY VOTESISSUER7490.0000000AGAINST7490.000000AGAINSTS000047353AnaptysBio, Inc.032724106US032724106506/17/2025To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.SECTION 14A SAY-ON-PAY VOTESISSUER7490.0000000AGAINST7490.000000AGAINST2S000047353AnaptysBio, Inc.032724106US032724106506/17/2025To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.SECTION 14A SAY-ON-PAY VOTESISSUER7490.0000000AGAINST7490.000000AGAINST5S000047353AnaptysBio, Inc.032724106US032724106506/17/2025To approve an amendment to our 2017 Equity Incentive Plan.COMPENSATIONISSUER7490.0000000AGAINST7490.000000AGAINSTS000047353AnaptysBio, Inc.032724106US032724106506/17/2025Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7490.0000000ONE YEAR7490.000000FORS000047353AnaptysBio, Inc.032724106US032724106506/17/2025Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7490.0000000ONE YEAR7490.000000FOR2S000047353AnaptysBio, Inc.032724106US032724106506/17/2025Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7490.0000000ONE YEAR7490.000000FOR5S000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Election of Class II Directors for terms expiring in 2028: Lisa Bollinger, M.D.DIRECTOR ELECTIONSISSUER2537.0000000WITHHOLD2537.000000AGAINSTS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Election of Class II Directors for terms expiring in 2028: Tomas KiselakDIRECTOR ELECTIONSISSUER2537.0000000FOR2537.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Election of Class II Directors for terms expiring in 2028: Nimish ShahDIRECTOR ELECTIONSISSUER2537.0000000WITHHOLD2537.000000AGAINSTS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER2537.0000000FOR2537.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Vote on the frequency of future advisory votes to approve our named executive officers compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2537.0000000ONE YEAR2537.000000FORS000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Vote on the frequency of future advisory votes to approve our named executive officers compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2537.0000000ONE YEAR2537.000000FOR2S000047353Apogee Therapeutics, Inc.03770N101US03770N101906/17/2025Vote on the frequency of future advisory votes to approve our named executive officers compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2537.0000000ONE YEAR2537.000000FOR5S000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To re-elect Alessandro Riva as a director, who retires in accordance with the Articles of Association.DIRECTOR ELECTIONSISSUER4131.0000001980.000000AGAINST4131.000000AGAINSTS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To re-elect Stephen Sands as a director, who retires in accordance with the Articles of Association.DIRECTOR ELECTIONSISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER4131.0000001980.000000FOR4131.000000FOR2S000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER4131.0000001980.000000FOR4131.000000FOR5S000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.AUDIT-RELATEDISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2025.AUDIT-RELATEDISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. Annual Report").CORPORATE GOVERNANCEISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To approve our directors' remuneration report for the year ended December 31, 2024 (the "directors' remuneration report"), which is set forth as Annex A to the proxy statement.COMPENSATIONISSUER4131.0000001980.000000FOR4131.000000FORS000047353Bicycle Therapeutics Plc088786108US088786108806/17/2025To approve an amendment to our Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth as Annex C to the proxy statement.COMPENSATIONISSUER4131.0000001980.000000AGAINST4131.000000AGAINSTS000047353iTeos Therapeutics, Inc.46565G104US46565G104006/17/2025Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Tony HoDIRECTOR ELECTIONSISSUER14158.0000000WITHHOLD14158.000000AGAINSTS000047353iTeos Therapeutics, Inc.46565G104US46565G104006/17/2025Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Robert IannoneDIRECTOR ELECTIONSISSUER14158.0000000FOR14158.000000FORS000047353iTeos Therapeutics, Inc.46565G104US46565G104006/17/2025Election of the Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Ann D. RhoadsDIRECTOR ELECTIONSISSUER14158.0000000WITHHOLD14158.000000AGAINSTS000047353iTeos Therapeutics, Inc.46565G104US46565G104006/17/2025To ratify the appointment of Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises BV/SRL as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER14158.0000000FOR14158.000000FORS000047353Liquidia Corporation53635D202US53635D202706/17/2025Election of Directors: Stephen BlochDIRECTOR ELECTIONSISSUER13044.0000000WITHHOLD13044.000000AGAINSTS000047353Liquidia Corporation53635D202US53635D202706/17/2025Election of Directors: Joanna HorobinDIRECTOR ELECTIONSISSUER13044.0000000FOR13044.000000FORS000047353Liquidia Corporation53635D202US53635D202706/17/2025Election of Directors: Roger A. JeffsDIRECTOR ELECTIONSISSUER13044.0000000FOR13044.000000FORS000047353Liquidia Corporation53635D202US53635D202706/17/2025To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2025.AUDIT-RELATEDISSUER13044.0000000FOR13044.000000FORS000047353Liquidia Corporation53635D202US53635D202706/17/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13044.0000000FOR13044.000000FORS000047353Liquidia Corporation53635D202US53635D202706/17/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13044.0000000FOR13044.000000FOR2S000047353Liquidia Corporation53635D202US53635D202706/17/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER13044.0000000FOR13044.000000FOR5S000047353Rapport Therapeutics, Inc.75383L102US75383L102606/17/2025To elect Reid Huber, Ph.D., John Maraganore, Ph.D.,and Wendy B. Young, Ph.D. as Class I Directors: Reid Huber, Ph.D.DIRECTOR ELECTIONSISSUER1.0000005920.000000WITHHOLD1.000000AGAINSTS000047353Rapport Therapeutics, Inc.75383L102US75383L102606/17/2025To elect Reid Huber, Ph.D., John Maraganore, Ph.D.,and Wendy B. Young, Ph.D. as Class I Directors: John Maraganore, Ph.D.DIRECTOR ELECTIONSISSUER1.0000005920.000000WITHHOLD1.000000AGAINSTS000047353Rapport Therapeutics, Inc.75383L102US75383L102606/17/2025To elect Reid Huber, Ph.D., John Maraganore, Ph.D.,and Wendy B. Young, Ph.D. as Class I Directors: Wendy B. Young, Ph.D.DIRECTOR ELECTIONSISSUER1.0000005920.000000FOR1.000000FORS000047353Rapport Therapeutics, Inc.75383L102US75383L102606/17/2025To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1.0000005920.000000FOR1.000000FORS000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Scott MyersDIRECTOR ELECTIONSISSUER35939.0000000FOR35939.000000FORS000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Karan TakharDIRECTOR ELECTIONSISSUER35939.0000000WITHHOLD35939.000000AGAINSTS000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Luke Walker, M.D.DIRECTOR ELECTIONSISSUER35939.0000000WITHHOLD35939.000000AGAINSTS000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER35939.0000000FOR35939.000000FORS000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35939.0000000AGAINST35939.000000AGAINSTS000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35939.0000000AGAINST35939.000000AGAINST2S000047353Zentalis Pharmaceuticals, Inc.98943L107US98943L107006/17/2025To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35939.0000000AGAINST35939.000000AGAINST5S000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025Election of Directors: Elizabeth BarrettDIRECTOR ELECTIONSISSUER60814.0000000WITHHOLD60814.000000AGAINSTS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025Election of Directors: Arie Belldegrun, M.D.DIRECTOR ELECTIONSISSUER60814.0000000WITHHOLD60814.000000AGAINSTS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025Election of Directors: David Chang, M.D., Ph.D.DIRECTOR ELECTIONSISSUER60814.0000000WITHHOLD60814.000000AGAINSTS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER60814.0000000FOR60814.000000FORS000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER60814.0000000FOR60814.000000FOR2S000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER60814.0000000FOR60814.000000FOR5S000047353Allogene Therapeutics, Inc.019770106US019770106506/18/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER60814.0000000FOR60814.000000FORS000047353ArriVent BioPharma, Inc.04272N102US04272N102806/18/2025Election of Directors: Zhengbin (Bing) Yao, Ph.D.DIRECTOR ELECTIONSISSUER4349.0000000WITHHOLD4349.000000AGAINSTS000047353ArriVent BioPharma, Inc.04272N102US04272N102806/18/2025Election of Directors: Kristine PetersonDIRECTOR ELECTIONSISSUER4349.0000000WITHHOLD4349.000000AGAINSTS000047353ArriVent BioPharma, Inc.04272N102US04272N102806/18/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER4349.0000000FOR4349.000000FORS000047353CARGO Therapeutics, Inc.14179K101US14179K101606/18/2025To elect three Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Abraham BassanDIRECTOR ELECTIONSISSUER2720.0000004812.000000FOR2720.000000FORS000047353CARGO Therapeutics, Inc.14179K101US14179K101606/18/2025To elect three Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Kapil DhingraDIRECTOR ELECTIONSISSUER2720.0000004812.000000WITHHOLD2720.000000AGAINSTS000047353CARGO Therapeutics, Inc.14179K101US14179K101606/18/2025To elect three Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: David LubnerDIRECTOR ELECTIONSISSUER2720.0000004812.000000FOR2720.000000FORS000047353CARGO Therapeutics, Inc.14179K101US14179K101606/18/2025To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Deloitte & Touche LLP as the independent registered public accounting firm and independent auditor of the Company for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2720.0000004812.000000FOR2720.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Goran Ando, M.D.DIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Jay S. Duker, M.D.DIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Nancy LurkerDIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: John B. Landis, Ph.D.DIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Wendy DiCiccoDIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Karen ZaderejDIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Stuart DutyDIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Fred HassanDIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025Election of Directors: Reginald Sanders, M.D.DIRECTOR ELECTIONSISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To approve Amendment No. 2 to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 2,900,000 shares.COMPENSATIONISSUER18077.0000000AGAINST18077.000000AGAINSTS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER18077.0000000FOR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER18077.0000000FOR18077.000000FOR2S000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER18077.0000000FOR18077.000000FOR5S000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To vote, on an advisory basis, on the frequency of advisory stockholder votes on the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18077.0000000ONE YEAR18077.000000FORS000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To vote, on an advisory basis, on the frequency of advisory stockholder votes on the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18077.0000000ONE YEAR18077.000000FOR2S000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To vote, on an advisory basis, on the frequency of advisory stockholder votes on the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18077.0000000ONE YEAR18077.000000FOR5S000047353EyePoint Pharmaceuticals, Inc.30233G209US30233G209306/18/2025To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER18077.0000000FOR18077.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2025Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER15182.0000000FOR15182.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2025Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER15182.0000000FOR15182.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2025Reelect P.A. Chambre as DirectorDIRECTOR ELECTIONSISSUER15182.0000000AGAINST15182.000000AGAINSTS000047353Immatics N.V.N44445109NL001528594106/18/2025Reelect H.L. Mason as DirectorDIRECTOR ELECTIONSISSUER15182.0000000FOR15182.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2025Elect A.S. Reicin as DirectorDIRECTOR ELECTIONSISSUER15182.0000000FOR15182.000000FORS000047353Immatics N.V.N44445109NL001528594106/18/2025Authorize Repurchase of Ordinary Shares or Depositary ReceiptsCAPITAL STRUCTUREISSUER15182.0000000AGAINST15182.000000AGAINSTS000047353Immatics N.V.N44445109NL001528594106/18/2025Approve 2025 Stock Option and Incentive PlanCOMPENSATIONISSUER15182.0000000AGAINST15182.000000AGAINSTS000047353Immatics N.V.N44445109NL001528594106/18/2025Ratify PricewaterhouseCoopers Accountants N.V. as AuditorsAUDIT-RELATEDISSUER15182.0000000FOR15182.000000FORS000047353Nuvalent, Inc.670703107US670703107506/18/2025Election of the following nominees as Class I directors: Grant BogleDIRECTOR ELECTIONSISSUER1.0000001295.000000FOR1.000000FORS000047353Nuvalent, Inc.670703107US670703107506/18/2025Election of the following nominees as Class I directors: James R. Porter, Ph.D.DIRECTOR ELECTIONSISSUER1.0000001295.000000FOR1.000000FORS000047353Nuvalent, Inc.670703107US670703107506/18/2025Election of the following nominees as Class I directors: Anna ProtopapasDIRECTOR ELECTIONSISSUER1.0000001295.000000WITHHOLD1.000000AGAINSTS000047353Nuvalent, Inc.670703107US670703107506/18/2025To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000001295.000000AGAINST1.000000AGAINSTS000047353Nuvalent, Inc.670703107US670703107506/18/2025To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000001295.000000AGAINST1.000000AGAINST2S000047353Nuvalent, Inc.670703107US670703107506/18/2025To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000001295.000000AGAINST1.000000AGAINST5S000047353Nuvalent, Inc.670703107US670703107506/18/2025To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1.0000001295.000000FOR1.000000FORS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Election of Directors: Zachary Bogue, J.D.DIRECTOR ELECTIONSISSUER1.00000016113.000000FOR1.000000FORS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Election of Directors: Zavain DarDIRECTOR ELECTIONSISSUER1.00000016113.000000WITHHOLD1.000000AGAINSTS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Election of Directors: Robert Hershberg, M.D. Ph.D.DIRECTOR ELECTIONSISSUER1.00000016113.000000FOR1.000000FORS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000016113.000000FOR1.000000FORS000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000016113.000000FOR1.000000FOR2S000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000016113.000000FOR1.000000FOR5S000047353Recursion Pharmaceuticals, Inc.75629V104US75629V104406/18/2025Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1.00000016113.000000FOR1.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D.DIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Elisabeth Bjork, M.D., Ph.D.DIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten BoessDIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D.DIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Pedro GranadilloDIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gotham Makker, M.D.DIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D.DIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Piratip PratumsuwanDIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D.DIRECTOR ELECTIONSISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. SouthwellDIRECTOR ELECTIONSISSUER8946.0000000WITHHOLD8946.000000AGAINSTS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER8946.0000000FOR8946.000000FORS000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER8946.0000000FOR8946.000000FOR2S000047353Rocket Pharmaceuticals, Inc.77313F106US77313F106606/18/2025Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER8946.0000000FOR8946.000000FOR5S000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To re-appoint as a director Arjun Goyal, M.D., M.Phil., M.B.A., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To re-appoint as a director Samarth Kulkarni, Ph.D., who retires by rotation in accordance with the Company's articles of association.DIRECTOR ELECTIONSISSUER9743.0000000AGAINST9743.000000AGAINSTS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To re-appoint KPMG LLP, a United Kingdom entity, as UK statutory auditors of the Company, to hold office until the conclusion of the next meeting at which the Company's annual accounts and reports are laid before the Company.AUDIT-RELATEDISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To ratify the re-appointment of KPMG LLP, a Delaware limited liability partnership, as the Company's independent registered public accounting firm, for the financial year ending December 31, 2025.AUDIT-RELATEDISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To authorize the Audit Committee to determine the Company's auditors' remuneration for the financial year ending December 31, 2025.AUDIT-RELATEDISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To receive and adopt our UK statutory annual accounts and reports for the financial year ended December 31, 2024 and to note that the Company's directors do not recommend the payment of any dividend for the financial year ended December 31, 2024.CORPORATE GOVERNANCEISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To receive and approve, on an advisory basis, the Company's U.K. statutory directors' remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the proxy statement.COMPENSATIONISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To receive and approve the Directors' Remuneration Policy as set out in the Company's UK statutory directors' remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the proxy statement.COMPENSATIONISSUER9743.0000000FOR9743.000000FORS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the UK Companies Act 2006 (the "Companies Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds133,184.CAPITAL STRUCTUREISSUER9743.0000000AGAINST9743.000000AGAINSTS000047353Centessa Pharmaceuticals Plc152309100US152309100706/20/2025Subject to the passing of Resolution 9, to empower the Board of Directors to allot equity securities for cash, under section 570 of the Companies Act as if section 561(1) of the Companies Act did not apply to such allotment up to a maximum aggregate nominal amount of pounds133,184.CAPITAL STRUCTUREISSUER9743.0000000AGAINST9743.000000AGAINSTS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/20/2025To elect the Class III director nominees named below to hold office until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Harold E. Selick, Ph.D.DIRECTOR ELECTIONSISSUER3554.0000000WITHHOLD3554.000000AGAINSTS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/20/2025To elect the Class III director nominees named below to hold office until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Bryan GiraudoDIRECTOR ELECTIONSISSUER3554.0000000WITHHOLD3554.000000AGAINSTS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/20/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3554.0000000FOR3554.000000FORS000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/20/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3554.0000000FOR3554.000000FOR2S000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/20/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3554.0000000FOR3554.000000FOR5S000047353Protagonist Therapeutics, Inc.74366E102US74366E102906/20/2025To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3554.0000000FOR3554.000000FORS000047353Scilex Holding Company80880W205US80880W205206/20/2025Election of Directors: Henry Ji, Ph.D.DIRECTOR ELECTIONSISSUER512.0000000WITHHOLD512.000000AGAINSTS000047353Scilex Holding Company80880W205US80880W205206/20/2025Election of Directors: Jaisim ShahDIRECTOR ELECTIONSISSUER512.0000000WITHHOLD512.000000AGAINSTS000047353Scilex Holding Company80880W205US80880W205206/20/2025Proposal to ratify the appointment of BPM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER512.0000000FOR512.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To elect the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jeff AjerDIRECTOR ELECTIONSISSUER6834.0000000FOR6834.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To elect the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Chris Cain, Ph.D.DIRECTOR ELECTIONSISSUER6834.0000000FOR6834.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To elect the three Class I director nominees to serve until the 2028 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Sarah Gheuens, M.D., Ph.D.DIRECTOR ELECTIONSISSUER6834.0000000WITHHOLD6834.000000AGAINSTS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER6834.0000000FOR6834.000000FORS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6834.0000000AGAINST6834.000000AGAINSTS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6834.0000000AGAINST6834.000000AGAINST2S000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER6834.0000000AGAINST6834.000000AGAINST5S000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares.COMPENSATIONISSUER6834.0000000AGAINST6834.000000AGAINSTS000047353Viridian Therapeutics, Inc.92790C104US92790C104506/20/2025To approve the Viridian Therapeutics, Inc. 2025 Employee Stock Purchase Plan.COMPENSATIONISSUER6834.0000000FOR6834.000000FORS000047353Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Ilan OrenDIRECTOR ELECTIONSISSUER1.00000030466.000000WITHHOLD1.000000AGAINSTS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: James C. MomtazeeDIRECTOR ELECTIONSISSUER1.00000030466.000000WITHHOLD1.000000AGAINSTS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Mayukh SukhatmeDIRECTOR ELECTIONSISSUER1.00000030466.000000FOR1.000000FORS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2025, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2025, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2025.AUDIT-RELATEDISSUER1.00000030466.000000FOR1.000000FORS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To cast a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030466.000000FOR1.000000FORS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To cast a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030466.000000FOR1.000000FOR2S000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To cast a non-binding, advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030466.000000FOR1.000000FOR5S000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030466.000000ONE YEAR1.000000FORS000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030466.000000ONE YEAR1.000000FOR2S000047354Roivant Sciences Ltd.G76279101BMG76279101709/10/2024To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:SECTION 14A SAY-ON-PAY VOTESISSUER1.00000030466.000000ONE YEAR1.000000FOR5S000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Stuart A. ArbuckleDIRECTOR ELECTIONSISSUER1452.0000005971.000000WITHHOLD1452.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Christophe R. JeanDIRECTOR ELECTIONSISSUER1452.0000005971.000000WITHHOLD1452.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Lynn A. TetraultDIRECTOR ELECTIONSISSUER1452.0000005971.000000WITHHOLD1452.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024.AUDIT-RELATEDISSUER1452.0000005971.000000FOR1452.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER1452.0000005971.000000FOR1452.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER1452.0000005971.000000FOR1452.000000FOR2S000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER1452.0000005971.000000FOR1452.000000FOR5S000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105109/18/2024Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan.COMPENSATIONISSUER1452.0000005971.000000AGAINST1452.000000AGAINSTS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER7542.0000000FOR7542.000000FORS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Ratify Ernst & Young LLP as AuditorsAUDIT-RELATEDISSUER7542.0000000FOR7542.000000FORS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Elect Director Ye WangDIRECTOR ELECTIONSISSUER7542.0000000AGAINST7542.000000AGAINSTS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Elect Director Darren Xiaohui JiDIRECTOR ELECTIONSISSUER7542.0000000FOR7542.000000FORS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Elect Director Ying HuangDIRECTOR ELECTIONSISSUER7542.0000000FOR7542.000000FORS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Elect Director Tomas HeymanDIRECTOR ELECTIONSISSUER7542.0000000FOR7542.000000FORS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Amend Restricted Stock PlanCOMPENSATIONISSUER7542.0000000FOR7542.000000FORS000047354Legend Biotech Corporation52490G102US52490G102210/21/2024Authorize Board to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER7542.0000000FOR7542.000000FORS000047354Intra-Cellular Therapies, Inc.46116X101US46116X101903/27/2025To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated January 10, 2025, by and among Intra-Cellular Therapies, Inc. ("ITI"), Johnson & Johnson, a New Jersey corporation ("Johnson & Johnson"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into ITI (the "Merger"), with ITI surviving the Merger as a wholly owned subsidiary of Johnson & Johnson.EXTRAORDINARY TRANSACTIONSISSUER4193.0000000FOR4193.000000FORS000047354Intra-Cellular Therapies, Inc.46116X101US46116X101903/27/2025To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.SECTION 14A SAY-ON-PAY VOTESISSUER4193.0000000AGAINST4193.000000AGAINSTS000047354Intra-Cellular Therapies, Inc.46116X101US46116X101903/27/2025To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.SECTION 14A SAY-ON-PAY VOTESISSUER4193.0000000AGAINST4193.000000AGAINST2S000047354Intra-Cellular Therapies, Inc.46116X101US46116X101903/27/2025To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.SECTION 14A SAY-ON-PAY VOTESISSUER4193.0000000AGAINST4193.000000AGAINST5S000047354Intra-Cellular Therapies, Inc.46116X101US46116X101903/27/2025To adjourn the Company Stockholders' Meeting to a later date or dates as provided in the Merger Agreement, if necessary or appropriate, including to solicit additional votes if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting of Stockholders.CORPORATE GOVERNANCEISSUER4193.0000000FOR4193.000000FORS000047354BeiGene Ltd.07725L102US07725L102604/28/2025THAT a special resolution that the deregistration of the Company in the Cayman Islands and the continuation of the Company to Switzerland be and hereby is approved and authorized (the "Continuation").EXTRAORDINARY TRANSACTIONSCORPORATE GOVERNANCEISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102604/28/2025Subject to, and effective only upon, (i) the approval of Resolution 1, (ii) the de-registration of the Company from the Register of Companies in the Cayman Islands and (iii) the simultaneous registration of the Continuation with the Swiss Commercial Register, THAT: 1. The seventh amended and restated memorandum and articles of association be amended and restated in the form set forth in Exhibit A to the proxy statement/prospectus (the "Proposed Swiss Articles") to be effective from the effective date of the Continuation. 2. The holders of ordinary shares represented in person or by proxy at the EGM hereby waive the option to discuss each individual article of the Proposed Swiss Articles and hereby approve the Proposed Swiss Articles in the form set forth in Exhibit A to the proxy statement/prospectus.CORPORATE GOVERNANCEISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102604/28/2025Subject to the approval of the Continuation and as required by Swiss law, THAT the election of Ernst & Young AG to serve as the Company's statutory auditor (for Swiss legal purposes) until the Company's first annual general meeting following the completion of the Continuation and provide the related audit services and the authorization to board of directors to fix the remuneration of Ernst & Young AG be and hereby is approved and authorized.AUDIT-RELATEDISSUER1940.0000000FOR1940.000000FORS000047354Moderna, Inc.60770K107US60770K107904/30/2025To elect three Class I director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Noubar B. AfeyanDIRECTOR ELECTIONSISSUER8166.0000000FOR8166.000000FORS000047354Moderna, Inc.60770K107US60770K107904/30/2025To elect three Class I director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Stephane BancelDIRECTOR ELECTIONSISSUER8166.0000000FOR8166.000000FORS000047354Moderna, Inc.60770K107US60770K107904/30/2025To elect three Class I director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Francois Nader, M.D.DIRECTOR ELECTIONSISSUER8166.0000000AGAINST8166.000000AGAINSTS000047354Moderna, Inc.60770K107US60770K107904/30/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8166.0000000AGAINST8166.000000AGAINSTS000047354Moderna, Inc.60770K107US60770K107904/30/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8166.0000000AGAINST8166.000000AGAINST2S000047354Moderna, Inc.60770K107US60770K107904/30/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8166.0000000AGAINST8166.000000AGAINST5S000047354Moderna, Inc.60770K107US60770K107904/30/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER8166.0000000FOR8166.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/01/2025Election of Class III Directors: Jeffrey W. HendersonDIRECTOR ELECTIONSISSUER7310.0000000FOR7310.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/01/2025Election of Class III Directors: Helen I. TorleyDIRECTOR ELECTIONSISSUER7310.0000000FOR7310.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/01/2025To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7310.0000000FOR7310.000000FORS000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/01/2025To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7310.0000000FOR7310.000000FOR2S000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/01/2025To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7310.0000000FOR7310.000000FOR5S000047354Halozyme Therapeutics, Inc.40637H109US40637H109505/01/2025To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7310.0000000FOR7310.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.DIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.DIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.DIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. KramerDIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.DIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish ManwaniDIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'DayDIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. RodriguezDIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony WeltersDIRECTOR ELECTIONSISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3817.0000000FOR3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3817.0000000FOR3817.000000FOR2S000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3817.0000000FOR3817.000000FOR5S000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting.DIVERSITY, EQUITY, AND INCLUSIONSECURITY HOLDER3817.0000000AGAINST3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER3817.0000000AGAINST3817.000000FORS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting.HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER3817.0000000FOR3817.000000AGAINSTS000047354Gilead Sciences, Inc.375558103US375558103605/07/2025To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting.ENVIRONMENT OR CLIMATEDIVERSITY, EQUITY, AND INCLUSIONOTHER SOCIAL ISSUESSECURITY HOLDER3817.0000000AGAINST3817.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To elect the following nominees as Class III directors of Alnylam: Carolyn R. Bertozzi, Ph.D.DIRECTOR ELECTIONSISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To elect the following nominees as Class III directors of Alnylam: Margaret A. Hamburg, M.D.DIRECTOR ELECTIONSISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To elect the following nominees as Class III directors of Alnylam: Colleen F. ReitanDIRECTOR ELECTIONSISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To elect the following nominees as Class III directors of Alnylam: Amy W. SchulmanDIRECTOR ELECTIONSISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To approve an Amendment to our Restated Certificate of Incorporation allowing for officer exculpation.CORPORATE GOVERNANCEISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To approve the second amended and restated 2018 Stock Incentive Plan.COMPENSATIONISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1426.0000000FOR1426.000000FORS000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1426.0000000FOR1426.000000FOR2S000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1426.0000000FOR1426.000000FOR5S000047354Alnylam Pharmaceuticals, Inc.02043Q107US02043Q107605/08/2025To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1426.0000000FOR1426.000000FORS000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Election of Class III Directors: Alan FuhrmanDIRECTOR ELECTIONSISSUER9037.0000000WITHHOLD9037.000000AGAINSTS000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Election of Class III Directors: Julie Hambleton, M.D.DIRECTOR ELECTIONSISSUER9037.0000000FOR9037.000000FORS000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Election of Class III Directors: Daniel S. Lynch, M.B.A.DIRECTOR ELECTIONSISSUER9037.0000000FOR9037.000000FORS000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Ratification of the appointment of Ernst & Young LLP as SpringWorks Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER9037.0000000FOR9037.000000FORS000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Non-binding advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER9037.0000000FOR9037.000000FORS000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Non-binding advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER9037.0000000FOR9037.000000FOR2S000047354SpringWorks Therapeutics, Inc.85205L107US85205L107005/14/2025Non-binding advisory vote on executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER9037.0000000FOR9037.000000FOR5S000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Sangeeta BhatiaDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Lloyd CarneyDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Alan GarberDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Reshma KewalramaniDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Michel LagardeDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Jeffrey LeidenDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Diana McKenzieDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Bruce SachsDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Jennifer SchneiderDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Nancy ThornberryDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Election of Directors: Suketu UpadhyayDIRECTOR ELECTIONSISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER753.0000000FOR753.000000FORS000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER753.0000000FOR753.000000FOR2S000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER753.0000000FOR753.000000FOR5S000047354Vertex Pharmaceuticals Incorporated92532F100US92532F100305/14/2025Shareholder proposal, if properly presented at the meeting, regarding excessive golden parachutes.COMPENSATIONSECURITY HOLDER753.0000000FOR753.000000AGAINSTS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Election of Directors: Kevin TangDIRECTOR ELECTIONSISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Election of Directors: Jeffrey A. BaileyDIRECTOR ELECTIONSISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Election of Directors: Kathy GoetzDIRECTOR ELECTIONSISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Election of Directors: Peter GreenleafDIRECTOR ELECTIONSISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Election of Directors: Craig JohnsonDIRECTOR ELECTIONSISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Election of Directors: Tina S. NovaDIRECTOR ELECTIONSISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the 2026 annual general meeting of shareholders or until a successor is appointed.AUDIT-RELATEDISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.SECTION 14A SAY-ON-PAY VOTESISSUER37051.0000000FOR37051.000000FORS000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.SECTION 14A SAY-ON-PAY VOTESISSUER37051.0000000FOR37051.000000FOR2S000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.SECTION 14A SAY-ON-PAY VOTESISSUER37051.0000000FOR37051.000000FOR5S000047354Aurinia Pharmaceuticals Inc.05156V102CA05156V102205/15/2025Amendment to Equity Incentive Plan To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular.COMPENSATIONISSUER37051.0000000FOR37051.000000FORS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/15/2025To elect three Class II directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Juan A. SabaterDIRECTOR ELECTIONSISSUER1.00000010974.000000WITHHOLD1.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/15/2025To elect three Class II directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Gary SenderDIRECTOR ELECTIONSISSUER1.00000010974.000000WITHHOLD1.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/15/2025To elect three Class II directors to serve until our 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Linda SzyperDIRECTOR ELECTIONSISSUER1.00000010974.000000WITHHOLD1.000000AGAINSTS000047354Harmony Biosciences Holdings, Inc.413197104US413197104005/15/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1.00000010974.000000FOR1.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER33.00000011503.000000FOR33.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER33.00000011503.000000AGAINST33.000000AGAINST2S000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER33.00000011503.000000AGAINST33.000000AGAINST5S000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2025.AUDIT-RELATEDISSUER33.00000011503.000000FOR33.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.AUDIT-RELATEDISSUER33.00000011503.000000FOR33.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2025.AUDIT-RELATEDISSUER33.00000011503.000000FOR33.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2024.CORPORATE GOVERNANCEISSUER33.00000011503.000000FOR33.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To approve the directors' remuneration report for the year ended 31 December 2024, which is set forth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-5 to A-15 of Annex A to the proxy statement).COMPENSATIONISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy statement, which will take effect immediately after the end of the AGM.COMPENSATIONISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To authorize the Company to make political donations/incur political expenditure.OTHER SOCIAL ISSUESISSUER33.00000011503.000000FOR33.000000FORS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into shares up to an aggregate nominal amount of pounds150,000.CAPITAL STRUCTUREISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Immunocore Holdings Plc45258D105US45258D105405/15/2025To empower the directors to allot equity securities for cash pursuant to the authorization in resolution 12 as if U.K. statutory pre-emption rights did not apply.CAPITAL STRUCTUREISSUER33.00000011503.000000AGAINST33.000000AGAINSTS000047354Insmed Incorporated457669307US457669307505/15/2025Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Shareholders: Leo LeeDIRECTOR ELECTIONSISSUER4853.0000000FOR4853.000000FORS000047354Insmed Incorporated457669307US457669307505/15/2025Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Shareholders: William H. LewisDIRECTOR ELECTIONSISSUER4853.0000000FOR4853.000000FORS000047354Insmed Incorporated457669307US457669307505/15/2025An advisory vote on the 2024 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4853.0000000FOR4853.000000FORS000047354Insmed Incorporated457669307US457669307505/15/2025An advisory vote on the 2024 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4853.0000000FOR4853.000000FOR2S000047354Insmed Incorporated457669307US457669307505/15/2025An advisory vote on the 2024 compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4853.0000000FOR4853.000000FOR5S000047354Insmed Incorporated457669307US457669307505/15/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER4853.0000000FOR4853.000000FORS000047354Insmed Incorporated457669307US457669307505/15/2025Approval of Amendment No. 2 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.COMPENSATIONISSUER4853.0000000FOR4853.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Roy BaynesDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Suzanne BruhnDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Timothy CoughlinDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Eric DubeDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Gary LyonsDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Jeffrey MecklerDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: John OrwinDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Sandra PooleDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Ron SquarerDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year: Ruth Williams-BrinkleyDIRECTOR ELECTIONSISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares.COMPENSATIONISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19523.0000000FOR19523.000000FORS000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19523.0000000FOR19523.000000FOR2S000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19523.0000000FOR19523.000000FOR5S000047354Travere Therapeutics, Inc.89422G107US89422G107605/15/2025To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER19523.0000000FOR19523.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Nominees: Matthew K. FustDIRECTOR ELECTIONSISSUER7457.0000000FOR7457.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Nominees: Amrit Ray, M.D.DIRECTOR ELECTIONSISSUER7457.0000000FOR7457.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Approval of the Second Amended and Restated 2023 Incentive Plan.COMPENSATIONISSUER7457.0000000AGAINST7457.000000AGAINSTS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7457.0000000FOR7457.000000FORS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Advisory (non-binding) vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7457.0000000AGAINST7457.000000AGAINSTS000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Advisory (non-binding) vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7457.0000000AGAINST7457.000000AGAINST2S000047354Ultragenyx Pharmaceutical Inc.90400D108US90400D108105/15/2025Advisory (non-binding) vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER7457.0000000AGAINST7457.000000AGAINST5S000047354BioNTech SE09075V102US09075V102605/16/2025Approve Allocation of Income and Omission of DividendsCAPITAL STRUCTUREISSUER2976.0000000FOR2976.000000FORS000047354BioNTech SE09075V102US09075V102605/16/2025Approve Discharge of Management Board for Fiscal Year 2024CORPORATE GOVERNANCEISSUER2976.0000000FOR2976.000000FORS000047354BioNTech SE09075V102US09075V102605/16/2025Approve Discharge of Supervisory Board for Fiscal Year 2024CORPORATE GOVERNANCEISSUER2976.0000000FOR2976.000000FORS000047354BioNTech SE09075V102US09075V102605/16/2025Ratify EY GmbH & Co. KG as Auditors for Fiscal Year 2025AUDIT-RELATEDISSUER2976.0000000FOR2976.000000FORS000047354BioNTech SE09075V102US09075V102605/16/2025Appoint EY GmbH & Co. KG as Auditor for Sustainability Reporting for Fiscal Year 2025AUDIT-RELATEDISSUER2976.0000000FOR2976.000000FORS000047354BioNTech SE09075V102US09075V102605/16/2025Approve Remuneration ReportCOMPENSATIONISSUER2976.0000000AGAINST2976.000000AGAINSTS000047354BioNTech SE09075V102US09075V102605/16/2025Approve Creation of EUR 124.3 Million Pool of Authorized Capital with or without Exclusion of Preemptive RightsCAPITAL STRUCTUREISSUER2976.0000000FOR2976.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/16/2025Election of Class II Directors: Daniel S. JanneyDIRECTOR ELECTIONSISSUER2016.0000000WITHHOLD2016.000000AGAINSTS000047354Krystal Biotech, Inc.501147102US501147102705/16/2025Election of Class II Directors: Dino A. RossiDIRECTOR ELECTIONSISSUER2016.0000000FOR2016.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/16/2025Election of Class II Directors: E. Rand SutherlandDIRECTOR ELECTIONSISSUER2016.0000000FOR2016.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/16/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2016.0000000FOR2016.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/16/2025Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER2016.0000000FOR2016.000000FORS000047354Krystal Biotech, Inc.501147102US501147102705/16/2025Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER2016.0000000FOR2016.000000FOR2S000047354Krystal Biotech, Inc.501147102US501147102705/16/2025Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER2016.0000000FOR2016.000000FOR5S000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025Election of Directors: Rick E WinninghamDIRECTOR ELECTIONSISSUER35426.0000000FOR35426.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025Election of Directors: Jeremy T. GrantDIRECTOR ELECTIONSISSUER35426.0000000FOR35426.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025Election of Directors: Susannah GrayDIRECTOR ELECTIONSISSUER35426.0000000FOR35426.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025Election of Directors: Donal O'ConnorDIRECTOR ELECTIONSISSUER35426.0000000FOR35426.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025To ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER35426.0000000FOR35426.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025To vote on a non-binding advisory resolution regarding the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35426.0000000FOR35426.000000FORS000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025To vote on a non-binding advisory resolution regarding the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35426.0000000FOR35426.000000FOR2S000047354Theravance Biopharma, Inc.G8807B106KYG8807B106805/19/2025To vote on a non-binding advisory resolution regarding the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER35426.0000000FOR35426.000000FOR5S000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Elizabeth M. AndersonDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Barbara W. BodemDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Athena CountouriotisDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Willard DereDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Mark J. EnyedyDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Alexander HardyDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Maykin HoDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Robert J. HombachDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Richard A. MeierDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025Election of Directors: Timothy P. WalbertDIRECTOR ELECTIONSISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5277.0000000FOR5277.000000FORS000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5277.0000000FOR5277.000000FOR2S000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5277.0000000FOR5277.000000FOR5S000047354BioMarin Pharmaceutical Inc.09061G101US09061G101305/20/2025To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended.COMPENSATIONISSUER5277.0000000FOR5277.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT Mr. Anthony C. Hooper be and is hereby re-elected to serve as a Class III director of the Company until the 2028 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.DIRECTOR ELECTIONSISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT Mr. Ranjeev Krishana be and is hereby re-elected to serve as a Class III director of the Company until the 2028 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.DIRECTOR ELECTIONSISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT Dr. Xiaodong Wang be and is hereby re-elected to serve as a Class III director of the Company until the 2028 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.DIRECTOR ELECTIONSISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT Mr. Qingqing Yi be and is hereby re-elected to serve as a Class III director of the Company until the 2028 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.DIRECTOR ELECTIONSISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT Ms. Shalini Sharp be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, subject to her earlier resignation or removal.DIRECTOR ELECTIONSISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2025 be and is hereby ratified and confirmed.AUDIT-RELATEDISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.CAPITAL STRUCTUREISSUER1940.0000000AGAINST1940.000000AGAINSTS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary shares (excluding the Company's ordinary shares listed on the Science and Technology Innovation Board of Shanghai Stock Exchange and traded in RMB ("RMB shares")) and/or ADSs, not exceeding 10% of the total number of issued ordinary shares (excluding RMB shares and treasury shares) of the Company as of the date of passing of this ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.CAPITAL STRUCTUREISSUER1940.0000000FOR1940.000000FORS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 8 for a period of five years, which period will be subject to an extension on a rolling basis each year.CAPITAL STRUCTUREISSUER1940.0000000AGAINST1940.000000AGAINSTS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER1940.0000000AGAINST1940.000000AGAINSTS000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER1940.0000000AGAINST1940.000000AGAINST2S000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER1940.0000000AGAINST1940.000000AGAINST5S000047354BeiGene Ltd.07725L102US07725L102605/21/2025THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals described above, be and is hereby approved.CORPORATE GOVERNANCEISSUER1940.0000000AGAINST1940.000000AGAINSTS000047354Geron Corporation374163103US374163103605/21/2025To elect the two nominees for director named below to hold office as Class II members of the Board of Directors until the 2028 annual meeting of stockholders: Dawn C. BirDIRECTOR ELECTIONSISSUER89198.0000000FOR89198.000000FORS000047354Geron Corporation374163103US374163103605/21/2025To elect the two nominees for director named below to hold office as Class II members of the Board of Directors until the 2028 annual meeting of stockholders: Elizabeth G. O'FarrellDIRECTOR ELECTIONSISSUER89198.0000000FOR89198.000000FORS000047354Geron Corporation374163103US374163103605/21/2025To approve an amendment to our 2018 Equity Incentive Plan to, among other items, increase the total number of shares of our common stock issuable thereunder by 20,000,000 shares.COMPENSATIONISSUER89198.0000000FOR89198.000000FORS000047354Geron Corporation374163103US374163103605/21/2025To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares of our common stock issuable thereunder by 6,000,000 shares.COMPENSATIONISSUER89198.0000000FOR89198.000000FORS000047354Geron Corporation374163103US374163103605/21/2025To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER89198.0000000FOR89198.000000FORS000047354Geron Corporation374163103US374163103605/21/2025To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER89198.0000000FOR89198.000000FOR2S000047354Geron Corporation374163103US374163103605/21/2025To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER89198.0000000FOR89198.000000FOR5S000047354Geron Corporation374163103US374163103605/21/2025To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER89198.0000000FOR89198.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Kyle W. Gano, Ph.D.DIRECTOR ELECTIONSISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Richard F. PopsDIRECTOR ELECTIONSISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Shalini SharpDIRECTOR ELECTIONSISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025The election of the four nominees for Class II directors named below to the Board of Directors to serve for a term of three years: Stephen A. Sherwin, M.D.DIRECTOR ELECTIONSISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025Advisory vote on the compensation paid to the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025Advisory vote on the compensation paid to the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2758.0000000FOR2758.000000FOR2S000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025Advisory vote on the compensation paid to the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER2758.0000000FOR2758.000000FOR5S000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025To approve the Company's 2025 Equity Incentive Plan;COMPENSATIONISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025To approve an amendment and restatement of the Company's 2018 Employee Stock Purchase Plan; andCOMPENSATIONISSUER2758.0000000FOR2758.000000FORS000047354Neurocrine Biosciences, Inc.64125C109US64125C109905/21/2025To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2758.0000000FOR2758.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. AustinDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. BradwayDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. DrakeDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. DrukerDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. EckertDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. GarlandDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.DIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar IshrakDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler JacksDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. KlotmanDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. KullmanDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. MilesDIRECTOR ELECTIONSISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1276.0000000FOR1276.000000FORS000047354Amgen Inc.031162100US031162100905/23/2025Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1276.0000000FOR1276.000000FOR2S000047354Amgen Inc.031162100US031162100905/23/2025Advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1276.0000000FOR1276.000000FOR5S000047354Amgen Inc.031162100US031162100905/23/2025To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1276.0000000FOR1276.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Elect Lars Luthjohan as Chair of MeetingCORPORATE GOVERNANCEISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Accept Financial Statements and Statutory Reports; Approve Discharge of Management and BoardCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Approve Treatment of Net LossCAPITAL STRUCTUREISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Reelect Albert Cha as DirectorDIRECTOR ELECTIONSISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Reelect Lars Holtug as DirectorDIRECTOR ELECTIONSISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Reelect Jan Moller Mikkelsen as DirectorDIRECTOR ELECTIONSISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Reelect Lisa Jane Morrison as DirectorDIRECTOR ELECTIONSISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Reelect William Carl Fairey Jr as DirectorDIRECTOR ELECTIONSISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Reelect Siham Imani as DirectorDIRECTOR ELECTIONSISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Ratify Deloitte as AuditorAUDIT-RELATEDISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Approve Creation of DKK 3.8 Million Pool of Capital without Preemptive RightsCAPITAL STRUCTUREISSUER2747.0000000FOR2747.000000FORS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Approve Issuance of Warrants to Board MembersCOMPENSATIONISSUER2747.0000000AGAINST2747.000000AGAINSTS000047354Ascendis Pharma A/S04351P101US04351P101205/27/2025Amend Articles Re: Board-RelatedCORPORATE GOVERNANCEISSUER2747.0000000FOR2747.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D.DIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D.DIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D.DIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. HeymanDIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. JohnsonDIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D.DIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr.DIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D.DIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRSDIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne SmithDIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. WyszomierskiDIRECTOR ELECTIONSISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 2, 2026.AUDIT-RELATEDISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER10209.0000000FOR10209.000000FORS000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER10209.0000000FOR10209.000000FOR2S000047354Exelixis, Inc.30161Q104US30161Q104005/28/2025To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER10209.0000000FOR10209.000000FOR5S000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To elect three Class III directors to hold office until the Company's 2028 Annual Meeting of Stockholders: Laura A. BregeDIRECTOR ELECTIONSISSUER20804.0000000FOR20804.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To elect three Class III directors to hold office until the Company's 2028 Annual Meeting of Stockholders: Elizabeth A. Garofalo, M.D.DIRECTOR ELECTIONSISSUER20804.0000000FOR20804.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To elect three Class III directors to hold office until the Company's 2028 Annual Meeting of Stockholders: Catherine Owen AdamsDIRECTOR ELECTIONSISSUER20804.0000000FOR20804.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER20804.0000000FOR20804.000000FORS000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER20804.0000000FOR20804.000000FOR2S000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER20804.0000000FOR20804.000000FOR5S000047354Acadia Pharmaceuticals Inc.004225108US004225108405/29/2025To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER20804.0000000FOR20804.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025Election of Class II Directors: Jay P. ShepardDIRECTOR ELECTIONSISSUER140800.0000000FOR140800.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025Election of Class II Directors: Seth H.Z. FischerDIRECTOR ELECTIONSISSUER140800.0000000FOR140800.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025To approve the non-binding advisory resolution on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER140800.0000000FOR140800.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025To approve the non-binding advisory resolution on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER140800.0000000FOR140800.000000FOR2S000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025To approve the non-binding advisory resolution on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER140800.0000000FOR140800.000000FOR5S000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER140800.0000000FOR140800.000000FORS000047354Esperion Therapeutics, Inc.29664W105US29664W105305/29/2025To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan.COMPENSATIONISSUER140800.0000000FOR140800.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To elect the Board's three Class III nominees for director to hold office until the Company's 2028 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christopher PeetzDIRECTOR ELECTIONSISSUER8492.0000000FOR8492.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To elect the Board's three Class III nominees for director to hold office until the Company's 2028 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Laura BregeDIRECTOR ELECTIONSISSUER8492.0000000WITHHOLD8492.000000AGAINSTS000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To elect the Board's three Class III nominees for director to hold office until the Company's 2028 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Michael GreyDIRECTOR ELECTIONSISSUER8492.0000000FOR8492.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8492.0000000FOR8492.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER8492.0000000FOR8492.000000FORS000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER8492.0000000FOR8492.000000FOR2S000047354Mirum Pharmaceuticals, Inc.604749101US604749101305/29/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER8492.0000000FOR8492.000000FOR5S000047354Day One Biopharmaceuticals, Inc.23954D109US23954D109006/02/2025Election of Class I Directors: Natalie HollesDIRECTOR ELECTIONSISSUER735.00000027295.000000FOR735.000000FORS000047354Day One Biopharmaceuticals, Inc.23954D109US23954D109006/02/2025Election of Class I Directors: Garry NicholsonDIRECTOR ELECTIONSISSUER735.00000027295.000000WITHHOLD735.000000AGAINSTS000047354Day One Biopharmaceuticals, Inc.23954D109US23954D109006/02/2025Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER735.00000027295.000000FOR735.000000FORS000047354Day One Biopharmaceuticals, Inc.23954D109US23954D109006/02/2025Approval, on a non-binding advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER735.00000027295.000000FOR735.000000FORS000047354Day One Biopharmaceuticals, Inc.23954D109US23954D109006/02/2025Approval, on a non-binding advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER735.00000027295.000000FOR735.000000FOR2S000047354Day One Biopharmaceuticals, Inc.23954D109US23954D109006/02/2025Approval, on a non-binding advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER735.00000027295.000000FOR735.000000FOR5S000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Election of Directors: Raymond DebbaneDIRECTOR ELECTIONSISSUER436672.0000000FOR436672.000000FORS000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Election of Directors: Ivan H. CheungDIRECTOR ELECTIONSISSUER436672.0000000FOR436672.000000FORS000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Ratification and approval of the amendment to the Company's 2017 Equity Incentive PlanCOMPENSATIONISSUER436672.0000000AGAINST436672.000000AGAINSTS000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Ratification and approval of the amendment to the Company's 2017 Non-Employee Directors' Equity Incentive PlanCOMPENSATIONISSUER436672.0000000FOR436672.000000FORS000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Approval of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's board of directors, a reverse split of its common stock, at a ratio within a range of 1-for-10 to 1-for-50, at any time prior to the Company's 2026 annual meeting of stockholders and with the actual ratio to be determined within that range at the discretion of the Company's board of directorsCAPITAL STRUCTUREISSUER436672.0000000FOR436672.000000FORS000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Advisory vote to approve the compensation paid to the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER436672.0000000FOR436672.000000FORS000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Advisory vote to approve the compensation paid to the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER436672.0000000FOR436672.000000FOR2S000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Advisory vote to approve the compensation paid to the Company's named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER436672.0000000FOR436672.000000FOR5S000047354Lexicon Pharmaceuticals, Inc.528872302US528872302706/02/2025Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER436672.0000000FOR436672.000000FORS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: A. Sinclair DunlopDIRECTOR ELECTIONSISSUER10967.0000000WITHHOLD10967.000000AGAINSTS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: Alec MachielsDIRECTOR ELECTIONSISSUER10967.0000000FOR10967.000000FORS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: Keli WalbertDIRECTOR ELECTIONSISSUER10967.0000000FOR10967.000000FORS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER10967.0000000FOR10967.000000FORS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025To hold an advisory vote to approve the compensation paid to our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER10967.0000000FOR10967.000000FORS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025To hold an advisory vote to approve the compensation paid to our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER10967.0000000FOR10967.000000FOR2S000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025To hold an advisory vote to approve the compensation paid to our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER10967.0000000FOR10967.000000FOR5S000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER10967.0000000ONE YEAR10967.000000FORS000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER10967.0000000ONE YEAR10967.000000FOR2S000047354Apellis Pharmaceuticals, Inc.03753U106US03753U106006/03/2025To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER10967.0000000ONE YEAR10967.000000FOR5S000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Sanj K. PatelDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Thomas R. MalleyDIRECTOR ELECTIONSISSUER17828.0000000AGAINST17828.000000AGAINSTS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class I Directors to serve until the 2028 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Richard S. LevyDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class II Directors to serve until the 2026 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. BiggarDIRECTOR ELECTIONSISSUER17828.0000000AGAINST17828.000000AGAINSTS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class II Directors to serve until the 2026 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley ColeDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class II Directors to serve until the 2026 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. QuartDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Felix J. Baker, Ph.D.DIRECTOR ELECTIONSISSUER17828.0000000AGAINST17828.000000AGAINSTS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: M. Cantey BoydDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Tracey L. McCainDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Election of Class III Directors to serve until the 2027 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Kimberly J. PopovitsDIRECTOR ELECTIONSISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of our next Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To authorize the Company's Board of Directors, through its Audit Committee, the authority to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of our next Annual General Meeting of Shareholders.AUDIT-RELATEDISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2024.CORPORATE GOVERNANCEISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2024.COMPENSATIONISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To approve the Company's UK Statutory Directors' Remuneration Policy.COMPENSATIONISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER17828.0000000FOR17828.000000FORS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER17828.0000000FOR17828.000000FOR2S000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER17828.0000000FOR17828.000000FOR5S000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To authorize the Board of Directors, generally and unconditionally for the purpose of section 551 of the UK Companies Act 2006 (the "Companies Act") to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the company ("Rights") up to a maximum aggregate nominal amount of $6,976.33, which represents approximately 35% of the issued ordinary share capital of the Company on the record date for the 2025 Annual General Meeting of Shareholders. This authority shall expire (unless previously renewed, varied or revoked) on June 2, 2030, but we may at any time before the expiration of this authority make an offer or agreement which would or might require shares to be allotted, or Rights to be granted, pursuant to this authority after its expiration, and the Board of Directors may allot shares or grant Rights in pursuance of that offer or agreement as if the authority conferred by this resolution had not expired. The authority granted by this resolution shall replace all of our existing authorities to allot any shares and to grant Rights previously granted in connection with the adoption of the Articles in June 2024, but without prejudice to any allotment of shares or grant of Rights already made or agreed or offered to be made pursuant to such authorities.CAPITAL STRUCTUREISSUER17828.0000000AGAINST17828.000000AGAINSTS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025Subject to the passing of Proposal No. 11, to empower the Board of Directors generally pursuant to section 570(1) and section 573 of the Companies Act to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the general authority conferred on them by Proposal No. 11 as if section 561(1) of the Companies Act did not apply to that allotment. This power (a) shall be limited to the allotment of equity securities up to a maximum aggregate of $6,976.33; (b) will expire (unless previously renewed, varied or revoked) on June 2, 2030, but we may at any time before the expiration of this power make an offer or agreement which would or might require equity securities to be allotted after that expiry and the Board of Directors may allot equity securities pursuant to any of those offers or agreements as if the power had not expired; and (c) will apply in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(3) of the Companies Act as if in the first paragraph of this proposal the words "pursuant to the general authority conferred on them by Proposal No. 11" were omitted. For purposes of this resolution, references to the allotment of equity securities shall be interpreted in accordance with section 560 of the Companies Act. This resolution replaces all unexercised powers previously granted to the Board of Directors, pursuant to the adoption of the Articles in June 2024, to allot equity securities as if section 561 of the Companies Act did not apply but shall be without prejudice to any allotment of equity securities already made or agreed or agreed to be made pursuant to such authorities.CAPITAL STRUCTUREISSUER17828.0000000AGAINST17828.000000AGAINSTS000047354Kiniksa Pharmaceuticals International, plcG52694109GB00BRXB0C0706/03/2025To authorize the Board of Directors to conduct a transaction with the Company's wholly-owned subsidiary, Kiniksa Pharmaceuticals, Ltd. ("Kiniksa Bermuda"), whereby the Company will redeem the preference shares previously issued to Kiniksa Bermuda through the capitalization of the Company's merger reserve account and subsequently cancelling the merger reserve bonus share issued as part of such capitalization via a court-approved process, thus creating distributable reserves to be utilized to redeem such preference shares and thereby allowing for the liquidation of Kiniksa Bermuda.EXTRAORDINARY TRANSACTIONSISSUER17828.0000000FOR17828.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To elect two class II directors to hold office until the 2026 Annual Meeting of Stockholders: Heidi KunzDIRECTOR ELECTIONSISSUER19857.00000025107.000000FOR19857.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To elect two class II directors to hold office until the 2026 Annual Meeting of Stockholders: James Topper, M.D., Ph.D.DIRECTOR ELECTIONSISSUER19857.00000025107.000000WITHHOLD19857.000000AGAINSTS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER19857.00000025107.000000FOR19857.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").SECTION 14A SAY-ON-PAY VOTESISSUER19857.00000025107.000000FOR19857.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").SECTION 14A SAY-ON-PAY VOTESISSUER19857.00000025107.000000FOR19857.000000FOR2S000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").SECTION 14A SAY-ON-PAY VOTESISSUER19857.00000025107.000000FOR19857.000000FOR5S000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency").SECTION 14A SAY-ON-PAY VOTESISSUER19857.00000025107.000000ONE YEAR19857.000000FORS000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency").SECTION 14A SAY-ON-PAY VOTESISSUER19857.00000025107.000000ONE YEAR19857.000000FOR2S000047354Phathom Pharmaceuticals, Inc.71722W107US71722W107106/03/2025To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency").SECTION 14A SAY-ON-PAY VOTESISSUER19857.00000025107.000000ONE YEAR19857.000000FOR5S000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S.DIRECTOR ELECTIONSISSUER19230.0000000FOR19230.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Lawrence P. GuiheenDIRECTOR ELECTIONSISSUER19230.0000000FOR19230.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER19230.0000000FOR19230.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19230.0000000FOR19230.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19230.0000000FOR19230.000000FOR2S000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19230.0000000FOR19230.000000FOR5S000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19230.0000000ONE YEAR19230.000000FORS000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19230.0000000ONE YEAR19230.000000FOR2S000047354ADMA Biologics, Inc.000899104US000899104606/04/2025To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER19230.0000000ONE YEAR19230.000000FOR5S000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Election of Directors: Michael A. KellyDIRECTOR ELECTIONSISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Election of Directors: Margaret G. McGlynnDIRECTOR ELECTIONSISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Election of Directors: Michael G. RaabDIRECTOR ELECTIONSISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Election of Directors: Glenn P. SblendorioDIRECTOR ELECTIONSISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Approval of the 2025 Equity Incentive Plan.COMPENSATIONISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Approval, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35370.0000000FOR35370.000000FORS000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Approval, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35370.0000000FOR35370.000000FOR2S000047354Amicus Therapeutics, Inc.03152W109US03152W109906/05/2025Approval, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER35370.0000000FOR35370.000000FOR5S000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2024.CORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Approval of the appropriation of financial results.CAPITAL STRUCTUREISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Discharge of the members of the Board of Directors and the Executive Committee.CORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Election or re-election of the members to the Board of Directors and the Chairman: 4.a Re-election of Samarth Kulkarni, Ph.D., as member and ChairmanDIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.b Re-election of Ali Behbahani, M.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.c Re-election of Maria Fardis, Ph.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.d Re-election of H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.e Re-election of Simeon J. George, M.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.f Re-election of John T. GreeneDIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.g Re-election of Katherine A. High, M.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.h Re-election of Sandesh Mahatme, LL.M.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.i Re-election of Christian Rommel, Ph.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.j Re-election of Douglas A. Treco, Ph.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20254.k Election of Briggs W. Morrison, M.D.DIRECTOR ELECTIONSISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Election or Re-election of the members of the Compensation Committee: 5.a Re-election of Ali Behbahani, M.D.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20255.b Re-election of H. Edward Fleming, Jr., M.D.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20255.c Re-election of John T. GreeneDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20255.d Election of Briggs W. Morrison, M.D.DIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2024 Compensation Report: 6.a Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.COMPENSATIONISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20256.b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.COMPENSATIONISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20256.c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026.COMPENSATIONISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20256.d Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025.COMPENSATIONISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20256.e Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders.COMPENSATIONISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/20256.f Non-binding advisory vote on the 2024 Compensation Report.COMPENSATIONISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007904.000000AGAINST1.000000AGAINST2S000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000007904.000000AGAINST1.000000AGAINST5S000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Approval of increasing the maximum size of the Board of Directors.CORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Re-election of the independent voting rights representative.CORPORATE GOVERNANCEISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Re-election of the auditors.AUDIT-RELATEDISSUER1.0000007904.000000FOR1.000000FORS000047354CRISPR Therapeutics AGH17182108CH033408113706/05/2025Transact any other business that may properly come before the 2025 Annual General Meeting or any adjournment or postponement thereof.CORPORATE GOVERNANCEISSUER1.0000007904.000000AGAINST1.000000AGAINSTS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025Election of Directors: Allene M. DiazDIRECTOR ELECTIONSISSUER9701.0000000FOR9701.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025Election of Directors: Michael HaydenDIRECTOR ELECTIONSISSUER9701.0000000FOR9701.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025Election of Directors: Joseph Klein, IIIDIRECTOR ELECTIONSISSUER9701.0000000FOR9701.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025Election of Directors: Joseph LoscalzoDIRECTOR ELECTIONSISSUER9701.0000000FOR9701.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025To make an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9701.0000000FOR9701.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025To make an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9701.0000000FOR9701.000000FOR2S000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025To make an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER9701.0000000FOR9701.000000FOR5S000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 4,000,000 shares to an aggregate of 42,500,000 shares.COMPENSATIONISSUER9701.0000000FOR9701.000000FORS000047354Ionis Pharmaceuticals, Inc.462222100US462222100406/05/2025To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2025 fiscal year.AUDIT-RELATEDISSUER9701.0000000FOR9701.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: RICHARD J. BARRYDIRECTOR ELECTIONSISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: M. KATHLEEN BEHRENS, PH.D.DIRECTOR ELECTIONSISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: STEPHEN L. MAYO, PH.D.DIRECTOR ELECTIONSISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025TO ELECT, AS CLASS II DIRECTORS TO HOLD OFFICE UNTIL THE 2027 ANNUAL MEETING OF STOCKHOLDERS, OR UNTIL THEIR SUCCESSORS ARE EARLIER ELECTED, THE FOLLOWING DIRECTOR NOMINEES: CLAUDE NICAISE, M.D.DIRECTOR ELECTIONSISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER2883.0000000FOR2883.000000FOR2S000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATIONSECTION 14A SAY-ON-PAY VOTESISSUER2883.0000000FOR2883.000000FOR5S000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025APPROVE AN AMENDMENT TO THE COMPANY'S 2018 EQUITY INCENTIVE PLAN (THE "2018 PLAN") TO INCREASE THE MAXIMUM AGGREGATE NUMBER OF SHARES OF COMMON STOCK THAT MAY BE ISSUED PURSUANT TO AWARDS GRANTED UNDER THE 2018 PLAN BY 4,300,000 SHARES TO 17,487,596 SHARESCOMPENSATIONISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025APPROVE AN AMENDMENT TO THE AMENDED AND RESTATED 2013 EMPLOYEE STOCK PURCHASE PLAN (AS AMENDED AND RESTATED ON JUNE 27, 2016, AND AMENDED ON JUNE 6, 2019 AND ON JUNE 8, 2023) (THE "2016 ESPP") TO INCREASE THE NUMBER OF SHARES OF THE COMPANY'S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2016 ESPP BY 300,000 SHARES TO 1,700,000 SHARESCOMPENSATIONISSUER2883.0000000FOR2883.000000FORS000047354Sarepta Therapeutics, Inc.803607100US803607100406/05/2025RATIFY THE SELECTION OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT YEAR ENDING DECEMBER 31, 2025AUDIT-RELATEDISSUER2883.0000000FOR2883.000000FORS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/06/2025Election of Director: Roger Jeffs, Ph.D.DIRECTOR ELECTIONSISSUER1.0000003805.000000WITHHOLD1.000000AGAINSTS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/06/2025To approve the Company's 2025 Long-Term Incentive Plan.COMPENSATIONISSUER1.0000003805.000000AGAINST1.000000AGAINSTS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/06/2025To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER1.0000003805.000000FOR1.000000FORS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/06/2025To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000003805.000000FOR1.000000FORS000047354Axsome Therapeutics, Inc.05464T104US05464T104306/06/2025To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000003805.000000FOR1.000000FOR2S000047354Axsome Therapeutics, Inc.05464T104US05464T104306/06/2025To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.0000003805.000000FOR1.000000FOR5S000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: Jason M. AryehDIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: Todd C. DavisDIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: Nancy R. Gray, Ph.D.DIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: Jason HaasDIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: John W. Kozarich, Ph.D.DIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: John L. LaMattina, Ph.D.DIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: Stephen L. Sabba, M.D.DIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Election of Directors: Martine Zimmermann, Pharm.D.DIRECTOR ELECTIONSISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Approval, on an advisory basis, of the compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER3162.0000000FOR3162.000000FORS000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Approval, on an advisory basis, of the compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER3162.0000000FOR3162.000000FOR2S000047354Ligand Pharmaceuticals Incorporated53220K504US53220K504806/06/2025Approval, on an advisory basis, of the compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER3162.0000000FOR3162.000000FOR5S000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Julian C. BakerDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Jean-Jacques BienaimeDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Otis W. BrawleyDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Paul J. ClancyDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Jacqualyn A. FouseDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Edmund P. HarriganDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Katherine A. HighDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Herve HoppenotDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Election of Directors: Susanne SchaffertDIRECTOR ELECTIONSISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5072.0000000FOR5072.000000FOR2S000047354Incyte Corporation45337C102US45337C102706/10/2025Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5072.0000000FOR5072.000000FOR5S000047354Incyte Corporation45337C102US45337C102706/10/2025Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan.COMPENSATIONISSUER5072.0000000AGAINST5072.000000AGAINSTS000047354Incyte Corporation45337C102US45337C102706/10/2025Approve an amendment of the Company's 1997 Employee Stock Purchase Plan.COMPENSATIONISSUER5072.0000000FOR5072.000000FORS000047354Incyte Corporation45337C102US45337C102706/10/2025Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER5072.0000000FOR5072.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: lain Dukes, D. Phil.DIRECTOR ELECTIONSISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Athena Countouriotis, M.D.DIRECTOR ELECTIONSISSUER45107.0000000AGAINST45107.000000AGAINSTS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Ryan MaynardDIRECTOR ELECTIONSISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wayne P. RothbaumDIRECTOR ELECTIONSISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D.DIRECTOR ELECTIONSISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D.DIRECTOR ELECTIONSISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Wendy YarnoDIRECTOR ELECTIONSISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To approve, by non-binding advisory vote, the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To approve, by non-binding advisory vote, the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER45107.0000000FOR45107.000000FOR2S000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To approve, by non-binding advisory vote, the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTESISSUER45107.0000000FOR45107.000000FOR5S000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 12,500,000 shares; andCOMPENSATIONISSUER45107.0000000FOR45107.000000FORS000047354Iovance Biotherapeutics, Inc.462260100US462260100706/10/2025To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares.COMPENSATIONISSUER45107.0000000FOR45107.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Mark Currie, Ph.D.DIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Alexander Denner, Ph.D.DIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Andrew DreyfusDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jon DuaneDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Marla KesslerDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Thomas McCourtDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Julie McHughDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Catherine MoukheibirDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Election of Directors. To elect nine director nominees numbered 01 through 09 to serve for a one-year term extending until the 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jay ShepardDIRECTOR ELECTIONSISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER100851.0000000FOR100851.000000FORS000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER100851.0000000FOR100851.000000FOR2S000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER100851.0000000FOR100851.000000FOR5S000047354Ironwood Pharmaceuticals, Inc.46333X108US46333X108106/10/2025Ratification of the selection of Ernst & Young LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER100851.0000000FOR100851.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Brent MacGregoDIRECTOR ELECTIONSISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Scott MyersDIRECTOR ELECTIONSISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Lauren SilvernailDIRECTOR ELECTIONSISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: BOARD NOMINEES: Elaine SunDIRECTOR ELECTIONSISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Brett ErkmanDIRECTOR ELECTIONSSECURITY HOLDER27636.0000000WITHHOLD27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Jeffrey FarrowDIRECTOR ELECTIONSSECURITY HOLDER27636.0000000WITHHOLD27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Michael MulletteDIRECTOR ELECTIONSSECURITY HOLDER27636.0000000WITHHOLD27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four (4) nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES OPPOSED BY THE COMPANY: Donald SantelDIRECTOR ELECTIONSSECURITY HOLDER27636.0000000WITHHOLD27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve, on an advisory basis, executive compensation for certain of our executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve, on an advisory basis, executive compensation for certain of our executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER27636.0000000FOR27636.000000FOR2S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve, on an advisory basis, executive compensation for certain of our executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER27636.0000000FOR27636.000000FOR5S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to declassify on a phased basis the Company's Board of Directors and to implement certain other changes.SHAREHOLDER RIGHTS AND DEFENSESISSUER27636.0000000FOR27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025Stockholder proposal to amend the Company's Amended and Restated Bylaws to repeal each provision of, or amendment to, the Company's Amended and Restated Bylaws adopted by the Board without stockholder approval subsequent to November 6, 2018, if properly presented by Deep Track at the Annual Meeting.CORPORATE GOVERNANCESECURITY HOLDER27636.0000000AGAINST27636.000000FORS000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Brett A. ErkmanDIRECTOR ELECTIONSSECURITY HOLDER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Jeffrey S. FarrowDIRECTOR ELECTIONSSECURITY HOLDER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Michael MulletteDIRECTOR ELECTIONSSECURITY HOLDER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: DEEP TRACK NOMINEES: Donald J. SantelDIRECTOR ELECTIONSSECURITY HOLDER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Brent MacGregorDIRECTOR ELECTIONSISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Scott MyersDIRECTOR ELECTIONSISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Lauren SilvernailDIRECTOR ELECTIONSISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To elect four nominees as Class I directors to hold office until the 2028 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: COMPANY NOMINEES OPPOSED BY DEEP TRACK CAPITAL: Elaine SunDIRECTOR ELECTIONSISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER0.00000002S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER0.00000005S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to declassify the Company's Board of Directors on a phased. basis and implement certain other changes.SHAREHOLDER RIGHTS AND DEFENSESISSUER0.0000000S000047354Dynavax Technologies Corporation268158201US268158201906/11/2025Deep Track's proposal to amend the Company's Amended and Restated Bylaws to repeal each provision of, or amendment to, the Company's Amended and Restated Bylaws adopted by the Board without stockholder approval subsequent to November 6, 2018.CORPORATE GOVERNANCESECURITY HOLDER0.0000000S000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, subject to his earlier death, resignation, or removal: James M. FratesDIRECTOR ELECTIONSISSUER63321.0000000FOR63321.000000FORS000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To elect two directors, James M. Frates and George Golumbeski, Ph.D., each to serve as a Class II director until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, subject to his earlier death, resignation, or removal: George Golumbeski, Ph.D.DIRECTOR ELECTIONSISSUER63321.0000000WITHHOLD63321.000000AGAINSTS000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER63321.0000000FOR63321.000000FORS000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To hold a non-binding advisory vote to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER63321.0000000FOR63321.000000FORS000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To hold a non-binding advisory vote to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER63321.0000000FOR63321.000000FOR2S000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To hold a non-binding advisory vote to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER63321.0000000FOR63321.000000FOR5S000047354Sage Therapeutics, Inc.78667J108US78667J108806/11/2025To approve an amendment to our 2014 Employee Stock Purchase Plan, as amended, or the 2014 ESPP, to increase the number of shares of our common stock authorized for issuance under the 2014 ESPP by 500,000 shares.COMPENSATIONISSUER63321.0000000FOR63321.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025Election of Directors (each to serve until the 2028 Annual Meeting of Stockholders): Steven Galson, M.D., MPHDIRECTOR ELECTIONSISSUER47239.0000000FOR47239.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025Election of Directors (each to serve until the 2028 Annual Meeting of Stockholders): Alan LevinDIRECTOR ELECTIONSISSUER47239.0000000FOR47239.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025To ratify the selection of Ernst & Young LLP as the Company's independent registered public accountants for 2025.AUDIT-RELATEDISSUER47239.0000000FOR47239.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025To hold a non-binding, advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER47239.0000000FOR47239.000000FORS000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025To hold a non-binding, advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER47239.0000000FOR47239.000000FOR2S000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025To hold a non-binding, advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER47239.0000000FOR47239.000000FOR5S000047354BioCryst Pharmaceuticals, Inc.09058V103US09058V103506/12/2025To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.COMPENSATIONISSUER47239.0000000AGAINST47239.000000AGAINSTS000047354Legend Biotech Corporation52490G102US52490G102206/12/2025Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER11568.0000000FOR11568.000000FORS000047354Legend Biotech Corporation52490G102US52490G102206/12/2025Ratify Ernst & Young LLP as AuditorsAUDIT-RELATEDISSUER11568.0000000FOR11568.000000FORS000047354Legend Biotech Corporation52490G102US52490G102206/12/2025Elect Director Patrick CaseyDIRECTOR ELECTIONSISSUER11568.0000000FOR11568.000000FORS000047354Legend Biotech Corporation52490G102US52490G102206/12/2025Elect Director Yau Wai Man PhilipDIRECTOR ELECTIONSISSUER11568.0000000FOR11568.000000FORS000047354Legend Biotech Corporation52490G102US52490G102206/12/2025Elect Director Fangliang ZhangDIRECTOR ELECTIONSISSUER11568.0000000FOR11568.000000FORS000047354Legend Biotech Corporation52490G102US52490G102206/12/2025Authorize Board to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER11568.0000000FOR11568.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To elect Class II directors, to serve until the 2028 annual meeting of stockholders or until their respective successor have been elected or appointed: Bobak AzamianDIRECTOR ELECTIONSISSUER7025.0000000WITHHOLD7025.000000AGAINSTS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To elect Class II directors, to serve until the 2028 annual meeting of stockholders or until their respective successor have been elected or appointed: Katherine GoodrichDIRECTOR ELECTIONSISSUER7025.0000000FOR7025.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7025.0000000FOR7025.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7025.0000000FOR7025.000000FOR2S000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7025.0000000FOR7025.000000FOR5S000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.SECTION 14A SAY-ON-PAY VOTESISSUER7025.0000000ONE YEAR7025.000000FORS000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.SECTION 14A SAY-ON-PAY VOTESISSUER7025.0000000ONE YEAR7025.000000FOR2S000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.SECTION 14A SAY-ON-PAY VOTESISSUER7025.0000000ONE YEAR7025.000000FOR5S000047354Tarsus Pharmaceuticals, Inc.87650L103US87650L103506/12/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7025.0000000FOR7025.000000FORS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025Election of Directors: Laurence CharneyDIRECTOR ELECTIONSISSUER1.00000011696.000000WITHHOLD1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025Election of Directors: Yann EchelardDIRECTOR ELECTIONSISSUER1.00000011696.000000WITHHOLD1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025Election of Directors: Kenneth HobermanDIRECTOR ELECTIONSISSUER1.00000011696.000000WITHHOLD1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025Election of Directors: Daniel HumeDIRECTOR ELECTIONSISSUER1.00000011696.000000WITHHOLD1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025Election of Directors: Sagar Lonial, MDDIRECTOR ELECTIONSISSUER1.00000011696.000000WITHHOLD1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025Election of Directors: Michael S. WeissDIRECTOR ELECTIONSISSUER1.00000011696.000000WITHHOLD1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER1.00000011696.000000FOR1.000000FORS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025An advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000011696.000000AGAINST1.000000AGAINSTS000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025An advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000011696.000000AGAINST1.000000AGAINST2S000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025An advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1.00000011696.000000AGAINST1.000000AGAINST5S000047354TG Therapeutics, Inc.88322Q108US88322Q108506/12/2025To approve Amendment No. 2 to our 2022 Incentive Plan to increase the number of shares of common stock authorized for issuance under the 2022 Incentive Plan from 17,000,000 to 22,000,000 sharesCOMPENSATIONISSUER1.00000011696.000000FOR1.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Election of Directors: Bonnie L. Bassler, Ph.D.DIRECTOR ELECTIONSISSUER486.0000000AGAINST486.000000AGAINSTS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Election of Directors: Michael S. Brown, M.D.DIRECTOR ELECTIONSISSUER486.0000000AGAINST486.000000AGAINSTS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Election of Directors: Leonard S. Schleifer, M.D., Ph.D.DIRECTOR ELECTIONSISSUER486.0000000FOR486.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Election of Directors: George D. Yancopoulos, M.D., Ph.D.DIRECTOR ELECTIONSISSUER486.0000000FOR486.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER486.0000000FOR486.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Proposal to approve, on an advisory basis, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER486.0000000FOR486.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Proposal to approve, on an advisory basis, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER486.0000000FOR486.000000FOR2S000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Proposal to approve, on an advisory basis, executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER486.0000000FOR486.000000FOR5S000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors.SHAREHOLDER RIGHTS AND DEFENSESISSUER486.0000000FOR486.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of IncorporationCORPORATE GOVERNANCEISSUER486.0000000FOR486.000000FORS000047354Regeneron Pharmaceuticals, Inc.75886F107US75886F107506/13/2025Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article VI of the Certificate of Incorporation.CORPORATE GOVERNANCEISSUER486.0000000FOR486.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. DorsaDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. FreireDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: William A. HawkinsDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. LangerDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. MantasDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd MinorDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Menelas PangalosDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Monish PatolawalaDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. RowinskyDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. SherwinDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. ViehbacherDIRECTOR ELECTIONSISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025AUDIT-RELATEDISSUER2311.0000000FOR2311.000000FORS000047354Biogen Inc.09062X103US09062X103706/17/2025Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2311.0000000AGAINST2311.000000AGAINSTS000047354Biogen Inc.09062X103US09062X103706/17/2025Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2311.0000000AGAINST2311.000000AGAINST2S000047354Biogen Inc.09062X103US09062X103706/17/2025Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2311.0000000AGAINST2311.000000AGAINST5S000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Election of Three Class III Directors: Allan Jacobson, Ph.D.DIRECTOR ELECTIONSISSUER7583.0000000FOR7583.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Election of Three Class III Directors: David P. SouthwellDIRECTOR ELECTIONSISSUER7583.0000000FOR7583.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Election of Three Class III Directors: Alethia YoungDIRECTOR ELECTIONSISSUER7583.0000000FOR7583.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7583.0000000FOR7583.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7583.0000000FOR7583.000000FORS000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7583.0000000FOR7583.000000FOR2S000047354PTC Therapeutics, Inc.69366J200US69366J200606/17/2025Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER7583.0000000FOR7583.000000FOR5S000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Jacqualyn A. Fouse, Ph.D.DIRECTOR ELECTIONSISSUER9408.0000000FOR9408.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: David Scadden, M.D.DIRECTOR ELECTIONSISSUER9408.0000000FOR9408.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To vote, on an advisory basis, to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9408.0000000FOR9408.000000FORS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To vote, on an advisory basis, to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9408.0000000FOR9408.000000FOR2S000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To vote, on an advisory basis, to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER9408.0000000FOR9408.000000FOR5S000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, to increase the number of shares of common stock available thereunder by 2,500,000 shares.COMPENSATIONISSUER9408.0000000AGAINST9408.000000AGAINSTS000047354Agios Pharmaceuticals, Inc.00847X104US00847X104606/18/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER9408.0000000FOR9408.000000FORS000047354Ardelyx, Inc.039697107US039697107106/18/2025To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: David MottDIRECTOR ELECTIONSISSUER68515.0000000WITHHOLD68515.000000AGAINSTS000047354Ardelyx, Inc.039697107US039697107106/18/2025To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: Michael RaabDIRECTOR ELECTIONSISSUER68515.0000000WITHHOLD68515.000000AGAINSTS000047354Ardelyx, Inc.039697107US039697107106/18/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay");SECTION 14A SAY-ON-PAY VOTESISSUER68515.0000000FOR68515.000000FORS000047354Ardelyx, Inc.039697107US039697107106/18/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay");SECTION 14A SAY-ON-PAY VOTESISSUER68515.0000000FOR68515.000000FOR2S000047354Ardelyx, Inc.039697107US039697107106/18/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay");SECTION 14A SAY-ON-PAY VOTESISSUER68515.0000000FOR68515.000000FOR5S000047354Ardelyx, Inc.039697107US039697107106/18/2025To ratify the selection, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER68515.0000000FOR68515.000000FORS000047354Ardelyx, Inc.039697107US039697107106/18/2025To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan; andCOMPENSATIONISSUER68515.0000000AGAINST68515.000000AGAINSTS000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Jeffrey AlbersDIRECTOR ELECTIONSISSUER3878.0000000WITHHOLD3878.000000AGAINSTS000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Mark Goldberg, M.D.DIRECTOR ELECTIONSISSUER3878.0000000WITHHOLD3878.000000AGAINSTS000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: John Tsai, M.D.DIRECTOR ELECTIONSISSUER3878.0000000WITHHOLD3878.000000AGAINSTS000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Approval of a non-binding advisory vote on the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3878.0000000FOR3878.000000FORS000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Approval of a non-binding advisory vote on the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3878.0000000FOR3878.000000FOR2S000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Approval of a non-binding advisory vote on the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3878.0000000FOR3878.000000FOR5S000047354Blueprint Medicines Corporation09627Y109US09627Y109106/18/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3878.0000000FOR3878.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Patrick Soon-Shiong, M.D.DIRECTOR ELECTIONSISSUER201.000000117899.000000WITHHOLD201.000000AGAINSTS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Cheryl L. CohenDIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Richard AdcockDIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Michael D. BlaszykDIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Wesley ClarkDIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Linda Maxwell, M.D.DIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Christobel SeleckyDIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025Election of Directors: Barry J. Simon, M.D.DIRECTOR ELECTIONSISSUER201.000000117899.000000FOR201.000000FORS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025To approve the ImmunityBio, Inc. 2025 Equity Incentive Plan.COMPENSATIONISSUER201.000000117899.000000AGAINST201.000000AGAINSTS000047354ImmunityBio, Inc.45256X103US45256X103706/18/2025To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER201.000000117899.000000FOR201.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Samantha (Ying) DuDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: John D. DiekmanDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Richard GaynorDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Nisa LeungDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: William LisDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Scott MorrisonDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Leon O. Moulder, Jr.DIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Michel VounatsosDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, each director nominee identified below is hereby re-elected to serve as a director until the 2026 annual general meeting of shareholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal: Peter WirthDIRECTOR ELECTIONSISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, the appointment of KPMG LLP and KPMG as the Company's independent registered public accounting firms and auditors to audit the Company's consolidated financial statements to be filed with the U.S. Securities and Exchange Commission and The Stock Exchange of Hong Kong Limited for the year ending December 31, 2025, respectively, is hereby approved.AUDIT-RELATEDISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, the authority of the Board of Directors to fix auditor compensation for 2025, is hereby approved.AUDIT-RELATEDISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER13435.0000000AGAINST13435.000000AGAINSTS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER13435.0000000AGAINST13435.000000AGAINST2S000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.SECTION 14A SAY-ON-PAY VOTESISSUER13435.0000000AGAINST13435.000000AGAINST5S000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, a general mandate to the Board of Directors to allot and issue ordinary shares and/or ADSs and/or resell treasury shares of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2026 annual general meeting of shareholders is hereby approved.CAPITAL STRUCTUREISSUER13435.0000000FOR13435.000000FORS000047354Zai Lab Limited98887Q104US98887Q104006/18/2025THAT, a general mandate to repurchase ordinary shares and/or ADSs of up to 10% of the total number of issued ordinary shares of the Company (excluding treasury shares) as of the date of the Annual Meeting until the 2026 annual general meeting of shareholders is hereby approved.CAPITAL STRUCTUREISSUER13435.0000000FOR13435.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Neil Kumar, Ph.D.DIRECTOR ELECTIONSISSUER342.00000012636.000000FOR342.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Charles Homcy, M.D.DIRECTOR ELECTIONSISSUER342.00000012636.000000FOR342.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Douglas A. DachilleDIRECTOR ELECTIONSISSUER342.00000012636.000000WITHHOLD342.000000AGAINSTS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Ronald J. DanielsDIRECTOR ELECTIONSISSUER342.00000012636.000000FOR342.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To elect five (5) nominees for director, Neil Kumar, Ph.D., Charles Homcy, M.D., Douglas A. Dachille, Ronald J. Daniels and Andrew W. Lo, Ph.D., to serve as Class III directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2027 and until their successors are duly elected and qualified: Andrew W. Lo, Ph.D.DIRECTOR ELECTIONSISSUER342.00000012636.000000WITHHOLD342.000000AGAINSTS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER342.00000012636.000000AGAINST342.000000AGAINSTS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER342.00000012636.000000AGAINST342.000000AGAINST2S000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER342.00000012636.000000AGAINST342.000000AGAINST5S000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER342.00000012636.000000FOR342.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares.COMPENSATIONISSUER342.00000012636.000000AGAINST342.000000AGAINSTS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of our officers as permitted under current Delaware law.CORPORATE GOVERNANCEISSUER342.00000012636.000000FOR342.000000FORS000047354BridgeBio Pharma, Inc.10806X102US10806X102806/20/2025To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals.CORPORATE GOVERNANCEISSUER342.00000012636.000000AGAINST342.000000AGAINSTS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Re-election of Class III directors: Julian BakerDIRECTOR ELECTIONSISSUER1358.0000000FOR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Re-election of Class III directors: Raymond Cheong, M.D., Ph.D.DIRECTOR ELECTIONSISSUER1358.0000000FOR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Re-election of Class III directors: Jacqualyn Fouse, Ph.D.DIRECTOR ELECTIONSISSUER1358.0000000FOR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Re-election of Class III directors: Richard Levy, M.D.DIRECTOR ELECTIONSISSUER1358.0000000FOR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER1358.0000000FOR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1358.0000000FOR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1358.0000000FOR1358.000000FOR2S000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Advisory vote to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1358.0000000FOR1358.000000FOR5S000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Advisory vote to approve the frequency of future advisory votes to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1358.0000000ONE YEAR1358.000000FORS000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Advisory vote to approve the frequency of future advisory votes to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1358.0000000ONE YEAR1358.000000FOR2S000047354Madrigal Pharmaceuticals, Inc.558868105US558868105706/20/2025Advisory vote to approve the frequency of future advisory votes to approve executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER1358.0000000ONE YEAR1358.000000FOR5S000047354Novavax, Inc.670002401US670002401006/20/2025Election of three Class III directors to serve on the board of directors, each for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Rachel K. KingDIRECTOR ELECTIONSISSUER1041.00000038764.000000FOR1041.000000FORS000047354Novavax, Inc.670002401US670002401006/20/2025Election of three Class III directors to serve on the board of directors, each for a three-year term expiring at the 2028 Annual Meeting of Stockholders: John W. Shiver, Ph.D.DIRECTOR ELECTIONSISSUER1041.00000038764.000000FOR1041.000000FORS000047354Novavax, Inc.670002401US670002401006/20/2025Election of three Class III directors to serve on the board of directors, each for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Charles W. NewtonDIRECTOR ELECTIONSISSUER1041.00000038764.000000FOR1041.000000FORS000047354Novavax, Inc.670002401US670002401006/20/2025The approval, on an advisory basis, of the compensation paid of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1041.00000038764.000000FOR1041.000000FORS000047354Novavax, Inc.670002401US670002401006/20/2025The approval, on an advisory basis, of the compensation paid of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1041.00000038764.000000FOR1041.000000FOR2S000047354Novavax, Inc.670002401US670002401006/20/2025The approval, on an advisory basis, of the compensation paid of our Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER1041.00000038764.000000FOR1041.000000FOR5S000047354Novavax, Inc.670002401US670002401006/20/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1041.00000038764.000000FOR1041.000000FORS000047354ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: J. Kevin AkersDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: John C. AleDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Kim R. CocklinDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Kelly H. ComptonDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Sean DonohueDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Rafael G. GarzaDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Edward J. GeiserDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Nancy K. QuinnDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Richard A. SampsonDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Telisa ToliverDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Election of Director: Frank YohoDIRECTOR ELECTIONSISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Proposal to approve an amendment to the Company's 1998 Long - Term Incentive Plan to provide for an increase of 2,000,000 shares of common stock reserved for issuance under the plan.COMPENSATIONISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2025.AUDIT-RELATEDISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Proposal for an advisory vote by shareholders to approve the compensation of the Company's named executive officers for fiscal 2024 ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER85224.0000000.000000FOR85224.000000FORS000049397ATMOS ENERGY CORPORATION049560105US049560105802/05/2025Proposal for an advisory vote by shareholders to approve the compensation of the Company's named executive officers for fiscal 2024 ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER85224.0000000.000000FOR85224.000000FOR3S000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Wendy Montoya CloonanDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Barbara J. DuganierDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Laurie L. FitchDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Christopher H. FranklinDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Raquelle W. LewisDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Thaddeus J. MalikDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Manuel B. MirandaDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Theodore F. PoundDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Dean L. SeaversDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Phillip R. SmithDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Election of Director: Jason P. WellsDIRECTOR ELECTIONSISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Approve the advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER624948.0000000.000000FOR624948.000000FORS000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Approve the advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER624948.0000000.000000FOR624948.000000FOR3S000049397CENTERPOINT ENERGY, INC.15189T107US15189T107904/16/2025Approve an amendment to the CenterPoint Energy, Inc. Stock Plan for Outside Directors, as amended and restated, to increase the number of shares of our common stock reserved for issuance under the plan by 350,000 shares.COMPENSATIONISSUER624948.0000000.000000FOR624948.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Ralph A. LaRossaDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Susan TomaskyDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Willie A. DeeseDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Jamie M. GentosoDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Barry H. OstrowskyDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Ricardo G. PerezDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Valerie A. SmithDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Scott G. StephensonDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Laura A. SuggDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: John P. SurmaDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Election of Director: Kenneth Y. TanjiDIRECTOR ELECTIONSISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Advisory Vote on the Approval of Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Advisory Vote on the Approval of Executive Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER227348.0000000.000000FOR227348.000000FOR3S000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Management Proposal to Eliminate Supermajority Voting Requirements for Certain Business Combinations.CORPORATE GOVERNANCEISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Management Proposal to Eliminate Supermajority Voting Requirements to Remove a Director Without Cause.CORPORATE GOVERNANCEISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Management Proposal to Eliminate Supermajority Voting Requirement to Make Certain Amendments to Our By-Laws.CORPORATE GOVERNANCEISSUER227348.0000000.000000FOR227348.000000FORS000049397PUBLIC SERVICE ENTERPRISE GROUP INC.744573106US744573106704/22/2025Ratification of the Appointment of Deloitte as Independent Auditor for 2025.AUDIT-RELATEDISSUER227348.0000000.000000FOR227348.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025Election of Director: 1. Yves de BalmannDIRECTOR ELECTIONSISSUER169276.0000000.000000FOR169276.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025Election of Director: 2. Robert LawlessDIRECTOR ELECTIONSISSUER169276.0000000.000000FOR169276.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025Election of Director: 3. Peter OppenheimerDIRECTOR ELECTIONSISSUER169276.0000000.000000FOR169276.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025Election of Director: 4. Eileen PatersonDIRECTOR ELECTIONSISSUER169276.0000000.000000FOR169276.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025Election of Director: 5. John RichardsonDIRECTOR ELECTIONSISSUER169276.0000000.000000FOR169276.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025To consider and act on an advisory vote regarding the approval of compensation paid to named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER169276.0000000.000000FOR169276.000000FORS000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025To consider and act on an advisory vote regarding the approval of compensation paid to named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER169276.0000000.000000FOR169276.000000FOR3S000049397CONSTELLATION ENERGY CORP21037T109US21037T109704/29/2025To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025AUDIT-RELATEDISSUER169276.0000000.000000FOR169276.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: W. Paul BowersDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Calvin G. Butler, Jr.DIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Marjorie Rodgers CheshireDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: David DeWaltDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Linda JojoDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Charisse LillieDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Anna RichoDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Matthew RogersDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Election of Director: Bryan SegediDIRECTOR ELECTIONSISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Ratification of PricewaterhouseCoopers LLP as Exelon's Independent Auditor for 2025.AUDIT-RELATEDISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Advisory vote to approve the compensation paid to Exelon's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1267.0000000.000000FOR1267.000000FORS000049397EXELON CORPORATION30161N101US30161N101904/29/2025Advisory vote to approve the compensation paid to Exelon's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1267.0000000.000000FOR1267.000000FOR3S000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Scott B. HelmDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Hilary E. AckermannDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Arcilia C. AcostaDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Gavin R. BaieraDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Paul M. BarbasDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: James A. BurkeDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Lisa CrutchfieldDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Julie A. LagacyDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: John W. (Bill) PitesaDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: John R. (J. R.) SultDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025Election of Director: Robert C. WaltersDIRECTOR ELECTIONSISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025To approve, on a non-binding advisory basis, the 2024 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025To approve, on a non-binding advisory basis, the 2024 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER347117.0000000.000000FOR347117.000000FOR3S000049397VISTRA CORP.92840M102US92840M102704/30/2025To approve an amendment to the Company's certificate of incorporation (as amended and restated, the "Restated Certificate of Incorporation") to provide for the exculpation of officers as permitted by Delaware Law.CORPORATE GOVERNANCEISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025To approve an amendment to the Restated Certificate of Incorporation to repeal provisions relating to the waiver of corporate opportunities in favor of former principal stockholders of the Company.CORPORATE GOVERNANCEISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025To approve an amendment to the Restated Certificate of Incorporation to remove supermajority voting standards.CORPORATE GOVERNANCEISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025To approve the Company's 2025 Employee Stock Purchase Plan.CAPITAL STRUCTUREISSUER347117.0000000.000000FOR347117.000000FORS000049397VISTRA CORP.92840M102US92840M102704/30/2025To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER347117.0000000.000000FOR347117.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Deborah H. ButlerDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Kurt L. DarrowDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Ralph IzzoDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Garrick J. RochowDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: John G. RussellDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Suzanne F. ShankDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Myrna M. SotoDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: John G. SznewajsDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Ronald J. TanskiDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Election of Director: Laura H. WrightDIRECTOR ELECTIONSISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER44498.0000000.000000FOR44498.000000FOR3S000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Ratify the appointment of independent registered public accounting firm (PricewaterhouseCoopers LLP).AUDIT-RELATEDISSUER44498.0000000.000000FOR44498.000000FORS000049397CMS ENERGY CORPORATION125896100US125896100205/02/2025Vote on a Shareholder Proposal: Support Shareholder Ability to Call for a Special Shareholder Meeting.CORPORATE GOVERNANCESECURITY HOLDER44498.0000000.000000AGAINST44498.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Gina F. AdamsDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: John H. BlackDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: John R. BurbankDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Kirkland H. DonaldDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Brian W. EllisDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Philip L. FredericksonDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: M. Elise HylandDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Stuart L. LevenickDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Andrew S. MarshDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Election of Director: Karen A. PuckettDIRECTOR ELECTIONSISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Ratification of the Appointment of Deloitte & Touche LLP as Entergy's Independent Registered Public Accountants for 2025.AUDIT-RELATEDISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER259979.0000000.000000FOR259979.000000FORS000049397ENTERGY CORPORATION29364G103US29364G103105/02/2025Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER259979.0000000.000000FOR259979.000000FOR3S000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 1. Stephen SchaeferDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 2. Mark "Mac" McFarlandDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 3. Gizman AbbasDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 4. Anthony HortonDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 5. Karen HydeDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 6. Joseph NigroDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025Election of Director: 7. C. Benson SchwartzsteinDIRECTOR ELECTIONSISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER156476.0000000.000000FOR156476.000000FOR3S000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025To approve, on an advisory basis, the frequency of advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER156476.0000000.000000ONE YEAR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025To approve, on an advisory basis, the frequency of advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER156476.0000000.000000ONE YEAR156476.000000FOR3S000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025To approve our 2025 Employee Stock Purchase Plan.CAPITAL STRUCTUREISSUER156476.0000000.000000FOR156476.000000FORS000049397TALEN ENERGY CORPORATION87422Q109US87422Q109405/07/2025To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER156476.0000000.000000FOR156476.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 1. Nicholas K. AkinsDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 2. David A. BrandonDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 3. Deborah L. ByersDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 4. Charles G. McClure, Jr.DIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 5. Gail J. McGovernDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 6. Mark A. MurrayDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 7. Gerardo NorciaDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 8. Cassandra SantosDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 9. Robert C. Skaggs, Jr.DIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 10. David A. ThomasDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 11. Gary H. TorgowDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Election of Director: 12. Valerie M. WilliamsDIRECTOR ELECTIONSISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Ratify the appointment of PricewaterhouseCoopers LLP as our independent auditorsAUDIT-RELATEDISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Provide a nonbinding vote to approve the Company's executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Provide a nonbinding vote to approve the Company's executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER35622.0000000.000000FOR35622.000000FOR3S000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Vote to approve the DTE Energy Company 2025 Long-Term Incentive PlanCOMPENSATIONISSUER35622.0000000.000000FOR35622.000000FORS000049397DTE ENERGY COMPANY233331107US233331107205/08/2025Vote on a shareholder proposal relating to elimination of the holding period for shares required to call a special shareholder meetingCORPORATE GOVERNANCESECURITY HOLDER35622.0000000.000000AGAINST35622.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Peter A. AltabefDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Sondra L. BarbourDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Theodore H. Bunting, Jr.DIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Eric L. ButlerDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Deborah A. HenrettaDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Deborah A. P. HersmanDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Michael E. JesanisDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: William D. JohnsonDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Kevin T. KabatDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Cassandra S. LeeDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: John McAvoyDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025Election of Director to hold office until the next Annual Stockholders' Meeting and until their respective successors have been elected or appointed and qualified: Lloyd M. YatesDIRECTOR ELECTIONSISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025To approve named executive officer compensation on an advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025To approve named executive officer compensation on an advisory basis.SECTION 14A SAY-ON-PAY VOTESISSUER514328.0000000.000000FOR514328.000000FOR3S000049397NISOURCE INC.65473P105US65473P105705/12/2025To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER514328.0000000.000000FOR514328.000000FORS000049397NISOURCE INC.65473P105US65473P105705/12/2025To consider a stockholder proposal requesting to support special shareholder meeting improvement.CORPORATE GOVERNANCESECURITY HOLDER514328.0000000.000000AGAINST514328.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Andres ConesaDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Pablo A. FerreroDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Jennifer M. KirkDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Richard J. MarkDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Jeffrey W. MartinDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Michael N. MearsDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Kevin C. SagaraDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Jack T. TaylorDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Cynthia J. WarnerDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: Anya WeavingDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Election of Director: James C. YardleyDIRECTOR ELECTIONSISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Ratification of appointment of independent registered public accounting firmAUDIT-RELATEDISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Advisory approval of our executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER354400.0000000.000000FOR354400.000000FORS000049397SEMPRA816851109US816851109005/13/2025Advisory approval of our executive compensationSECTION 14A SAY-ON-PAY VOTESISSUER354400.0000000.000000FOR354400.000000FOR3S000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Vicky A. BaileyDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Norman P. BeckerDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Patricia K. CollawnDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: E. Renae ConleyDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Sidney M. GutierrezDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: James A. HughesDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Steven C. MaestasDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Lillian J. MontoyaDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Maureen T. MullarkeyDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Election of Director: Joseph D. TarryDIRECTOR ELECTIONSISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Ratify appointment of KPMG LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER382234.0000000.000000FOR382234.000000FORS000049397TXNM ENERGY, INC.69349H107US69349H107705/13/2025Approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER382234.0000000.000000FOR382234.000000FOR3S000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Odette C. BolanoDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Annette G. ElgDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Lisa A. GrowDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Judith A. JohansenDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Dennis L. JohnsonDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Nate R. JorgensenDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Michael J. KennedyDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Scott W. MadisonDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Susan D. MorrisDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Election of Director for one-year term: Dr. Mark T. PetersDIRECTOR ELECTIONSISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Advisory resolution to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Advisory resolution to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER171911.0000000.000000FOR171911.000000FOR3S000049397IDACORP, INC.451107106US451107106405/15/2025Approve the IDACORP, Inc. 2000 Long-Term Incentive and Compensation Plan, as amended and restated, including the authorization of 1,100,000 additional shares.COMPENSATIONISSUER171911.0000000.000000FOR171911.000000FORS000049397IDACORP, INC.451107106US451107106405/15/2025Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER171911.0000000.000000FOR171911.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Frank A. BozichDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Peter D. ClarkeDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Cathy R. GatesDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: David L. HauserDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Luther C. Kissam, IVDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Judy R. McReynoldsDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: David E. RainboltDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: J. Michael SannerDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Sheila G. TaltonDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Election of Director: Sean TrauschkeDIRECTOR ELECTIONSISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Ratification of the appointment of Ernst & Young LLP as the Company's principal independent accountants for 2025.AUDIT-RELATEDISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER88279.0000000.000000FOR88279.000000FORS000049397OGE ENERGY CORP.670837103US670837103305/15/2025Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER88279.0000000.000000FOR88279.000000FOR3S000049397OGE ENERGY CORP.670837103US670837103305/15/2025Amendment of the Restated Certificate of Incorporation to Eliminate Supermajority Voting Provisions.CORPORATE GOVERNANCEISSUER88279.0000000.000000FOR88279.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Election of Director for term ending in 2028: N. Joy FaloticoDIRECTOR ELECTIONSISSUER63146.0000000.000000FOR63146.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Election of Director for term ending in 2028: Thomas F. O'TooleDIRECTOR ELECTIONSISSUER63146.0000000.000000FOR63146.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Election of Director for term ending in 2028: Christie RaymondDIRECTOR ELECTIONSISSUER63146.0000000.000000FOR63146.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER63146.0000000.000000FOR63146.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER63146.0000000.000000FOR63146.000000FOR3S000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER63146.0000000.000000FOR63146.000000FORS000049397ALLIANT ENERGY CORPORATION018802108US018802108505/16/2025Shareowner Proposal Requesting Third-Party Evaluation of Greenhouse Gas Emissions Reduction Targets.ENVIRONMENT OR CLIMATESECURITY HOLDER63146.0000000.000000AGAINST63146.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Arthur P. BeattieDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Raja RajamannarDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Heather B. RedmanDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Craig A. RogersonDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Vincent SorgiDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Linda G. SullivanDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Natica von AlthannDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Keith H. WilliamsonDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Phoebe A. WoodDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Election of Director: Armando Zagalo de LimaDIRECTOR ELECTIONSISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Advisory vote to approve compensation of named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Advisory vote to approve compensation of named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER600491.0000000.000000FOR600491.000000FOR3S000049397PPL CORPORATION69351T106US69351T106005/16/2025Ratification of the appointment of Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER600491.0000000.000000FOR600491.000000FORS000049397PPL CORPORATION69351T106US69351T106005/16/2025Shareowner Proposal regarding Independent Evaluation of Greenhouse Gas Reduction TargetsENVIRONMENT OR CLIMATESECURITY HOLDER600491.0000000.000000AGAINST600491.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 1. Glynis A. BryanDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 2. Ronald Butler, Jr.DIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 3. G. A. de la Melena, Jr.DIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 4. Carol S. EicherDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 5. Susan T. FlanaganDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 6. Richard P. FoxDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 7. Theodore N. GeislerDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 8. Paula J. SimsDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 9. William H. SpenceDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 10. Kristine L. SvinickiDIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025Election of Director: 11. James E. Trevathan, Jr.DIRECTOR ELECTIONSISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025To hold an advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025To hold an advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER222167.0000000.000000FOR222167.000000FOR3S000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025To ratify the appointment of our independent accountant for the year ending December 31, 2025.AUDIT-RELATEDISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025To amend the Restated Articles of Incorporation, as amended, to increase the number of authorized common stock of Pinnacle West.CAPITAL STRUCTUREISSUER222167.0000000.000000FOR222167.000000FORS000049397PINNACLE WEST CAPITAL CORPORATION723484101US723484101005/21/2025To act upon a shareholder proposal entitled "Support Special Shareholder Meeting Improvement" that seeks to remove the one- year holding requirement to call a special shareholder meeting.CORPORATE GOVERNANCESECURITY HOLDER222167.0000000.000000AGAINST222167.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Megan BurkhartDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Lynn CaseyDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Bob FrenzelDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Netha JohnsonDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Patricia KamplingDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: George KehlDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Richard O'BrienDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Charles PardeeDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: James ProkopankoDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Devin StockfishDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Election of Director: Timothy WelshDIRECTOR ELECTIONSISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)SECTION 14A SAY-ON-PAY VOTESISSUER390037.0000000.000000FOR390037.000000FORS000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)SECTION 14A SAY-ON-PAY VOTESISSUER390037.0000000.000000FOR390037.000000FOR3S000049397XCEL ENERGY INC.98389B100US98389B100805/21/2025Ratification of the appointment of Deloitte & Touche LLP as Xcel Energy Inc.'s independent registered public accounting firm for 2025AUDIT-RELATEDISSUER390037.0000000.000000FOR390037.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Nicole S. ArnaboldiDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: James L. CamarenDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Naren K. GursahaneyDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Kirk S. HachigianDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Maria G. HenryDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: John W. KetchumDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Amy B. LaneDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Geoffrey S. MarthaDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: David L. PorgesDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Deborah L. "Dev" StahlkopfDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: John A. StallDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Election of Director: Darryl L. WilsonDIRECTOR ELECTIONSISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Ratification of appointment of Deloitte & Touche LLP as NextEra Energy's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER213909.0000000.000000FOR213909.000000FORS000049397NEXTERA ENERGY, INC.65339F101US65339F101205/22/2025Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER213909.0000000.000000FOR213909.000000FOR3S000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Rajat BahriDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Cheryl F. CampbellDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Edward G. CannizzaroDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Kerry W. CooperDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Leo P. DenaultDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Jessica L. DenecourDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Mark E. Ferguson IIIDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: W. Craig FugateDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Arno L. HarrisDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Carlos M. HernandezDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: John O. LarsenDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Patricia K. PoppeDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: William L. SmithDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Election of Director: Benjamin F. WilsonDIRECTOR ELECTIONSISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Advisory Vote to Approve Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER583502.0000000.000000FOR583502.000000FOR3S000049397PG&E CORPORATION69331C108US69331C108005/22/2025Ratification of the Appointment of Deloitte and Touche LLP as the Independent Public Accounting FirmAUDIT-RELATEDISSUER583502.0000000.000000FOR583502.000000FORS000049397PG&E CORPORATION69331C108US69331C108005/22/2025Approval of the 2025 PG&E Corporation Employee Stock Purchase PlanCAPITAL STRUCTUREISSUER583502.0000000.000000FOR583502.000000FORS000049397Banco Bilbao Vizcaya Argentaria S.A.ES011321183507/04/2024Issuance of Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER7050.0000000.000000FOR7050.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183507/04/2024Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER7050.0000000.000000FOR7050.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403707/10/2024Elect Claude Sarrailh to the Management BoardDIRECTOR ELECTIONSISSUER841.0000000.000000FOR841.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Accounts and ReportsCORPORATE GOVERNANCEISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Final DividendCAPITAL STRUCTUREISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Paula Rosput ReynoldsDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect John PettigrewDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Andy AggDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Jacqui FergusonDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Ian P. LivingstonDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Iain J. MackayDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Anne RobinsonDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Earl L. ShippDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Jonathan SilverDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Antony WoodDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Elect Martha B. WyrschDIRECTOR ELECTIONSISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Appointment of AuditorAUDIT-RELATEDISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Authority to Set Auditor's FeesAUDIT-RELATEDISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Remuneration ReportCOMPENSATIONISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Approval of Updated Climate Transition PlanENVIRONMENT OR CLIMATEISSUER9770.0000000.000000ABSTAIN9770.000000AGAINSTS000058304National Grid plcGB00BDR05C0107/10/2024Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Authority to Repurchase SharesCAPITAL STRUCTUREISSUER9770.0000000.000000FOR9770.000000FORS000058304National Grid plcGB00BDR05C0107/10/2024Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER9770.0000000.000000FOR9770.000000FORS000058304Mapletree Pan Asia Commercial TrustSG2D1896958407/29/2024Accounts and ReportsCORPORATE GOVERNANCEISSUER36513.0000000.000000FOR36513.000000FORS000058304Mapletree Pan Asia Commercial TrustSG2D1896958407/29/2024Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER36513.0000000.000000FOR36513.000000FORS000058304Mapletree Pan Asia Commercial TrustSG2D1896958407/29/2024Authority to Issue Units and Convertible Debt w or w/o Preemptive RightsCAPITAL STRUCTUREISSUER36513.0000000.000000FOR36513.000000FORS000058304Mapletree Pan Asia Commercial TrustSG2D1896958407/29/2024Amendments to Trust Deed to Include Provisions of Unit Buy-Back SupplementCORPORATE GOVERNANCEISSUER36513.0000000.000000FOR36513.000000FORS000058304Mapletree Pan Asia Commercial TrustSG2D1896958407/29/2024Authority to Repurchase UnitsCAPITAL STRUCTUREISSUER36513.0000000.000000FOR36513.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Accounts and ReportsCORPORATE GOVERNANCEISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Jean-Francois M. L. van BoxmeerDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Margherita Della ValleDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Luka MucicDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Stephen A. CarterDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Michel DemareDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Hatem DowidarDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Delphine Ernotte CunciDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Deborah L. KerrDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Amparo MoraledaDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect David T. NishDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Kandimathie (Christine) RamonDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Elect Simon SegarsDIRECTOR ELECTIONSISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Final DividendCAPITAL STRUCTUREISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Remuneration ReportCOMPENSATIONISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Appointment of AuditorAUDIT-RELATEDISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authority to Set Auditor's FeesAUDIT-RELATEDISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authority to Repurchase SharesCAPITAL STRUCTUREISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER49152.0000000.000000FOR49152.000000FORS000058304Vodafone Group plcGB00BH4HKS3907/30/2024Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER49152.0000000.000000FOR49152.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119209/24/2024Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER32088.0000000.000000FOR32088.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2510/14/2024Scheme of ArrangementEXTRAORDINARY TRANSACTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2510/14/2024Consortium TransactionEXTRAORDINARY TRANSACTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304StocklandAU000000SGP010/21/2024Re-elect Adam TindallDIRECTOR ELECTIONSISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Elect Robert W. JohnstonDIRECTOR ELECTIONSISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Re-elect Laurence R. BrindleDIRECTOR ELECTIONSISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Re-elect Melinda B. ConradDIRECTOR ELECTIONSISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Remuneration ReportCOMPENSATIONISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Equity Grant (MD/CEO Tarun Gupta)COMPENSATIONISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Approve Potential Termination BenefitsCOMPENSATIONISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Approve Increase in NEDs' Fee CapCOMPENSATIONISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Amendments to ConstitutionCORPORATE GOVERNANCEISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Renew Proportional Takeover ProvisionsSHAREHOLDER RIGHTS AND DEFENSESISSUER24281.0000000.000000FOR24281.000000FORS000058304StocklandAU000000SGP010/21/2024Approve Financial AssistanceCORPORATE GOVERNANCEISSUER24281.0000000.000000FOR24281.000000FORS000058304Transurban GroupAU000000TCL610/22/2024Elect Gary LennonDIRECTOR ELECTIONSISSUER1456.0000000.000000FOR1456.000000FORS000058304Transurban GroupAU000000TCL610/22/2024Re-elect Craig DrummondDIRECTOR ELECTIONSISSUER1456.0000000.000000FOR1456.000000FORS000058304Transurban GroupAU000000TCL610/22/2024Re-elect Timothy J ReedDIRECTOR ELECTIONSISSUER1456.0000000.000000FOR1456.000000FORS000058304Transurban GroupAU000000TCL610/22/2024Re-elect Robert WhitfieldDIRECTOR ELECTIONSISSUER1456.0000000.000000FOR1456.000000FORS000058304Transurban GroupAU000000TCL610/22/2024Remuneration ReportCOMPENSATIONISSUER1456.0000000.000000FOR1456.000000FORS000058304Transurban GroupAU000000TCL610/22/2024Equity Grant (MD/CEO Michelle Jablko)COMPENSATIONISSUER1456.0000000.000000FOR1456.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Accounts and ReportsCORPORATE GOVERNANCEISSUER12491.0000000.000000FOR12491.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER12491.0000000.000000FOR12491.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Elect Allan ZemanDIRECTOR ELECTIONSISSUER12491.0000000.000000AGAINST12491.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/23/2024Elect Steven ONG Kay EngDIRECTOR ELECTIONSISSUER12491.0000000.000000AGAINST12491.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/23/2024Elect WONG Cho BauDIRECTOR ELECTIONSISSUER12491.0000000.000000FOR12491.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Elect Daryl NG Win KongDIRECTOR ELECTIONSISSUER12491.0000000.000000AGAINST12491.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/23/2024Directors' FeesCOMPENSATIONISSUER12491.0000000.000000FOR12491.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER12491.0000000.000000FOR12491.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Authority to Repurchase SharesCAPITAL STRUCTUREISSUER12491.0000000.000000FOR12491.000000FORS000058304Sino Land Company LimitedHK008300050210/23/2024Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER12491.0000000.000000AGAINST12491.000000AGAINSTS000058304Sino Land Company LimitedHK008300050210/23/2024Authority to Issue Repurchased SharesCAPITAL STRUCTUREISSUER12491.0000000.000000AGAINST12491.000000AGAINSTS000058304APA GroupAU000000APA110/24/2024Remuneration ReportCOMPENSATIONISSUER23196.0000000.000000FOR23196.000000FORS000058304APA GroupAU000000APA110/24/2024Elect Samantha LewisDIRECTOR ELECTIONSISSUER23196.0000000.000000FOR23196.000000FORS000058304APA GroupAU000000APA110/24/2024Elect David LamontDIRECTOR ELECTIONSISSUER23196.0000000.000000FOR23196.000000FORS000058304APA GroupAU000000APA110/24/2024Re-elect Michael A. FraserDIRECTOR ELECTIONSISSUER23196.0000000.000000FOR23196.000000FORS000058304APA GroupAU000000APA110/24/2024Re-elect Debra L. GoodinDIRECTOR ELECTIONSISSUER23196.0000000.000000AGAINST23196.000000AGAINSTS000058304APA GroupAU000000APA110/24/2024Equity Grant (MD/CEO Adam Watson)COMPENSATIONISSUER23196.0000000.000000FOR23196.000000FORS000058304APA GroupAU000000APA110/24/2024Shareholder Proposal Regarding Facilitating Nonbinding Proposals (APA Infrastructure Trust)CORPORATE GOVERNANCESECURITY HOLDER23196.0000000.000000AGAINST23196.000000FORS000058304APA GroupAU000000APA110/24/2024Shareholder Proposal Regarding Facilitating Nonbinding Proposals (APA Investment Trust)CORPORATE GOVERNANCESECURITY HOLDER23196.0000000.000000AGAINST23196.000000FORS000058304APA GroupAU000000APA110/24/2024Shareholder Proposal Regarding Consistency of CapEx with Climate Commitments and Net Zero by 2050ENVIRONMENT OR CLIMATESECURITY HOLDER23196.0000000.000000AGAINST23196.000000FORS000058304APA GroupAU000000APA110/24/2024Board SpillCORPORATE GOVERNANCEISSUER23196.0000000.000000AGAINST23196.000000FORS000058304CapitaLand Integrated Commercial TrustSG1M5190465410/29/2024Property Purchase (Related Party Transaction)EXTRAORDINARY TRANSACTIONSISSUER8695.0000000.000000FOR8695.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Elect Donald R. LindsayDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Elect Ross McEwanDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Xiaoqun Clever-StegDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Gary J. GoldbergDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Michelle A HinchliffeDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Ken N. MacKenzieDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Christine E. O'ReillyDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Catherine TannaDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Re-elect Dion J. WeislerDIRECTOR ELECTIONSISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Remuneration ReportCOMPENSATIONISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Equity Grant (CEO Mike Henry)COMPENSATIONISSUER6069.0000000.000000FOR6069.000000FORS000058304BHP Group LimitedAU000000BHP410/30/2024Approval of 2024 Climate Transition Action PlanENVIRONMENT OR CLIMATEISSUER6069.0000000.000000FOR6069.000000FORS000058304DexusAU000000DXS110/30/2024Remuneration ReportCOMPENSATIONISSUER3580.0000000.000000FOR3580.000000FORS000058304DexusAU000000DXS110/30/2024Equity Grant (MD/CEO Ross Du Vernet)COMPENSATIONISSUER3580.0000000.000000AGAINST3580.000000AGAINSTS000058304DexusAU000000DXS110/30/2024Appointment of AuditorAUDIT-RELATEDISSUER3580.0000000.000000FOR3580.000000FORS000058304DexusAU000000DXS110/30/2024Elect Peeyush K. GuptaDIRECTOR ELECTIONSISSUER3580.0000000.000000FOR3580.000000FORS000058304DexusAU000000DXS110/30/2024Re-elect Warwick M. NegusDIRECTOR ELECTIONSISSUER3580.0000000.000000FOR3580.000000FORS000058304DexusAU000000DXS110/30/2024Re-elect Mark H. FordDIRECTOR ELECTIONSISSUER3580.0000000.000000FOR3580.000000FORS000058304DexusAU000000DXS110/30/2024Board Spill (Conditional)CORPORATE GOVERNANCEISSUER3580.0000000.000000AGAINST3580.000000FORS000058304Spark New Zealand LimitedNZTELE0001S411/01/2024Authority to Set Auditor's FeesAUDIT-RELATEDISSUER50997.0000000.000000FOR50997.000000NONES000058304Spark New Zealand LimitedNZTELE0001S411/01/2024Re-elect David HavercroftDIRECTOR ELECTIONSISSUER50997.0000000.000000FOR50997.000000NONES000058304Spark New Zealand LimitedNZTELE0001S411/01/2024Elect Lisa NelsonDIRECTOR ELECTIONSISSUER50997.0000000.000000FOR50997.000000NONES000058304Spark New Zealand LimitedNZTELE0001S411/01/2024Re-elect Warwick BrayDIRECTOR ELECTIONSISSUER50997.0000000.000000FOR50997.000000NONES000058304Computershare LimitedAU000000CPU511/14/2024Re-elect Paul J. ReynoldsDIRECTOR ELECTIONSISSUER3107.0000000.000000FOR3107.000000FORS000058304Computershare LimitedAU000000CPU511/14/2024Re-elect Lisa M. GayDIRECTOR ELECTIONSISSUER3107.0000000.000000FOR3107.000000FORS000058304Computershare LimitedAU000000CPU511/14/2024Re-elect John NendickDIRECTOR ELECTIONSISSUER3107.0000000.000000FOR3107.000000FORS000058304Computershare LimitedAU000000CPU511/14/2024Elect Gerrard B. SchmidDIRECTOR ELECTIONSISSUER3107.0000000.000000FOR3107.000000FORS000058304Computershare LimitedAU000000CPU511/14/2024REMUNERATION REPORTCOMPENSATIONISSUER3107.0000000.000000FOR3107.000000FORS000058304Computershare LimitedAU000000CPU511/14/2024Equity Grant (CEO Stuart Irving FY2025 LTI)COMPENSATIONISSUER3107.0000000.000000FOR3107.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Accounts and ReportsCORPORATE GOVERNANCEISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Remuneration ReportCOMPENSATIONISSUER1739.0000000.000000AGAINST1739.000000AGAINSTS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Appointment of AuditorAUDIT-RELATEDISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Alison PlattDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Dan OlleyDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Amy StirlingDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect John TroianoDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Andrea BlanceDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Adrian CollinsDIRECTOR ELECTIONSISSUER1739.0000000.000000AGAINST1739.000000AGAINSTS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Penny J. JamesDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Darren PopeDIRECTOR ELECTIONSISSUER1739.0000000.000000AGAINST1739.000000AGAINSTS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Elect Michael MorleyDIRECTOR ELECTIONSISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Authority to Repurchase SharesCAPITAL STRUCTUREISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER1739.0000000.000000FOR1739.000000FORS000058304Hargreaves Lansdown plcGB00B1VZ0M2512/06/2024Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER1739.0000000.000000FOR1739.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Remuneration ReportCOMPENSATIONISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Final DividendCAPITAL STRUCTUREISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Therese EsperdyDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Stefan BomhardDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Susan M. ClarkDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Ngozi EdozienDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Andrew GilchristDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Alan JohnsonDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Robert Kunze-ConcewitzDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Lukas ParaviciniDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Jon StantonDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Elect Julie HamiltonDIRECTOR ELECTIONSISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Appointment of AuditorAUDIT-RELATEDISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER4862.0000000.000000FOR4862.000000FORS000058304Imperial Brands plcGB000454492901/29/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER4862.0000000.000000FOR4862.000000FORS000058304Siemens AGDE000723610102/13/2025Allocation of DividendsCAPITAL STRUCTUREISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Roland BuschCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Cedrik NeikeCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Matthias RebelliusCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Ralf P. ThomasCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Judith WieseCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Jim Hagemann SnabeCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Birgit SteinbornCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Werner BrandtCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Tobias BaumlerCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Regina E. DuganCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Andrea FehrmannCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Bettina HallerCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Oliver HartmannCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Keryn Lee JamesCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Harald KernCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Jurgen KernerCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Martina MerzCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Christian PfeifferCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Benoit PotierCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Hagen ReimerCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Kasper RorstedCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Nathalie von SiemensCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Dorothea SimonCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Mimon UhamouCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Grazia VittadiniCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Ratify Matthias ZachertCORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Appointment of AuditorAUDIT-RELATEDISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Remuneration ReportCOMPENSATIONISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Elect Jim Hagemann SnabeDIRECTOR ELECTIONSISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Elect Kasper RorstedDIRECTOR ELECTIONSISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Elect Ulf Mark SchneiderDIRECTOR ELECTIONSISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Elect Grazia VittadiniDIRECTOR ELECTIONSISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Elect Werner BrandtDIRECTOR ELECTIONSISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Supervisory Board Remuneration PolicyCOMPENSATIONISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Amendments to Articles (Virtual AGM)CORPORATE GOVERNANCEISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Authority to Repurchase Shares Using Equity DerivativesCAPITAL STRUCTUREISSUER78.0000000.000000FOR78.000000FORS000058304Siemens AGDE000723610102/13/2025Authority to Issue Convertible Debt Instruments; Increase in Conditional CapitalCAPITAL STRUCTUREISSUER78.0000000.000000FOR78.000000FORS000058304Banco Bpm SpAIT000521838002/28/2025Acquisition (Increase in Tender Offer Price for Anima Holding S.p.A., and Authority to Waive Closing Conditions)EXTRAORDINARY TRANSACTIONSISSUER2018.0000000.000000FOR2018.000000FORS000058304KONE CorporationFI000901340303/05/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Remuneration ReportCOMPENSATIONISSUER618.0000000.000000AGAINST618.000000AGAINSTS000058304KONE CorporationFI000901340303/05/2025Directors' FeesCOMPENSATIONISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Board SizeCORPORATE GOVERNANCEISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Banmali AgrawalaDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Matti AlahuhtaDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Susan DuinhovenDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Marika FredrikssonDIRECTOR ELECTIONSISSUER618.0000000.000000AGAINST618.000000AGAINSTS000058304KONE CorporationFI000901340303/05/2025Elect Antti HerlinDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Iiris HerlinDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Jussi HerlinDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Timo IhamuotilaDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Elect Krishna MikkilineniDIRECTOR ELECTIONSISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Number of AuditorsAUDIT-RELATEDISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Appointment of AuditorAUDIT-RELATEDISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER618.0000000.000000FOR618.000000FORS000058304KONE CorporationFI000901340303/05/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER618.0000000.000000FOR618.000000FORS000058304Novartis AGCH001200526703/07/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Allocation of DividendsCAPITAL STRUCTUREISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Cancellation of Shares and Reduction in Share CapitalCAPITAL STRUCTUREISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Confirmation of Virtual Annual General Meeting AuthorisationCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Board CompensationCOMPENSATIONISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Executive Compensation (Total)COMPENSATIONISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Compensation ReportCOMPENSATIONISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Giovanni Caforio as Board ChairDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Nancy C. AndrewsDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Ton BuchnerDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Patrice BulaDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Elizabeth DohertyDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Bridgette P. HellerDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Daniel HochstrasserDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Frans van HoutenDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Simon MoroneyDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Ana de Pro GonzaloDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect John D. YoungDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Elizabeth McNallyDIRECTOR ELECTIONSISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Patrice Bula as Compensation Committee MemberCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Bridgette P. Heller as Compensation Committee MemberCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect Simon Moroney as Compensation Committee MemberCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Elect John D. Young as Compensation Committee MemberCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Appointment of AuditorAUDIT-RELATEDISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Novartis AGCH001200526703/07/2025Transaction of Other BusinessCORPORATE GOVERNANCEISSUER3022.0000000.000000TAKENOACTION3022.000000NONES000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Elect Carlos Torres VilaDIRECTOR ELECTIONSISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Elect Onur GencDIRECTOR ELECTIONSISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Elect Connie Hedegaard KoksbangDIRECTOR ELECTIONSISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Authority to Cancel Treasury Shares and Reduce CapitalCAPITAL STRUCTUREISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Renew Delegation Resolution Regarding Increase Capital in Consideration for Contributions in KindCAPITAL STRUCTUREISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Maximum Variable Pay RatioCOMPENSATIONISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Appointment of AuditorAUDIT-RELATEDISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER8057.0000000.000000FOR8057.000000FORS000058304Banco Bilbao Vizcaya Argentaria S.A.ES011321183503/20/2025Remuneration ReportCOMPENSATIONISSUER8057.0000000.000000FOR8057.000000FORS000058304Kesko OyjFI000900020203/24/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Remuneration ReportCOMPENSATIONISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Directors' FeesCOMPENSATIONISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Board SizeCORPORATE GOVERNANCEISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Election of DirectorsDIRECTOR ELECTIONSISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Appointment of AuditorAUDIT-RELATEDISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER5802.0000000.000000FOR5802.000000FORS000058304Kesko OyjFI000900020203/24/2025Charitable DonationsOTHER SOCIAL ISSUESISSUER5802.0000000.000000FOR5802.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Mutsuo IwaiDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Shigeaki OkamotoDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Masamichi TerabatakeDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Koji ShimayoshiDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Kei NakanoDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Yukiko Nagashima @ Yukiko WatanabeDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Masato KiteraDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Tetsuya ShojiDIRECTOR ELECTIONSISSUER5678.0000000.000000AGAINST5678.000000AGAINSTS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Hiroko YamashinaDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304JAPAN TOBACCO INC.JP372680000003/26/2025Elect Kenji AsakuraDIRECTOR ELECTIONSISSUER5678.0000000.000000FOR5678.000000FORS000058304SGS SACH125674092403/26/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Compensation ReportCOMPENSATIONISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Allocation of DividendsCAPITAL STRUCTUREISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Issuance of Shares without Preemptive RightsCAPITAL STRUCTUREISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Calvin GriederDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Sami AtiyaDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Phyllis CheungDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Ian GallienneDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Tobias HartmannDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Kory SorensonDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Janet S. VergisDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Patrick KronDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Geraldine PicaudDIRECTOR ELECTIONSISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Calvin Grieder as Board ChairCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Sami Atiya as Compensation Committee MemberCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Kory Sorenson as Compensation Committee MemberCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Elect Patrick Kron as Compensation Committee MemberCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Appointment of AuditorAUDIT-RELATEDISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Board CompensationCOMPENSATIONISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Executive Compensation (Fixed)COMPENSATIONISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Executive Compensation (Short-Term)COMPENSATIONISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Executive Compensation (Long-Term)COMPENSATIONISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Change of Company HeadquartersCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304SGS SACH125674092403/26/2025Transaction of Other BusinessCORPORATE GOVERNANCEISSUER653.0000000.000000TAKENOACTION653.000000NONES000058304OTSUKA CORPORATIONJP318820000403/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Yuji OtsukaDIRECTOR ELECTIONSISSUER525.0000000.000000AGAINST525.000000AGAINSTS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Kazuyuki KatakuraDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Hironobu TsurumiDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Hironobu SaitoDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Minoru SakuraiDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Koichiro YamadaDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Kazuo UnenoDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Jiro MakinoDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Tetsuo SaitoDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Makiko Hamabe @ Makiko YasuiDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304OTSUKA CORPORATIONJP318820000403/27/2025Elect Fuminori SuzumuraDIRECTOR ELECTIONSISSUER525.0000000.000000FOR525.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Remuneration ReportCOMPENSATIONISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Directors' FeesCOMPENSATIONISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Board SizeCORPORATE GOVERNANCEISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Election of DirectorsDIRECTOR ELECTIONSISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Appointment of AuditorAUDIT-RELATEDISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Amendments to Articles (Sustainability Reporting Assurer)CORPORATE GOVERNANCEISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Amendments to Articles (Virtual Meeting)CORPORATE GOVERNANCEISSUER345.0000000.000000FOR345.000000FORS000058304UPM-Kymmene OyjFI000900598703/27/2025Charitable DonationsOTHER SOCIAL ISSUESISSUER345.0000000.000000FOR345.000000FORS000058304CANON INC.JP324280000503/28/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Fujio MitaraiDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Toshizo TanakaDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Toshio HommaDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Kazuto OgawaDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Hiroaki TakeishiDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Minoru AsadaDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Yusuke KawamuraDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Masayuki IkegamiDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Masaki SuzukiDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Akiko Ito @ Akiko NodaDIRECTOR ELECTIONSISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Takeshi MorikawaCORPORATE GOVERNANCEISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025Elect Yuka ShigetomiCORPORATE GOVERNANCEISSUER4886.0000000.000000FOR4886.000000FORS000058304CANON INC.JP324280000503/28/2025BonusCOMPENSATIONISSUER4886.0000000.000000FOR4886.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Hiroshi GeshiroDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Tomoaki TeraiDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Seiji SatoDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Hideaki TakuboDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Tetsuya HibiDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Yoshiaki OzawaDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Kaku KatoDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Keiko KanekoDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Gideon FranklinDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Haruyuki YoshidaDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Elect Yuki KanzakiDIRECTOR ELECTIONSISSUER689.0000000.000000FOR689.000000FORS000058304DAIFUKU CO., LTD.JP349740000603/28/2025Amendments to Performance-Linked Equity Compensation PlanCOMPENSATIONISSUER689.0000000.000000FOR689.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Directors' FeesCOMPENSATIONISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Elect Olivier LIM Tse GhowDIRECTOR ELECTIONSISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Elect CHO BonghanDIRECTOR ELECTIONSISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Elect THAM Sai ChoyDIRECTOR ELECTIONSISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Elect TAN Su ShanDIRECTOR ELECTIONSISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025AUTHORITY TO ISSUE SHARES PURSUANT TO THE DBSH SCRIP DIVIDEND SCHEMECAPITAL STRUCTUREISSUER4337.0000000.000000FOR4337.000000FORS000058304DBS Group Holdings LtdSG1L0100170103/28/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER4337.0000000.000000FOR4337.000000FORS000058304Elisa OyjFI000900788404/02/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Ratification of Board and CEO ActsCORPORATE GOVERNANCEISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025REMUNERATION REPORTCOMPENSATIONISSUER1051.0000000.000000AGAINST1051.000000AGAINSTS000058304Elisa OyjFI000900788404/02/2025REMUNERATION POLICYCOMPENSATIONISSUER1051.0000000.000000AGAINST1051.000000AGAINSTS000058304Elisa OyjFI000900788404/02/2025Directors' FeesCOMPENSATIONISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Board SizeCORPORATE GOVERNANCEISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Election of DirectorsDIRECTOR ELECTIONSISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Appointment of AuditorAUDIT-RELATEDISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Authority to Set Sustainability Reporting Auditor's FeesAUDIT-RELATEDISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER1051.0000000.000000FOR1051.000000FORS000058304Elisa OyjFI000900788404/02/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER1051.0000000.000000FOR1051.000000FORS000058304Volvo ABSE000011544604/02/2025Election of Presiding ChairCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025AgendaCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Compliance with the Rules of ConvocationCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Matti AlahuhtaCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Bo AnnvikCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Par BomanCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Jan CarlsonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Eric ElzvikCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Martha Finn BrooksCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Kurt JofsCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Martin Lundstedt (Board member)CORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Kathryn V. MarinelloCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Martina MerzCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Helena StjernholmCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Carl-Henric SvanbergCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Lars AskCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Mari LarssonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Urban SpannarCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Therese KoggdalCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Danny BilgerCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Camilla JohanssonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Erik SvenssonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Ratify Martin Lundstedt (President and CEO)CORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Board SizeCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Number of Deputy DirectorsCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Directors' FeesCOMPENSATIONISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Matti AlahuhtaDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Bo AnnvikDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Par BomanDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Jan CarlsonDIRECTOR ELECTIONSISSUER5693.0000000.000000AGAINST5693.000000AGAINSTS000058304Volvo ABSE000011544604/02/2025Elect Eric A. ElzvikDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Martha Finn BrooksDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Kurt JofsDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Martin LundstedtDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Kathryn V. MarinelloDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Martina MerzDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Helena StjernholmDIRECTOR ELECTIONSISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Elect Par Boman as ChairCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Appointment of AuditorAUDIT-RELATEDISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Election of Fredrik PerssonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Election of Anders OscarssonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Election of Carina SilbergCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Election of Anders AlgotssonCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Election of the Chair of the Board as Nominating Committee MemberCORPORATE GOVERNANCEISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Remuneration ReportCOMPENSATIONISSUER5693.0000000.000000FOR5693.000000FORS000058304Volvo ABSE000011544604/02/2025Shareholder Proposal Regarding Development of Low-Power ChargersENVIRONMENT OR CLIMATESECURITY HOLDER5693.0000000.000000AGAINST5693.000000NONES000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Ammar Al-JoundiDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Nanci E. CaldwellDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Michelle L. CollinsDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Victor G. DodigDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Kevin J. KellyDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Christine E. LarsenDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Mary Lou MaherDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect William F. MorneauDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Mark W. PodlaslyDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Francois L. PoirierDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Katharine B. StevensonDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Martine TurcotteDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Elect Barry L. ZubrowDIRECTOR ELECTIONSISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Appointment of AuditorAUDIT-RELATEDISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER2748.0000000.000000FOR2748.000000FOR4S000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Amendment to By-Law Regarding Directors' RenumerationCORPORATE GOVERNANCEISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Amendments to By-Law No. 1CORPORATE GOVERNANCEISSUER2748.0000000.000000FOR2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Energy Supply RatioENVIRONMENT OR CLIMATESECURITY HOLDER2748.0000000.000000FOR2748.000000AGAINSTS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Report on Forced and Child Labor in Loan PortfoliosHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER2748.0000000.000000AGAINST2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Disclosure of Employee Language FluencyCORPORATE GOVERNANCESECURITY HOLDER2748.0000000.000000AGAINST2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER2748.0000000.000000AGAINST2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER2748.0000000.000000AGAINST2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Carbon Risk Scoring and Client Transition PlansENVIRONMENT OR CLIMATESECURITY HOLDER2748.0000000.000000AGAINST2748.000000FORS000058304Canadian Imperial Bank of CommerceCA136069101004/03/2025Shareholder Proposal Regarding Pay Ratio DisclosureCOMPENSATIONSECURITY HOLDER2748.0000000.000000AGAINST2748.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Remuneration Report (UK)COMPENSATIONISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Remuneration Report (AUS)COMPENSATIONISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Sharon ThorneDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Dominic BartonDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Peter CunninghamDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Dean Dalla ValleDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Simon P. HenryDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Susan Lloyd-HurwitzDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Martina MerzDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Jennifer NasonDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect James C. O'RourkeDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Jakob StausholmDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Ngaire WoodsDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Elect Ben WyattDIRECTOR ELECTIONSISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Appointment of AuditorAUDIT-RELATEDISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Approval of Climate Action PlanENVIRONMENT OR CLIMATEISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER3571.0000000.000000FOR3571.000000FORS000058304Rio Tinto plcGB000718875704/03/2025SHP Requesting Unification ReviewOTHER SOCIAL ISSUESSECURITY HOLDER3571.0000000.000000AGAINST3571.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Nora A. AufreiterDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Guillermo E. BabatzDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Daniel H. CallahanDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect W. Dave DowrichDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Michael B. MedlineDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Lynn K. PattersonDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Una M. PowerDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Aaron W. RegentDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Sandra StuartDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect L. Scott ThomsonDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Steven C. Van WykDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Elect Benita M. WarmboldDIRECTOR ELECTIONSISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Appointment of AuditorAUDIT-RELATEDISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3089.0000000.000000FOR3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3089.0000000.000000FOR3089.000000FOR4S000058304The Bank of Nova ScotiaCA064149107504/08/2025Shareholder Proposal Regarding Racial Equity AuditDIVERSITY, EQUITY, AND INCLUSIONSECURITY HOLDER3089.0000000.000000AGAINST3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Shareholder Proposal Regarding Report on Forced and Child Labour in Loan PortfoliosHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER3089.0000000.000000AGAINST3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Shareholder Proposal Regarding Adhering to Voluntary Code of Conduct on AI SystemsOTHER SOCIAL ISSUESSECURITY HOLDER3089.0000000.000000AGAINST3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Shareholder Proposal Regarding Disclosure of Employee Language FluencyCORPORATE GOVERNANCESECURITY HOLDER3089.0000000.000000AGAINST3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER3089.0000000.000000AGAINST3089.000000FORS000058304The Bank of Nova ScotiaCA064149107504/08/2025Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER3089.0000000.000000AGAINST3089.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Allocation of DividendsCAPITAL STRUCTUREISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025REMUNERATION REPORTCOMPENSATIONISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Elect Jan Zijderveld to the Supervisory BoardDIRECTOR ELECTIONSISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Elect Per Bank to the Supervisory BoardDIRECTOR ELECTIONSISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Supervisory Board Remuneration PolicyCOMPENSATIONISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Appointment of AuditorAUDIT-RELATEDISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Authority to Suppress Preemptive RightsCAPITAL STRUCTUREISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER468.0000000.000000FOR468.000000FORS000058304Koninklijke Ahold Delhaize N.V.NL001179403704/09/2025Cancellation of SharesCAPITAL STRUCTUREISSUER468.0000000.000000FOR468.000000FORS000058304Telefonica SAES0178430E1804/09/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Appointment of AuditorAUDIT-RELATEDISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Ratify Co-Option and Elect Marc Thomas Murtra MillarDIRECTOR ELECTIONSISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Ratify Co-Option and Elect Emilio Gayo RodriguezDIRECTOR ELECTIONSISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Ratify Co-Option and Elect Carlos Ocana OrbisDIRECTOR ELECTIONSISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Ratify Co-Option and Elect Olayan M. AlwetaidDIRECTOR ELECTIONSISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Ratify Co-Option and Elect Ana Maria Sala AndresDIRECTOR ELECTIONSISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Special DividendCAPITAL STRUCTUREISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Authority to Issue Convertible Securities w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER8760.0000000.000000FOR8760.000000FORS000058304Telefonica SAES0178430E1804/09/2025Remuneration ReportCOMPENSATIONISSUER8760.0000000.000000FOR8760.000000FORS000058304Zurich Insurance Group AGCH001107539404/09/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Compensation ReportCOMPENSATIONISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Allocation of DividendsCAPITAL STRUCTUREISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Michel M. Lies as Board ChairDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Joan Lordi C. AmbleDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Catherine P. BessantDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Christoph FranzDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Michael HalbherrDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Sabine Keller-BusseDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Kishore MahbubaniDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Peter MaurerDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect John RafterDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Jasmin StaiblinDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Barry StoweDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Thomas JordanDIRECTOR ELECTIONSISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Michel M. Lies as Compensation Committee MemberCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Catherine P. Bessant as Compensation Committee MemberCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Christoph Franz as Compensation Committee MemberCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Sabine Keller-Busse as Compensation Committee MemberCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Kishore Mahbubani as Compensation Committee MemberCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Elect Jasmin Staiblin as Compensation Committee MemberCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Appointment of AuditorAUDIT-RELATEDISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Board CompensationCOMPENSATIONISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Executive Compensation (Total)COMPENSATIONISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304Zurich Insurance Group AGCH001107539404/09/2025Transaction of Other BusinessCORPORATE GOVERNANCEISSUER203.0000000.000000TAKENOACTION203.000000NONES000058304CaixaBank SAES014060901904/10/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Appointment of AuditorAUDIT-RELATEDISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Koro Usarraga UnsainDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Fernando Maria Costa Duarte UlrichDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Maria Teresa Santero QuintillaDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Rosa Maria Garcia PineiroDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Luis Alvarez SatorreDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Bernardo Sanchez InceraDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Pablo Arturo Forero CalderonDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Elect Jose Maria Mendez Alvarez-CedronDIRECTOR ELECTIONSISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Authority to Cancel Treasury Shares and Reduce Share CapitalCAPITAL STRUCTUREISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Directors' FeesCOMPENSATIONISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Remuneration PolicyCOMPENSATIONISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Authority to Issue Shares Pursuant to Equity Remuneration PlanCAPITAL STRUCTUREISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Maximum Variable Pay RatioCOMPENSATIONISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Remuneration ReportCOMPENSATIONISSUER13047.0000000.000000FOR13047.000000FORS000058304CaixaBank SAES014060901904/10/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER13047.0000000.000000FOR13047.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Mirko BibicDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Andrew A. ChisholmDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Jacynthe CoteDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Toos N. DaruvalaDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Cynthia DevineDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Roberta JamiesonDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect David I. McKayDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Amanda NortonDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Barry V. PerryDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Maryann TurckeDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Thierry VandalDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Frank VetteseDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Elect Jeffery W. YabukiDIRECTOR ELECTIONSISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Appointment of AuditorAUDIT-RELATEDISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER137.0000000.000000FOR137.000000FOR4S000058304Royal Bank of CanadaCA780087102104/10/2025Amendment to the Stock Option PlanCOMPENSATIONISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Amendment to By-Law Regarding Directors' RemunerationCORPORATE GOVERNANCEISSUER137.0000000.000000FOR137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Pay Ratio DisclosureCOMPENSATIONSECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Report on Forced and Child Labour in Loan PortfoliosHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Adhering to Voluntary Code of Conduct on AI SystemsOTHER SOCIAL ISSUESSECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Disclosure of Employee Language FluencyCORPORATE GOVERNANCESECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding Reporting Circular Economy LoansENVIRONMENT OR CLIMATESECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304Royal Bank of CanadaCA780087102104/10/2025Shareholder Proposal Regarding In-Person Shareholder MeetingsCORPORATE GOVERNANCESECURITY HOLDER137.0000000.000000AGAINST137.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Ayman AntounDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Ana ArsovDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Cherie L. BrantDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Raymond ChunDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Elio R. LuongoDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Alan N. MacGibbonDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect John B. MacintyreDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Keith G. MartellDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Nathalie M. PalladitcheffDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect S. Jane RoweDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Nancy G. TowerDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Ajay K. VirmaniDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Mary A. WinstonDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Elect Paul C. WirthDIRECTOR ELECTIONSISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Appointment of AuditorAUDIT-RELATEDISSUER1650.0000000.000000FOR1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1650.0000000.000000AGAINST1650.000000AGAINSTS000058304The Toronto-Dominion BankCA891160509204/10/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER1650.0000000.000000AGAINST1650.000000AGAINST4S000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Energy Supply RatioENVIRONMENT OR CLIMATESECURITY HOLDER1650.0000000.000000FOR1650.000000AGAINSTS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Report on Forced and Child Labour in Loan PortfoliosHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Adhering to Voluntary Code of Conduct on AI SystemsOTHER SOCIAL ISSUESSECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Disclosure of Employee Language FluencyCORPORATE GOVERNANCESECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Dismissal of Bharat Masrani as AdvisorCORPORATE GOVERNANCESECURITY HOLDER1650.0000000.000000FOR1650.000000AGAINSTS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Retirement Age and Term Limits of DirectorsCORPORATE GOVERNANCESECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304The Toronto-Dominion BankCA891160509204/10/2025Shareholder Proposal Regarding Demotion of CEO and Hiring of New CEOCORPORATE GOVERNANCESECURITY HOLDER1650.0000000.000000AGAINST1650.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect George A. CopeDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Janice M. BabiakDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Craig W. BroderickDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Hazel ClaxtonDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Diane L. CooperDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Stephen DentDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Martin S. EichenbaumDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect David HarquailDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Eric R. La FlecheDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Brian McManusDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Lorraine MitchelmoreDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Madhu RanganathanDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Elect Darryl WhiteDIRECTOR ELECTIONSISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Appointment of AuditorAUDIT-RELATEDISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER688.0000000.000000FOR688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER688.0000000.000000FOR688.000000FOR4S000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Disclosure of Country-by-Country ReportingCORPORATE GOVERNANCESECURITY HOLDER688.0000000.000000AGAINST688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Say on ClimateENVIRONMENT OR CLIMATESECURITY HOLDER688.0000000.000000AGAINST688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Disclosure of Employee Language FluencyCORPORATE GOVERNANCESECURITY HOLDER688.0000000.000000AGAINST688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Adhering to Voluntary Code of Conduct on AI SystemsOTHER SOCIAL ISSUESSECURITY HOLDER688.0000000.000000AGAINST688.000000FORS000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Energy Supply RatioENVIRONMENT OR CLIMATESECURITY HOLDER688.0000000.000000FOR688.000000AGAINSTS000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Lobbying Activity Alignment with the Paris AgreementENVIRONMENT OR CLIMATESECURITY HOLDER688.0000000.000000FOR688.000000AGAINSTS000058304Bank of MontrealCA063671101604/11/2025Shareholder Proposal Regarding Pay Ratio DisclosureCOMPENSATIONSECURITY HOLDER688.0000000.000000AGAINST688.000000FORS000058304Swiss Re LtdCH012688156104/11/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Compensation ReportCOMPENSATIONISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Allocation of DividendsCAPITAL STRUCTUREISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Jacques de Vaucleroy as Board ChairDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Karen GavanDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Vanessa LauDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Geraldine MatchettDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Joachim OechslinDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Deanna OngDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Jay RalphDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Jorg ReinhardtDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Pia TischhauserDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Larry D. ZimplemanDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Morten HubbeDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect George QuinnDIRECTOR ELECTIONSISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Deanna Ong as Compensation Committee MemberCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Jay Ralph as Compensation Committee MemberCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Jorg Reinhardt as Compensation Committee MemberCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Elect Morten Hubbe as Compensation Committee MemberCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Appointment of AuditorAUDIT-RELATEDISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Board CompensationCOMPENSATIONISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Executive Compensation (Short-Term)COMPENSATIONISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Executive Compensation (Fixed and Long-term)COMPENSATIONISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Approval of a Capital BandCAPITAL STRUCTUREISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Swiss Re LtdCH012688156104/11/2025Additional or Amended ProposalsCORPORATE GOVERNANCEISSUER643.0000000.000000TAKENOACTION643.000000NONES000058304Stellantis N.VNL00150001Q904/15/2025Annual Report: 2024 Remuneration Report 2024 (advisory voting)COMPENSATIONISSUER4357.0000000.000000AGAINST4357.000000AGAINSTS000058304Stellantis N.VNL00150001Q904/15/2025Annual Report: Adoption of the Annual Accounts 2024CORPORATE GOVERNANCEISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Annual Report: Approval of 2024 dividendCAPITAL STRUCTUREISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Annual Report: Granting of discharge to the directors in respect of the performance of their duties during the financial year 2024CORPORATE GOVERNANCEISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Fiona Clare Cicconi as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Nicolas Dufourcq as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Ann Frances Godbehere as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Claudia Parzani as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Daniel Ramot as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Benoit Ribadeau-Dumas as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of Non-Executive Directors: Proposal to appoint Alice Davey Schroeder as Non-Executive DirectorDIRECTOR ELECTIONSISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of the auditor and assurance provider: Proposal to appoint Deloitte Accountants B.V. as the Company's independent Auditor for the financial year 2025AUDIT-RELATEDISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Appointment of the auditor and assurance provider: Proposal to appoint Deloitte Accountants B.V. as the Company's assurance provider for the financial year 2025AUDIT-RELATEDISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Remuneration: Proposal to approve the revised Remuneration policy of the Board of DirectorsCOMPENSATIONISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Remuneration: Proposal to approve the revised Equity Incentive Plan and authorization to the Board of Directors (i) to issue shares or grant rights to subscribe for shares and (ii) to exclude pre-emptive rights in connection with the Equity Incentive PlanCOMPENSATIONISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Delegation to the Board of Directors of the authority to issue shares in the capital of the Company and to limit or to exclude pre-emptive rights: Proposal to designate the Board of Directors as the corporate body authorized to issue common shares and to grant rights to subscribe for common shares as provided for in article 7 of the Company's articles of associationCAPITAL STRUCTUREISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Delegation to the Board of Directors of the authority to issue shares in the capital of the Company and to limit or to exclude pre-emptive rights: Proposal to designate the Board of Directors as the corporate body authorized to limit or to exclude pre-emption rights for common shares as provided for in article 8 of the Company's articles of associationCAPITAL STRUCTUREISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Delegation to the Board of Directors of the authority to acquire common shares in the Company's capital: Proposal to authorize the Board of Directors to acquire fully paid-up common shares in the Company's own share capital in accordance with article 9 of the Company's articles of associationCAPITAL STRUCTUREISSUER4357.0000000.000000FOR4357.000000FORS000058304Stellantis N.VNL00150001Q904/15/2025Cancellation of shares in the capital of the Company: Proposal to cancel common shares held by the Company in its own share capital as specified in article 10 of the Company's articles of associationCAPITAL STRUCTUREISSUER4357.0000000.000000FOR4357.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Remuneration PolicyCOMPENSATIONISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Remuneration ReportCOMPENSATIONISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Appointment of AuditorAUDIT-RELATEDISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Luc JobinDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Tadeu MarrocoDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Krishnan AnandDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Karen GuerraDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Holly K. KoeppelDIRECTOR ELECTIONSISSUER5139.0000000.000000AGAINST5139.000000AGAINSTS000058304British American Tobacco plcGB000287580404/16/2025Elect Veronique LauryDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect J. Darrell ThomasDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Serpil TimurayDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Soraya BenchikhDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Elect Uta Kemmerich-KeilDIRECTOR ELECTIONSISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Performance Share PlanCOMPENSATIONISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER5139.0000000.000000FOR5139.000000FORS000058304British American Tobacco plcGB000287580404/16/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER5139.0000000.000000FOR5139.000000FORS000058304BP plcGB000798059104/17/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Remuneration ReportCOMPENSATIONISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Helge LundDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Murray AuchinclossDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Kate ThomsonDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Amanda J. BlancDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Tushar MorzariaDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Melody B. MeyerDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Pamela DaleyDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Karen A. RichardsonDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Satish PaiDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Hina NagarajanDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Johannes TeyssenDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Elect Ian TylerDIRECTOR ELECTIONSISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Appointment of AuditorAUDIT-RELATEDISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Share Award Plan 2025COMPENSATIONISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Global Share Match 2025COMPENSATIONISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER5452.0000000.000000FOR5452.000000FORS000058304BP plcGB000798059104/17/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER5452.0000000.000000FOR5452.000000FORS000058304CovivioFR000006457804/17/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252024 Remuneration ReportCOMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252024 Remuneration of Jean-Luc Biamonti, ChairCOMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252024 Remuneration of Christophe Kullmann, CEOCOMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252024 Remuneration of Olivier Esteve, Deputy CEOCOMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252025 Remuneration Policy (Deputy CEO)COMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Elect Jerome GrivetDIRECTOR ELECTIONSISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Elect Micaela Le DivelecDIRECTOR ELECTIONSISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Appointment of Auditor (Ernst & Young)AUDIT-RELATEDISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Appointment of Auditor for Sustainability Reporting (Ernst & Young)AUDIT-RELATEDISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Appointment of Auditor for Sustainability Reporting (KPMG S.A)AUDIT-RELATEDISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Issue Shares and Convertible Debt w/o Preemptive Rights (Qualified Investors)CAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025GreenshoeCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Employee Stock Purchase PlanCOMPENSATIONISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER876.0000000.000000FOR876.000000FORS000058304CovivioFR000006457804/17/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER876.0000000.000000FOR876.000000FORS000058304GecinaFR001004086504/17/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Scrip DividendCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/20252024 Remuneration ReportCOMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/20252024 Remuneration of Jerome Brunel, ChairCOMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/20252024 Remuneration of Benat Ortega, CEOCOMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Ratification of the Co-option of Ouma SananikoneDIRECTOR ELECTIONSISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Elect Laurence Danon ArnaudDIRECTOR ELECTIONSISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Elect Ivanhoe Cambridge (Stephane Villemain)DIRECTOR ELECTIONSISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Elect Philippe BrassacDIRECTOR ELECTIONSISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Appointment of Auditor for Sustainability Reporting (KPMG)AUDIT-RELATEDISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Amendments to Articles Regarding Written ConsultationsCORPORATE GOVERNANCEISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Amendments to Articles Regarding Powers of the Board of DirectorsCORPORATE GOVERNANCEISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Amendments to Articles Regarding AuditorsCORPORATE GOVERNANCEISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025GreenshoeCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Employee Stock Purchase PlanCOMPENSATIONISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER989.0000000.000000FOR989.000000FORS000058304GecinaFR001004086504/17/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER989.0000000.000000FOR989.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Elect CHONG Chuan NeoDIRECTOR ELECTIONSISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Elect CHUA Kim ChiuDIRECTOR ELECTIONSISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Elect Helen WONGDIRECTOR ELECTIONSISSUER13366.0000000.000000AGAINST13366.000000AGAINSTS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Elect LIAN Wee CheowDIRECTOR ELECTIONSISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Directors' Fees in CashCOMPENSATIONISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Authority to Issue Ordinary Shares to Non-Executive DirectorsCOMPENSATIONISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Scrip DividendCAPITAL STRUCTUREISSUER13366.0000000.000000FOR13366.000000FORS000058304Oversea-Chinese Banking Corporation LimitedSG1S0492622004/17/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER13366.0000000.000000FOR13366.000000FORS000058304Vinci SAFR000012548604/17/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Elect Yannick AssouadDIRECTOR ELECTIONSISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Elect Pierre AnjolrasDIRECTOR ELECTIONSISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Elect Karla Bertocco TrindadeDIRECTOR ELECTIONSISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Elect Maria Victoria ZingoniDIRECTOR ELECTIONSISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Appointment of Auditor (PricewaterhouseCoopers)AUDIT-RELATEDISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Appointment of Auditor (Ernst & Young)AUDIT-RELATEDISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Appointment of Auditor for Sustainability Reporting (Ernst & Young)AUDIT-RELATEDISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/20252025 Remuneration Policy (Chair and CEO)COMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/20252025 Remuneration Policy (Incoming CEO)COMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/20252024 Remuneration ReportCOMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/20252024 Remuneration of Xavier Huillard, Chair and CEOCOMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025GreenshoeCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Employee Stock Purchase PlanCOMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Stock Purchase Plan for Overseas EmployeesCOMPENSATIONISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER936.0000000.000000FOR936.000000FORS000058304Vinci SAFR000012548604/17/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER936.0000000.000000FOR936.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Merger/Acquisition (Public Exchange Offer for Banca Popolare di Sondrio S.p.A.)EXTRAORDINARY TRANSACTIONSISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Allocation of DividendsCAPITAL STRUCTUREISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Remuneration PolicyCOMPENSATIONISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Remuneration ReportCOMPENSATIONISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Approval of 2025 Variable Incentive PlanCOMPENSATIONISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Approval of the 2025-2027 Long-Term Incentive PlanCOMPENSATIONISSUER11334.0000000.000000FOR11334.000000FORS000058304Bper Banca SpAIT000006612304/18/2025Authority to Repurchase and Reissue Shares to Service Incentive PlansCAPITAL STRUCTUREISSUER11334.0000000.000000FOR11334.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Directors' FeesCOMPENSATIONISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Elect WEE Ee LimDIRECTOR ELECTIONSISSUER4172.0000000.000000AGAINST4172.000000AGAINSTS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Elect Tracey WOON Kim HongDIRECTOR ELECTIONSISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Elect TEO Lay LimDIRECTOR ELECTIONSISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Authority to Issue Shares under the UOB Scrip Dividend SchemeCAPITAL STRUCTUREISSUER4172.0000000.000000FOR4172.000000FORS000058304United Overseas Bank LimitedSG1M3100196904/21/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER4172.0000000.000000FOR4172.000000FORS000058304CapitaLand Integrated Commercial TrustSG1M5190465404/22/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER7695.0000000.000000FOR7695.000000FORS000058304CapitaLand Integrated Commercial TrustSG1M5190465404/22/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER7695.0000000.000000FOR7695.000000FORS000058304CapitaLand Integrated Commercial TrustSG1M5190465404/22/2025Authority to Issue Units w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER7695.0000000.000000FOR7695.000000FORS000058304CapitaLand Integrated Commercial TrustSG1M5190465404/22/2025Authority to Repurchase and Reissue UnitsCAPITAL STRUCTUREISSUER7695.0000000.000000FOR7695.000000FORS000058304ageas SA/NVBE097426493004/23/2025Increase in Authorised CapitalCAPITAL STRUCTUREISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493004/23/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER295.0000000.000000FOR295.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Remuneration ReportCOMPENSATIONISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Allocation of DividendsCAPITAL STRUCTUREISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Long Term Incentive Plan; Authority to Issue SharesCOMPENSATIONISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Management Board Remuneration PolicyCOMPENSATIONISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Supervisory Board Remuneration PolicyCOMPENSATIONISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Elect Birgit Conix to the Supervisory BoardDIRECTOR ELECTIONSISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Elect Karien van Gennip to the Supervisory BoardDIRECTOR ELECTIONSISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Appointment of AuditorAUDIT-RELATEDISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Authority to Issue Shares w/ Preemptive Rights (5% for General Purposes; 5% for M&A Purposes)CAPITAL STRUCTUREISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Authority to Suppress Preemptive Rights (5% for General Purposes; 5% for M&A Purposes)CAPITAL STRUCTUREISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER17.0000000.000000FOR17.000000FORS000058304ASML Holding N.V.NL001027321504/23/2025Cancellation of SharesCAPITAL STRUCTUREISSUER17.0000000.000000FOR17.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Allocation of DividendsCAPITAL STRUCTUREISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Board SizeCORPORATE GOVERNANCEISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025List presented by MediobancaDIRECTOR ELECTIONSISSUER3082.0000000.000000FOR3082.000000NONES000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025List presented by VM 2006 S.r.l.DIRECTOR ELECTIONSISSUER3082.0000000.000000TAKENOACTION3082.000000NONES000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025List presented by Group of Institutional Investors representing 0.78% of Share CapitalDIRECTOR ELECTIONSISSUER3082.0000000.000000TAKENOACTION3082.000000NONES000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Directors' Fees (Board Proposal)COMPENSATIONISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Directors' Fees (VM 2006 S.r.l. Proposal)COMPENSATIONISSUER3082.0000000.000000ABSTAIN3082.000000NONES000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Elect Annalisa Firmani as Alternate Statutory AuditorDIRECTOR ELECTIONSISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Remuneration PolicyCOMPENSATIONISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Remuneration ReportCOMPENSATIONISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/20252025-2027 Long-Term Incentive PlanCOMPENSATIONISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Authority to Repurchase Shares to Service Incentive PlansCAPITAL STRUCTUREISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Cancellation of SharesCAPITAL STRUCTUREISSUER3082.0000000.000000FOR3082.000000FORS000058304Assicurazioni Generali S.p.A.IT000006207204/23/2025Amendments to Article 9.1 (Share Capital)CORPORATE GOVERNANCEISSUER3082.0000000.000000FOR3082.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Remuneration PolicyCOMPENSATIONISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Remuneration ReportCOMPENSATIONISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Final DividendCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Richard HaythornthwaiteDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Paul ThwaiteDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Katie MurrayDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Frank E. DangeardDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Roisin DonnellyDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Patrick FlynnDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Geeta GopalanDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Yasmin JethaDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Stuart LewisDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Gill WhiteheadDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Elect Lena WilsonDIRECTOR ELECTIONSISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Appointment of AuditorAUDIT-RELATEDISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Issue Equity Convertible Notes w/ Preemptive RightsCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Issue Equity Convertible Notes w/o Preemptive RightsCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Repurchase Shares from HM TreasuryCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304NatWest Group plcGB00BM8PJY7104/23/2025Authority to Repurchase Preference SharesCAPITAL STRUCTUREISSUER2072.0000000.000000FOR2072.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Yoshihiro NakaiDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Satoshi TanakaDIRECTOR ELECTIONSISSUER4821.0000000.000000AGAINST4821.000000AGAINSTS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Toru IshiiDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Hiroshi ShinozakiDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Yasushi OmuraDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Yukiko YoshimaruDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Toshifumi KitazawaDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Yoshimi NakajimaDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Shinichi AbeDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Yukiko Kuroda @ Yukiko MatsumotoDIRECTOR ELECTIONSISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Osamu MinagawaCORPORATE GOVERNANCEISSUER4821.0000000.000000FOR4821.000000FORS000058304Sekisui House, Ltd.JP342060000304/23/2025Elect Yuko TamaiCORPORATE GOVERNANCEISSUER4821.0000000.000000FOR4821.000000FORS000058304AXAFR000012062804/24/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/20252024 Remuneration ReportCOMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/20252024 Remuneration of Antoine Gosset-Grainville, ChairCOMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/20252024 Remuneration of Thomas Buberl, CEOCOMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Elect Guillaume FauryDIRECTOR ELECTIONSISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Elect Ramon FernandezDIRECTOR ELECTIONSISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Ratification of the Co-option of Ewout SteenbergenDIRECTOR ELECTIONSISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Shares w/o Preemptive Rights in Consideration for Securities Issued by SubsidiariesCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Shares w/ Preemptive Rights in Consideration for Securities Issued by SubsidiariesCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Employee Stock Purchase PlanCOMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Stock Purchase Plan for Overseas EmployeesCOMPENSATIONISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Authority to Issue Performance Shares Pursuant to Defined Contribution Pension PlanCAPITAL STRUCTUREISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER4006.0000000.000000FOR4006.000000FORS000058304AXAFR000012062804/24/2025Amendments to Articles Regarding Written ConsultationsCORPORATE GOVERNANCEISSUER4006.0000000.000000FOR4006.000000FORS000058304CapitaLand Ascendas Real Estate Investment TrustSG1M7790691504/25/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER5951.0000000.000000FOR5951.000000FORS000058304CapitaLand Ascendas Real Estate Investment TrustSG1M7790691504/25/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER5951.0000000.000000FOR5951.000000FORS000058304CapitaLand Ascendas Real Estate Investment TrustSG1M7790691504/25/2025Authority to Issue Units w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER5951.0000000.000000FOR5951.000000FORS000058304CapitaLand Ascendas Real Estate Investment TrustSG1M7790691504/25/2025Authority to Repurchase UnitsCAPITAL STRUCTUREISSUER5951.0000000.000000FOR5951.000000FORS000058304Bouygues SAFR000012050304/29/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/20252025 Remuneration Policy (CEO and Deputy CEOs)COMPENSATIONISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/20252024 Remuneration ReportCOMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/20252024 Remuneration of Martin Bouygues, ChairCOMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/20252024 Remuneration of Olivier Roussat, CEOCOMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/20252024 Remuneration of Pascal Grange, Deputy CEOCOMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/20252024 Remuneration of Edward Bouygues, Deputy CEOCOMPENSATIONISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Elect Felicie BurelleDIRECTOR ELECTIONSISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Elect Clara GaymardDIRECTOR ELECTIONSISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Elect Olivier BouyguesDIRECTOR ELECTIONSISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Elect SCDM (Cyril Bouygues)DIRECTOR ELECTIONSISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Elect Charlotte BouyguesDIRECTOR ELECTIONSISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Elect Nathalie Bellon-SzaboDIRECTOR ELECTIONSISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Elect Raphaelle DeflesselleDIRECTOR ELECTIONSISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Elect Sylvie BruneauDIRECTOR ELECTIONSISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025GreenshoeCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Shares w/o Preemptive Rights in Consideration for Securities Issued by SubsidiariesCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Employee Stock Purchase PlanCOMPENSATIONISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Authority to Grant Stock OptionsCAPITAL STRUCTUREISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Performance Shares (Pension Plan)CAPITAL STRUCTUREISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Authority to Issue Warrants as a Takeover DefenseSHAREHOLDER RIGHTS AND DEFENSESISSUER3253.0000000.000000AGAINST3253.000000AGAINSTS000058304Bouygues SAFR000012050304/29/2025Amendments to Articles Regarding Share Ownership Disclosure RequirementsCORPORATE GOVERNANCEISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Amendments to Articles Regarding Staggered BoardCORPORATE GOVERNANCEISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER3253.0000000.000000FOR3253.000000FORS000058304Bouygues SAFR000012050304/29/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER3253.0000000.000000FOR3253.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Allocation of DividendsCAPITAL STRUCTUREISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Board SizeCORPORATE GOVERNANCEISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025List Presented by Shareholders' AgreementDIRECTOR ELECTIONSISSUER37426.0000000.000000TAKENOACTION37426.000000NONES000058304Intesa Sanpaolo SpaIT000007261804/29/2025List Presented by Group of Institutional Investors Representing 1.51% of Share CapitalDIRECTOR ELECTIONSISSUER37426.0000000.000000FOR37426.000000NONES000058304Intesa Sanpaolo SpaIT000007261804/29/2025Elect Gian Maria Gros-Pietro as Chair and Paola Tagliavini as Vice ChairCORPORATE GOVERNANCEISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Remuneration Policy (Board of Directors)COMPENSATIONISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Directors' FeesCOMPENSATIONISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Remuneration Policy (Group)COMPENSATIONISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Remuneration ReportCOMPENSATIONISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/20252025 Annual Incentive PlanCOMPENSATIONISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Authority to Repurchase and Reissue Shares to Service Incentive PlansCAPITAL STRUCTUREISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER37426.0000000.000000FOR37426.000000FORS000058304Intesa Sanpaolo SpaIT000007261804/29/2025Cancellation of SharesCAPITAL STRUCTUREISSUER37426.0000000.000000FOR37426.000000FORS000058304RexelFR001045120304/29/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/20252024 Remuneration ReportCOMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/20252024 Remuneration of Agnes Touraine, ChairCOMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/20252024 Remuneration of Guillaume Texier, CEOCOMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Elect Marcus AlexandersonDIRECTOR ELECTIONSISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Elect Guillaume TexierDIRECTOR ELECTIONSISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Elect Agnes TouraineDIRECTOR ELECTIONSISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025GreenshoeCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Employee Stock Purchase PlanCOMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Stock Purchase Plan for Overseas EmployeesCOMPENSATIONISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Amendments to Articles Regarding Board DeliberationsCORPORATE GOVERNANCEISSUER583.0000000.000000FOR583.000000FORS000058304RexelFR001045120304/29/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER583.0000000.000000FOR583.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Elect XUE MingyuanDIRECTOR ELECTIONSISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Elect LAI ZhiyongDIRECTOR ELECTIONSISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Elect YANG XinDIRECTOR ELECTIONSISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Elect TSE Siu NganDIRECTOR ELECTIONSISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Elect Rebecca LIU Ka YingDIRECTOR ELECTIONSISSUER21535.0000000.000000AGAINST21535.000000AGAINSTS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Elect HU Mantian (Mandy)DIRECTOR ELECTIONSISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Directors' FeesCOMPENSATIONISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER21535.0000000.000000FOR21535.000000FORS000058304Sitc International Holdings Co LtdKYG8187G105504/29/2025Authority to Issue Repurchased SharesCAPITAL STRUCTUREISSUER21535.0000000.000000FOR21535.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER22844.0000000.000000FOR22844.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER22844.0000000.000000FOR22844.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Directors' FeesCOMPENSATIONISSUER22844.0000000.000000FOR22844.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Elect Raymond POH Boon HuDIRECTOR ELECTIONSISSUER22844.0000000.000000FOR22844.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Elect YEE Chia HsingDIRECTOR ELECTIONSISSUER22844.0000000.000000AGAINST22844.000000AGAINSTS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER22844.0000000.000000FOR22844.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER22844.0000000.000000FOR22844.000000FORS000058304Yangzijiang Shipbuilding (Holdings) Ltd.SG1U7693481904/29/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER22844.0000000.000000FOR22844.000000FORS000058304Banco Bpm SpAIT000521838004/30/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/2025Allocation of DividendsCAPITAL STRUCTUREISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/2025Remuneration PolicyCOMPENSATIONISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/2025Remuneration ReportCOMPENSATIONISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/20252025 Short-Term Incentive PlanCOMPENSATIONISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/20252025-2027 Long-Term Incentive PlanCOMPENSATIONISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/2025Severance AgreementsCOMPENSATIONISSUER2359.0000000.000000FOR2359.000000FORS000058304Banco Bpm SpAIT000521838004/30/2025Authority to Repurchase and Reissue Shares to Service Variable Incentive PlansCAPITAL STRUCTUREISSUER2359.0000000.000000FOR2359.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Remuneration PolicyCOMPENSATIONISSUER11198.0000000.000000AGAINST11198.000000AGAINSTS000058304M&G plcGB00BKFB1C6504/30/2025Remuneration ReportCOMPENSATIONISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Paul EvansDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Clive AdamsonDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Edward BrahamDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Clare M. ChapmanDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Kathryn McLelandDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Paolo Andrea RossiDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Dev SanyalDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Elisabeth StheemanDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Clare ThompsonDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Elect Massimo TosatoDIRECTOR ELECTIONSISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Appointment of AuditorAUDIT-RELATEDISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Issue Preference Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER11198.0000000.000000AGAINST11198.000000AGAINSTS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Issue Mandatory Convertible Securities w/ Preemptive RightsCAPITAL STRUCTUREISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Issue Mandatory Convertible Securities w/o Preemptive RightsCAPITAL STRUCTUREISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER11198.0000000.000000FOR11198.000000FORS000058304M&G plcGB00BKFB1C6504/30/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER11198.0000000.000000FOR11198.000000FORS000058304Sanofi SAFR000012057804/30/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Related Party Transactions (L'Oreal)CORPORATE GOVERNANCEISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Ratification of the Co-option of Jean-Paul KressDIRECTOR ELECTIONSISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Elect Carole FerrandDIRECTOR ELECTIONSISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Elect Barbara LavernosDIRECTOR ELECTIONSISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Elect Emile VoestDIRECTOR ELECTIONSISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Elect Antoine YverDIRECTOR ELECTIONSISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/20252024 Remuneration ReportCOMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/20252024 Remuneration of Frederic Oudea, ChairCOMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/20252024 Remuneration of Paul Hudson, CEOCOMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Issue Debt InstrumentsCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025GreenshoeCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Employee Stock Purchase PlanCOMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Stock Purchase Plan for Overseas EmployeesCOMPENSATIONISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER1425.0000000.000000FOR1425.000000FORS000058304Sanofi SAFR000012057804/30/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER1425.0000000.000000FOR1425.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Remuneration ReportCOMPENSATIONISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Benoit PotierDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Zoe A. YujnovichDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Fernando FernandezDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Adrian HennahDIRECTOR ELECTIONSISSUER199.0000000.000000AGAINST199.000000AGAINSTS000058304Unilever plcGB00B10RZP7804/30/2025Elect Susan KilsbyDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Ruby LuDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Judith McKennaDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Ian K. MeakinsDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Elect Nelson PeltzDIRECTOR ELECTIONSISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Appointment of AuditorAUDIT-RELATEDISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER199.0000000.000000FOR199.000000FORS000058304Unilever plcGB00B10RZP7804/30/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER199.0000000.000000FOR199.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Final DividendCAPITAL STRUCTUREISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Remuneration ReportCOMPENSATIONISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Meagen BurnettDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Johanna KyrklundDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Elizabeth CorleyDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Richard OldfieldDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Ian G. KingDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Rakhi (Parekh) Goss-CustardDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Iain J. MackayDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Annette ThomasDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Frederic WakemanDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Matthew WestermanDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Claire Fitzalan HowardDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Elect Leonie SchroderDIRECTOR ELECTIONSISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Appointment of AuditorAUDIT-RELATEDISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Waiver of Mandatory Takeover RequirementSHAREHOLDER RIGHTS AND DEFENSESISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER10453.0000000.000000FOR10453.000000FORS000058304Schroders plcGB00BP9LHF2305/01/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER10453.0000000.000000FOR10453.000000FORS000058304The GPT GroupAU000000GPT805/01/2025Re-elect Anne B. BrennanDIRECTOR ELECTIONSISSUER33586.0000000.000000FOR33586.000000FORS000058304The GPT GroupAU000000GPT805/01/2025Re-elect Tracey A. HortonDIRECTOR ELECTIONSISSUER33586.0000000.000000FOR33586.000000FORS000058304The GPT GroupAU000000GPT805/01/2025Remuneration ReportCOMPENSATIONISSUER33586.0000000.000000FOR33586.000000FORS000058304The GPT GroupAU000000GPT805/01/2025Equity Grant (MD/CEO Russel Proutt)COMPENSATIONISSUER33586.0000000.000000FOR33586.000000FORS000058304BASF SEDE000BASF11105/02/2025Allocation of DividendsCAPITAL STRUCTUREISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Appointment of AuditorAUDIT-RELATEDISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Amendments to Articles (Virtual Meeting)CORPORATE GOVERNANCEISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Approval of Intra-Company Control Agreement with BASF Agricultural Solutions Deutschland GmbHEXTRAORDINARY TRANSACTIONSISSUER1783.0000000.000000FOR1783.000000FORS000058304BASF SEDE000BASF11105/02/2025Remuneration ReportCOMPENSATIONISSUER1783.0000000.000000FOR1783.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Allocation of DividendsCAPITAL STRUCTUREISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Appointment of Auditor; Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Elect Ingrid DeltenreDIRECTOR ELECTIONSISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Elect Georg A. PolzlDIRECTOR ELECTIONSISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Elect Lawrence A. RosenDIRECTOR ELECTIONSISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Increase in Authorised CapitalCAPITAL STRUCTUREISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Equity Incentive Plan; Increase in Conditional CapitalCOMPENSATIONISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Authority to Repurchase Shares Using Equity DerivativesCAPITAL STRUCTUREISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Management Board Remuneration PolicyCOMPENSATIONISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Remuneration ReportCOMPENSATIONISSUER1752.0000000.000000FOR1752.000000FORS000058304Deutsche Post AGDE000555200405/02/2025Amendments to Articles (Virtual Meetings)CORPORATE GOVERNANCEISSUER1752.0000000.000000FOR1752.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Remuneration ReportCOMPENSATIONISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Remuneration PolicyCOMPENSATIONISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Pam KaurDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Geraldine BuckinghamDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Rachel DuanDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Georges ElhederyDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Dame Carolyn FairbairnDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect James J. ForeseDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Ann F. GodbehereDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Steven GuggenheimerDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Jose Antonio Meade KuribrenaDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Kalpana MorpariaDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Eileen MurrayDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Brendan R. NelsonDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Swee Lian TeoDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Elect Mark E. TuckerDIRECTOR ELECTIONSISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Appointment of AuditorAUDIT-RELATEDISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Issue Repurchased SharesCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Repurchase Shares Off-MarketCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Issue Contingent Convertible Securities w/ Preemptive RightsCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Issue Contingent Convertible Securities w/o Preemptive RightsCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Scrip DividendCAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Amendment to the Share PlanCOMPENSATIONISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025CANCELLATION OF SHARE PREMIUM ACCOUNT AND CAPITAL REDEMPTION RESERVECAPITAL STRUCTUREISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER9563.0000000.000000FOR9563.000000FORS000058304HSBC Holdings plcGB000540528605/02/2025Shareholder Proposal Regarding Pension SchemeCOMPENSATIONSECURITY HOLDER9563.0000000.000000AGAINST9563.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Mayank M. AsharDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Gaurdie E. Banister Jr.DIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Susan M. CunninghamDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Gregory L. EbelDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Jason B. FewDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Douglas L. FosheeDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Theresa B.Y. JangDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Teresa S. MaddenDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Manjit MinhasDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Stephen S. PolozDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect S. Jane RoweDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Elect Steven W. WilliamsDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3793.0000000.000000FOR3793.000000FORS000058304Enbridge Inc.CA29250N105005/07/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3793.0000000.000000FOR3793.000000FOR4S000058304Mercedes-Benz Group AGDE000710000005/07/2025Allocation of DividendsCAPITAL STRUCTUREISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Appointment of AuditorAUDIT-RELATEDISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Appointment of Auditor for Interim Financial StatementsAUDIT-RELATEDISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Remuneration ReportCOMPENSATIONISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Elect Ben Van BeurdenDIRECTOR ELECTIONSISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Elect Elizabeth CentoniDIRECTOR ELECTIONSISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Elect Timotheus HottgesDIRECTOR ELECTIONSISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Elect Olaf KochDIRECTOR ELECTIONSISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Elect Helene SvahnDIRECTOR ELECTIONSISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Authority to Repurchase Shares Using Equity DerivativesCAPITAL STRUCTUREISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Authority to Issue Convertible Debt Instruments; Increase in Conditional CapitalCAPITAL STRUCTUREISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Supervisory Board Remuneration PolicyCOMPENSATIONISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Management Board Remuneration PolicyCOMPENSATIONISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Amendments to Articles (General Meeting Venue)CORPORATE GOVERNANCEISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Amendments to Articles (Virtual Meeting)CORPORATE GOVERNANCEISSUER2249.0000000.000000FOR2249.000000FORS000058304Mercedes-Benz Group AGDE000710000005/07/2025Additional or Amended Shareholder ProposalsCORPORATE GOVERNANCESECURITY HOLDER2249.0000000.000000AGAINST2249.000000NONES000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Ratify Co-Option and Elect Isidro Faine CasasDIRECTOR ELECTIONSISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Elect Carmen Fernandez RozadoDIRECTOR ELECTIONSISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Elect Jose Eladio Seco DominguezDIRECTOR ELECTIONSISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Board SizeCORPORATE GOVERNANCEISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Remuneration ReportCOMPENSATIONISSUER1663.0000000.000000AGAINST1663.000000AGAINSTS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Remuneration PolicyCOMPENSATIONISSUER1663.0000000.000000AGAINST1663.000000AGAINSTS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Scrip Dividend; Authority to Cancel Shares and Reduce Share CapitalCAPITAL STRUCTUREISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025AUTHORISATION TO THE BOARD, IN ACCORDANCE WITH SECTION 297(1)(B) OF THE SPANISH CORPORATE ENTERPRISES ACT [LEY DE SOCIEDADES DE CAPITAL], TO INCREASE THE SHARE CAPITAL BY MEANS OF CASH CONTRIBUTIONS OF UP TO HALF THE AMOUNT OF THE SHARE CAPITAL, WITHIN A MAXIMUM PERIOD OF 5 YEARS, ON ONE OR MORE OCCASIONS, AND AT THE TIME AND IN THE AMOUNT IT DEEMS APPROPRIATE. WITHIN THE AFOREMENTIONED MAXIMUM AMOUNT, THE BOARD IS ASSIGNED THE POWER TO EXCLUDE PRE EMPTION RIGHTS UP TO A MAXIMUM OF 20PCT OF THE SHARE CAPITALCAPITAL STRUCTUREISSUER1663.0000000.000000FOR1663.000000FORS000058304ACS Actividades de Construccion y Servicios, S.A.ES016705091505/08/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER1663.0000000.000000FOR1663.000000FORS000058304Allianz SEDE000840400505/08/2025Allocation of DividendsCAPITAL STRUCTUREISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Oliver BateCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Sirma BoshnakovaCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Claire-Marie Coste-LepoutreCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Barbara Karuth-ZelleCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Klaus-Peter RohlerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Gunther ThallingerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Christopher TownsendCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Renate WagnerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Andreas WimmerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Michael DiekmannCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Gabriele Burkhardt-BergCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Jorg SchneiderCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Sophie BoissardCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Christine BosseCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Nadine BrandlCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Stephanie BruceCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Rashmy ChatterjeeCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Friedrich EichinerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Jean-Claude Le GoaerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Martina GrundlerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Herbert HainerCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Frank KirschCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Jurgen LawrenzCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Primiano Di PaoloCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Ratify Katharina WesenickCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Appointment of AuditorAUDIT-RELATEDISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Remuneration ReportCOMPENSATIONISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Management Board Remuneration PolicyCOMPENSATIONISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Elect Ralf P. Thomas to the Supervisory BoardDIRECTOR ELECTIONSISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304Allianz SEDE000840400505/08/2025Amendments to Articles (Virtual Meetings)CORPORATE GOVERNANCEISSUER759.0000000.000000FOR759.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Mirko BibicDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Robert P. DexterDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Katherine LeeDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Monique F. LerouxDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Sheila A. MurrayDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Gordon M. NixonDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Louis P. PagnuttiDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Calin RovinescuDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Karen H. SheriffDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Jennifer ToryDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Louis VachonDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Johan WiberghDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Elect Cornell WrightDIRECTOR ELECTIONSISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Appointment of AuditorAUDIT-RELATEDISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3360.0000000.000000FOR3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3360.0000000.000000FOR3360.000000FOR4S000058304BCE Inc.CA05534B760405/08/2025Shareholder Proposal Regarding Disclosure of Employee Language FluencyCORPORATE GOVERNANCESECURITY HOLDER3360.0000000.000000AGAINST3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Shareholder Proposal Regarding In-Person Shareholder MeetingsCORPORATE GOVERNANCESECURITY HOLDER3360.0000000.000000AGAINST3360.000000FORS000058304BCE Inc.CA05534B760405/08/2025Shareholder Proposal Regarding Adhering to Voluntary Code of Conduct on AI SystemsOTHER SOCIAL ISSUESSECURITY HOLDER3360.0000000.000000AGAINST3360.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Nicole S. ArnaboldiDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Guy L.T. BainbridgeDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Nancy J. CarrollDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Julie E. DicksonDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect J. Michael DurlandDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Donald P. KanakDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Donald R. LindsayDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Anna ManningDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect John MontalbanoDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect May TanDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Leagh E. TurnerDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect Philip J. WitheringtonDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Elect John WongDIRECTOR ELECTIONSISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Appointment of AuditorAUDIT-RELATEDISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER6325.0000000.000000FOR6325.000000FORS000058304Manulife Financial CorporationCA56501R106405/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER6325.0000000.000000FOR6325.000000FOR4S000058304Mondi plcGB00BMWC6P4905/08/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Remuneration ReportCOMPENSATIONISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Final DividendCAPITAL STRUCTUREISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Sucheta GovilDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Svein Richard BrandtzaegDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Susan M. ClarkDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Anke GrothDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Andrew KingDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Sakumzi (Saki) J. MacozomaDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Michael PowellDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Dame Angela StrankDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Philip YeaDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Elect Stephen YoungDIRECTOR ELECTIONSISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Appointment of AuditorAUDIT-RELATEDISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Long-Term Incentive PlanCOMPENSATIONISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Bonus Share PlanCOMPENSATIONISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER1106.0000000.000000FOR1106.000000FORS000058304Mondi plcGB00BMWC6P4905/08/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER1106.0000000.000000FOR1106.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Remuneration ReportCOMPENSATIONISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Remuneration PolicyCOMPENSATIONISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Final DividendCAPITAL STRUCTUREISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Andrew RJ BonfieldDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Margherita Della ValleDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Mehmood KhanDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Elane B. StockDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect D. Jeremy DarrochDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Tamara IngramDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Kris LichtDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Shannon EisenhardtDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Marybeth HaysDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Fiona DawsonDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Stefan OschmannDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Elect Mahesh MadhavanDIRECTOR ELECTIONSISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Appointment of AuditorAUDIT-RELATEDISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Long-Term Incentive PlanCOMPENSATIONISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Approval of the Sharesave Plan 2025COMPENSATIONISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER1170.0000000.000000FOR1170.000000FORS000058304Reckitt Benckiser Group plcGB00B24CGK7705/08/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER1170.0000000.000000FOR1170.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Scott B. BonhamDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Cheryl F. CampbellDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Michael R. CulbertDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect William D. JohnsonDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Susan C. JonesDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect John E. LoweDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Dawn Madahbee LeachDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Francois L. PoirierDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Una M. PowerDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Mary Pat SalomoneDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Siim A. VanaseljaDIRECTOR ELECTIONSISSUER3171.0000000.000000AGAINST3171.000000AGAINSTS000058304TC Energy CorporationCA87807B107605/08/2025Elect Thierry VandalDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Elect Dheeraj D VermaDIRECTOR ELECTIONSISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3171.0000000.000000FOR3171.000000FORS000058304TC Energy CorporationCA87807B107605/08/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER3171.0000000.000000FOR3171.000000FOR4S000058304TC Energy CorporationCA87807B107605/08/2025Amendment to Shareholder Rights PlanSHAREHOLDER RIGHTS AND DEFENSESISSUER3171.0000000.000000FOR3171.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Remuneration ReportCOMPENSATIONISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Final DividendCAPITAL STRUCTUREISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Mike RogersDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Milena Mondini-De-FocatiisDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Geraint JonesDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Evelyn BourkeDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Michael BrierleyDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Andrew CrossleyDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Karen GreenDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Fiona MuldoonDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Jayaprakasa RangaswamiDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Bill RobertsDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Elect Justine RobertsDIRECTOR ELECTIONSISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Appointment of AuditorAUDIT-RELATEDISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Approval of the 2025 Discretionary Free Share SchemeCOMPENSATIONISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER2362.0000000.000000FOR2362.000000FORS000058304Admiral Group plcGB00B02J639805/09/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER2362.0000000.000000FOR2362.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Marc BibeauDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Andra BolotinDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Betsey ChungDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Marcel CoutuDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Andre DesmaraisDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Paul Desmarais, Jr.DIRECTOR ELECTIONSISSUER421.0000000.000000AGAINST421.000000AGAINSTS000058304IGM Financial Inc.CA449586106005/09/2025Elect Gary DoerDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Susan DonizDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Claude GenereuxDIRECTOR ELECTIONSISSUER421.0000000.000000AGAINST421.000000AGAINSTS000058304IGM Financial Inc.CA449586106005/09/2025Elect Sharon HodgsonDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Jake LawrenceDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Sharon MacLeodDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Susan McArthurDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect John McCallumDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect R. Jeffrey OrrDIRECTOR ELECTIONSISSUER421.0000000.000000AGAINST421.000000AGAINSTS000058304IGM Financial Inc.CA449586106005/09/2025Elect James O' SullivanDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Elect Elizabeth WilsonDIRECTOR ELECTIONSISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Appointment of AuditorAUDIT-RELATEDISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER421.0000000.000000FOR421.000000FORS000058304IGM Financial Inc.CA449586106005/09/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER421.0000000.000000FOR421.000000FOR4S000058304Norsk Hydro ASANO000505260505/09/2025Election of Presiding ChairCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025MinutesCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Notice of Meeting; AgendaCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Accounts and Reports; Allocation of Profits and DividendsCAPITAL STRUCTUREISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Cancellation of SharesCAPITAL STRUCTUREISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Remuneration ReportCOMPENSATIONISSUER3496.0000000.000000AGAINST3496.000000AGAINSTS000058304Norsk Hydro ASANO000505260505/09/2025Election of Kim Wahl to the Board of DirectorsDIRECTOR ELECTIONSISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Election of Susanne Munch Thore as Nomination Committee ChairCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Election of Muriel Bjorseth Hansen to the Nomination CommitteeCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Election of Karl Mathisen to the Nomination CommitteeCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Election of Harald Serc-Hanssen to the Nomination CommitteeCORPORATE GOVERNANCEISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Directors' FeesCOMPENSATIONISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Nomination Committee FeesCOMPENSATIONISSUER3496.0000000.000000FOR3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Shareholder Proposal Regarding Establishment of a Small Nuclear ReactorOTHER SOCIAL ISSUESSECURITY HOLDER3496.0000000.000000AGAINST3496.000000FORS000058304Norsk Hydro ASANO000505260505/09/2025Shareholder Proposal Regarding Investigating Involvement in Nuclear PowerOTHER SOCIAL ISSUESSECURITY HOLDER3496.0000000.000000AGAINST3496.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Raymond T. ChanDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Hazel ClaxtonDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Lisa de WildeDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Victor G. DodigDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Darren EntwistleDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Martha Hall FindlayDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Thomas E. FlynnDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Mary Jo HaddadDIRECTOR ELECTIONSISSUER7428.0000000.000000AGAINST7428.000000AGAINSTS000058304TELUS CorporationCA87971M996905/09/2025Elect Christine MageeDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect John P. ManleyDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect David MowatDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Marc ParentDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect Denise PickettDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Elect W. Sean WillyDIRECTOR ELECTIONSISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER7428.0000000.000000FOR7428.000000FORS000058304TELUS CorporationCA87971M996905/09/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER7428.0000000.000000AGAINST7428.000000AGAINSTS000058304TELUS CorporationCA87971M996905/09/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER7428.0000000.000000AGAINST7428.000000AGAINST4S000058304TELUS CorporationCA87971M996905/09/2025Shareholder Rights Plan RenewalSHAREHOLDER RIGHTS AND DEFENSESISSUER7428.0000000.000000FOR7428.000000FORS000058304Aker BP ASANO001034585305/13/2025Election of Presiding Chair; MinutesCORPORATE GOVERNANCEISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Notice of Meeting; AgendaCORPORATE GOVERNANCEISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Accounts and Reports; Corporate Governance ReportCORPORATE GOVERNANCEISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Remuneration ReportCOMPENSATIONISSUER5751.0000000.000000AGAINST5751.000000AGAINSTS000058304Aker BP ASANO001034585305/13/2025Approval of Nomination Committee GuidelinesCORPORATE GOVERNANCEISSUER5751.0000000.000000ABSTAIN5751.000000AGAINSTS000058304Aker BP ASANO001034585305/13/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Directors' FeesCOMPENSATIONISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Nomination Committee FeesCOMPENSATIONISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Election of DirectorsDIRECTOR ELECTIONSISSUER5751.0000000.000000FOR5751.000000FORS000058304Aker BP ASANO001034585305/13/2025Election of Nomination Committee MembersCORPORATE GOVERNANCEISSUER5751.0000000.000000AGAINST5751.000000AGAINSTS000058304Aker BP ASANO001034585305/13/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER5751.0000000.000000AGAINST5751.000000AGAINSTS000058304Aker BP ASANO001034585305/13/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER5751.0000000.000000AGAINST5751.000000AGAINSTS000058304Aker BP ASANO001034585305/13/2025Authority to Distribute Profits/DividendsCAPITAL STRUCTUREISSUER5751.0000000.000000FOR5751.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Remuneration ReportCOMPENSATIONISSUER18229.0000000.000000AGAINST18229.000000AGAINSTS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Final DividendCAPITAL STRUCTUREISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Andrew D. BriggsDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Eleanor BucksDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Sherry CoutuDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Karen GreenDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Mark GregoryDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Hiroyuki IiokaDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Nicholas LyonsDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Katie MurrayDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Nicolaos NicandrouDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Belinda RichardsDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect David ScottDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Maggie SempleDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Elect Nicholas ShottDIRECTOR ELECTIONSISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Appointment of AuditorAUDIT-RELATEDISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER18229.0000000.000000FOR18229.000000FORS000058304Phoenix Group Holdings plcGB00BGXQNP2905/13/2025Adoption of New ArticlesCORPORATE GOVERNANCEISSUER18229.0000000.000000FOR18229.000000FORS000058304Tele2 ABSE000519023805/13/2025Election of Presiding ChairCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025AgendaCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Compliance with the Rules of ConvocationCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Thomas ReynaudCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Stina BergforsCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Aude DurandCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Jean Marc Harion (CEO)CORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Nicholas HogbergCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Sam KiniCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Eva LindqvistCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Lars-Ake NorlingCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Kjell Johnsen (Former CEO)CORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Andrew BarronCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Ratify Georgi GanevCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Board SizeCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Directors' FeesCOMPENSATIONISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Thomas ReynaudDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Stina BergforsDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Aude DurantDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Jean-Marc HarionDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Nicholas HogbergDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Sam KiniDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Mathias HermanssonDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Maxime LombardiniDIRECTOR ELECTIONSISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Elect Thomas Reynaud as Chair of the BoardCORPORATE GOVERNANCEISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Appointment of AuditorAUDIT-RELATEDISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Remuneration PolicyCOMPENSATIONISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Remuneration ReportCOMPENSATIONISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Adoption of Share-Based Incentives (LTI 2025)COMPENSATIONISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Authority to Issue Shares (LTI 2025)CAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Authority to Repurchase Shares (LTI 2025)CAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Authority to Transfer Treasury Shares (LTI 2025)CAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Authority to Issue Treasury Shares (LTI 2025)CAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Approve Equity Swap AgreementCAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER9518.0000000.000000FOR9518.000000FORS000058304Tele2 ABSE000519023805/13/2025Shareholder Proposal Regarding Board and Management QualificationsCORPORATE GOVERNANCESECURITY HOLDER9518.0000000.000000AGAINST9518.000000NONES000058304Tele2 ABSE000519023805/13/2025Shareholder Proposal Regarding Board and Management QualificationsCORPORATE GOVERNANCESECURITY HOLDER9518.0000000.000000AGAINST9518.000000NONES000058304Tele2 ABSE000519023805/13/2025Shareholder Proposal Regarding Board and Management QualificationsCORPORATE GOVERNANCESECURITY HOLDER9518.0000000.000000AGAINST9518.000000NONES000058304Eni S.p.A.IT000313247605/14/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Allocation of DividendsCAPITAL STRUCTUREISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Amendment to 2023-2025 Long Term Incentive PlanCOMPENSATIONISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Remuneration PolicyCOMPENSATIONISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Remuneration ReportCOMPENSATIONISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Use of Reserves (FY2025 Interim Dividend)CAPITAL STRUCTUREISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Reduction of Reserves (FY2025 Interim Dividend)CAPITAL STRUCTUREISSUER4950.0000000.000000FOR4950.000000FORS000058304Eni S.p.A.IT000313247605/14/2025Cancellation of SharesCAPITAL STRUCTUREISSUER4950.0000000.000000FOR4950.000000FORS000058304Holcim LtdCH001221405905/14/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Compensation ReportCOMPENSATIONISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Report on Non-Financial MattersCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Advisory Vote on Climate ReportENVIRONMENT OR CLIMATEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Ratification of Board and Management ActsCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Dividend in Kind to Effect Spin-Off of Amrize AGCAPITAL STRUCTUREISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Allocation of Profits; Dividend from ReservesCAPITAL STRUCTUREISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Cancellation of Shares and Reduction in Share CapitalCAPITAL STRUCTUREISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Kim Fausing as Board ChairDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Philippe BlockDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Leanne GealeDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Catrin HinkelDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Naina Lal KidwaiDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Ilias LaberDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Michael H. McGarryDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Claudia Sender RamirezDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Adolfo OriveDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Sven SchneiderDIRECTOR ELECTIONSISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Ilias Laber as Nominating, Compensation and Governance Committee MemberCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Michael H. McGarry as Nominating, Compensation and Governance Committee MemberCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Claudia Sender Ramirez as Nominating, Compensation and Governance Committee MemberCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Elect Leanne Geale as Nominating, Compensation and Governance Committee MemberCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Appointment of AuditorAUDIT-RELATEDISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Appointment of Independent ProxyCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Board CompensationCOMPENSATIONISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Executive Compensation (Total)COMPENSATIONISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Holcim LtdCH001221405905/14/2025Transaction of Other BusinessCORPORATE GOVERNANCEISSUER109.0000000.000000TAKENOACTION109.000000NONES000058304Snam S.p.A.IT000315341505/14/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Allocation of DividendsCAPITAL STRUCTUREISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/20252025-2027 Employee Stock Ownership PlanCOMPENSATIONISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Remuneration PolicyCOMPENSATIONISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Remuneration ReportCOMPENSATIONISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Board SizeCORPORATE GOVERNANCEISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Board Term LengthCORPORATE GOVERNANCEISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025List Presented by CDP Reti S.p.A.DIRECTOR ELECTIONSISSUER24929.0000000.000000TAKENOACTION24929.000000NONES000058304Snam S.p.A.IT000315341505/14/2025List Presented by Group of Institutional Investors Representing 1.37% of Share CapitalDIRECTOR ELECTIONSISSUER24929.0000000.000000FOR24929.000000NONES000058304Snam S.p.A.IT000315341505/14/2025Elect Alessandro Zehentner as Chair of BoardCORPORATE GOVERNANCEISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Directors' FeesCOMPENSATIONISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025List Presented by CDP Reti S.p.A.DIRECTOR ELECTIONSISSUER24929.0000000.000000AGAINST24929.000000NONES000058304Snam S.p.A.IT000315341505/14/2025List Presented by Group of Institutional Investors Representing 1.37% of Share CapitalDIRECTOR ELECTIONSISSUER24929.0000000.000000FOR24929.000000NONES000058304Snam S.p.A.IT000315341505/14/2025Election of Chair of Board of Statutory AuditorsCORPORATE GOVERNANCEISSUER24929.0000000.000000FOR24929.000000FORS000058304Snam S.p.A.IT000315341505/14/2025Statutory Auditors' FeesCOMPENSATIONISSUER24929.0000000.000000FOR24929.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Elect Richard LI Tzar KaiDIRECTOR ELECTIONSISSUER37550.0000000.000000AGAINST37550.000000AGAINSTS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Elect Susanna HUI Hon HingDIRECTOR ELECTIONSISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Elect Peter Anthony ALLENDIRECTOR ELECTIONSISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Elect ZHAO XingfuDIRECTOR ELECTIONSISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Directors' FeesCOMPENSATIONISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Authority to Issue Share Stapled Units w/o Preemptive RightsCAPITAL STRUCTUREISSUER37550.0000000.000000AGAINST37550.000000AGAINSTS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Authority to Repurchase Share Stapled UnitsCAPITAL STRUCTUREISSUER37550.0000000.000000FOR37550.000000FORS000058304HKT Trust and HKT LimitedHK000009339005/15/2025Authority to Issue Repurchased Share Stapled UnitsCAPITAL STRUCTUREISSUER37550.0000000.000000AGAINST37550.000000AGAINSTS000058304ageas SA/NVBE097426493005/21/2025Accounts and Reports; Allocation of ProfitsCAPITAL STRUCTUREISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Allocation of DividendsCAPITAL STRUCTUREISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Ratification of Auditor's ActsCORPORATE GOVERNANCEISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Remuneration ReportCOMPENSATIONISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Elect Bart De Smet to the Board of DirectorsDIRECTOR ELECTIONSISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Elect Jean-Michel Chatagny to the Board of DirectorsDIRECTOR ELECTIONSISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Elect Katleen Vandeweyer to the Board of DirectorsDIRECTOR ELECTIONSISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Appointment of Auditor for Sustainability Reporting; Authority to Set FeesAUDIT-RELATEDISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Approval to Increase Authorised CapitalCAPITAL STRUCTUREISSUER295.0000000.000000FOR295.000000FORS000058304ageas SA/NVBE097426493005/21/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER295.0000000.000000FOR295.000000FORS000058304Orange S.A.FR000013330805/21/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Elect Nadia Zak-Calvet (Employee Shareholder Representative)DIRECTOR ELECTIONSISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Elect Bpifrance Participations (Thierry Sommelet)DIRECTOR ELECTIONSISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/20252024 Remuneration ReportCOMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/20252024 Remuneration of Christel Heydemann, CEOCOMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/20252024 Remuneration of Jacques Aschenbroich, ChairCOMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Amendments to Articles Regarding Written ConsultationCORPORATE GOVERNANCEISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Amendments to Articles Regarding General MeetingsCORPORATE GOVERNANCEISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Amendments to Article Regarding Alternate Statutory AuditorsCORPORATE GOVERNANCEISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025GreenshoeCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Global Ceiling on Capital IncreasesCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Employee Stock Purchase PlanCOMPENSATIONISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER11213.0000000.000000FOR11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Shareholder Proposal A Regarding Equity Remuneration for EmployeesCOMPENSATIONSECURITY HOLDER11213.0000000.000000AGAINST11213.000000FORS000058304Orange S.A.FR000013330805/21/2025Shareholder Proposal B Regarding Limit on Board Memberships for the ChairCORPORATE GOVERNANCESECURITY HOLDER11213.0000000.000000AGAINST11213.000000FORS000058304Telenor ASANO001006330805/21/2025Notice of Meeting; AgendaCORPORATE GOVERNANCEISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025MinutesCORPORATE GOVERNANCEISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Accounts and Reports; Allocation of Profits and DividendsCAPITAL STRUCTUREISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Approval of Group Contribution to SubsidiaryCORPORATE GOVERNANCEISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Remuneration PolicyCOMPENSATIONISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Remuneration ReportCOMPENSATIONISSUER8238.0000000.000000AGAINST8238.000000AGAINSTS000058304Telenor ASANO001006330805/21/2025Authority to Repurchase Shares (Employee Share Purchase Plan)CAPITAL STRUCTUREISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Appointment of AuditorAUDIT-RELATEDISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Nils BastiansenDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Hanne NordgaardDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Kurt KristoffersenDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect John Gordon BernanderDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Heidi FinskasDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Widar SalbuvikDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Silvija SeresDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Lisbeth Karin NaeroDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Trine Saether RomuldDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Maalfrid BrathDIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Elin Myrmel-Johansen (Deputy)DIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Randi Marjamaa (Deputy)DIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Anette Hjerto (Deputy)DIRECTOR ELECTIONSISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Election of Nomination Committee MemberCORPORATE GOVERNANCEISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Elect Anette Hjerto to the Nomination CommitteeCORPORATE GOVERNANCEISSUER8238.0000000.000000FOR8238.000000FORS000058304Telenor ASANO001006330805/21/2025Corporate Assembly Fees; Nomination Committee FeesCOMPENSATIONISSUER8238.0000000.000000FOR8238.000000FORS000058304Teleperformance SEFR000005180705/21/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Severance Agreement, Bhupender Singh, Former Deputy CEOCOMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Non-Compete Agreeement, Thomas Mackenbrock, Deputy CEOCOMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252024 Remuneration ReportCOMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252024 Remuneration of Daniel Julien, CEOCOMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252024 Remuneration of Moulay Hafid Elalamy, Chair (Since August 28, 2024)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252024 Remuneration of Bhupender Singh, Former Deputy CEO (Until August 28, 2024)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252024 Remuneration of Thomas Mackenbrock, Deputy CEO (Since October 1, 2024)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252024 Remuneration of Olivier Rigaudy, CFO and Deputy CEOCOMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252025 Remuneration Policy (Chair)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252025 Remuneration Policy (CEO)COMPENSATIONISSUER185.0000000.000000AGAINST185.000000AGAINSTS000058304Teleperformance SEFR000005180705/21/20252025 Remuneration Policy (Deputy CEO)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/20252025 Remuneration Policy (CFO and Deputy CEO)COMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Elect Pauline GinestieDIRECTOR ELECTIONSISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Elect Kevin NiuDIRECTOR ELECTIONSISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Elect Mehdi GhissassiDIRECTOR ELECTIONSISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Elect Vera SongweDIRECTOR ELECTIONSISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Non-Renewal of Jean GuezDIRECTOR ELECTIONSISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Amendment to the 2023 Long-Term Incentive PlanCOMPENSATIONISSUER185.0000000.000000AGAINST185.000000AGAINSTS000058304Teleperformance SEFR000005180705/21/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025GreenshoeCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Employee Stock Purchase PlanCOMPENSATIONISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Amendments to Articles Regarding the Chair's AppointmentCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Amendments to Articles Regarding the Use of Means of TelecommunicationCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Amendments to Articles Regarding Statutory AuditorsCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Amendments to Articles Regarding Shareholder MeetingsCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Teleperformance SEFR000005180705/21/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER185.0000000.000000FOR185.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Scott C. BalfourDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Jim V. BertramDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Henry E. DemoneDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Paula Y. Gold-WilliamsDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Kent M. HarveyDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Lynn LoewenDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Brian J. PorterDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Ian E. RobertsonDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect M. Jacqueline SheppardDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Karen H. SheriffDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Jochen E. TilkDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Elect Carla M. TullyDIRECTOR ELECTIONSISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Appointment of AuditorAUDIT-RELATEDISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER984.0000000.000000FOR984.000000FORS000058304Emera IncorporatedCA290876101805/22/2025Advisory Vote on Executive CompensationSECTION 14A SAY-ON-PAY VOTESISSUER984.0000000.000000FOR984.000000FOR4S000058304Enel S.p.A.IT000312836705/22/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Allocation of DividendsCAPITAL STRUCTUREISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025List Presented by Ministry of Economy and FinanceDIRECTOR ELECTIONSISSUER16401.0000000.000000FOR16401.000000NONES000058304Enel S.p.A.IT000312836705/22/2025List Presented by Group of Institutional Investors Representing 1.15% of Share CapitalDIRECTOR ELECTIONSISSUER16401.0000000.000000TAKENOACTION16401.000000NONES000058304Enel S.p.A.IT000312836705/22/2025Statutory Auditors' FeesCOMPENSATIONISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/20252025 Long-Term Incentive PlanCOMPENSATIONISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Remuneration PolicyCOMPENSATIONISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Remuneration ReportCOMPENSATIONISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Amendments to Article 5 (Elimination of Par Value)CORPORATE GOVERNANCEISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Amendments to Article 16 (Board of Directors Meetings)CORPORATE GOVERNANCEISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Amendments to Article 25 (Board of Statutory Auditors Meetings)CORPORATE GOVERNANCEISSUER16401.0000000.000000FOR16401.000000FORS000058304Enel S.p.A.IT000312836705/22/2025Cancellation of SharesCAPITAL STRUCTUREISSUER16401.0000000.000000FOR16401.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Accounts and Reports; Non Tax-Deductible ExpensesCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Elect Alix BoulnoisDIRECTOR ELECTIONSISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/20252024 Remuneration ReportCOMPENSATIONISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/20252024 Remuneration of Stephane Pallez, Chair and CEOCOMPENSATIONISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/20252024 Remuneration of Charles Lantieri, Deputy CEOCOMPENSATIONISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/20252025 Directors' FeesCOMPENSATIONISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/20252025 Remuneration Policy (Corporate Officers)COMPENSATIONISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025GreenshoeCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Increase Capital in Case of Exchange OffersCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Employee Stock Purchase PlanCOMPENSATIONISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Issue Restricted SharesCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Amendments to Articles Regarding Corporate MissionCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Amendments to Articles Regarding Change in Company NameCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Amendments to Articles Regarding Board of DirectorsCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Amendments to Articles Regarding Written ConsultationsCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304La Francaise Des Jeux S.A.FR001345133305/22/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER2191.0000000.000000FOR2191.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Final DividendCAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Clare BousfieldDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Henrietta BaldockDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Philip BroadleyDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Stuart Jeffrey DaviesDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Carolyn JohnsonDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Nilufer von BismarckDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Sir John KingmanDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect M. George LewisDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Ric LewisDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Tushar MorzariaDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Antonio SimoesDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Elect Laura Wade-GeryDIRECTOR ELECTIONSISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Appointment of AuditorAUDIT-RELATEDISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Remuneration ReportCOMPENSATIONISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authorisation of Political DonationsOTHER SOCIAL ISSUESISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Issue Contingent Convertible Securities w/ Preemptive RightsCAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Issue Contingent Convertible Securities w/o Preemptive RightsCAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER44269.0000000.000000FOR44269.000000FORS000058304Legal & General Group plcGB000560399705/22/2025Authority to Set General Meeting Notice Period at 14 DaysCORPORATE GOVERNANCEISSUER44269.0000000.000000FOR44269.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Elect Lise CroteauDIRECTOR ELECTIONSISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Elect Helen Lee BouyguesDIRECTOR ELECTIONSISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Elect Laurent MignonDIRECTOR ELECTIONSISSUER3803.0000000.000000AGAINST3803.000000AGAINSTS000058304TotalEnergies SEFR000012027105/23/2025Elect Valerie della Puppa Tibi as Employee Shareholder RepresentativeDIRECTOR ELECTIONSISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Elect Hazel Clinton Fowler as Employee Shareholder RepresentativeDIRECTOR ELECTIONSISSUER3803.0000000.000000AGAINST3803.000000FORS000058304TotalEnergies SEFR000012027105/23/20252024 Remuneration ReportCOMPENSATIONISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/20252024 Remuneration of Patrick Pouyanne, Chair and CEOCOMPENSATIONISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/20252025 Remuneration Policy (Chair and CEO)COMPENSATIONISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER3803.0000000.000000FOR3803.000000FORS000058304TotalEnergies SEFR000012027105/23/2025Employee Stock Purchase PlanCOMPENSATIONISSUER3803.0000000.000000FOR3803.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Final DividendCAPITAL STRUCTUREISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Remuneration ReportCOMPENSATIONISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Philip JansenDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Angela AhrendtsDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Simon DingemansDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Sandrine DufourDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Tom IlubeDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Mark ReadDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Cindy RoseDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Andrew ScottDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Keith WeedDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Jasmine WhitbreadDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect Joanne WilsonDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Elect ZHANG Ya-QinDIRECTOR ELECTIONSISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Appointment of AuditorAUDIT-RELATEDISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Authority to Issue Shares w/ Preemptive RightsCAPITAL STRUCTUREISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Renewal of Share Option PlanCOMPENSATIONISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER1421.0000000.000000FOR1421.000000FORS000058304WPP plcJE00B8KF9B4905/23/2025Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment)CAPITAL STRUCTUREISSUER1421.0000000.000000FOR1421.000000FORS000058304OMV AGAT000074305905/27/2025Approve Payment of Regular DividendCAPITAL STRUCTUREISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Approve Payment of Additional DividendCAPITAL STRUCTUREISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Appointment of Auditor; Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Remuneration ReportCOMPENSATIONISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Supervisory Board Remuneration PolicyCOMPENSATIONISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Elect Elisabeth StadlerDIRECTOR ELECTIONSISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Elect Hans Joachim MullerDIRECTOR ELECTIONSISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Elect Jean-Baptiste RenardDIRECTOR ELECTIONSISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Elect Robert StajicDIRECTOR ELECTIONSISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER2598.0000000.000000FOR2598.000000FORS000058304OMV AGAT000074305905/27/2025Authority to Issue Treasury Shares to Employees and ExecutivesCAPITAL STRUCTUREISSUER2598.0000000.000000FOR2598.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Appointment of Auditor (PricewaterhouseCoopers)AUDIT-RELATEDISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Appointment of Auditor for Sustainability Reporting (PricewaterhouseCoopers)AUDIT-RELATEDISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Appointment of Auditor for Sustainability Reporting (KPMG)AUDIT-RELATEDISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration ReportCOMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration of Maurice Levy, Former Supervisory Board Chair (until May 29, 2024)COMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration of Arthur Sadoun, Management Board Chair (until May 29, 2024)COMPENSATIONISSUER252.0000000.000000AGAINST252.000000AGAINSTS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration of Anne-Gabrielle Heilbronner, Management Board Member (until May 29, 2024)COMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration of Loris Nold, Management Board Member (from February 8 until May 29, 2024)COMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration of Michel-Alain Proch, Former Management Board Member (until February 8, 2024)COMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/20252024 Remuneration of Arthur Sadoun, Chair and CEO (since May 29, 2024)COMPENSATIONISSUER252.0000000.000000AGAINST252.000000AGAINSTS000058304Publicis Groupe S.A.FR000013057705/27/20252025 Remuneration Policy (Chair and CEO)COMPENSATIONISSUER252.0000000.000000AGAINST252.000000AGAINSTS000058304Publicis Groupe S.A.FR000013057705/27/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER252.0000000.000000AGAINST252.000000AGAINSTS000058304Publicis Groupe S.A.FR000013057705/27/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Authority to Grant Stock OptionsCAPITAL STRUCTUREISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Employee Stock Purchase Plan (Domestic and Overseas)COMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Employee Stock Purchase Plan (Specific Categories)COMPENSATIONISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER252.0000000.000000FOR252.000000FORS000058304Publicis Groupe S.A.FR000013057705/27/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER252.0000000.000000FOR252.000000FORS000058304Carrefour SAFR000012017205/28/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Consolidated Accounts and ReportsCORPORATE GOVERNANCEISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Special Auditors Report on Regulated AgreementsAUDIT-RELATEDISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Elect Flavia Buarque de AlmeidaDIRECTOR ELECTIONSISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Elect Eduardo RossiDIRECTOR ELECTIONSISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Elect Charles EdelstenneDIRECTOR ELECTIONSISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Ratification of the Co-Option of Anne BrowaeysDIRECTOR ELECTIONSISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/20252024 Remuneration ReportCOMPENSATIONISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/20252024 Remuneration of Alexandre Bompard, Chair and CEOCOMPENSATIONISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/20252025 Remuneration Policy (Chair and CEO)COMPENSATIONISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/20252025 Remuneration Policy (Board of Directors)COMPENSATIONISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Cancel Shares and Reduce CapitalCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Issue Shares and Convertible Debt w/ Preemptive RightsCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Issue Shares and Convertible Debt w/o Preemptive RightsCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Issue Shares and Convertible Debt Through Private PlacementCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025GreenshoeCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Increase Capital in Consideration for Contributions In KindCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Increase Capital Through CapitalisationsCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Employee Stock Purchase PlanCOMPENSATIONISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authority to Issue Performance SharesCAPITAL STRUCTUREISSUER5087.0000000.000000FOR5087.000000FORS000058304Carrefour SAFR000012017205/28/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER5087.0000000.000000FOR5087.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Allocation of DividendsCAPITAL STRUCTUREISSUER640.0000000.000000FOR640.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Ratification of Management Board ActsCORPORATE GOVERNANCEISSUER640.0000000.000000FOR640.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Ratification of Supervisory Board ActsCORPORATE GOVERNANCEISSUER640.0000000.000000FOR640.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Appointment of AuditorAUDIT-RELATEDISSUER640.0000000.000000FOR640.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Appointment of Auditor for Sustainability ReportingAUDIT-RELATEDISSUER640.0000000.000000FOR640.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Remuneration ReportCOMPENSATIONISSUER640.0000000.000000FOR640.000000FORS000058304Evonik Industries AGDE000EVNK01305/28/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER640.0000000.000000FOR640.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Appointment of AuditorAUDIT-RELATEDISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025First Special DividendCAPITAL STRUCTUREISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Second Special DividendCAPITAL STRUCTUREISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025First Authority to Cancel Treasury Shares and Reduce CapitalCAPITAL STRUCTUREISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Second Authority to Cancel Treasury Shares and Reduce CapitalCAPITAL STRUCTUREISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Authority to Issue Convertible Debt InstrumentsCAPITAL STRUCTUREISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Elect Aurora Cata SalaDIRECTOR ELECTIONSISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Elect Isabel Torremocha FerrezueloDIRECTOR ELECTIONSISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Elect Mariano Marzo CarpioDIRECTOR ELECTIONSISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Remuneration ReportCOMPENSATIONISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Remuneration PolicyCOMPENSATIONISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Amendment to the Long-Term Incentive PlanCOMPENSATIONISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Long-Term Incentive PlanCOMPENSATIONISSUER2627.0000000.000000FOR2627.000000FORS000058304Repsol, S.A.ES017351611505/29/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER2627.0000000.000000FOR2627.000000FORS000058304IberdrolaES0144580Y1405/30/2025AccountsCORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Management ReportsCORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Report on Non-Financial InformationCORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Ratification of Board ActsCORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to Articles (7, 9, and 33)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to Articles (5, 6, 20, 25, 27, 34 and 63)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (Preamble)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (1 through 6)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (7 through 18)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (19 through 21)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (22 through 28)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (29 through 48)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (49 through 61)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Amendments to General Shareholders' Meeting Regulations (62 through 65)CORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Special Dividend (Engagement Dividend)CAPITAL STRUCTUREISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025First Scrip DividendCAPITAL STRUCTUREISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Second Scrip DividendCAPITAL STRUCTUREISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Authority to Cancel Treasury Shares and Reduce Share CapitalCAPITAL STRUCTUREISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Remuneration ReportCOMPENSATIONISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Elect Angel Jesus Acebes PaniaguaDIRECTOR ELECTIONSISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Elect Juan Manuel Gonzalez SernaDIRECTOR ELECTIONSISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Ratify Co-Option and Elect Ana Colonques Garcia-PlanasDIRECTOR ELECTIONSISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Board SizeCORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Authority to Issue Debt InstrumentsCAPITAL STRUCTUREISSUER922.0000000.000000FOR922.000000FORS000058304IberdrolaES0144580Y1405/30/2025Authorisation of Legal FormalitiesCORPORATE GOVERNANCEISSUER922.0000000.000000FOR922.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Remuneration ReportCOMPENSATIONISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Allocation of DividendsCAPITAL STRUCTUREISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Appointment of AuditorAUDIT-RELATEDISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Elect William L. Connelly to the Board of DirectorsDIRECTOR ELECTIONSISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Elect Mark A. Ellman to the Board of DirectorsDIRECTOR ELECTIONSISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Elect Jack F. McGarry to the Board of DirectorsDIRECTOR ELECTIONSISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Elect Lori Dickerson Fouche to the Board of DirectorsDIRECTOR ELECTIONSISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Elect David L. Herzog to the Board of DirectorsDIRECTOR ELECTIONSISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Elect Jay Ralph to the Board of DirectorsDIRECTOR ELECTIONSISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Authority to Suppress Preemptive RightsCAPITAL STRUCTUREISSUER2625.0000000.000000FOR2625.000000FORS000058304Aegon Ltd.BMG0112X105606/12/2025Authority to Suppress Preemptive Rights (Rights Issue)CAPITAL STRUCTUREISSUER2625.0000000.000000AGAINST2625.000000AGAINSTS000058304Aegon Ltd.BMG0112X105606/12/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER2625.0000000.000000FOR2625.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Akio ToyodaDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Koji SatoDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Hiroki NakajimaDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Yoichi MiyazakiDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Shigeaki OkamotoDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Kumi Fujisawa @ Kumi TsunodaDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Christopher P. ReynoldsDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect George OlcottDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Masahiko OshimaDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Elect Hiromi OsadaDIRECTOR ELECTIONSISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Non-Audit Committee Directors' FeesCOMPENSATIONISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Audit Committee Directors' FeesCOMPENSATIONISSUER12314.0000000.000000FOR12314.000000FORS000058304TOYOTA MOTOR CORPORATIONJP363340000106/12/2025Approval of the Restricted Stock PlanCOMPENSATIONISSUER12314.0000000.000000FOR12314.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Toshiki KawaiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Sadao SasakiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Kazushi TaharaDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Michio SasakiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Sachiko IchikawaDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Joseph A. Kraft Jr.DIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Yukari SuzukiDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Yukihiro ShinoharaDIRECTOR ELECTIONSISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Tsuguhiko MatsuuraCORPORATE GOVERNANCEISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Elect Ayako MakinoCORPORATE GOVERNANCEISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Short-term Performance-linked Compensation to Inside DirectorsCOMPENSATIONISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Approval of Medium- to Long-term Performance-linked Compensation to Inside DirectorsCOMPENSATIONISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Approval of Non-performance-linked Compensation to Inside DirectorsCOMPENSATIONISSUER389.0000000.000000FOR389.000000FORS000058304Tokyo Electron LimitedJP357140000506/17/2025Amendment to Stock-based Compensation to Outside DirectorsCOMPENSATIONISSUER389.0000000.000000FOR389.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Tatsuo YasunagaDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Kenichi HoriDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Yoshiaki TakemasuDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Tetsuya ShigetaDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Kazumasa NakaiDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Tetsuya FukudaDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Samuel WalshDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Takeshi UchiyamadaDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Masako EgawaDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Fujiyo IshiguroDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Sarah L. CasanovaDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Jessica TAN Soon NeoDIRECTOR ELECTIONSISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Elect Hiroyuki Takanami as Statutory AuditorCORPORATE GOVERNANCEISSUER2780.0000000.000000FOR2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Shareholder Proposal Regarding Assessment of RiskCORPORATE GOVERNANCESECURITY HOLDER2780.0000000.000000AGAINST2780.000000FORS000058304MITSUI & CO., LTD.JP389360000106/18/2025Shareholder Proposal Regarding Disclosure of Assessment for Not Meeting Paris Agreement TargetENVIRONMENT OR CLIMATESECURITY HOLDER2780.0000000.000000AGAINST2780.000000FORS000058304SalMar ASANO001031095606/18/2025Notice of Meeting; AgendaCORPORATE GOVERNANCEISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Election of Presiding Chair; MinutesCORPORATE GOVERNANCEISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Directors' FeesCOMPENSATIONISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Authority to Set Auditor's FeesAUDIT-RELATEDISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Remuneration PolicyCOMPENSATIONISSUER2078.0000000.000000AGAINST2078.000000AGAINSTS000058304SalMar ASANO001031095606/18/2025Remuneration ReportCOMPENSATIONISSUER2078.0000000.000000AGAINST2078.000000AGAINSTS000058304SalMar ASANO001031095606/18/2025Adoption of Share-Based IncentivesCOMPENSATIONISSUER2078.0000000.000000AGAINST2078.000000AGAINSTS000058304SalMar ASANO001031095606/18/2025Elect Margrethe HaugeDIRECTOR ELECTIONSISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Elect Leif Inge NordhammerDIRECTOR ELECTIONSISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Elect Bjorn WiggenCORPORATE GOVERNANCEISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Authority to Issue Shares w/ or w/o Preemptive RightsCAPITAL STRUCTUREISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Authority to Issue Convertible Debt InstrumentsCAPITAL STRUCTUREISSUER2078.0000000.000000FOR2078.000000FORS000058304SalMar ASANO001031095606/18/2025Authority to Repurchase and Reissue SharesCAPITAL STRUCTUREISSUER2078.0000000.000000FOR2078.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Kenji YasukawaDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Naoki OkamuraDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Katsuyoshi SugitaDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Takashi TanakaDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Eriko SakuraiDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Masahiro MiyazakiDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Yoichi OnoDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Andreas BuschDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Mark J. EnyedyDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Elect Rie Akiyama as Audit Committee DirectorDIRECTOR ELECTIONSISSUER4981.0000000.000000FOR4981.000000FORS000058304Astellas Pharma Inc.JP394240000706/19/2025Outside Non-Audit Committee Directors' FeesCOMPENSATIONISSUER4981.0000000.000000FOR4981.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Toshihiro MibeDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Noriya KaiharaDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Katsushi InoueDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Eiji FujimuraDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Asako SuzukiDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Jiro MorisawaDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Kunihiko SakaiDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Fumiya KokubuDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Yoichiro OgawaDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Kazuhiro HigashiDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Ryoko NagataDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304HONDA MOTOR CO., LTD.JP385460000806/19/2025Elect Mika AgatsumaDIRECTOR ELECTIONSISSUER13768.0000000.000000FOR13768.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Hiroyuki OgawaDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Takuya ImayoshiDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Takeshi HorikoshiDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Mitsuko YokomotoDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Takeshi KunibeDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Arthur M. MitchellDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Naoko SaikiDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Michitaka SawadaDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Taisuke KusabaDIRECTOR ELECTIONSISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Keiko FujiwaraCORPORATE GOVERNANCEISSUER4095.0000000.000000FOR4095.000000FORS000058304KOMATSU LTD.JP330420000306/19/2025Elect Yukio KaiCORPORATE GOVERNANCEISSUER4095.0000000.000000FOR4095.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Masumi KakinokiDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Masayuki OmotoDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Kenichiro OikawaDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Takayuki FuruyaDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Yuri OkinaDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Shigeki IshizukaDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Hisayoshi AndoDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Soichiro MinamiDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Keiji KojimaDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Yumiko KajiwaraDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Miki Iwamura @ Miki OkuDIRECTOR ELECTIONSISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Satoru YokoshikiCORPORATE GOVERNANCEISSUER2927.0000000.000000FOR2927.000000FORS000058304Marubeni CorporationJP387760000106/20/2025Elect Yasuo FukamiCORPORATE GOVERNANCEISSUER2927.0000000.000000FOR2927.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Takehiko KakiuchiDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Katsuya NakanishiDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Kotaro TsukamotoDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Yutaka KashiwagiDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Yuzo NouchiDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Yoshiyuki NojimaDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Shunichi MiyanagaDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Sakie AkiyamaDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Mari Sagiya @ Mari ItayaDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Elect Mari KogisoDIRECTOR ELECTIONSISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Non-Audit Committee Directors' FeesCOMPENSATIONISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Approval of Trust Type Equity PlanCOMPENSATIONISSUER707.0000000.000000FOR707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Shareholder Proposal Regarding Assessment of RiskCORPORATE GOVERNANCESECURITY HOLDER707.0000000.000000AGAINST707.000000FORS000058304Mitsubishi CorporationJP389840000106/20/2025Shareholder Proposal Regarding Disclosure of Assessment for Not Meeting Paris Agreement TargetENVIRONMENT OR CLIMATESECURITY HOLDER707.0000000.000000AGAINST707.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Toshio HiroeDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Masato GotoDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Yoichi KondoDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Yoshihisa IshikawaDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Hidemi TakasuDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Hiroko Okudaira @ Hiroko KimuraDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Seiji NaraharaDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Elect Fumikazu SatoDIRECTOR ELECTIONSISSUER277.0000000.000000FOR277.000000FORS000058304SCREEN Holdings Co., Ltd.JP349460000406/20/2025Amendments to the Performance-Linked Equity Compensation PlanCOMPENSATIONISSUER277.0000000.000000FOR277.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Masayuki HyodoDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Toshikazu NambuDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Shingo UenoDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Takayuki SeishimaDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Reiji MorookaDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Akiko IdeDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Takashi MitachiDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Takahisa TakaharaDIRECTOR ELECTIONSISSUER2804.0000000.000000AGAINST2804.000000AGAINSTS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Haruyasu AsakuraDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Nana OtsukiDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Daisuke MikogamiDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Kazunari SakataDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Yukiko Nagashima @ Yukiko WatanabeDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Nobuo InadaDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Taisei KuniiDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Elect Nana Otsuki as Alternate Audit Committee DirectorDIRECTOR ELECTIONSISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Non-Audit Committee Directors' FeesCOMPENSATIONISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Audit Committee Directors' FeesCOMPENSATIONISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Approval of the Restricted Stock PlanCOMPENSATIONISSUER2804.0000000.000000FOR2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Shareholder Proposal Regarding Assessment of RiskCORPORATE GOVERNANCESECURITY HOLDER2804.0000000.000000AGAINST2804.000000FORS000058304SUMITOMO CORPORATIONJP340460000306/20/2025Shareholder Proposal Regarding Disclosure of Assessment for Not Meeting Paris Agreement TargetENVIRONMENT OR CLIMATESECURITY HOLDER2804.0000000.000000AGAINST2804.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Nobuhiko MurakamiDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Ichiro KashitaniDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Toshimitsu ImaiDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Hideyuki IwamotoDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Tatsuya WatanukiDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Didier LeroyDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Yukari InoueDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Chieko MatsudaDIRECTOR ELECTIONSISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Goro YamaguchiDIRECTOR ELECTIONSISSUER3056.0000000.000000AGAINST3056.000000AGAINSTS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Elect Kazuya Kawashima as Statutory AuditorCORPORATE GOVERNANCEISSUER3056.0000000.000000FOR3056.000000FORS000058304TOYOTA TSUSHO CORPORATIONJP363500000706/20/2025Amendment to the Monetary Compensation and Restricted Stock PlanCOMPENSATIONISSUER3056.0000000.000000FOR3056.000000FORS000058304RiverNorth Opportunities Fund, Inc.76881Y208US76881Y208109/19/2024To elect two Class I Directors to the Board of Directors: John K. CarterOTHERPreferred share-related matterISSUER91148.0000000.000000FOR91148.000000FORS000059080RiverNorth Opportunities Fund, Inc.76881Y208US76881Y208109/19/2024To elect two Class I Directors to the Board of Directors: Lisa B. MouginOTHERPreferred share-related matterISSUER91148.0000000.000000FOR91148.000000FORS000059080Oxford Lane Capital Corp.691543805US691543805410/22/2024To vote on the election of one director of the Company to be elected by the holders of the Company's outstanding common stock, par value $0.01 per share, and outstanding preferred stock, par value $0.01 per share, voting together as single class, with such director to serve for a term of three years, or until his successor is duly elected and qualified: Saul B. RosenthalOTHERPreferred share-related matterISSUER65233.0000000.000000FOR65233.000000FORS000059080Oxford Lane Capital Corp.691543805US691543805410/22/2024To vote on the election of one director of the Company to be elected by the holders of the Company's outstanding common stock, par value $0.01 per share, and outstanding preferred stock, par value $0.01 per share, voting together as single class, with such director to serve for a term of three years, or until his successor is duly elected and qualified: David S. ShinOTHERPreferred share-related matterISSUER65233.0000000.000000FOR65233.000000FORS000059080Enstar Group Limited29359U109US29359U109711/06/2024To approve (a) the Agreement and Plan of Merger dated as of July 29, 2024 (the "Merger Agreement"), by and among Enstar Elk Bidco Limited ("Parent"), Elk Merger Sub Limited ("Parent Merger Sub"), Deer Ltd. ("New Company Holdco") and Deer Merger Sub Ltd. ("Company Merger Sub"), pursuant to which (i) Company Merger Sub will merge with and into Enstar, with Enstar surviving the merger (the "First Merger"), in accordance with the terms of the Merger Agreement and the terms of the First Statutory Merger Agreement in the form substantially attached to the Merger Agreement, (ii) as soon as practicable following the consummation of the First Merger, New Company Holdco will merge with and into Enstar, with Enstar surviving such merger (the "Second Merger"), in accordance with the terms of the Merger Agreement and the terms of the Second Statutory Merger Agreement in the form substantially attached to the Merger Agreement, and (iii) as soon as practicable following the consummation of such merger, Parent Merger Sub will merge with and into Enstar, with Enstar surviving such merger (the "Third Merger" and together with the Second Merger and the Third Merger, the "Mergers"), in accordance with the terms of the Merger Agreement and the terms of the Third Statutory Merger Agreement in the form substantially attached to the Merger Agreement, (b) the Statutory Merger Agreements and (c) the Mergers.OTHERPreferred share-related matterISSUER46.0000000.000000FOR46.000000FORS000059080Enstar Group Limited29359U109US29359U109711/06/2024To approve an adjournment of the Special Meeting, from time to time, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the proposal to approve the Merger Agreement and the Mergers.OTHERPreferred share-related matterISSUER46.0000000.000000FOR46.000000FORS000059080Prospect Capital Corporation74348T565US74348T565312/17/2024To elect two Class II directors of the Company to serve until the Annual Meeting of Stockholders in 2027 or, in each case, until his successor is duly elected and qualifies: M. Grier EliasekDIRECTOR ELECTIONSISSUER651295.0000000.000000FOR651295.000000FORS000059080Prospect Capital Corporation74348T565US74348T565312/17/2024To elect two Class II directors of the Company to serve until the Annual Meeting of Stockholders in 2027 or, in each case, until his successor is duly elected and qualifies: Andrew C. CooperDIRECTOR ELECTIONSISSUER651295.0000000.000000FOR651295.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Mario LonghiDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: David BingenheimerDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: M. Shawn BortDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Theodore A. DoschDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Tina FaracaDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Robert FlexonDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Alan N. HarrisDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Kelly A. RomanoDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Melanie RuizDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Election of Directors Elect ten director nominees: Santiago SeageDIRECTOR ELECTIONSISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025An advisory vote to approve the Fiscal 2024 compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025An advisory vote to approve the Fiscal 2024 compensation of the Company's named executive officers ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTESISSUER11662.0000000.000000FOR11662.000000FOR1S000059080UGI Corporation902681105US902681105201/31/2025Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER11662.0000000.000000FOR11662.000000FORS000059080UGI Corporation902681105US902681105201/31/2025Shareholder proposal regarding a director election resignation governance guideline, if properly presented.CORPORATE GOVERNANCESECURITY HOLDER11662.0000000.000000AGAINST11662.000000FORS000059080Liberty Broadband Corporation530307503US530307503102/26/2025A proposal to approve the adoption of the Agreement and Plan of Merger, dated November 12, 2024, by and among Charter Communications, Inc. ("Charter"), Liberty Broadband Corporation ("Liberty Broadband"), Fusion Merger Sub 1, LLC, a wholly owned subsidiary of Charter ("Merger LLC"), and Fusion Merger Sub 2, Inc., a wholly owned subsidiary of Merger LLC ("Merger Sub"), pursuant to which Merger Sub will merge with and into Liberty Broadband (the "merger"), with Liberty Broadband surviving the merger as the surviving corporation and becoming an indirect wholly owned subsidiary of Charter. Immediately following the merger, Liberty Broadband, as the surviving corporation of the merger, will merge with and into Merger LLC (the "upstream merger"), with Merger LLC surviving the upstream merger as the surviving company and as a wholly owned subsidiary of Charter.EXTRAORDINARY TRANSACTIONSISSUER194641.0000000.000000FOR194641.000000FORS000059080Liberty Broadband Corporation530307503US530307503102/26/2025A proposal to approve the adjournment of the special meeting by Liberty Broadband from time to time to solicit additional proxies in favor of the above listed proposal if there are insufficient votes at the time of such adjournment to approve the above listed proposal or if otherwise determined by the chairperson of the meeting to be necessary or appropriate.CORPORATE GOVERNANCEISSUER194641.0000000.000000FOR194641.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/12/2025Election of Directors: Richard R. GreenDIRECTOR ELECTIONSISSUER209247.0000000.000000FOR209247.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/12/2025Election of Directors: Sue Ann R. HamiltonDIRECTOR ELECTIONSISSUER209247.0000000.000000FOR209247.000000FORS000059080Liberty Broadband Corporation530307503US530307503105/12/2025The auditor ratification proposal, to ratify the selection of KPMG LLP as our independent auditors for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER209247.0000000.000000FOR209247.000000FORS000059080Eagle Point Credit Company Inc.269809877US269809877705/23/2025Election of Directors: James R. Matthews Class II directorOTHERPreferred share-related matterISSUER35237.0000000.000000FOR35237.000000FORS000059080Eagle Point Credit Company Inc.269809877US269809877705/23/2025Election of Directors: Paul E. Tramontano Class II directorOTHERPreferred share-related matterISSUER35237.0000000.000000FOR35237.000000FORS000059080Eagle Point Income Company Inc.269817300US269817300005/23/2025Election of Directors: James R. Matthews Class II directorOTHERPreferred share-related matterISSUER18091.0000000.000000FOR18091.000000FORS000059080Eagle Point Income Company Inc.269817300US269817300005/23/2025Election of Directors: Paul E. Tramontano Class II directorOTHERPreferred share-related matterISSUER18091.0000000.000000FOR18091.000000FORS000059080Eagle Point Income Company Inc.269817409US269817409905/23/2025Election of Directors: James R. Matthews Class II directorOTHERPreferred share-related matterISSUER58243.0000000.000000FOR58243.000000FORS000059080Eagle Point Income Company Inc.269817409US269817409905/23/2025Election of Directors: Paul E. Tramontano Class II directorOTHERPreferred share-related matterISSUER58243.0000000.000000FOR58243.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Ratify Ernst & Young LLP as AuditorsAUDIT-RELATEDISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Brett C. CarterDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Amee ChandeDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Daniel S. GoldbergDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Christopher (Chris) G. HuskilsonDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director D. Randall LaneyDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director David LevensonDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Christopher F. LopezDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Conditional On and Effective Upon Receipt of Approval by the Federal Energy Regulatory Commission: Elect Director Gavin MolinelliDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Dilek SamilDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director DeAnn WalkerDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Elect Director Roderick WestDIRECTOR ELECTIONSISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Re-approve Shareholder Rights PlanSHAREHOLDER RIGHTS AND DEFENSESISSUER19222.0000000.000000FOR19222.000000FORS000059080Algonquin Power & Utilities Corp.015857105CA015857105306/03/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER19222.0000000.000000FOR19222.000000FORS000059080Prospect Capital Corporation74348T565US74348T565306/17/2025To renew the Company's authorization, with approval of its Board of Directors, to sell shares of its common stock (during the next 12 months) at a price or prices below the Company's then current net asset value per share in one or more offerings subject to certain conditions as set forth in the accompanying proxy statement (including that the number of shares sold on any given date does not exceed 25% of its outstanding common stock immediately prior to such sale).CAPITAL STRUCTUREISSUER809222.0000000.000000FOR809222.000000FORS000059080Barings BDC, Inc.06759L103US06759L103507/02/2024The election of the following three persons as Class III Directors who will serve as directors of Barings BDC, Inc. until the 2027 Annual Meeting and until their successors have been duly elected and qualified: David MihalickDIRECTOR ELECTIONSISSUER31855.00000038600.000000FOR31855.000000FORS000064727Barings BDC, Inc.06759L103US06759L103507/02/2024The election of the following three persons as Class III Directors who will serve as directors of Barings BDC, Inc. until the 2027 Annual Meeting and until their successors have been duly elected and qualified: Thomas W. OkelDIRECTOR ELECTIONSISSUER31855.00000038600.000000AGAINST31855.000000AGAINSTS000064727Barings BDC, Inc.06759L103US06759L103507/02/2024The election of the following three persons as Class III Directors who will serve as directors of Barings BDC, Inc. until the 2027 Annual Meeting and until their successors have been duly elected and qualified: Jill OlmsteadDIRECTOR ELECTIONSISSUER31855.00000038600.000000AGAINST31855.000000AGAINSTS000064727Barings BDC, Inc.06759L103US06759L103507/02/2024To authorize the Company, with subsequent approval of its Board of Directors, to issue and sell shares of its common stock at a price below its then current net asset value per share in one or more offerings, subject to certain limitations (including, without limitation, that the number of shares does not exceed 30% of its then outstanding common stock immediately prior to each such offering).CAPITAL STRUCTUREISSUER31855.00000038600.000000FOR31855.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To elect six directors to serve until the 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Christine S. BattistDIRECTOR ELECTIONSISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To elect six directors to serve until the 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: David R. BrooksDIRECTOR ELECTIONSISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To elect six directors to serve until the 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Bowen S. DiehlDIRECTOR ELECTIONSISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To elect six directors to serve until the 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Jack D. FurstDIRECTOR ELECTIONSISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To elect six directors to serve until the 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: Ramona Rogers-WindsorDIRECTOR ELECTIONSISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To elect six directors to serve until the 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified: William R. ThomasDIRECTOR ELECTIONSISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To approve, on an advisory basis, the compensation of Capital Southwest Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER20431.00000014300.000000FOR20431.000000FORS000064727Capital Southwest Corporation140501107US140501107307/25/2024To approve, on an advisory basis, the compensation of Capital Southwest Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER20431.00000014300.000000FOR20431.000000FOR2S000064727Capital Southwest Corporation140501107US140501107307/25/2024To approve, on an advisory basis, the compensation of Capital Southwest Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER20431.00000014300.000000FOR20431.000000FOR5S000064727Capital Southwest Corporation140501107US140501107307/25/2024To ratify the appointment of RSM US LLP as Capital Southwest Corporation's independent registered public accounting firm for the fiscal year ending March 31, 2025.AUDIT-RELATEDISSUER20431.00000014300.000000FOR20431.000000FORS000064727BlackRock 2037 Municipal Target Term Trust09262G108US09262G108507/26/2024To Elect Board Member Nominees: R. Glenn HubbardDIRECTOR ELECTIONSISSUER6971.0000000FOR6971.000000FORS000064727BlackRock 2037 Municipal Target Term Trust09262G108US09262G108507/26/2024To Elect Board Member Nominees: W. Carl KesterDIRECTOR ELECTIONSISSUER6971.0000000FOR6971.000000FORS000064727BlackRock 2037 Municipal Target Term Trust09262G108US09262G108507/26/2024To Elect Board Member Nominees: John M. PerlowskiDIRECTOR ELECTIONSISSUER6971.0000000FOR6971.000000FORS000064727BlackRock Debt Strategies Fund, Inc.09255R202US09255R202207/26/2024To Elect Board Member Nominees: R. Glenn HubbardDIRECTOR ELECTIONSISSUER65399.0000000FOR65399.000000FORS000064727BlackRock Debt Strategies Fund, Inc.09255R202US09255R202207/26/2024To Elect Board Member Nominees: W. Carl KesterDIRECTOR ELECTIONSISSUER65399.0000000FOR65399.000000FORS000064727BlackRock Debt Strategies Fund, Inc.09255R202US09255R202207/26/2024To Elect Board Member Nominees: John M. PerlowskiDIRECTOR ELECTIONSISSUER65399.0000000FOR65399.000000FORS000064727BlackRock Floating Rate Income Strategies Fund, Inc.09255X100US09255X100007/26/2024To Elect Board Member Nominees: R. Glenn HubbardDIRECTOR ELECTIONSISSUER57213.0000000FOR57213.000000FORS000064727BlackRock Floating Rate Income Strategies Fund, Inc.09255X100US09255X100007/26/2024To Elect Board Member Nominees: W. Carl KesterDIRECTOR ELECTIONSISSUER57213.0000000FOR57213.000000FORS000064727BlackRock Floating Rate Income Strategies Fund, Inc.09255X100US09255X100007/26/2024To Elect Board Member Nominees: John M. PerlowskiDIRECTOR ELECTIONSISSUER57213.0000000FOR57213.000000FORS000064727BlackRock Floating Rate Income Trust091941104US091941104307/26/2024To Elect Board Member Nominees: J. Phillip HollomanDIRECTOR ELECTIONSISSUER55611.0000000FOR55611.000000FORS000064727BlackRock Floating Rate Income Trust091941104US091941104307/26/2024To Elect Board Member Nominees: Arthur P. SteinmetzDIRECTOR ELECTIONSISSUER55611.0000000FOR55611.000000FORS000064727BlackRock Floating Rate Income Trust091941104US091941104307/26/2024To Elect Board Member Nominees: Catherine A. LynchDIRECTOR ELECTIONSISSUER55611.0000000FOR55611.000000FORS000064727BlackRock Income Trust, Inc.09247F209US09247F209207/26/2024To Elect Board Member Nominees: J. Phillip HollomanDIRECTOR ELECTIONSISSUER75358.0000000FOR75358.000000FORS000064727BlackRock Income Trust, Inc.09247F209US09247F209207/26/2024To Elect Board Member Nominees: Arthur P. SteinmetzDIRECTOR ELECTIONSISSUER75358.0000000FOR75358.000000FORS000064727BlackRock Income Trust, Inc.09247F209US09247F209207/26/2024To Elect Board Member Nominees: Catherine A. LynchDIRECTOR ELECTIONSISSUER75358.0000000FOR75358.000000FORS000064727BlackRock Limited Duration Income Trust09249W101US09249W101807/26/2024To Elect Board Member Nominees: J. Phillip HollomanDIRECTOR ELECTIONSISSUER56140.0000000FOR56140.000000FORS000064727BlackRock Limited Duration Income Trust09249W101US09249W101807/26/2024To Elect Board Member Nominees: Arthur P. SteinmetzDIRECTOR ELECTIONSISSUER56140.0000000FOR56140.000000FORS000064727BlackRock Limited Duration Income Trust09249W101US09249W101807/26/2024To Elect Board Member Nominees: Catherine A. LynchDIRECTOR ELECTIONSISSUER56140.0000000FOR56140.000000FORS000064727WhiteHorse Finance, Inc.96524V106US96524V106107/31/2024Election of Directors: John BolducDIRECTOR ELECTIONSISSUER78181.0000000FOR78181.000000FORS000064727WhiteHorse Finance, Inc.96524V106US96524V106107/31/2024Election of Directors: Rick D. PuckettDIRECTOR ELECTIONSISSUER78181.0000000AGAINST78181.000000AGAINSTS000064727WhiteHorse Finance, Inc.96524V106US96524V106107/31/2024To ratify the selection of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.AUDIT-RELATEDISSUER78181.0000000FOR78181.000000FORS000064727Gladstone Investment Corporation376546107US376546107008/01/2024Election of Directors to hold office until the 2027 Annual Meeting of Stockholders: Walter H. WilkinsonDIRECTOR ELECTIONSISSUER24526.00000038800.000000FOR24526.000000FORS000064727Gladstone Investment Corporation376546107US376546107008/01/2024Election of Directors to hold office until the 2027 Annual Meeting of Stockholders: Paula NovaraDIRECTOR ELECTIONSISSUER24526.00000038800.000000FOR24526.000000FORS000064727Gladstone Investment Corporation376546107US376546107008/01/2024To ratify our Audit Committee's selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2025.AUDIT-RELATEDISSUER24526.00000038800.000000FOR24526.000000FORS000064727Eaton Vance Senior Floating-Rate Trust27828Q105US27828Q105808/07/2024Election of two Class III Trustees: Marcus L. SmithDIRECTOR ELECTIONSISSUER46161.00000012300.000000FOR46161.000000FORS000064727Eaton Vance Senior Floating-Rate Trust27828Q105US27828Q105808/07/2024Election of two Class III Trustees: Susan J. SutherlandDIRECTOR ELECTIONSISSUER46161.00000012300.000000FOR46161.000000FORS000064727Ares Capital Corporation04010L103US04010L103508/08/2024To authorize the Company, with the approval of its board of directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share subject to the limitations set forth in the proxy statement for the special meeting of stockholders (including, without limitation, that the number of shares issued does not exceed 25% of the Company's then outstanding common stock). If approved, the authorization would be effective for common stock issued during a twelve-month period expiring on the anniversary of the date of this Special Meeting.CAPITAL STRUCTUREISSUER37517.0000000FOR37517.000000FORS000064727Hercules Capital, Inc.427096508US427096508408/15/2024Election of three Independent Directors: Gayle CrowellDIRECTOR ELECTIONSISSUER24546.0000004092.000000AGAINST24546.000000AGAINSTS000064727Hercules Capital, Inc.427096508US427096508408/15/2024Election of three Independent Directors: Thomas J. FallonDIRECTOR ELECTIONSISSUER24546.0000004092.000000AGAINST24546.000000AGAINSTS000064727Hercules Capital, Inc.427096508US427096508408/15/2024Election of three Independent Directors: Nikos TheodosopoulosDIRECTOR ELECTIONSISSUER24546.0000004092.000000FOR24546.000000FORS000064727Hercules Capital, Inc.427096508US427096508408/15/2024Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER24546.0000004092.000000FOR24546.000000FORS000064727Hercules Capital, Inc.427096508US427096508408/15/2024Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER24546.0000004092.000000FOR24546.000000FOR2S000064727Hercules Capital, Inc.427096508US427096508408/15/2024Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER24546.0000004092.000000FOR24546.000000FOR5S000064727Hercules Capital, Inc.427096508US427096508408/15/2024Authorization of the Company to sell or issue shares of its common stock at a price below its then-current NAV per share, subject to the conditions set forth in Proposal 3.CAPITAL STRUCTUREISSUER24546.0000004092.000000FOR24546.000000FORS000064727Hercules Capital, Inc.427096508US427096508408/15/2024Ratification of the selection of the Independent Public Accountant for the fiscal year ending December 31, 2024.AUDIT-RELATEDISSUER24546.0000004092.000000FOR24546.000000FORS000064727FS KKR Capital Corp.302635206US302635206808/16/2024Election of Class B Directors: Brian R. FordDIRECTOR ELECTIONSISSUER48334.0000000WITHHOLD48334.000000AGAINSTS000064727FS KKR Capital Corp.302635206US302635206808/16/2024Election of Class B Directors: Richard I. GoldsteinDIRECTOR ELECTIONSISSUER48334.0000000WITHHOLD48334.000000AGAINSTS000064727FS KKR Capital Corp.302635206US302635206808/16/2024Election of Class B Directors: Osagie ImasogieDIRECTOR ELECTIONSISSUER48334.0000000WITHHOLD48334.000000AGAINSTS000064727FS KKR Capital Corp.302635206US302635206808/16/2024Election of Class B Directors: Daniel PietrzakDIRECTOR ELECTIONSISSUER48334.0000000WITHHOLD48334.000000AGAINSTS000064727FS KKR Capital Corp.302635206US302635206808/16/2024To approve a proposal to allow the Company in future offerings to sell its shares below net asset value per share in order to provide flexibility for future sales.CAPITAL STRUCTUREISSUER48334.0000000FOR48334.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100008/22/2024To elect three directors, including one director to serve for the remainder of the Class III director term until the Company's 2025 annual meeting of stockholders, and until his successor is duly elected and qualified and two directors each to serve for a term of three years, and until their successors are duly elected and qualify: Julie PersilyDIRECTOR ELECTIONSISSUER77012.0000000WITHHOLD77012.000000AGAINSTS000064727Runway Growth Finance Corp.78163D100US78163D100008/22/2024To elect three directors, including one director to serve for the remainder of the Class III director term until the Company's 2025 annual meeting of stockholders, and until his successor is duly elected and qualified and two directors each to serve for a term of three years, and until their successors are duly elected and qualify: John F. EngelDIRECTOR ELECTIONSISSUER77012.0000000WITHHOLD77012.000000AGAINSTS000064727Runway Growth Finance Corp.78163D100US78163D100008/22/2024To elect three directors, including one director to serve for the remainder of the Class III director term until the Company's 2025 annual meeting of stockholders, and until his successor is duly elected and qualified and two directors each to serve for a term of three years, and until their successors are duly elected and qualify: Gregory M. ShareDIRECTOR ELECTIONSISSUER77012.0000000FOR77012.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100008/22/2024To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.AUDIT-RELATEDISSUER77012.0000000FOR77012.000000FORS000064727Oxford Square Capital Corp.69181V107US69181V107008/23/2024To elect two directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Jonathan H. CohenDIRECTOR ELECTIONSISSUER118150.00000041700.000000FOR118150.000000FORS000064727Oxford Square Capital Corp.69181V107US69181V107008/23/2024To elect two directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: George Stelljes IIIDIRECTOR ELECTIONSISSUER118150.00000041700.000000WITHHOLD118150.000000AGAINSTS000064727Oxford Square Capital Corp.69181V107US69181V107008/23/2024To ratify the selection of PricewaterhouseCoopers LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.AUDIT-RELATEDISSUER118150.00000041700.000000FOR118150.000000FORS000064727CION Investment Corporation17259U204US17259U204208/27/2024To elect two directors of the Company, who will each serve for a term of three years expiring in 2027, or until their successors are duly elected and qualified (the "Class III Director Proposal"): Mark GattoDIRECTOR ELECTIONSISSUER69907.0000000WITHHOLD69907.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204208/27/2024To elect two directors of the Company, who will each serve for a term of three years expiring in 2027, or until their successors are duly elected and qualified (the "Class III Director Proposal"): Michael A. ReisnerDIRECTOR ELECTIONSISSUER69907.0000000WITHHOLD69907.000000AGAINSTS000064727CION Investment Corporation17259U204US17259U204208/27/2024To approve a proposal to authorize flexibility for the Company, with the approval of the Board, to offer and sell Shares, up to 25% of the Company's outstanding Shares, at a price below net asset value ("NAV") during the twelve months following shareholder approval, subject to certain limitations described in the proxy statement (the "Share Issuance Proposal").CAPITAL STRUCTUREISSUER69907.0000000FOR69907.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding diversification (with the exception of VPV).INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding borrowing.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding issuing senior securities.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding underwriting securities issued by other persons.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding lending.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding purchasing and selling real estate.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding purchasing and selling commodities.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024To amend the fundamental investment restriction regarding industry concentration.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI, OIA, VKQ, VGM, VCV, VKI, VBF, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding purchasing on margin.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI, OIA, VKQ, VCV, VKI, VBF, VGM, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction(s) regarding making short sales, writing, purchasing or selling puts or calls or purchasing or selling futures or options.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI and OIA, to remove the fundamental investment restriction regarding short sales of securities.*INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI and OIA, to remove the fundamental investment restriction regarding writing, purchasing or selling puts or calls.*INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI, OIA, VKQ, VGM, VCV, VKI, VBF, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding investing for control or management.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI, OIA and VBF, to remove the fundamental investment restriction regarding investing in management-owned securities.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI, OIA, VKQ, VCV, VGM, VKI, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding investing in oil, gas or mineral exploration or development programs.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI and OIA, to remove the fundamental investment restriction regarding purchasing taxable debt.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI and OIA, to remove the fundamental investment restriction regarding investing in unseasoned companies.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI and OIA, to remove the fundamental investment restriction regarding investing in common stock.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust46133G107US46133G107608/29/2024For IQI and OIA, to remove the fundamental investment restriction regarding pledging of assets.INVESTMENT COMPANY MATTERSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust08/29/2024To elect trustees: Elizabeth KrentzmanDIRECTOR ELECTIONSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust08/29/2024To elect trustees: Robert C. TroccoliDIRECTOR ELECTIONSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust08/29/2024To elect trustees: Carol DeckbarDIRECTOR ELECTIONSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Quality Municipal Income Trust08/29/2024To elect trustees: Douglas SharpDIRECTOR ELECTIONSISSUER40678.00000012100.000000FOR40678.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding diversification (with the exception of VPV).INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding borrowing.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding issuing senior securities.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding underwriting securities issued by other persons.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding lending.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding purchasing and selling real estate.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding purchasing and selling commodities.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024To amend the fundamental investment restriction regarding industry concentration.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024For IQI, OIA, VKQ, VGM, VCV, VKI, VBF, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding purchasing on margin.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024For IQI, OIA, VKQ, VCV, VKI, VBF, VGM, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction(s) regarding making short sales, writing, purchasing or selling puts or calls or purchasing or selling futures or options.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024For IQI, OIA, VKQ, VGM, VCV, VKI, VBF, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding investing for control or management.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024For VKQ, VCV, VGM, VKI, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding investing in other investment companies.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024For IQI, OIA, VKQ, VCV, VGM, VKI, VLT, VVR, VTN, VMO and VPV, to remove the fundamental investment restriction regarding investing in oil, gas or mineral exploration or development programs.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust46131H107US46131H107708/29/2024For VVR, to remove the fundamental investment restriction regarding investing in investment companies with substantially the same investment objective, policies and restrictions as the Fund.INVESTMENT COMPANY MATTERSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust08/29/2024To elect trustees: Elizabeth KrentzmanDIRECTOR ELECTIONSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust08/29/2024To elect trustees: Robert C. TroccoliDIRECTOR ELECTIONSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust08/29/2024To elect trustees: Carol DeckbarDIRECTOR ELECTIONSISSUER224313.0000000FOR224313.000000FORS000064727Invesco Senior Income Trust08/29/2024To elect trustees: Douglas SharpDIRECTOR ELECTIONSISSUER224313.0000000FOR224313.000000FORS000064727First Trust Senior Floating Rate Income Fund II33733U108US33733U108809/09/2024Election of Two Class II Trustees: Denise M. KeefeDIRECTOR ELECTIONSISSUER75295.0000000FOR75295.000000FORS000064727First Trust Senior Floating Rate Income Fund II33733U108US33733U108809/09/2024Election of Two Class II Trustees: Niel B. NielsonDIRECTOR ELECTIONSISSUER75295.0000000FOR75295.000000FORS000064727Blackstone Secured Lending Fund09261X102US09261X102809/12/2024Elect two Class III Trustee nominees listed in the Proxy Statement: Brad MarshallDIRECTOR ELECTIONSISSUER6243.00000012544.000000FOR6243.000000FORS000064727Blackstone Secured Lending Fund09261X102US09261X102809/12/2024Elect two Class III Trustee nominees listed in the Proxy Statement: Tracy CollinsDIRECTOR ELECTIONSISSUER6243.00000012544.000000WITHHOLD6243.000000AGAINSTS000064727Blackstone Secured Lending Fund09261X102US09261X102809/12/2024Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31,2024.AUDIT-RELATEDISSUER6243.00000012544.000000FOR6243.000000FORS000064727Eaton Vance Senior Income Trust27826S103US27826S103310/09/2024Election of three Class II Trustees: Mark R. FettingDIRECTOR ELECTIONSISSUER104159.0000007400.000000FOR104159.000000FORS000064727Eaton Vance Senior Income Trust27826S103US27826S103310/09/2024Election of three Class II Trustees: Keith QuintonDIRECTOR ELECTIONSISSUER104159.0000007400.000000FOR104159.000000FORS000064727Eaton Vance Senior Income Trust27826S103US27826S103310/09/2024Election of three Class II Trustees: Scott E. WennerholmDIRECTOR ELECTIONSISSUER104159.0000007400.000000FOR104159.000000FORS000064727Oxford Lane Capital Corp.691543102US691543102610/22/2024To vote on the election of one director of the Company to be elected by the holders of the Company's outstanding common stock, par value $0.01 per share, and outstanding preferred stock, par value $0.01 per share, voting together as single class, with such director to serve for a term of three years, or until his successor is duly elected and qualified: Saul B. RosenthalDIRECTOR ELECTIONSISSUER80650.000000169400.000000WITHHOLD80650.000000AGAINSTS000064727Pioneer Floating Rate Fund, Inc.72369J102US72369J102510/23/2024To elect three Class III Directors of the Fund, as named in the proxy statement, each to serve until the third annual meeting following his or her election and until his or her successor is duly elected and qualifies: Craig C. MacKayDIRECTOR ELECTIONSISSUER81547.0000000FOR81547.000000FORS000064727Pioneer Floating Rate Fund, Inc.72369J102US72369J102510/23/2024To elect three Class III Directors of the Fund, as named in the proxy statement, each to serve until the third annual meeting following his or her election and until his or her successor is duly elected and qualifies: Thomas J. PernaDIRECTOR ELECTIONSISSUER81547.0000000FOR81547.000000FORS000064727Pioneer Floating Rate Fund, Inc.72369J102US72369J102510/23/2024To elect three Class III Directors of the Fund, as named in the proxy statement, each to serve until the third annual meeting following his or her election and until his or her successor is duly elected and qualifies: Fred J. RicciardiDIRECTOR ELECTIONSISSUER81547.0000000FOR81547.000000FORS000064727Saratoga Investment Corp.80349A208US80349A208710/23/2024Election of Director: Christian L. OberbeckDIRECTOR ELECTIONSISSUER37901.000000100.000000WITHHOLD37901.000000AGAINSTS000064727SLR Investment Corp.83413U100US83413U100711/20/2024The election of each of the following persons (except as marked to the contrary) as a director of SLR Investment Corp., who will each serve as a director of SLR Investment Corp. until 2027, or until their respective successors are duly elected and qualified: Michael S. GrossDIRECTOR ELECTIONSISSUER50426.0000000FOR50426.000000FORS000064727SLR Investment Corp.83413U100US83413U100711/20/2024The election of each of the following persons (except as marked to the contrary) as a director of SLR Investment Corp., who will each serve as a director of SLR Investment Corp. until 2027, or until their respective successors are duly elected and qualified: Leonard A. PotterDIRECTOR ELECTIONSISSUER50426.0000000WITHHOLD50426.000000AGAINSTS000064727SLR Investment Corp.83413U100US83413U100711/20/2024The ratification of the selection of KPMG LLP as SLR Investment Corp.'s independent registered public accounting firm for the year ending December 31, 2024.AUDIT-RELATEDISSUER50426.0000000FOR50426.000000FORS000064727Prospect Capital Corporation74348T102US74348T102512/17/2024To elect two Class II directors of the Company to serve until the Annual Meeting of Stockholders in 2027 or, in each case, until his successor is duly elected and qualifies: M. Grier EliasekDIRECTOR ELECTIONSISSUER202133.0000000AGAINST202133.000000AGAINSTS000064727Prospect Capital Corporation74348T102US74348T102512/17/2024To elect two Class II directors of the Company to serve until the Annual Meeting of Stockholders in 2027 or, in each case, until his successor is duly elected and qualifies: Andrew C. CooperDIRECTOR ELECTIONSISSUER202133.0000000AGAINST202133.000000AGAINSTS000064727KKR Income Opportunities Fund48249T106US48249T106001/15/2025To approve the issuance of additional common shares of beneficial interest of KKR Income Opportunities Fund in connection with the transfer at net asset value of all of the assets and certain liabilities of the Insight Select Income Fund to the KKR Income Opportunities Fund.EXTRAORDINARY TRANSACTIONSISSUER32299.00000030500.000000FOR32299.000000FORS000064727KKR Income Opportunities Fund48249T106US48249T106001/15/2025To Transact Such Other Business as May Properly Come Before the Meeting.CORPORATE GOVERNANCEISSUER32299.00000030500.000000AGAINST32299.000000AGAINSTS000064727Runway Growth Finance Corp.78163D100US78163D100001/23/2025To approve a new investment management agreement (the "New Advisory Agreement") between the Company and Runway Growth Capital LLC (the "Adviser") (the "New Advisory Agreement Proposal").INVESTMENT COMPANY MATTERSISSUER60551.00000056700.000000FOR60551.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100001/23/2025To elect a director to serve for the remainder of the Class III director term until the Company's 2025 annual meeting of stockholders, and until her successor is duly elected and qualified (the "Director Proposal"): Catherine FreyDIRECTOR ELECTIONSISSUER60551.00000056700.000000FOR60551.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100001/23/2025To approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the New Advisory Agreement (the "Adjournment Proposal").CORPORATE GOVERNANCEISSUER60551.00000056700.000000FOR60551.000000FORS000064727PennantPark Floating Rate Capital Ltd.70806A106US70806A106002/04/2025Election of Directors: Adam BernsteinDIRECTOR ELECTIONSISSUER80018.0000000AGAINST80018.000000AGAINSTS000064727PennantPark Floating Rate Capital Ltd.70806A106US70806A106002/04/2025Election of Directors: Jeffrey FlugDIRECTOR ELECTIONSISSUER80018.0000000AGAINST80018.000000AGAINSTS000064727PennantPark Floating Rate Capital Ltd.70806A106US70806A106002/04/2025To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER80018.0000000FOR80018.000000FORS000064727PennantPark Investment Corporation708062104US708062104502/04/2025Election of Directors: Arthur H. PennDIRECTOR ELECTIONSISSUER131359.0000000AGAINST131359.000000AGAINSTS000064727PennantPark Investment Corporation708062104US708062104502/04/2025Election of Directors: Jose A. Briones, Jr.DIRECTOR ELECTIONSISSUER131359.0000000AGAINST131359.000000AGAINSTS000064727PennantPark Investment Corporation708062104US708062104502/04/2025To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER131359.0000000FOR131359.000000FORS000064727Gladstone Capital Corporation376535878US376535878902/06/2025Election of Directors: David GladstoneDIRECTOR ELECTIONSISSUER20587.0000000FOR20587.000000FORS000064727Gladstone Capital Corporation376535878US376535878902/06/2025Election of Directors: John H. OutlandDIRECTOR ELECTIONSISSUER20587.0000000FOR20587.000000FORS000064727Gladstone Capital Corporation376535878US376535878902/06/2025To ratify our Audit Committee's selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER20587.0000000FOR20587.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/21/2025Election of Directors - To elect three Class III directors of the Company who will each serve until the 2028 Annual Meeting of Stockholders of the Company or until his successor is duly elected and qualified: Lawrence E. GolubDIRECTOR ELECTIONSISSUER50177.0000000FOR50177.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/21/2025Election of Directors - To elect three Class III directors of the Company who will each serve until the 2028 Annual Meeting of Stockholders of the Company or until his successor is duly elected and qualified: Lofton P. HolderDIRECTOR ELECTIONSISSUER50177.0000000FOR50177.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/21/2025Election of Directors - To elect three Class III directors of the Company who will each serve until the 2028 Annual Meeting of Stockholders of the Company or until his successor is duly elected and qualified: William M. Webster IVDIRECTOR ELECTIONSISSUER50177.0000000FOR50177.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/21/2025To ratify the selection of Ernst & Young LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER50177.0000000FOR50177.000000FORS000064727Golub Capital BDC, Inc.38173M102US38173M102702/21/2025To approve an amendment to the Company's certificate of incorporation to increase the number of authorized shares of capital stock from 351,000,000 shares to 501,000,000 shares, consisting of 500,000,000 shares of common stock, par value $0.001 per share, and 1,000,000 shares of preferred stock, par value $0.001 per share.CAPITAL STRUCTUREISSUER50177.0000000FOR50177.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102502/21/2025To approve a new investment management agreement between the Company and Horizon Technology Finance Management LLC, the Company's Investment adviser.INVESTMENT COMPANY MATTERSISSUER116433.0000008000.000000FOR116433.000000FORS000064727Monroe Capital Corporation610335101US610335101002/21/2025To approve a new investment advisory and management agreement between the Company and Monroe Capital BDC Advisors, LLC, the Company's investment advisor.INVESTMENT COMPANY MATTERSISSUER60862.0000000FOR60862.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/04/2025To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.CAPITAL STRUCTUREISSUER75651.0000000FOR75651.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/04/2025To elect one director of the Company, who will serve until the Company's 2028 Annual Meeting of Stockholders and until her successor is duly elected and qualifies: Phyllis R. CaldwellDIRECTOR ELECTIONSISSUER75651.0000000FOR75651.000000FORS000064727Oaktree Specialty Lending Corporation67401P405US67401P405403/04/2025To ratify the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for the Company for the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER75651.0000000FOR75651.000000FORS000064727Eaton Vance Floating-Rate Income Trust278279104US278279104803/12/2025Election of two Class III Trustees: Mark R. FettingDIRECTOR ELECTIONSISSUER1987.00000053100.000000FOR1987.000000FORS000064727Eaton Vance Floating-Rate Income Trust278279104US278279104803/12/2025Election of two Class III Trustees: Marcus L. SmithDIRECTOR ELECTIONSISSUER1987.00000053100.000000FOR1987.000000FORS000064727KKR Income Opportunities Fund48249T106US48249T106003/19/2025To elect one (1) Class II Trustee to the Board of Trustees of the Fund: Catherine B. Sidamon-EristoffDIRECTOR ELECTIONSISSUER2.00000070200.000000FOR2.000000FORS000064727Carlyle Secured Lending, Inc.872280102US872280102903/26/2025to approve the issuance of shares of common stock, par value $0.01 per share, of CGBD ("CGBD Common Stock") to be issued pursuant to the Agreement and Plan of Merger, dated as of August 2, 2024 (as it has been or may be amended, supplemented or modified from time to time, the "Merger Agreement"), among Carlyle Secured Lending III, a Delaware statutory trust ("CSL III"), CGBD, Blue Fox Merger Sub, Inc., a Maryland corporation and a direct wholly-owned subsidiary of CGBD ("Merger Sub"), and, for the limited purposes set forth therein, CSL III Advisor, LLC, a Delaware limited liability company and investment adviser of CSL III, and Carlyle Global Credit Investment Management L.L.C., a Delaware limited liability company and investment adviser of CGBD (the "Merger Stock Issuance Proposal").EXTRAORDINARY TRANSACTIONSISSUER47761.0000000FOR47761.000000FORS000064727Pioneer Floating Rate Fund, Inc.72369J102US72369J102503/26/2025To approve a New Investment Advisory Agreement with Victory Capital Management Inc.INVESTMENT COMPANY MATTERSISSUER49777.00000044000.000000FOR49777.000000FORS000064727Pioneer Floating Rate Fund, Inc.72369J102US72369J102503/26/2025To approve a new investment advisory agreement with Victory Capital Management Inc.INVESTMENT COMPANY MATTERSISSUER0.00000044000.000000S000064727Morgan Stanley Direct Lending Fund61774A103US61774A103403/28/2025To approve an amendment to the Company's certificate of incorporation to increase the number of authorized shares of capital stock from 101,000,000 shares to 501,000,000 shares, consisting of 500,000,000 shares of common stock, par value $0.001 per share and 1,000,000 shares of preferred stock, par value $0.001 per share.CAPITAL STRUCTUREISSUER13820.0000000AGAINST13820.000000AGAINSTS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108504/17/2025To approve an amendment to the Fund's fundamental investment restriction with respect to industry concentration to allow the Fund to concentrate its investments in companies operating in one or more industries within the technology group of industries.INVESTMENT COMPANY MATTERSISSUER143477.0000000FOR143477.000000FORS000064727BlackRock Technology and Private Equity Term Trust09260Q108US09260Q108504/17/2025To approve a change in the Fund's status from diversified to non-diversified as such terms are defined under the Investment Company Act of 1940, as amended (the "1940 Act").INVESTMENT COMPANY MATTERSISSUER143477.0000000FOR143477.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/17/2025Election of Board Members: Class I: Michael A. ForresterDIRECTOR ELECTIONSISSUER146719.00000018300.000000FOR146719.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/17/2025Election of Board Members: Class I: Thomas J. KennyDIRECTOR ELECTIONSISSUER146719.00000018300.000000FOR146719.000000FORS000064727Nuveen Credit Strategies Income Fund67073D102US67073D102804/17/2025Election of Board Members: Class I: Robert L. YoungDIRECTOR ELECTIONSISSUER146719.00000018300.000000FOR146719.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/17/2025Election of Board Members: Class I: Michael A. ForresterDIRECTOR ELECTIONSISSUER4104.000000103800.000000FOR4104.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/17/2025Election of Board Members: Class I: Thomas J. KennyDIRECTOR ELECTIONSISSUER4104.000000103800.000000FOR4104.000000FORS000064727Nuveen Floating Rate Income Fund67072T108US67072T108804/17/2025Election of Board Members: Class I: Robert L. YoungDIRECTOR ELECTIONSISSUER4104.000000103800.000000FOR4104.000000FORS000064727Blackstone Long-Short Credit Income Fund09257D102US09257D102804/23/2025Election of one Nominee for Trustee: Daniel LeiterDIRECTOR ELECTIONSISSUER62137.0000001200.000000FOR62137.000000FORS000064727Blackstone Senior Floating Rate 2027 Term Fund09256U105US09256U105104/23/2025Election of one Nominee for Trustee: Daniel LeiterDIRECTOR ELECTIONSISSUER50437.000000900.000000FOR50437.000000FORS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/30/2025To elect three Class II directors of the Company who will each serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Gilbert E. AhyeDIRECTOR ELECTIONSISSUER241970.000000100.000000WITHHOLD241970.000000AGAINSTS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/30/2025To elect three Class II directors of the Company who will each serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Steven P. BirdDIRECTOR ELECTIONSISSUER241970.000000100.000000WITHHOLD241970.000000AGAINSTS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/30/2025To elect three Class II directors of the Company who will each serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Kimberley H. VogelDIRECTOR ELECTIONSISSUER241970.000000100.000000WITHHOLD241970.000000AGAINSTS000064727TriplePoint Venture Growth BDC Corp.89677Y100US89677Y100104/30/2025To ratify the selection of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER241970.000000100.000000FOR241970.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: J. Kevin GriffinDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: John E. JacksonDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: Brian E. LaneDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: Dunia ShiveDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: Stephen B. SolcherDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: Vincent D. FosterDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Election of Directors: Dwayne L. HyzakDIRECTOR ELECTIONSISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Proposal to ratify our appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2025AUDIT-RELATEDISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Advisory non-binding approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER490.0000009051.000000FOR490.000000FORS000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Advisory non-binding approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER490.0000009051.000000FOR490.000000FOR2S000064727Main Street Capital Corporation56035L104US56035L104405/05/2025Advisory non-binding approval of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER490.0000009051.000000FOR490.000000FOR5S000064727Barings BDC, Inc.06759L103US06759L103505/08/2025The election of the following three persons as Class I Directors who will serve as directors of Barings BDC, Inc. until the 2028 Annual Meeting and until their successors have been duly elected and qualified: Eric LloydDIRECTOR ELECTIONSISSUER90440.0000000FOR90440.000000FORS000064727Barings BDC, Inc.06759L103US06759L103505/08/2025The election of the following three persons as Class I Directors who will serve as directors of Barings BDC, Inc. until the 2028 Annual Meeting and until their successors have been duly elected and qualified: Mark F. MulhernDIRECTOR ELECTIONSISSUER90440.0000000AGAINST90440.000000AGAINSTS000064727Barings BDC, Inc.06759L103US06759L103505/08/2025The election of the following three persons as Class I Directors who will serve as directors of Barings BDC, Inc. until the 2028 Annual Meeting and until their successors have been duly elected and qualified: Robert KnappDIRECTOR ELECTIONSISSUER90440.0000000AGAINST90440.000000AGAINSTS000064727Barings BDC, Inc.06759L103US06759L103505/08/2025To authorize the Company, with subsequent approval of its Board of Directors, to issue and sell shares of its common stock at a price below its then current net asset value per share in one or more offerings, subject to certain limitations (including, without limitation, that the number of shares does not exceed 30% of its then outstanding common stock immediately prior to each such offering).CAPITAL STRUCTUREISSUER90440.0000000FOR90440.000000FORS000064727Ares Capital Corporation04010L103US04010L103505/12/2025Election of Directors: Daniel G. Kelly, Jr.DIRECTOR ELECTIONSISSUER1912.00000035490.000000AGAINST1912.000000AGAINSTS000064727Ares Capital Corporation04010L103US04010L103505/12/2025Election of Directors: Eric B. SiegelDIRECTOR ELECTIONSISSUER1912.00000035490.000000AGAINST1912.000000AGAINSTS000064727Ares Capital Corporation04010L103US04010L103505/12/2025Election of Directors: R. Kipp deVeerDIRECTOR ELECTIONSISSUER1912.00000035490.000000FOR1912.000000FORS000064727Ares Capital Corporation04010L103US04010L103505/12/2025To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER1912.00000035490.000000FOR1912.000000FORS000064727Barings Participation Investors06761A103US06761A103405/15/2025Election of Trustees: Susan B. SweeneyDIRECTOR ELECTIONSISSUER39608.0000000FOR39608.000000FORS000064727Barings Participation Investors06761A103US06761A103405/15/2025Election of Trustees: David M. MihalickDIRECTOR ELECTIONSISSUER39608.0000000FOR39608.000000FORS000064727Crescent Capital BDC, Inc.225655109US225655109205/16/2025To elect two Class I Directors of the Corporation, to serve until the 2028 Annual Meeting and until their respective successors are duly elected and qualify: Kathleen S. BriscoeDIRECTOR ELECTIONSISSUER54258.0000000FOR54258.000000FORS000064727Crescent Capital BDC, Inc.225655109US225655109205/16/2025To elect two Class I Directors of the Corporation, to serve until the 2028 Annual Meeting and until their respective successors are duly elected and qualify: George G. Strong, Jr.DIRECTOR ELECTIONSISSUER54258.0000000FOR54258.000000FORS000064727Crescent Capital BDC, Inc.225655109US225655109205/16/2025To ratify the selection of Ernst & Young LLP ("E&Y") as the Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025, as more particularly described in the accompanying Proxy Statement.AUDIT-RELATEDISSUER54258.0000000FOR54258.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/16/2025The election of the following persons (except as marked to the contrary) as directors, who will each serve as a director of New Mountain Finance Corporation until 2028, or until their respective successors are duly elected and qualify: Barbara DanielDIRECTOR ELECTIONSISSUER99628.0000000FOR99628.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/16/2025The election of the following persons (except as marked to the contrary) as directors, who will each serve as a director of New Mountain Finance Corporation until 2028, or until their respective successors are duly elected and qualify: Robert A. HamweeDIRECTOR ELECTIONSISSUER99628.0000000WITHHOLD99628.000000AGAINSTS000064727New Mountain Finance Corporation647551100US647551100105/16/2025The election of the following persons (except as marked to the contrary) as directors, who will each serve as a director of New Mountain Finance Corporation until 2028, or until their respective successors are duly elected and qualify: Alfred F. Hurley, Jr.DIRECTOR ELECTIONSISSUER99628.0000000FOR99628.000000FORS000064727New Mountain Finance Corporation647551100US647551100105/16/2025To ratify the appointment of Deloitte & Touche LLP to serve as New Mountain Finance Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER99628.0000000FOR99628.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/22/2025Election of Directors: P. Emery CovingtonDIRECTOR ELECTIONSISSUER39958.0000000FOR39958.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/22/2025Election of Directors: Jennifer GordonDIRECTOR ELECTIONSISSUER39958.0000000FOR39958.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/22/2025Election of Directors: Judy SlotkinDIRECTOR ELECTIONSISSUER39958.0000000FOR39958.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109705/22/2025To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER39958.0000000FOR39958.000000FORS000064727Eagle Point Credit Company Inc.269808101US269808101305/23/2025Election of Director: James R. Matthews Class II directorDIRECTOR ELECTIONSISSUER213016.00000031400.000000FOR213016.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/28/2025To elect three Class II directors of the Company, who will serve until the 2028 annual meeting of stockholders or until his or her successor is duly elected and qualified: Jaime ArdilaDIRECTOR ELECTIONSISSUER109637.0000000FOR109637.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/28/2025To elect three Class II directors of the Company, who will serve until the 2028 annual meeting of stockholders or until his or her successor is duly elected and qualified: Richard A. MarkDIRECTOR ELECTIONSISSUER109637.0000000FOR109637.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/28/2025To elect three Class II directors of the Company, who will serve until the 2028 annual meeting of stockholders or until his or her successor is duly elected and qualified: Kaysie UniackeDIRECTOR ELECTIONSISSUER109637.0000000FOR109637.000000FORS000064727Goldman Sachs BDC, Inc.38147U107US38147U107905/28/2025To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER109637.0000000FOR109637.000000FORS000064727Nuveen Churchill Direct Lending Corp.67090S108US67090S108705/29/2025The election of the following persons as directors, who will each serve as a director of Nuveen Churchill Direct Lending Corp.'s (the "Company") board of directors until 2028, or until their respective successor is duly elected and qualified: Reena AggarwalDIRECTOR ELECTIONSISSUER16315.0000003700.000000WITHHOLD16315.000000AGAINSTS000064727Nuveen Churchill Direct Lending Corp.67090S108US67090S108705/29/2025The election of the following persons as directors, who will each serve as a director of Nuveen Churchill Direct Lending Corp.'s (the "Company") board of directors until 2028, or until their respective successor is duly elected and qualified: James RitchieDIRECTOR ELECTIONSISSUER16315.0000003700.000000WITHHOLD16315.000000AGAINSTS000064727Nuveen Churchill Direct Lending Corp.67090S108US67090S108705/29/2025Approval of a proposal to authorize the Company, subject to the approval of the Company's board of directors, to sell or otherwise issue shares of its common stock during the next year at a price below the Company's then current net asset value per share, subject to certain conditions as set forth in the proxy statement.CAPITAL STRUCTUREISSUER16315.0000003700.000000FOR16315.000000FORS000064727Morgan Stanley Direct Lending Fund61774A103US61774A103406/02/2025To elect two Directors of the Company, each to serve for a three-year term until his or her successor has been elected and qualified or until his or her earlier resignation, removal, death or incapacity: Bruce D. FrankDIRECTOR ELECTIONSISSUER21135.0000000WITHHOLD21135.000000AGAINSTS000064727Morgan Stanley Direct Lending Fund61774A103US61774A103406/02/2025To elect two Directors of the Company, each to serve for a three-year term until his or her successor has been elected and qualified or until his or her earlier resignation, removal, death or incapacity: Adam MetzDIRECTOR ELECTIONSISSUER21135.0000000WITHHOLD21135.000000AGAINSTS000064727Morgan Stanley Direct Lending Fund61774A103US61774A103406/02/2025To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER21135.0000000FOR21135.000000FORS000064727XAI Octagon Floating Rate & Alternative Income Trust98400T106US98400T106006/04/2025Election of Class II Trustee to be elected by the holders of Common Shares and Preferred Shares, voting together as a single class, to serve until the Trust's 2028 annual meeting of shareholders or until his successor shall have been elected and qualified: Gregory G. DingensDIRECTOR ELECTIONSISSUER212081.00000013500.000000FOR212081.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102506/05/2025Election of Directors. Class III Nominees: Jonathan J. GoodmanDIRECTOR ELECTIONSISSUER122690.0000006600.000000FOR122690.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102506/05/2025Election of Directors. Class III Nominees: Robert D. Pomeroy, Jr.DIRECTOR ELECTIONSISSUER122690.0000006600.000000FOR122690.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102506/05/2025Election of Directors. Class III Nominees: Joseph J. SavageDIRECTOR ELECTIONSISSUER122690.0000006600.000000WITHHOLD122690.000000AGAINSTS000064727Horizon Technology Finance Corporation44045A102US44045A102506/05/2025Election of Directors. Class I Nominee: Kimberley A. O'ConnorDIRECTOR ELECTIONSISSUER122690.0000006600.000000FOR122690.000000FORS000064727Horizon Technology Finance Corporation44045A102US44045A102506/05/2025Ratification of the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending 0 December 31, 2025.AUDIT-RELATEDISSUER122690.0000006600.000000FOR122690.000000FORS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2025Election of Directors - To elect two Class III directors, to serve for a three-year term, until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal: Leslie E. Bradford (Class III Nominee)DIRECTOR ELECTIONSISSUER48390.0000000WITHHOLD48390.000000AGAINSTS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2025Election of Directors - To elect two Class III directors, to serve for a three-year term, until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal: John G. Nestor (Class III Nominee)DIRECTOR ELECTIONSISSUER48390.0000000WITHHOLD48390.000000AGAINSTS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2025To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER48390.0000000FOR48390.000000FORS000064727Carlyle Secured Lending, Inc.872280102US872280102906/09/2025To approve a proposal to authorize the Company, with the approval of the Company's Board of Directors, to sell or otherwise issue shares of the Company's common stock, during the next 12 months following stockholder approval, at a price below the then-current net asset value per share, subject to certain limitations described in the proxy statement.CAPITAL STRUCTUREISSUER48390.0000000FOR48390.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100006/10/2025To elect three Class III directors who will each serve for a term of three years and until their successors are elected and qualified: R. David SprengDIRECTOR ELECTIONSISSUER102216.0000004200.000000WITHHOLD102216.000000AGAINSTS000064727Runway Growth Finance Corp.78163D100US78163D100006/10/2025To elect three Class III directors who will each serve for a term of three years and until their successors are elected and qualified: Catherine FreyDIRECTOR ELECTIONSISSUER102216.0000004200.000000FOR102216.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100006/10/2025To elect three Class III directors who will each serve for a term of three years and until their successors are elected and qualified: Robert WarshauerDIRECTOR ELECTIONSISSUER102216.0000004200.000000FOR102216.000000FORS000064727Runway Growth Finance Corp.78163D100US78163D100006/10/2025To ratify the selection of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER102216.0000004200.000000FOR102216.000000FORS000064727Fidus Investment Corporation316500107US316500107006/11/2025The election for each of the nominees listed below to serve as a Class II Director until his successor has been duly elected and qualified: Thomas C. LauerDIRECTOR ELECTIONSISSUER43098.0000000FOR43098.000000FORS000064727Fidus Investment Corporation316500107US316500107006/11/2025The election for each of the nominees listed below to serve as a Class II Director until his successor has been duly elected and qualified: Edward X. TuneDIRECTOR ELECTIONSISSUER43098.0000000WITHHOLD43098.000000AGAINSTS000064727Fidus Investment Corporation316500107US316500107006/11/2025To authorize the Company, subject to the approval of the Company's Board of Directors, to sell or otherwise issue shares of its common stock during the next year at a price below the Company's then current net asset value per share, subject to certain conditions as set forth in the proxy statement (including that the cumulative number of shares sold pursuant to such authority does not exceed 25% of its then outstanding common stock immediately prior to each such sale).CAPITAL STRUCTUREISSUER43098.0000000FOR43098.000000FORS000064727OFS Capital Corporation67103B100US67103B100806/11/2025Election of Directors: Nominee: Class I Director: Elaine E. HealyDIRECTOR ELECTIONSISSUER71776.0000000FOR71776.000000FORS000064727OFS Capital Corporation67103B100US67103B100806/11/2025The ratification of the selection of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER71776.0000000FOR71776.000000FORS000064727Monroe Capital Corporation610335101US610335101006/17/2025The election of the nominees listed below to serve as Class I Directors until their respective successors have been duly elected and qualified: Thomas J. AllisonDIRECTOR ELECTIONSISSUER70367.0000000WITHHOLD70367.000000AGAINSTS000064727Monroe Capital Corporation610335101US610335101006/17/2025The election of the nominees listed below to serve as Class I Directors until their respective successors have been duly elected and qualified: Robert S. RubinDIRECTOR ELECTIONSISSUER70367.0000000WITHHOLD70367.000000AGAINSTS000064727Monroe Capital Corporation610335101US610335101006/17/2025To approve a proposal to authorize the Company, pursuant to approval of the Board of Directors of the Company, to sell shares of its common stock or warrants, options or rights to acquire its common stock during the next twelve months at a price below the Company's then current net asset value per share, subject to certain conditions as set forth in the proxy statement (including that the number of shares sold on any given date does not exceed 25% dilution to current investors not participating in the offering).CAPITAL STRUCTUREISSUER70367.0000000FOR70367.000000FORS000064727Prospect Capital Corporation74348T102US74348T102506/17/2025To renew the Company's authorization, with approval of its Board of Directors, to sell shares of its common stock (during the next 12 months) at a price or prices below the Company's then current net asset value per share in one or more offerings subject to certain conditions as set forth in the accompanying proxy statement (including that the number of shares sold on any given date does not exceed 25% of its outstanding common stock immediately prior to such sale).CAPITAL STRUCTUREISSUER346542.00000036532.000000FOR346542.000000FORS000064727Stellus Capital Investment Corporation858568108US858568108806/17/2025Election of Directors: Dean D'AngeloDIRECTOR ELECTIONSISSUER29020.00000033100.000000FOR29020.000000FORS000064727Stellus Capital Investment Corporation858568108US858568108806/17/2025Election of Directors: William C. RepkoDIRECTOR ELECTIONSISSUER29020.00000033100.000000WITHHOLD29020.000000AGAINSTS000064727Stellus Capital Investment Corporation858568108US858568108806/17/2025To approve a proposal to authorize the Company, with the approval of the Board, to sell or otherwise issue up to 25% of the Company's outstanding common stock at an offering price that is below the Company's then current NAV per share.CAPITAL STRUCTUREISSUER29020.00000033100.000000FOR29020.000000FORS000064727Stellus Capital Investment Corporation858568108US858568108806/17/2025To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies.CORPORATE GOVERNANCEISSUER29020.00000033100.000000AGAINST29020.000000AGAINSTS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To elect all six Director nominees to the Board of Directors of the Company to serve until the 2026 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: John R. BaronDIRECTOR ELECTIONSISSUER116296.00000044200.000000FOR116296.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To elect all six Director nominees to the Board of Directors of the Company to serve until the 2026 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Eric J. DrautDIRECTOR ELECTIONSISSUER116296.00000044200.000000FOR116296.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To elect all six Director nominees to the Board of Directors of the Company to serve until the 2026 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Karen L. LeetsDIRECTOR ELECTIONSISSUER116296.00000044200.000000FOR116296.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To elect all six Director nominees to the Board of Directors of the Company to serve until the 2026 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Andrea L. PetroDIRECTOR ELECTIONSISSUER116296.00000044200.000000FOR116296.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To elect all six Director nominees to the Board of Directors of the Company to serve until the 2026 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Maureen K. UsiferDIRECTOR ELECTIONSISSUER116296.00000044200.000000FOR116296.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To elect all six Director nominees to the Board of Directors of the Company to serve until the 2026 Annual Meeting of Stockholders of the Company, or until his or her successor is duly elected and qualifies: Philip TsengDIRECTOR ELECTIONSISSUER116296.00000044200.000000FOR116296.000000FORS000064727BlackRock TCP Capital Corp.09259E108US09259E108206/18/2025To consider and vote on a proposal to authorize the Company, with approval of its Board of Directors, to sell shares of the Company's common stock at a price or prices below its then current net asset value per share in one or more offerings (for up to the next 12 months), subject to certain limitations set forth in the proxy statement (including, without limitation, that the number of shares sold on any given date does not exceed 25% of the Company's then outstanding common stock immediately prior to such sale).CAPITAL STRUCTUREISSUER116296.00000044200.000000FOR116296.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2025Election of three Directors: Scott BluesteinDIRECTOR ELECTIONSISSUER39577.0000000FOR39577.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2025Election of three Directors: Wade LooDIRECTOR ELECTIONSISSUER39577.0000000FOR39577.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2025Election of three Directors: DeAnne AguirreDIRECTOR ELECTIONSISSUER39577.0000000AGAINST39577.000000AGAINSTS000064727Hercules Capital, Inc.427096508US427096508406/18/2025Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER39577.0000000FOR39577.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2025Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER39577.0000000FOR39577.000000FOR2S000064727Hercules Capital, Inc.427096508US427096508406/18/2025Advisory vote to approve the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER39577.0000000FOR39577.000000FOR5S000064727Hercules Capital, Inc.427096508US427096508406/18/2025Authorization of the Company to sell or issue shares of its common stock at a price below its then-current NAV per share, subject to the conditions set forth in Proposal 3.CAPITAL STRUCTUREISSUER39577.0000000FOR39577.000000FORS000064727Hercules Capital, Inc.427096508US427096508406/18/2025Ratification of the selection of the Independent Public Accountant for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER39577.0000000FOR39577.000000FORS000064727MidCap Financial Investment Corporation03761U502US03761U502006/18/2025Election of Directors: Elliot Stein, Jr.DIRECTOR ELECTIONSISSUER64946.0000000WITHHOLD64946.000000AGAINSTS000064727MidCap Financial Investment Corporation03761U502US03761U502006/18/2025Election of Directors: Carmencita N.M. WhonderDIRECTOR ELECTIONSISSUER64946.0000000FOR64946.000000FORS000064727MidCap Financial Investment Corporation03761U502US03761U502006/18/2025To ratify the selection of Deloitte & Touche LLP as MidCap Financial Investment Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER64946.0000000FOR64946.000000FORS000064727Sixth Street Specialty Lending, Inc.83012A109US83012A109706/20/2025To approve a proposal to authorize the Company to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share in one or more offerings, in each case subject to the approval of its Board of Directors and subject to the conditions set forth in the accompanying proxy statement.CAPITAL STRUCTUREISSUER39958.0000000FOR39958.000000FORS000064727ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Yoav Doppelt as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Aviad Kaufman as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Avisar Paz as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Sagi Kabla as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Reem Aminoach as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Lior Reitblatt as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Tzipi Ozer Armon as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Gadi Lesin as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Michal Silverberg as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Shalom Shlomo as DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reelect Miriam Haran as External DirectorDIRECTOR ELECTIONSISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Amend Articles Re: Indemnification and Insurance of the Company's Directors and OfficersCORPORATE GOVERNANCEISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Approve Amendment to Issued Exemption, Insurance and Indemnification Letters to Each Directors/OfficersCORPORATE GOVERNANCEISSUER24408.00000010000.000000FOR24408.000000FORS000064728ICL Group Ltd.M53213100IL000281014607/17/2024Reappoint Somekh Chaikin, a Member Firm of KPMG International as AuditorsAUDIT-RELATEDISSUER24408.00000010000.000000FOR24408.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Election of Directors: Dr. Bobbie ByrneDIRECTOR ELECTIONSISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Election of Directors: Christine M. CournoyerDIRECTOR ELECTIONSISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Election of Directors: Randy HyunDIRECTOR ELECTIONSISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Election of Directors: Vincent D. KellyDIRECTOR ELECTIONSISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Election of Directors: Brett ShockleyDIRECTOR ELECTIONSISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Election of Directors: Todd SteinDIRECTOR ELECTIONSISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.AUDIT-RELATEDISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Advisory vote to approve named executive officer compensation for 2023.SECTION 14A SAY-ON-PAY VOTESISSUER10808.0000000FOR10808.000000FORS000064728Spok Holdings, Inc.84863T106US84863T106007/23/2024Advisory vote to approve named executive officer compensation for 2023.SECTION 14A SAY-ON-PAY VOTESISSUER10808.0000000FOR10808.000000FOR2S000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Sylvia Escovar GomezDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director James F. ParkDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Robert A. BedingfieldDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Carlos Enrique MacellariDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Brian Francis MaxtedDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Constantin PapadimitriouDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Marcela Vaca TorresDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Somit VarmaDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Elect Director Andres OcampoDIRECTOR ELECTIONSISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Ratify Ernst & Young Audit S.A.S. as AuditorsAUDIT-RELATEDISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Authorise the Audit Committee to Fix Remuneration of AuditorsAUDIT-RELATEDISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Amend Bye-Laws Section 49CORPORATE GOVERNANCEISSUER19079.0000000FOR19079.000000FORS000064728GeoPark LimitedG38327105BMG38327105007/24/2024Accept Financial Statements and Statutory Reports (Voting)CORPORATE GOVERNANCEISSUER19079.0000000FOR19079.000000FORS000064728ICL Group Ltd.M53213100IL000281014610/09/2024Reelect Dafna Gruber as External DirectorDIRECTOR ELECTIONSISSUER30240.00000010000.000000FOR30240.000000FORS000064728ICL Group Ltd.M53213100IL000281014610/09/2024Approve Amended and Restated Compensation Policy for the Directors and Officers of the CompanyCOMPENSATIONISSUER30240.00000010000.000000FOR30240.000000FORS000064728Vale SA91912E105US91912E105511/14/2024Elect Heloisa Belotti Bedicks as Independent DirectorDIRECTOR ELECTIONSISSUER16831.0000000FOR16831.000000FORS000064728Vale SA91912E105US91912E105511/14/2024Elect Reinaldo Duarte Castanheira Filho as Independent DirectorDIRECTOR ELECTIONSISSUER16831.0000000FOR16831.000000FORS000064728Vale SA91912E105US91912E105511/14/2024Approve Agreement to Absorb Acos Laminados do Para S.A. (ALPA)EXTRAORDINARY TRANSACTIONSISSUER16831.0000000FOR16831.000000FORS000064728Vale SA91912E105US91912E105511/14/2024Ratify Macso Legate Auditores Independentes as Independent Firm to Appraise Proposed TransactionEXTRAORDINARY TRANSACTIONSISSUER16831.0000000FOR16831.000000FORS000064728Vale SA91912E105US91912E105511/14/2024Approve Independent Firm's AppraisalEXTRAORDINARY TRANSACTIONSISSUER16831.0000000FOR16831.000000FORS000064728Vale SA91912E105US91912E105511/14/2024Approve Absorption of Acos Laminados do Para S.A. (ALPA)EXTRAORDINARY TRANSACTIONSISSUER16831.0000000FOR16831.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2025Election of the following three Directors that were named in the Proxy Statement; each for a term expiring in 2028: Gregory E. AliffDIRECTOR ELECTIONSISSUER3712.0000000FOR3712.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2025Election of the following three Directors that were named in the Proxy Statement; each for a term expiring in 2028: Thomas C. O'ConnorDIRECTOR ELECTIONSISSUER3712.0000000FOR3712.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2025Election of the following three Directors that were named in the Proxy Statement; each for a term expiring in 2028: Michael A. O'SullivanDIRECTOR ELECTIONSISSUER3712.0000000FOR3712.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2025To approve a non-binding advisory resolution approving the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3712.0000000FOR3712.000000FORS000064728New Jersey Resources Corporation646025106US646025106801/21/2025To approve a non-binding advisory resolution approving the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3712.0000000FOR3712.000000FOR2S000064728New Jersey Resources Corporation646025106US646025106801/21/2025To ratify the appointment by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm of the fiscal year ending September 30, 2025.AUDIT-RELATEDISSUER3712.0000000FOR3712.000000FORS000064728Retail Opportunity Investments Corp.76131N101US76131N101902/07/2025Proposal to approve the merger (the "company merger") of Montana Merger Sub Inc. with and into Retail Opportunity Investments Corp. pursuant to the terms of the Agreement and Plan of Merger, dated as of November 6, 2024, (the "merger agreement") as it may be amended from time to time, by and among Retail Opportunity Investments Corp., Retail Opportunity Investments Partnership, LP, Mountain Purchaser LLC, Montana Purchaser LLC, Big Sky Purchaser LLC, Montana Merger Sub Inc. and Montana Merger Sub II LLC, the merger agreement and the other transactions contemplated by the merger agreement, as more fully described in the Proxy Statement, which proposal we refer to as the "merger proposal,"EXTRAORDINARY TRANSACTIONSISSUER11250.0000000FOR11250.000000FORS000064728Retail Opportunity Investments Corp.76131N101US76131N101902/07/2025Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our principal executive officer, principal financial officer, and the three other most highly compensated executive officers that is based on or otherwise related to the company merger as more fully described in the Proxy Statement,SECTION 14A SAY-ON-PAY VOTESISSUER11250.0000000AGAINST11250.000000AGAINSTS000064728Retail Opportunity Investments Corp.76131N101US76131N101902/07/2025Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our principal executive officer, principal financial officer, and the three other most highly compensated executive officers that is based on or otherwise related to the company merger as more fully described in the Proxy Statement,SECTION 14A SAY-ON-PAY VOTESISSUER11250.0000000AGAINST11250.000000AGAINST2S000064728Retail Opportunity Investments Corp.76131N101US76131N101902/07/2025Proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are not sufficient votes at the special meeting to approve the merger proposal.CORPORATE GOVERNANCEISSUER11250.0000000FOR11250.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Accept Financial Statements and Statutory Reports for Fiscal Year Ended Dec. 31, 2024CORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Fix Number of Directors at 10CORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Approve Classification of Flavia Maria Bittencourt, Gesner Jose de Oliveira Filho, Herculano Anibal Alves, and Nicandro Durante as Independent DirectorsCORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Elect DirectorsDIRECTOR ELECTIONSISSUER12257.0000000AGAINST12257.000000AGAINSTS000064728TIM SA88706T108US88706T108803/27/2025Fix Number of Fiscal Council Members at ThreeCORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Elect Fiscal Council MembersCOMPENSATIONCORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Approve Remuneration of Company's Management, Committee Members, and Fiscal CouncilCOMPENSATIONISSUER12257.0000000AGAINST12257.000000AGAINSTS000064728TIM SA88706T108US88706T108803/27/2025Approve Prolonging of Cooperation and Support Agreement between Telecom Italia S.p.A and TIM S.A.CORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Approve 100-for-1 Reverse Stock Split, Followed by 100-for-1 Stock SplitCAPITAL STRUCTUREISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Authorize Executives to Define Start Date and Execute Proposed OperationCORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728TIM SA88706T108US88706T108803/27/2025Amend Article 3 Re: Corporate PurposeCORPORATE GOVERNANCEISSUER12257.0000000FOR12257.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve Meeting AgendaCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Elect Chairman of MeetingCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Appoint Committee in Charge of Scrutinizing Elections and PollingCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Elect Meeting Approval CommitteeCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve Board of Directors' Report on its Operation, Development and Compliance with the Corporate Governance CodeCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve 2024 Integrated Management ReportCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve Individual and Consolidated Financial StatementsCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve Allocation of IncomeCAPITAL STRUCTUREISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Elect DirectorsDIRECTOR ELECTIONSISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Amend Regulations on General MeetingsCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728Ecopetrol SA279158109US279158109103/28/2025Approve Board Succession PolicyCORPORATE GOVERNANCEISSUER214.00000019406.000000FOR214.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Approve Financial Statements and Allocation of IncomeCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Amend Articles of Incorporation (Record Date)CORPORATE GOVERNANCEISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Amend Articles of Incorporation (Bond Issuance)CORPORATE GOVERNANCEISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Elect Gwak Woo-young as Outside DirectorDIRECTOR ELECTIONSISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Elect Kim Seong-cheol as Outside DirectorDIRECTOR ELECTIONSISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Elect Lee Seung-hun as Outside DirectorDIRECTOR ELECTIONSISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Elect Kim Yong-heon as Outside DirectorDIRECTOR ELECTIONSISSUER1.00000011461.000000AGAINST1.000000AGAINSTS000064728KT Corp.48268K101US48268K101603/31/2025Elect Kim Seong-cheol as a Member of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Elect Lee Seung-hun as a Member of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.00000011461.000000FOR1.000000FORS000064728KT Corp.48268K101US48268K101603/31/2025Elect Kim Yong-heon as a Member of Audit CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER1.00000011461.000000AGAINST1.000000AGAINSTS000064728KT Corp.48268K101US48268K101603/31/2025Approve Total Remuneration of Inside Directors and Outside DirectorsCOMPENSATIONISSUER1.00000011461.000000FOR1.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Accept Financial Statements and Statutory Reports for Fiscal Year Ended Dec. 31, 2024CORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Elect DirectorsDIRECTOR ELECTIONSISSUER11495.0000000AGAINST11495.000000AGAINSTS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025In Case There is Any Change to the Board Slate Composition, May Your Votes Still be Counted for the Proposed Slate?CORPORATE GOVERNANCEISSUER11495.0000000AGAINST11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Do You Wish to Adopt Cumulative Voting for the Election of the Members of the Board of Directors, Under the Terms of Article 141 of the Brazilian Corporate Law?SHAREHOLDER RIGHTS AND DEFENSESISSUER11495.0000000FOR11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025In Case Cumulative Voting Is Adopted, Do You Wish to Equally Distribute Your Votes Amongst the Nominees below?DIRECTOR ELECTIONSISSUER11495.0000000FOR11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Pietro Adamo Sampaio Mendes as DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Magda Maria de Regina Chambriard as DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Renato Campos Galuppo as Independent DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Jose Fernando Coura as Independent DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Rafael Ramalho Dubeux as Independent DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Bruno Moretti as DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Benjamin Alves Rabelo Filho as DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Ivanyra Maura de Medeiros Correia as Independent DirectorDIRECTOR ELECTIONSISSUER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Jose Joao Abdalla Filho as Independent DirectorDIRECTOR ELECTIONSSECURITY HOLDER11495.0000000FOR11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Aloisio Macario Ferreira de Souza as Independent DirectorDIRECTOR ELECTIONSSECURITY HOLDER11495.0000000FOR11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Percentage of Votes to Be Assigned - Elect Thales Kroth de Souza as Independent DirectorDIRECTOR ELECTIONSSECURITY HOLDER11495.0000000ABSTAIN11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Renato Campos Galuppo as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Rafael Ramalho Dubeux as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000AGAINST11495.000000AGAINSTS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Ivanyra Maura de Medeiros Correia as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Jose Fernando Coura as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Jose Joao Abdalla Filho as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Aloisio Macario Ferreira de Souza as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Classification of Thales Kroth de Souza as Independent DirectorDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Elect Pietro Adamo Sampaio Mendes as Board ChairDIRECTOR ELECTIONSISSUER11495.0000000AGAINST11495.000000AGAINSTS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Fix Number of Fiscal Council Members at FiveCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Elect Ronaldo Dias as Fiscal Council Member and Ricardo Jose Martins Gimenez as Alternate Appointed by Minority ShareholderAUDIT-RELATEDCORPORATE GOVERNANCESECURITY HOLDER11495.0000000FOR11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Elect Fiscal Council MembersCOMPENSATIONCORPORATE GOVERNANCEISSUER11495.0000000ABSTAIN11495.000000AGAINSTS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025In Case One of the Nominees Leaves the Fiscal Council Slate Due to a Separate Minority Election, as Allowed Under Articles 161 and 240 of the Brazilian Corporate Law, May Your Votes Still Be Counted for the Proposed Slate?CORPORATE GOVERNANCEISSUER11495.0000000AGAINST11495.000000NONES000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Approve Remuneration of Company's Management, Fiscal Council, and Statutory Advisory CommitteesCOMPENSATIONISSUER11495.0000000AGAINST11495.000000AGAINSTS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025Amend Articles and Consolidate BylawsCORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000FORS000064728Petroleo Brasileiro SA71654V408US71654V408604/16/2025In the Event of a Second Call, Can the Voting Instructions Contained in this Proxy Card Be Considered Valid for the Second Call?CORPORATE GOVERNANCEISSUER11495.0000000FOR11495.000000NONES000064728Ryerson Holding Corporation783754104US783754104104/17/2025The election of the two directors named in this Proxy Statement: Bruce T. CrawfordDIRECTOR ELECTIONSISSUER7671.0000000FOR7671.000000FORS000064728Ryerson Holding Corporation783754104US783754104104/17/2025The election of the two directors named in this Proxy Statement: Stephen P. LarsonDIRECTOR ELECTIONSISSUER7671.0000000FOR7671.000000FORS000064728Ryerson Holding Corporation783754104US783754104104/17/2025The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2025;AUDIT-RELATEDISSUER7671.0000000FOR7671.000000FORS000064728Ryerson Holding Corporation783754104US783754104104/17/2025The adoption, on a non-binding, advisory basis, of a resolution approving the compensation of our named executive officers described under the heading Executive Compensation in our proxy statement ("say-on-pay" vote);SECTION 14A SAY-ON-PAY VOTESISSUER7671.0000000FOR7671.000000FORS000064728Ryerson Holding Corporation783754104US783754104104/17/2025The adoption, on a non-binding, advisory basis, of a resolution approving the compensation of our named executive officers described under the heading Executive Compensation in our proxy statement ("say-on-pay" vote);SECTION 14A SAY-ON-PAY VOTESISSUER7671.0000000FOR7671.000000FOR2S000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: James M. Taylor Jr.DIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: Sheryl M. CroslandDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: Michael BermanDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: Julie BowermanDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: Thomas W. DicksonDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: Daniel B. HurwitzDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: Sandra A. J. LawrenceDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: William D. RahmDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To elect nine directors to serve until our next annual meeting of stockholders and until their successors are duly elected and qualify: John Peter SuarezDIRECTOR ELECTIONSISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To approve, on a non-binding advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5471.0000000FOR5471.000000FORS000064728Brixmor Property Group Inc.11120U105US11120U105104/23/2025To approve, on a non-binding advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5471.0000000FOR5471.000000FOR2S000064728Enel Chile SA29278D105US29278D105404/28/2025Approve Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Maria Teresa Vial as Director Nominated by Enel S.p.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Gina Ocqueteau Tacchini as Director Nominated by Enel S.p.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Marcelo Castillo as Director Nominated by Enel S.p.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Rodolfo Avogadro Di Vigliano as Director Nominated by Enel S.p.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Salvatore Bernabei as Director Nominated by Enel S.p.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Valentina de Cesare as Director Nominated by Enel S.p.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Pablo Cruz as Director Nominated by AFP Cuprum S.A.DIRECTOR ELECTIONSISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Approve Remuneration of DirectorsCOMPENSATIONISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Approve Remuneration of Directors' Committee and Approve Their BudgetCOMPENSATIONISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Appoint AuditorsAUDIT-RELATEDISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Elect Two Supervisory Account Inspectors and their Alternates; Approve their RemunerationCOMPENSATIONCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Designate Risk Assessment CompaniesCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Approve Investment and Financing PolicyCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Other BusinessCORPORATE GOVERNANCEISSUER50986.0000000AGAINST50986.000000AGAINSTS000064728Enel Chile SA29278D105US29278D105404/28/2025Authorize Board to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Approve Cancellation of 1 Treasury Share Remaining as Remainder by Fractions of Shares due Merger of Enel Chile S.A. with Enel Green Power Latin America S.A. Approved by EGM on Dec. 20, 2017 and Consequently Reduction in Share CapitalCAPITAL STRUCTUREISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Amend Article 5 and Transitory Article 1 Re: Change of Company's functional Currency from Chilean Pesos to Dollars of United StatesCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Consolidate BylawsCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728Enel Chile SA29278D105US29278D105404/28/2025Adopt Necessary Resolutions to Carry out Proposed Amendments to Articles and to Grant Powers to Legalize, Finalize and Act upon Resolutions Adopted by this General MeetingCORPORATE GOVERNANCEISSUER50986.0000000FOR50986.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Bill FehrmanDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Ben FowkeDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Art A. GarciaDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Hunter C. GaryDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Sandra Beach LinDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Henry P. LinginfelterDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Margaret M. McCarthyDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Daryl RobertsDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Joseph G. SauvageDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Daniel G. StoddardDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Sara Martinez TuckerDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Election of Directors: Lewis Von ThaerDIRECTOR ELECTIONSISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Ratification of PricewaterhouseCoopers LLP as AEP'S independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Advisory vote to approve AEP's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1616.0000000FOR1616.000000FORS000064728American Electric Power Company, Inc.025537101US025537101704/29/2025Advisory vote to approve AEP's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1616.0000000FOR1616.000000FOR2S000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Andrew BerkenfieldDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Derrick BurksDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Philip CalianDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: David ContisDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Constance FreedmanDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Thomas HeneghanDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Marguerite NaderDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Radhika PapandreouDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Election of Nine (9) Directors: Scott PeppetDIRECTOR ELECTIONSISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Ratification of the selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for 2025.AUDIT-RELATEDISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Approval on a non-binding, advisory basis of our executive compensation as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER2250.0000000FOR2250.000000FORS000064728Equity LifeStyle Properties, Inc.29472R108US29472R108604/29/2025Approval on a non-binding, advisory basis of our executive compensation as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER2250.0000000FOR2250.000000FOR2S000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Ross CooperDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Philip E. CovielloDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Conor C. FlynnDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Nancy LashineDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Frank LourensoDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Henry MonizDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Mary Hogan PreusseDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Valerie RichardsonDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ELECTION OF EACH OF THE FOLLOWING NOMINEES: Richard B. SaltzmanDIRECTOR ELECTIONSISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ADVISORY RESOLUTION TO APPROVE THE COMPANY'S EXECUTIVE COMPENSATION (AS MORE PARTICULARLY DESCRIBED IN THE PROXY STATEMENT).SECTION 14A SAY-ON-PAY VOTESISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DIRECTORS RECOMMENDS: A VOTE FOR THE ADVISORY RESOLUTION TO APPROVE THE COMPANY'S EXECUTIVE COMPENSATION (AS MORE PARTICULARLY DESCRIBED IN THE PROXY STATEMENT).SECTION 14A SAY-ON-PAY VOTESISSUER6400.0000000FOR6400.000000FOR2S000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DRECTORS RECOMMENDS: A VOTE FOR RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.AUDIT-RELATEDISSUER6400.0000000FOR6400.000000FORS000064728Kimco Realty Corporation49446R109US49446R109504/29/2025THE BOARD OF DRECTORS RECOMMENDS: A VOTE FOR APPROVAL OF THE COMPANY'S 2025 EQUITY PARTICIPATION PLAN.COMPENSATIONISSUER6400.0000000FOR6400.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: James R. AbrahamsonDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: Diana F. CantorDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: Monica H. DouglasDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: Elizabeth I. HollandDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: Craig MacnabDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: Edward B. PitoniakDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025Election of Directors: Michael D. RumbolzDIRECTOR ELECTIONSISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025To approve (on a non-binding, advisory basis) the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5207.0000000FOR5207.000000FORS000064728VICI Properties Inc.925652109US925652109004/29/2025To approve (on a non-binding, advisory basis) the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5207.0000000FOR5207.000000FOR2S000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve CEO and Auditors' Report on Operations and Results and Board's Opinion on CEO and Auditors' ReportCORPORATE GOVERNANCEISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Board's Report on Principal Policies and Accounting Criteria Followed in Preparation of Financial InformationCORPORATE GOVERNANCEISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Report on Activities and Operations Undertaken by BoardCORPORATE GOVERNANCEISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Audit and Corporate Practices Committee's Report on their ActivitiesCORPORATE GOVERNANCEISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Consolidated Financial Statements, Allocation of Income and DividendsCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Report on Repurchased Shares ReserveCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Discharge of BoardCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Discharge of CEOCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Carlos Slim Domit as Board ChairDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Patrick Slim Domit as Vice-ChairDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Antonio Cosio Pando as DirectorDIRECTOR ELECTIONSISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Pablo Roberto Gonzalez Guajardo as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Daniel Hajj Aboumrad as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Vanessa Hajj Slim as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify David Ibarra Munoz as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Claudia Janez Sanchez as DirectorDIRECTOR ELECTIONSISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Rafael Moises Kalach Mizrahi as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Francisco Medina Chavez as DirectorDIRECTOR ELECTIONSISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Gisselle Moran Jimenez as DirectorDIRECTOR ELECTIONSISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Luis Alejandro Soberon Kuri as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Miriam Guadalupe de la Vega Arizpe as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Ernesto Vega Velasco as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Oscar Von Hauske Solis as DirectorDIRECTOR ELECTIONSISSUER11050.0000000AGAINST11050.000000AGAINSTS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Alejandro Cantu Jimenez as Secretary (Non-Member) of BoardCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Rafael Robles Miaja as Deputy Secretary (Non-Member) of BoardCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Remuneration of DirectorsCOMPENSATIONISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Discharge of Executive CommitteeCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Carlos Slim Domit as Chair of Executive CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Patrick Slim Domit as Member of Executive CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Daniel Hajj Aboumrad as Member of Executive CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Remuneration of Executive CommitteeCOMPENSATIONISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Discharge of Audit and Corporate Practices CommitteeCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Ernesto Vega Velasco as Chair of Audit and Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Pablo Roberto Gonzalez Guajardo as Member of Audit and Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Claudia Janez Sanchez as Member of Audit and Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Elect and/or Ratify Rafael Moises Kalach Mizrahi as Member of Audit and Corporate Practices CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Approve Remuneration of Members of Audit and Corporate Practices CommitteeCOMPENSATIONISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Set Amount of Share Repurchase ReserveCAPITAL STRUCTUREISSUER11050.0000000FOR11050.000000FORS000064728America Movil SAB de CV02390A101US02390A101604/30/2025Authorize Board to Ratify and Execute Approved ResolutionsCORPORATE GOVERNANCEISSUER11050.0000000FOR11050.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Douglas BrooksDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Daniel BrownDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Susan CunninghamDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Ian DundasDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Hilary FoulkesDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Samantha HolroydDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Kevin McCarthyDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Ward PolzinDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Jeff SheetsDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Anne TaylorDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To elect eleven directors to serve until the 2026 Annual Meeting: Marguerite Woung-ChapmanDIRECTOR ELECTIONSISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1353.0000000FOR1353.000000FORS000064728Chord Energy Corporation674215207US674215207604/30/2025To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER1353.0000000FOR1353.000000FOR2S000064728Chord Energy Corporation674215207US674215207604/30/2025To ratify the selection of Pricewaterhouse Coopers LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER1353.0000000FOR1353.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Accept Financial Statements and Statutory Reports for Fiscal Year Ended Dec. 31, 2024CORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Approve Treatment of Net LossCAPITAL STRUCTUREISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Fix Number of Directors at NineCORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Approve Classification of Independent DirectorsCORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Elect DirectorsDIRECTOR ELECTIONSISSUER28308.0000000AGAINST28308.000000AGAINSTS000064728Cosan SA22113B103US22113B103504/30/2025Do You Wish to Request Installation of a Fiscal Council, Under the Terms of Article 161 of the Brazilian Corporate Law?CORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Fix Number of Fiscal Council Members at ThreeCORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Elect Joao Ricardo Ducatti as Fiscal Council Member and Guilherme Jose de Vasconcelos Cerqueira as AlternateCOMPENSATIONCORPORATE GOVERNANCEISSUER28308.0000000ABSTAIN28308.000000AGAINSTS000064728Cosan SA22113B103US22113B103504/30/2025Elect Monica Pires da Silva as Fiscal Council Member and Moises Cunha Mouta as AlternateCOMPENSATIONCORPORATE GOVERNANCEISSUER28308.0000000ABSTAIN28308.000000AGAINSTS000064728Cosan SA22113B103US22113B103504/30/2025Elect Alexandre Yoiti Fujimoto as Fiscal Council Member and Guido Barbosa de Oliveira as Alternate Appointed by Minority ShareholderAUDIT-RELATEDCORPORATE GOVERNANCESECURITY HOLDER28308.0000000FOR28308.000000NONES000064728Cosan SA22113B103US22113B103504/30/2025Approve Remuneration of Company's Management and Fiscal CouncilCOMPENSATIONISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Approve Reduction in Share Capital without Cancellation of Shares and Amend Article 5 AccordinglyCAPITAL STRUCTUREISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Amend Article 5 to Reflect Changes in CapitalCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728Cosan SA22113B103US22113B103504/30/2025Consolidate BylawsCORPORATE GOVERNANCEISSUER28308.0000000FOR28308.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: Peter E. BaccileDIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: Teresa B. BazemoreDIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: Matthew S. DominskiDIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: H. Patrick Hackett, Jr.DIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: Denise A. OlsenDIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: John E. RauDIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025Election of seven directors. If elected, term expires in 2026: Marcus L. SmithDIRECTOR ELECTIONSISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025To approve, on an advisory (i.e. non-binding) basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement for the 2025 Annual Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER2955.0000000FOR2955.000000FORS000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025To approve, on an advisory (i.e. non-binding) basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement for the 2025 Annual Meeting.SECTION 14A SAY-ON-PAY VOTESISSUER2955.0000000FOR2955.000000FOR2S000064728First Industrial Realty Trust, Inc.32054K103US32054K103404/30/2025To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.AUDIT-RELATEDISSUER2955.0000000FOR2955.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Peter A. DeaDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Sippy ChhinaDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Meg A. GentleDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Ralph IzzoDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Terri G. KingDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Howard J. MaysonDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Brendan M. McCrackenDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Steven W. NanceDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: George L. PitaDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Thomas G. RicksDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Election of the 11 Director Nominees Named in the Proxy Statement: Brian G. ShawDIRECTOR ELECTIONSISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Advisory Vote to Approve Compensation of Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Advisory Vote to Approve Compensation of Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER3968.0000000FOR3968.000000FOR2S000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Third Amendment to the Omnibus Incentive PlanCOMPENSATIONISSUER3968.0000000FOR3968.000000FORS000064728Ovintiv Inc.69047Q102US69047Q102205/01/2025Ratify PricewaterhouseCoopers LLP as Independent AuditorsAUDIT-RELATEDISSUER3968.0000000FOR3968.000000FORS000064728Viper Energy, Inc.05/01/2025Drop Down Proposal: To approve the acquisition by Viper Energy Partners LLC (the "Operating Company"), Viper's operating subsidiary, of all of the issued and outstanding equity interests of 1979 Royalties, LP and 1979 Royalties GP, LLC from Endeavor Energy Resources, LP, each of which is a subsidiary of Diamondback Energy, Inc., Viper's parent, pursuant to the equity purchase agreement by and among Viper, the Operating Company, Endeavor Energy Resources, LP, 1979 Royalties, LP and 1979 Royalties GP, LLC.EXTRAORDINARY TRANSACTIONSISSUER3146.0000000FOR3146.000000FORS000064728Viper Energy, Inc.05/01/2025Equity Issuance Proposal: To approve, for the purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of an aggregate of (i) 69,626,640 units representing limited liability company interests in the Operating Company (the "Drop Down OpCo Units") and (ii) a number of shares of Viper's Class B Common Stock, par value $0.000001 per share, equal to the number of the Drop Down OpCo Units (the "Drop Down Class B Shares" and, together with the Drop Down OpCo Units, the "Equity Consideration"), in each case subject to the adjustments contemplated in, and otherwise subject to the terms and conditions of, the Drop Down Purchase Agreement, which Equity Consideration is exchangeable from time to time for an equal number of shares of Viper's Class A Common Stock, par value $0.000001 per share.EXTRAORDINARY TRANSACTIONSISSUER3146.0000000FOR3146.000000FORS000064728Viper Energy, Inc.05/01/2025Adjournment Proposal: To adjourn the special meeting to a later date or time if necessary or appropriate, including to solicit additional proxies if there are not sufficient votes cast at the special meeting to approve the Drop Down Proposal and the Equity Issuance Proposal.CORPORATE GOVERNANCEISSUER3146.0000000FOR3146.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Andrew B. BremnerDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Tiffany (TJ) Thom CepakDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: James N. ChapmanDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: James R. JacksonDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Christian S. KendallDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Francisco J. LeonDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Mark A. (Mac) McFarlandDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: William B. RobyDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Bobby SaadatiDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Election of Directors: Alejandra (Ale) VeltmannDIRECTOR ELECTIONSISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025To approve, by non-binding vote, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2965.0000000FOR2965.000000FORS000064728California Resources Corporation13057Q305US13057Q305605/02/2025To approve, by non-binding vote, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2965.0000000FOR2965.000000FOR2S000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Gina F. AdamsDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: John H. BlackDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: John R. BurbankDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Kirkland H. DonaldDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Brian W. EllisDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Philip L. FredericksonDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: M. Elise HylandDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Stuart L. LevenickDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Andrew S. MarshDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Election of Directors: Karen A. PuckettDIRECTOR ELECTIONSISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Ratification of the Appointment of Deloitte & Touche LLP as Entergy's Independent Registered Public Accountants for 2025.AUDIT-RELATEDISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1995.0000000FOR1995.000000FORS000064728Entergy Corporation29364G103US29364G103105/02/2025Advisory Vote to Approve Named Executive Officer Compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1995.0000000FOR1995.000000FOR2S000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: Peter C. BrownDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: William P. BrownDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: John P. Case IIIDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: James B. ConnorDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: Virginia E. ShanksDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: Gregory K. SilversDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: Robin P. SterneckDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: John Peter SuarezDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: Lisa G. TrimbergerDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025Election of Trustees: Caixia Y. ZieglerDIRECTOR ELECTIONSISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in these proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in these proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER3439.0000000FOR3439.000000FOR2S000064728EPR Properties26884U109US26884U109705/06/2025To approve amendments to the Company's 2016 Equity Incentive Plan, including an increase to the number of authorized shares issuable under the plan.COMPENSATIONISSUER3439.0000000FOR3439.000000FORS000064728EPR Properties26884U109US26884U109705/06/2025To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER3439.0000000FOR3439.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: David A. CampbellDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: B. Anthony IsaacDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Paul M. KeglevicDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Senator Mary L. LandrieuDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Sandra A.J. LawrenceDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Ann D. MurtlowDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Dean A. NewtonDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Sandra J. PriceDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Jonathan D. RolphDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: James ScarolaDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: Neal A. SharmaDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Elect the nominees named in the proxy statement as directors: C. John WilderDIRECTOR ELECTIONSISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Approve the 2024 compensation of our named executive officers on an advisory non-binding basis.SECTION 14A SAY-ON-PAY VOTESISSUER2440.0000000FOR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025Approve the 2024 compensation of our named executive officers on an advisory non-binding basis.SECTION 14A SAY-ON-PAY VOTESISSUER2440.0000000FOR2440.000000FOR2S000064728Evergy, Inc.30034W106US30034W106205/06/2025To recommend, on a non-binding advisory basis, the frequency of the advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2440.0000000ONE YEAR2440.000000FORS000064728Evergy, Inc.30034W106US30034W106205/06/2025To recommend, on a non-binding advisory basis, the frequency of the advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER2440.0000000ONE YEAR2440.000000FOR2S000064728Evergy, Inc.30034W106US30034W106205/06/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER2440.0000000FOR2440.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Stuart W. AitkenDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Amanda E. BlackDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Daniel J. BuschDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Scott A. NelsonDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Paula J. SabanDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Smita N. ShahDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Julie M. SwinehartDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify: Julian E. WhitehurstDIRECTOR ELECTIONSISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to ratify the selection of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to approve, on a non-binding advisory basis, a resolution approving the compensation of our named executive officers ("say-on-pay") as described in our proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER5030.0000000FOR5030.000000FORS000064728InvenTrust Properties Corp.46124J201US46124J201505/06/2025A proposal to approve, on a non-binding advisory basis, a resolution approving the compensation of our named executive officers ("say-on-pay") as described in our proxy materials.SECTION 14A SAY-ON-PAY VOTESISSUER5030.0000000FOR5030.000000FOR2S000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Ian R. AshbyDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Patricia M. BedientDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Russell K. GirlingDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Jean Paul (JP) GladuDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Richard M. KrugerDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Brian P. MacDonaldDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Lorraine MitchelmoreDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Jane L. PeverettDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Daniel RomaskoDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director Christopher R. SeasonsDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Elect Director M. Jacqueline SheppardDIRECTOR ELECTIONSISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Ratify KPMG LLP as AuditorsAUDIT-RELATEDISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER4345.0000000FOR4345.000000FORS000064728Suncor Energy Inc.867224107CA867224107905/06/2025SP 1: Report on Impact of Net Zero by 2050 PledgeENVIRONMENT OR CLIMATESECURITY HOLDER4345.0000000AGAINST4345.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Receive and Approve Board's and Auditor's Reports Re: Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Consolidated Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Financial StatementsCORPORATE GOVERNANCEISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Allocation of Income and DividendsCAPITAL STRUCTUREISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Elect Directors (Bundled)DIRECTOR ELECTIONSISSUER3955.0000000AGAINST3955.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Remuneration of DirectorsCOMPENSATIONISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Remuneration ReportCOMPENSATIONISSUER3955.0000000AGAINST3955.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Share RepurchaseCAPITAL STRUCTUREISSUER3955.0000000AGAINST3955.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/06/2025Allow Electronic Distribution of Company Documents to ShareholdersCORPORATE GOVERNANCEISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Reduction in Share Capital through Cancellation of SharesCAPITAL STRUCTUREISSUER3955.0000000FOR3955.000000FORS000064728Tenaris SA88031M109US88031M109905/06/2025Approve Renewal of Authorized Share Capital and Related Authorizations and WaiversCAPITAL STRUCTUREISSUER3955.0000000AGAINST3955.000000AGAINSTS000064728Tenaris SA88031M109US88031M109905/06/2025Amend Articles to Reflect Changes in CapitalCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER3955.0000000AGAINST3955.000000AGAINSTS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: W. Blake BairdDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: Michael A. CokeDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: Gary N. BostonDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: LeRoy E. CarlsonDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: Irene H. OhDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: Constance von MuehlenDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Election of Directors: Douglas M. PasqualeDIRECTOR ELECTIONSISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Adoption of a resolution to approve, on a non-binding advisory basis, the compensation of certain executives, as more fully described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Adoption of a resolution to approve, on a non-binding advisory basis, the compensation of certain executives, as more fully described in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER2541.0000000FOR2541.000000FOR2S000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Approval of the Terreno Realty Corporation 2025 Equity Incentive Plan.COMPENSATIONISSUER2541.0000000FOR2541.000000FORS000064728Terreno Realty Corporation88146M101US88146M101805/06/2025Ratification of the appointment of Ernst & Young LLP as our independent registered certified public accounting firm for the 2025 fiscal year.AUDIT-RELATEDISSUER2541.0000000FOR2541.000000FORS000064728Veren Inc.92340V107CA92340V107605/06/2025Approve Acquisition by Whitecap Resources Inc.EXTRAORDINARY TRANSACTIONSISSUER32167.0000000FOR32167.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: James A. BennettDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Robert M. BlueDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Paul M. DabbarDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: D. Maybank HagoodDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Mark J. KingtonDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Kristin G. LovejoyDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Joseph M. RigbyDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Pamela J. Royal, M.D.DIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Robert H. Spilman, Jr.DIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Susan N. StoryDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Election of Directors. The nominees are: Vanessa Allen SutherlandDIRECTOR ELECTIONSISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Advisory Vote on Approval of Executive Compensation (Say on Pay)SECTION 14A SAY-ON-PAY VOTESISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Advisory Vote on Approval of Executive Compensation (Say on Pay)SECTION 14A SAY-ON-PAY VOTESISSUER2793.0000000FOR2793.000000FOR2S000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Ratification of Appointment of Independent AuditorAUDIT-RELATEDISSUER2793.0000000FOR2793.000000FORS000064728Dominion Energy, Inc.25746U109US25746U109705/07/2025Shareholder Proposal Regarding Eliminating Non-Carbon Emitting Generation Goals in Executive Pay IncentivesENVIRONMENT OR CLIMATESECURITY HOLDER2793.0000000AGAINST2793.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Ronald L. Havner, Jr.DIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Tamara Hughes GustavsonDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Maria R. HawthorneDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Shankh S. MitraDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Rebecca OwenDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Kristy M. PipesDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Avedick B. PoladianDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: John ReyesDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Joseph D. Russell, Jr.DIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Tariq M. ShaukatDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Ronald P. SpogliDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Election of Trustees: Paul S. WilliamsDIRECTOR ELECTIONSISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Advisory vote to approve the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Advisory vote to approve the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER504.0000000FOR504.000000FOR2S000064728Public Storage74460D109US74460D109005/07/2025Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER504.0000000FOR504.000000FORS000064728Public Storage74460D109US74460D109005/07/2025Approval of the Amendment and Restatement of the Public Storage 2021 Equity and Performance-Based Incentive Compensation Plan.COMPENSATIONISSUER504.0000000FOR504.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Jeffrey S. OlsonDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Mary L. BaglivoDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Steven H. GrapsteinDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Norman K. JenkinsDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Kevin P. O'SheaDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Catherine D. RiceDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Katherine M. SandstromDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025Election of Trustees to serve until the 2026 Annual Meeting of Shareholders and until their respective successors are duly elected and qualify: Douglas W. SeslerDIRECTOR ELECTIONSISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025The approval, on a non-binding advisory basis, of a resolution approving the compensation of our named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6949.0000000FOR6949.000000FORS000064728Urban Edge Properties91704F104US91704F104905/07/2025The approval, on a non-binding advisory basis, of a resolution approving the compensation of our named executive officers as described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER6949.0000000FOR6949.000000FOR2S000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Catherine M. BestDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director M. Elizabeth CannonDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director N. Murray EdwardsDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Christopher L. FongDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Gordon D. GiffinDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Wilfred A. GobertDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Christine M. HealyDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Steve W. LautDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Frank J. McKennaDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Scott G. StauthDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director David A. TuerDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Elect Director Annette M. VerschurenDIRECTOR ELECTIONSISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their RemunerationAUDIT-RELATEDISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Re-approve Stock Option PlanCOMPENSATIONISSUER5068.0000000FOR5068.000000FORS000064728Canadian Natural Resources Limited136385101CA136385101705/08/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER5068.0000000FOR5068.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Ratify PricewaterhouseCoopers LLP as AuditorsAUDIT-RELATEDISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Stephen E. BradleyDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Keith M. CaseyDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Michael J. CrothersDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director James D. GirgulisDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Jane E. KinneyDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Eva L. KwokDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Melanie A. LittleDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Richard J. MarcoglieseDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Chana L. MartineauDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Jonathan M. McKenzieDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Claude MongeauDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Alexander J. PourbaixDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Frank J. SixtDIRECTOR ELECTIONSISSUER10395.0000000AGAINST10395.000000AGAINSTS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Elect Director Rhonda I. ZygockiDIRECTOR ELECTIONSISSUER10395.0000000FOR10395.000000FORS000064728Cenovus Energy Inc.15135U109CA15135U109305/08/2025Advisory Vote on Executive Compensation ApproachCOMPENSATIONISSUER10395.0000000FOR10395.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director D.W. (David) CornhillDIRECTOR ELECTIONSISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director S.R. (Sharon) DriscollDIRECTOR ELECTIONSISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director J.N. (John) FlorenDIRECTOR ELECTIONSISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director G.J. (Gary) GoldbergDIRECTOR ELECTIONSISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director N.A. (Neil) HansenDIRECTOR ELECTIONSISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director M.C. (Miranda) HubbsDIRECTOR ELECTIONSISSUER2428.0000000AGAINST2428.000000AGAINSTS000064728Imperial Oil Limited453038408CA453038408605/08/2025Elect Director J.R. (John) WhelanDIRECTOR ELECTIONSISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Ratify PricewaterhouseCoopers LLP as AuditorsAUDIT-RELATEDISSUER2428.0000000FOR2428.000000FORS000064728Imperial Oil Limited453038408CA453038408605/08/2025Amend By-Law No. 1CORPORATE GOVERNANCEISSUER2428.0000000AGAINST2428.000000AGAINSTS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Warner L. BaxterDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Ave M. BieDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Danny L. CunninghamDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: William M. Farrow IIIDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Cristina A. Garcia-ThomasDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Maria C. GreenDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Gale E. KlappaDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Thomas K. LaneDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: John D. LangeDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Scott J. LauberDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Ulice Payne, Jr.DIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Mary Ellen StanekDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Election of 13 Directors, each for a 1-year term expiring in 2026: Glen E. TellockDIRECTOR ELECTIONSISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Ratification of Deloitte & Touche LLP as independent auditors for 2025AUDIT-RELATEDISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Advisory vote to approve executive compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Advisory vote to approve executive compensation of the named executive officersSECTION 14A SAY-ON-PAY VOTESISSUER1586.0000000FOR1586.000000FOR2S000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Amendments to the Restated Articles of Incorporation to eliminate supermajority voting requirementsCORPORATE GOVERNANCEISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Amendments to the Bylaws to eliminate supermajority voting requirementsCORPORATE GOVERNANCEISSUER1586.0000000FOR1586.000000FORS000064728WEC Energy Group, Inc.92939U106US92939U106005/08/2025Stockholder proposal to support simple majority voteCORPORATE GOVERNANCESECURITY HOLDER1586.0000000FOR1586.000000AGAINSTS000064728Woodside Energy Group Ltd.980228308US980228308805/08/2025Elect Ann Pickard as DirectorDIRECTOR ELECTIONSISSUER844.00000010120.000000FOR844.000000FORS000064728Woodside Energy Group Ltd.980228308US980228308805/08/2025Elect Ben Wyatt as DirectorDIRECTOR ELECTIONSISSUER844.00000010120.000000FOR844.000000FORS000064728Woodside Energy Group Ltd.980228308US980228308805/08/2025Elect Tony O'Neill as DirectorDIRECTOR ELECTIONSISSUER844.00000010120.000000FOR844.000000FORS000064728Woodside Energy Group Ltd.980228308US980228308805/08/2025Approve Remuneration ReportCOMPENSATIONISSUER844.00000010120.000000FOR844.000000FORS000064728Woodside Energy Group Ltd.980228308US980228308805/08/2025Approve Grant of Restricted Shares and Performance Rights to Meg O'NeillCOMPENSATIONISSUER844.00000010120.000000FOR844.000000FORS000064728Woodside Energy Group Ltd.980228308US980228308805/08/2025Approve Renewal of Proportional Takeovers ProvisionSHAREHOLDER RIGHTS AND DEFENSESISSUER844.00000010120.000000FOR844.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Richard J. CampoDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Javier E. BenitoDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Heather J. BrunnerDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Mark D. GibsonDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Scott S. IngrahamDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Renu KhatorDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: D. Keith OdenDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Frances Aldrich Sevilla-SacasaDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Steven A. WebsterDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Election of Trust Managers: Kelvin R. WestbrookDIRECTOR ELECTIONSISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Approval, by an advisory vote, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1304.0000000FOR1304.000000FORS000064728Camden Property Trust133131102US133131102705/09/2025Approval, by an advisory vote, of executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1304.0000000FOR1304.000000FOR2S000064728Camden Property Trust133131102US133131102705/09/2025Ratification of Deloitte & Touche LLP as the independent registered public accounting firm.AUDIT-RELATEDISSUER1304.0000000FOR1304.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Jeffrey B. CitrinDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Sandeep L. MathraniDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Thomas J. ReddinDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Bridget M. Ryan-BermanDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Susan E. SkerrittDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Sonia SyngalDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Steven B. TangerDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Luis A. UbinasDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025Election of Directors: Stephen YalofDIRECTOR ELECTIONSISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025To approve, on an advisory (non-binding) basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER48.0000004317.000000FOR48.000000FORS000064728Tanger Inc.875465106US875465106005/09/2025To approve, on an advisory (non-binding) basis, named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER48.0000004317.000000FOR48.000000FOR2S000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Mark A. EmmertDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Rick R. HolleyDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Sara Grootwassink LewisDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Deidra C. MerriwetherDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Al MonacoDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: James C. O'RourkeDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Nicole W. PiaseckiDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Lawrence A. SelzerDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Devin W. StockfishDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Election of Directors: Kim WilliamsDIRECTOR ELECTIONSISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Approval, on an advisory basis, of the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5451.0000000FOR5451.000000FORS000064728Weyerhaeuser Company962166104US962166104305/09/2025Approval, on an advisory basis, of the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5451.0000000FOR5451.000000FOR2S000064728Weyerhaeuser Company962166104US962166104305/09/2025Ratification of the selection of the independent registered public accounting firm.AUDIT-RELATEDISSUER5451.0000000FOR5451.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Joyce DeLuccaDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Scott A. EstesDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Peter M. MavoidesDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Lawrence J. MinichDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Heather L. NearyDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Stephen D. SautelDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To elect seven (7) individuals to the Company's Board of Directors, each to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualify: Janaki SivanesanDIRECTOR ELECTIONSISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as more particularly described in the Proxy Statement; andSECTION 14A SAY-ON-PAY VOTESISSUER4754.0000000FOR4754.000000FORS000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as more particularly described in the Proxy Statement; andSECTION 14A SAY-ON-PAY VOTESISSUER4754.0000000FOR4754.000000FOR2S000064728Essential Properties Realty Trust, Inc.29670E107US29670E107305/12/2025To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER4754.0000000FOR4754.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Tamara D. FischerDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Arlen D. NordhagenDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: David G. CramerDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Warren W. AllanDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Lisa R. CohnDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Paul W. Hylbert, Jr.DIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Chad L. MeisingerDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Steven G. OsgoodDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Dominic M. PalazzoDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Michael J. SchallDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The election of eleven trustees to serve on the Board of Trustees: Charles F. WuDIRECTOR ELECTIONSISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025Shareholder advisory vote (non-binding) on the executive compensation of the Company's Named Executive Officers as more fully described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3961.0000000FOR3961.000000FORS000064728National Storage Affiliates Trust637870106US637870106305/12/2025Shareholder advisory vote (non-binding) on the executive compensation of the Company's Named Executive Officers as more fully described in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3961.0000000FOR3961.000000FOR2S000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Steven O. VondranDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Kelly C. ChamblissDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Teresa H. ClarkeDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Kenneth R. FrankDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Robert D. HormatsDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Rajesh KalathurDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Grace D. LiebleinDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Craig MacnabDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Neville R. RayDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Pamela D. A. ReeveDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To elect the following Directors: Bruce L. TannerDIRECTOR ELECTIONSISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER816.0000000FOR816.000000FORS000064728American Tower Corporation03027X100US03027X100005/14/2025To approve, on an advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER816.0000000FOR816.000000FOR2S000064728American Tower Corporation03027X100US03027X100005/14/2025To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER816.0000000FOR816.000000FORS000064728Dorchester Minerals, L.P.25820R105US25820R105905/14/2025Election of Managers with subsequent appointment to the Advisory Committee: Allen D. LassiterDIRECTOR ELECTIONSISSUER2981.0000001700.000000FOR2981.000000FORS000064728Dorchester Minerals, L.P.25820R105US25820R105905/14/2025Election of Managers with subsequent appointment to the Advisory Committee: C.W. (Bill) RussellDIRECTOR ELECTIONSISSUER2981.0000001700.000000FOR2981.000000FORS000064728Dorchester Minerals, L.P.25820R105US25820R105905/14/2025Election of Managers with subsequent appointment to the Advisory Committee: Sarah N. WarinerDIRECTOR ELECTIONSISSUER2981.0000001700.000000FOR2981.000000FORS000064728Dorchester Minerals, L.P.25820R105US25820R105905/14/2025Approval of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2025AUDIT-RELATEDISSUER2981.0000001700.000000FOR2981.000000FORS000064728Equinor ASA29446M102US29446M102705/14/2025Elect Chair of MeetingCORPORATE GOVERNANCEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Notice of Meeting and AgendaCORPORATE GOVERNANCEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Designate Inspector(s) of Minutes of MeetingCORPORATE GOVERNANCEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Accept Financial Statements and Statutory Reports; Approve Allocation of Income and Dividends of USD 0.37 Per ShareCAPITAL STRUCTURECORPORATE GOVERNANCEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Authorize Board to Distribute DividendsCAPITAL STRUCTUREISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Energy Transition Plan 2025ENVIRONMENT OR CLIMATEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Discontinue the Wind Power Business; Decommission All Wind Power PlantsENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Withdrawal from All Offshore Wind Globally; Eliminate Management BonusesENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Review Work Locations and Work Operations to Ensure that any Potentially Hazardous Conditions are IdentifiedHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Present a Plan for How the Company will Reach the Paris Agreement Goals and Net-zero Emissions by 2050 and Terminate All Overseas Oil and Gas ProjectsENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Separate the Renewable Energy Part of the Company and Invest NOK 5 Billion Annually in the Repair and Renewal of Ukraine's Energy InfrastructureCORPORATE GOVERNANCEOTHERCompany-specific matterSECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Renew Green Aims, Avoid Further International Investment in Oil and Gas and Donate Billions to UkraineENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Gradual Divestment From All International OperationsENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Review Guidelines and Procedures for Human Rights Due Diligence AssessmentsHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Identify and Manage Risks and Possibilities Regarding Climate and Integrate These in the Company's StrategyENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Assess if the Company's Planned Increase in Oil and Gas Production is Consistent with the Majority Shareholder ExpectationsENVIRONMENT OR CLIMATESECURITY HOLDER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Company's Corporate Governance StatementCORPORATE GOVERNANCEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Remuneration StatementCOMPENSATIONISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Remuneration of AuditorsAUDIT-RELATEDISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Elect Berit L. Henriksen as New Member of Corporate AssemblyDIRECTOR ELECTIONSISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Remuneration of Corporate Assembly in the Amount of NOK 160,000 for Chair, NOK 84,300 for Deputy Chair and NOK 59,200 for Other Directors; Approve Remuneration for Deputy DirectorsCOMPENSATIONISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Elect Karl C. W. Mathisen as Member of Nominating CommitteeDIRECTOR ELECTIONSCORPORATE GOVERNANCEISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve Remuneration of Nominating CommitteeCOMPENSATIONISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Authorize Share Repurchase Program in Connection With Employee Remuneration ProgramsCOMPENSATIONISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Approve NOK 590 Million Reduction in Share Capital via Share Cancellation and Redemption of Shares Belonging to the Norwegian StateCAPITAL STRUCTUREISSUER0.0000000S000064728Equinor ASA29446M102US29446M102705/14/2025Authorize Share Repurchase Program and Cancellation of Repurchased SharesCAPITAL STRUCTUREISSUER0.0000000S000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Anne-Marie N. AinsworthDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Anna C. CatalanoDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Leldon E. EcholsDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Manuel J. FernandezDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Timothy GoDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Rhoman J. HardyDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Jeanne M. JohnsDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: R. Craig KnockeDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Robert J. KostelnikDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Ross B. MatthewsDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Election of Directors: Franklin MyersDIRECTOR ELECTIONSISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4440.0000000FOR4440.000000FOR2S000064728HF Sinclair Corporation403949100US403949100005/14/2025Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2025 fiscal year.AUDIT-RELATEDISSUER4440.0000000FOR4440.000000FORS000064728HF Sinclair Corporation403949100US403949100005/14/2025Approval of HF Sinclair's Second Amended and Restated Certificate of Incorporation to provide for officer exculpation.CORPORATE GOVERNANCEISSUER4440.0000000FOR4440.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: C.P. DemingDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: L.R. DickersonDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: M.A. EarleyDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: E.M. HamblyDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: E.W. KellerDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: R.M. MurphyDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: J.W. NolanDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: R.N. Ryan, Jr.DIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: L.A. SuggDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Election of Directors: R.B. Tudor, IIIDIRECTOR ELECTIONSISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER5310.0000000FOR5310.000000FOR2S000064728Murphy Oil Corporation626717102US626717102205/14/2025Approval of proposed 2025 Long-Term Incentive Plan.COMPENSATIONISSUER5310.0000000FOR5310.000000FORS000064728Murphy Oil Corporation626717102US626717102205/14/2025Approval of the appointment of KPMG LLP as independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER5310.0000000FOR5310.000000FORS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Election of Directors: Gary N. BostonDIRECTOR ELECTIONSISSUER9696.0000000FOR9696.000000FORS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Election of Directors: John M. CattonarDIRECTOR ELECTIONSISSUER9696.0000000FOR9696.000000FORS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Election of Directors: Cynthia Foster CurryDIRECTOR ELECTIONSISSUER9696.0000000FOR9696.000000FORS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Election of Directors: David R. LukesDIRECTOR ELECTIONSISSUER9696.0000000FOR9696.000000FORS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Election of Directors: Dawn M. SweeneyDIRECTOR ELECTIONSISSUER9696.0000000FOR9696.000000FORS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER9696.0000000AGAINST9696.000000AGAINSTS000064728SITE Centers Corp.82981J851US82981J851405/14/2025Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER9696.0000000AGAINST9696.000000AGAINST2S000064728SITE Centers Corp.82981J851US82981J851405/14/2025Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting FirmAUDIT-RELATEDISSUER9696.0000000FOR9696.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Michael D. FascitelliDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Dallas B. TannerDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Jana Cohen BarbeDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: H. Wyman Howard IIIDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Jeffrey E. KelterDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Kellyn Smith KennyDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Joseph D. MargolisDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: John B. RheaDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Frances Aldrich Sevilla-SacasaDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To elect director nominees: Keith D. TaylorDIRECTOR ELECTIONSISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To approve, in a non-binding advisory vote, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4664.0000000FOR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To approve, in a non-binding advisory vote, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4664.0000000FOR4664.000000FOR2S000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To determine, in a non-binding advisory vote, the frequency of stockholder votes to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4664.0000000ONE YEAR4664.000000FORS000064728Invitation Homes Inc.46187W107US46187W107105/15/2025To determine, in a non-binding advisory vote, the frequency of stockholder votes to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER4664.0000000ONE YEAR4664.000000FOR2S000064728Alliant Energy Corporation018802108US018802108505/16/2025Election of Directors. Nominees for terms ending in 2028: N. Joy FaloticoDIRECTOR ELECTIONSISSUER2543.0000000FOR2543.000000FORS000064728Alliant Energy Corporation018802108US018802108505/16/2025Election of Directors. Nominees for terms ending in 2028: Thomas F. O'TooleDIRECTOR ELECTIONSISSUER2543.0000000FOR2543.000000FORS000064728Alliant Energy Corporation018802108US018802108505/16/2025Election of Directors. Nominees for terms ending in 2028: Christie RaymondDIRECTOR ELECTIONSISSUER2543.0000000FOR2543.000000FORS000064728Alliant Energy Corporation018802108US018802108505/16/2025Advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2543.0000000FOR2543.000000FORS000064728Alliant Energy Corporation018802108US018802108505/16/2025Advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER2543.0000000FOR2543.000000FOR2S000064728Alliant Energy Corporation018802108US018802108505/16/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER2543.0000000FOR2543.000000FORS000064728Alliant Energy Corporation018802108US018802108505/16/2025Shareowner Proposal Requesting Third-Party Evaluation of Greenhouse Gas Emissions Reduction Targets.ENVIRONMENT OR CLIMATESECURITY HOLDER2543.0000000AGAINST2543.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: John A. KiteDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Bonnie S. BiumiDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Derrick BurksDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Victor J. ColemanDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Steven P. GrimesDIRECTOR ELECTIONSISSUER5967.0000000AGAINST5967.000000AGAINSTS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Christie B. KellyDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Peter L. LynchDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: David R. O'ReillyDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Barton R. PetersonDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Charles H. WurtzebachDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025Election of Trustees: Caroline L. YoungDIRECTOR ELECTIONSISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025To approve, on an advisory (non-binding) basis, the compensation of Kite Realty Group Trust's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5967.0000000FOR5967.000000FORS000064728Kite Realty Group Trust49803T300US49803T300505/16/2025To approve, on an advisory (non-binding) basis, the compensation of Kite Realty Group Trust's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5967.0000000FOR5967.000000FOR2S000064728Kite Realty Group Trust49803T300US49803T300505/16/2025To ratify the appointment of KPMG LLP as the independent registered public accounting firm for Kite Realty Group Trust for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER5967.0000000FOR5967.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Glenn W. BuntingDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Jon A. FosheimDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Kristian M. GathrightDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Carolyn B. HandlonDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Glade M. KnightDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Justin G. KnightDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Blythe J. McGarvieDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: L. Hugh ReddDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Election of Directors: Howard E. WoolleyDIRECTOR ELECTIONSISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm to serve for 2025.AUDIT-RELATEDISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Approval on an advisory basis of executive compensation paid by the Company.SECTION 14A SAY-ON-PAY VOTESISSUER9603.0000000FOR9603.000000FORS000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Approval on an advisory basis of executive compensation paid by the Company.SECTION 14A SAY-ON-PAY VOTESISSUER9603.0000000FOR9603.000000FOR2S000064728Apple Hospitality REIT, Inc.03784Y200US03784Y200005/19/2025Approval of the Apple Hospitality REIT, Inc. Employee Stock Purchase Plan.COMPENSATIONISSUER9603.0000000FOR9603.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Elect the six director nominees, each to serve one-year term: Fernando AraujoDIRECTOR ELECTIONSISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Elect the six director nominees, each to serve one-year term: Matthew BobDIRECTOR ELECTIONSISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Elect the six director nominees, each to serve one-year term: Renee HornbakerDIRECTOR ELECTIONSISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Elect the six director nominees, each to serve one-year term: Anne MariucciDIRECTOR ELECTIONSISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Elect the six director nominees, each to serve one-year term: Rajath ShourieDIRECTOR ELECTIONSISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Elect the six director nominees, each to serve one-year term: James TrimbleDIRECTOR ELECTIONSISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Approve a non-binding resolution regarding the compensation of the Company's named executive officers for 2024 (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER39551.0000000FOR39551.000000FORS000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Approve a non-binding resolution regarding the compensation of the Company's named executive officers for 2024 (say-on-pay).SECTION 14A SAY-ON-PAY VOTESISSUER39551.0000000FOR39551.000000FOR2S000064728Berry Corporation (bry)08579X101US08579X101905/20/2025Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER39551.0000000FOR39551.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Piero BussaniDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Jit Kee ChinDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Dorothy DowlingDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: John W. FainDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Jair K. LynchDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Christopher P. MarrDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Deborah Ratner SalzbergDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: John F. RemondiDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025Election of Trustees: Jeffrey F. RogatzDIRECTOR ELECTIONSISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025To amend and restate the Amended and Restated CubeSmart 2007 Equity Incentive Plan.COMPENSATIONISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025To cast an advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3514.0000000FOR3514.000000FORS000064728CubeSmart229663109US229663109405/20/2025To cast an advisory vote to approve our executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3514.0000000FOR3514.000000FOR2S000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: H. Eric Bolton, Jr.DIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Deborah H. CaplanDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: John P. CaseDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Tamara FischerDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Alan B. Graf, Jr.DIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Brad HillDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Edith Kelly-GreenDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Sheila K. McGrathDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Claude B. NielsenDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: Gary S. ShorbDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Election of Directors: David P. StockertDIRECTOR ELECTIONSISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Advisory (non-binding) vote to approve the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER977.0000000FOR977.000000FORS000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Advisory (non-binding) vote to approve the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER977.0000000FOR977.000000FOR2S000064728Mid-America Apartment Communities, Inc.59522J103US59522J103405/20/2025Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2025.AUDIT-RELATEDISSUER977.0000000FOR977.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: Laurie H. ArgoDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: Spencer D. ArmourDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: Frank C. HuDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: W. Wesley PerryDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: James L. RubinDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: Travis D. SticeDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: Kaes Van't HofDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025Election of Directors: Steven E. WestDIRECTOR ELECTIONSISSUER3520.0000000FOR3520.000000FORS000064728Viper Energy, Inc.05/20/2025The approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3520.0000000AGAINST3520.000000AGAINSTS000064728Viper Energy, Inc.05/20/2025The approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3520.0000000AGAINST3520.000000AGAINST2S000064728Viper Energy, Inc.05/20/2025The ratification of Grant Thornton LLP as the Company's independent auditors for fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3520.0000000FOR3520.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: P. Robert BartoloDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Jason GenrichDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Andrea J. GoldsmithDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Tammy K. JonesDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Kevin T. KabatDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Anthony J. MeloneDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Katherine MotlaghDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Kevin A. StephensDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025Election of Directors: Matthew Thornton, IIIDIRECTOR ELECTIONSISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for fiscal year 2025.AUDIT-RELATEDISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025The non-binding, advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025The non-binding, advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1653.0000000FOR1653.000000FOR2S000064728Crown Castle Inc.22822V101US22822V101705/21/2025The amendment and restatement of the Company's Charter to eliminate supermajority vote requirements.CORPORATE GOVERNANCEISSUER1653.0000000FOR1653.000000FORS000064728Crown Castle Inc.22822V101US22822V101705/21/2025The amendments and restatement of the Company's Charter to eliminate unnecessary and outdated provisions.CORPORATE GOVERNANCEISSUER1653.0000000FOR1653.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Vincent K. BrooksDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Darin G. HoldernessDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Rebecca A. KleinDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Stephanie K. MainsDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Charles A. MeloyDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Mark L. PlaumannDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Robert K. ReevesDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Lance W. RobertsonDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Travis D. SticeDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Melanie M. TrentDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Frank D. TsuruDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Kaes Van't HofDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Election of Directors: Steven E. WestDIRECTOR ELECTIONSISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025The approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025The approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER982.0000000FOR982.000000FOR2S000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025The ratification of Grant Thornton LLP as the Company's independent auditors for fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER982.0000000FOR982.000000FORS000064728Diamondback Energy, Inc.25278X109US25278X109005/21/2025Stockholder proposal regarding certain executive severance arrangements.COMPENSATIONSECURITY HOLDER982.0000000FOR982.000000AGAINSTS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Janet F. ClarkDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Charles R. CrispDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Robert P. DanielsDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Lynn A. DugleDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: C. Christopher GautDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Michael T. KerrDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Julie J. RobertsonDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To elect eight directors of the Company to hold office until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualified: Ezra Y. YacobDIRECTOR ELECTIONSISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To ratify the appointment by the Audit Committee of the Board of Directors of Deloitte & Touche LLP, independent registered public accounting firm, as auditors for the Company for the year ending December 31, 2025.AUDIT-RELATEDISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To approve, by non-binding vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1259.0000000FOR1259.000000FORS000064728EOG Resources, Inc.26875P101US26875P101205/21/2025To approve, by non-binding vote, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1259.0000000FOR1259.000000FOR2S000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Kenneth M. WoolleyDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Joseph D. MargolisDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Mark G. BarberioDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Joseph D. BonnerDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Gary L. CrittendenDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Susan HarnettDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Spencer F. KirkDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Diane OlmsteadDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Joseph V. SaffireDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025The election of the 10 members of the Board of Directors: Julia Vander PloegDIRECTOR ELECTIONSISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm.AUDIT-RELATEDISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025Advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1020.0000000FOR1020.000000FORS000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025Advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1020.0000000FOR1020.000000FOR2S000064728Extra Space Storage Inc.30225T102US30225T102505/21/2025Approval of the amended and restated 2015 Extra Space Storage Inc. Incentive Award Plan.COMPENSATIONISSUER1020.0000000FOR1020.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Victor BurkDIRECTOR ELECTIONSISSUER8849.0000000FOR8849.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Kevin McCarthyDIRECTOR ELECTIONSISSUER8849.0000000FOR8849.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Harry PefanisDIRECTOR ELECTIONSISSUER8849.0000000FOR8849.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Gary PetersenDIRECTOR ELECTIONSISSUER8849.0000000FOR8849.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER8849.0000000FOR8849.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025The approval, on a non-binding advisory basis, of our 2024 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8849.0000000FOR8849.000000FORS000064728Plains All American Pipeline, L.P.726503105US726503105105/21/2025The approval, on a non-binding advisory basis, of our 2024 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8849.0000000FOR8849.000000FOR2S000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Victor BurkDIRECTOR ELECTIONSISSUER8236.0000000FOR8236.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Kevin McCarthyDIRECTOR ELECTIONSISSUER8236.0000000FOR8236.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Harry PefanisDIRECTOR ELECTIONSISSUER8236.0000000FOR8236.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025The election of four Class II directors to serve on the Board until the 2028 annual meeting: Gary PetersenDIRECTOR ELECTIONSISSUER8236.0000000FOR8236.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER8236.0000000FOR8236.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025The approval, on a non-binding advisory basis, of our 2024 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8236.0000000FOR8236.000000FORS000064728Plains GP Holdings, L.P.72651A207US72651A207805/21/2025The approval, on a non-binding advisory basis, of our 2024 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER8236.0000000FOR8236.000000FOR2S000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Annell R. BayDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Matthew R. BobDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: John J. Christmann IVDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Juliet S. EllisDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Kenneth M. FisherDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Charles W. HooperDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Chansoo JoungDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: H. Lamar McKayDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Peter A. RagaussDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: David L. StoverDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Election of Directors: Anya WeavingDIRECTOR ELECTIONSISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Ratification of Ernst & Young LLP as APA's Independent AuditorsAUDIT-RELATEDISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Advisory Vote to Approve Compensation of APA's Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER7124.0000000FOR7124.000000FORS000064728APA CORPORATION03743Q108US03743Q108505/22/2025Advisory Vote to Approve Compensation of APA's Named Executive OfficersSECTION 14A SAY-ON-PAY VOTESISSUER7124.0000000FOR7124.000000FOR2S000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: D. Pike AloianDIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: H. Eric Bolton, Jr.DIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: Donald F. ColleranDIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: David M. FieldsDIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: Marshall A. LoebDIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: Mary E. McCormickDIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025Election of Director Nominees to serve for a one-year term until the next annual meeting of shareholders and until their successors are duly elected and qualified: Katherine M. SandstromDIRECTOR ELECTIONSISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025To approve, by a non-binding, advisory vote, the compensation of the Company's Named Executive Officers as described in the Company's definitive proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER929.0000000FOR929.000000FORS000064728EastGroup Properties, Inc.277276101US277276101905/22/2025To approve, by a non-binding, advisory vote, the compensation of the Company's Named Executive Officers as described in the Company's definitive proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER929.0000000FOR929.000000FOR2S000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Bahram AkradiDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Lisa BromileyDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Roy EasleyDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Michael FrantzDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: William KimbleDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Stuart LasherDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Nicholas O'GradyDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025Election of Directors: Jennifer PomerantzDIRECTOR ELECTIONSISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4214.0000000FOR4214.000000FORS000064728Northern Oil and Gas, Inc.665531307US665531307905/22/2025To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4214.0000000FOR4214.000000FOR2S000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: T. Wilson EglinDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Lawrence L. GrayDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Arun GuptaDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Jamie HandwerkerDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Derrick JohnsonDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Claire A. KoenemanDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Nancy Elizabeth NoeDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025Election of Trustees: Howard RothDIRECTOR ELECTIONSISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025To consider and vote upon an advisory, non-binding resolution to approve the compensation of the named executive officers, as disclosed in the accompanying proxy statement;SECTION 14A SAY-ON-PAY VOTESISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025To consider and vote upon an advisory, non-binding resolution to approve the compensation of the named executive officers, as disclosed in the accompanying proxy statement;SECTION 14A SAY-ON-PAY VOTESISSUER18017.0000000FOR18017.000000FOR2S000064728LXP Industrial Trust529043101US529043101505/27/2025To consider and vote upon a proposal to approve an amendment to the LXP Industrial Trust 2022 Equity-Based Award Plan to increase the number of shares available for issuance thereunder by 5,000,000 common shares; andCOMPENSATIONISSUER18017.0000000FOR18017.000000FORS000064728LXP Industrial Trust529043101US529043101505/27/2025To consider and vote upon the ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER18017.0000000FOR18017.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Cheryl K. BeebeDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Gregory L. EbelDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Bruce M. BodineDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Timothy S. GitzelDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Emery N. KoenigDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Jody L. KuzenkoDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Sonya C. LittleDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: David T. SeatonDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Kathleen M. ShanahanDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Joao Roberto Goncalves TeixeiraDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Gretchen H. WatkinsDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Election of Directors: Kelvin R. WestbrookDIRECTOR ELECTIONSISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025An advisory vote to approve the compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5594.0000000FOR5594.000000FORS000064728The Mosaic Company61945C103US61945C103605/29/2025An advisory vote to approve the compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER5594.0000000FOR5594.000000FOR2S000064728American Assets Trust, Inc.024013104US024013104706/02/2025Election of Directors: Ernest S. RadyDIRECTOR ELECTIONSISSUER5765.0000000FOR5765.000000FORS000064728American Assets Trust, Inc.024013104US024013104706/02/2025Election of Directors: Robert S. SullivanDIRECTOR ELECTIONSISSUER5765.0000000WITHHOLD5765.000000AGAINSTS000064728American Assets Trust, Inc.024013104US024013104706/02/2025Election of Directors: Thomas S. OlingerDIRECTOR ELECTIONSISSUER5765.0000000FOR5765.000000FORS000064728American Assets Trust, Inc.024013104US024013104706/02/2025Election of Directors: Joy L. SchaeferDIRECTOR ELECTIONSISSUER5765.0000000WITHHOLD5765.000000AGAINSTS000064728American Assets Trust, Inc.024013104US024013104706/02/2025Election of Directors: Nina A. TranDIRECTOR ELECTIONSISSUER5765.0000000WITHHOLD5765.000000AGAINSTS000064728American Assets Trust, Inc.024013104US024013104706/02/2025The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER5765.0000000FOR5765.000000FORS000064728American Assets Trust, Inc.024013104US024013104706/02/2025An advisory resolution to approve our executive compensation for the fiscal year ended December 31, 2024.SECTION 14A SAY-ON-PAY VOTESISSUER5765.0000000FOR5765.000000FORS000064728American Assets Trust, Inc.024013104US024013104706/02/2025An advisory resolution to approve our executive compensation for the fiscal year ended December 31, 2024.SECTION 14A SAY-ON-PAY VOTESISSUER5765.0000000FOR5765.000000FOR2S000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Robert L. AntinDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Michael S. FrankelDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Diana J. IngramDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Angela L. KleimanDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Debra L. MorrisDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Tyler H. RoseDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025Election of Directors: Howard SchwimmerDIRECTOR ELECTIONSISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025The advisory resolution to approve the Company's named executive officer compensation for the fiscal year ended December 31, 2024, as described in the Rexford Industrial Realty, Inc. Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3988.0000000FOR3988.000000FORS000064728Rexford Industrial Realty, Inc.76169C100US76169C100906/03/2025The advisory resolution to approve the Company's named executive officer compensation for the fiscal year ended December 31, 2024, as described in the Rexford Industrial Realty, Inc. Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER3988.0000000FOR3988.000000FOR2S000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Wouter van KempenDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Deborah ByersDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Morris R. ClarkDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Carrie M. FoxDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Lloyd W. "Billy" Helms, Jr.DIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Carrie L. HudakDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: James M. TrimbleDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Howard A. Willard IIIDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: Jeffrey E. WojahnDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To elect ten directors named in the proxy statement to our board of directors: M. Christopher DoyleDIRECTOR ELECTIONSISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountant for 2025; andAUDIT-RELATEDISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4475.0000000FOR4475.000000FORS000064728Civitas Resources, Inc.17888H103US17888H103206/04/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER4475.0000000FOR4475.000000FOR2S000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Dustin DeMariaDIRECTOR ELECTIONSISSUER7344.0000000WITHHOLD7344.000000AGAINSTS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Jaffrey A. FirestoneDIRECTOR ELECTIONSISSUER7344.0000000FOR7344.000000FORS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Robert E. FlintDIRECTOR ELECTIONSISSUER7344.0000000WITHHOLD7344.000000AGAINSTS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Colin KwakDIRECTOR ELECTIONSISSUER7344.0000000WITHHOLD7344.000000AGAINSTS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: David L. LampDIRECTOR ELECTIONSISSUER7344.0000000WITHHOLD7344.000000AGAINSTS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Stephen MongilloDIRECTOR ELECTIONSISSUER7344.0000000FOR7344.000000FORS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Mark J. SmithDIRECTOR ELECTIONSISSUER7344.0000000FOR7344.000000FORS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To elect eight directors for terms of one year each, to serve until their successors have been duly elected and qualified: Julia Heidenreich VolivaDIRECTOR ELECTIONSISSUER7344.0000000FOR7344.000000FORS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To approve, on an advisory basis, our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7344.0000000AGAINST7344.000000AGAINSTS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To approve, on an advisory basis, our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTESISSUER7344.0000000AGAINST7344.000000AGAINST2S000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan.COMPENSATIONISSUER7344.0000000AGAINST7344.000000AGAINSTS000064728CVR Energy, Inc.12662P108US12662P108406/05/2025To ratify the appointment of Grant Thornton LLP as CVR Energy, Inc.'s independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER7344.0000000FOR7344.000000FORS000064728CVR Partners LP126633205US126633205506/05/2025Approve the CVR Partners, LP 2025 Long-Term Incentive Plan ("LTIP Proposal").COMPENSATIONISSUER2065.0000000FOR2065.000000FORS000064728CVR Partners LP126633205US126633205506/05/2025Ratify the appointment of Grant Thornton LLP as CVR Partners, LP's independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER2065.0000000FOR2065.000000FORS000064728CVR Partners LP126633205US126633205506/05/2025Approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for the LTIP Proposal.CORPORATE GOVERNANCEISSUER2065.0000000FOR2065.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Domenic J. Dell'Osso, Jr.DIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Timothy S. DuncanDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Benjamin C. Duster, IVDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Sarah A. EmersonDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Matthew M. GallagherDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: John D. GassDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: S.P. "Chip" Johnson IVDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Catherine A. KehrDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Shameek KonarDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Brian SteckDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025Election of Directors: Michael A. WichterichDIRECTOR ELECTIONSISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025To approve on an advisory basis our named executive officer compensation for 2024.SECTION 14A SAY-ON-PAY VOTESISSUER1450.0000000FOR1450.000000FORS000064728Expand Energy Corporation165167735US165167735306/05/2025To approve on an advisory basis our named executive officer compensation for 2024.SECTION 14A SAY-ON-PAY VOTESISSUER1450.0000000FOR1450.000000FOR2S000064728Expand Energy Corporation165167735US165167735306/05/2025To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1450.0000000FOR1450.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Leslie A. BeyerDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Tiffany (TJ) Thom CepakDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Robert W. DrummondDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Gary M. HalversonDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: William A. Hendricks, Jr.DIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Curtis W. HuffDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Cesar JaimeDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Janeen S. JudahDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Amy H. NelsonDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: Julie J. RobertsonDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Election of Directors: James C. StewartDIRECTOR ELECTIONSISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Patterson-UTI for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Approval, on an advisory basis, of Patterson-UTI's compensation of its named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18579.0000000FOR18579.000000FORS000064728Patterson-UTI Energy, Inc.703481101US703481101506/05/2025Approval, on an advisory basis, of Patterson-UTI's compensation of its named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18579.0000000FOR18579.000000FOR2S000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: Carin M. BarthDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: Thomas L. Carter, Jr.DIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: D. Mark DeWalchDIRECTOR ELECTIONSISSUER1096.0000009100.000000WITHHOLD1096.000000AGAINSTS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: Jerry V. Kyle, Jr.DIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: Michael C. LinnDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: Ashley J. LongmaidDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: William N. MathisDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: William E. RandallDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: Alexander D. StuartDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Election of directors to the board of directors of Black Stone Minerals, L.P.'s general partner, each to serve until the 2026 annual meeting of limited partners and thereafter until such director's successor shall have been duly elected and qualified, or until such director's earlier death, resignation or removal: James W. WhiteheadDIRECTOR ELECTIONSISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Ratification of the appointment of Deloitte & Touche LLP as Black Stone Minerals, L.P.'s independent registered public accounting firm for the year ending December 31, 2025.AUDIT-RELATEDISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Approval on a non-binding advisory basis, of the compensation of the executive officers of Black Stone Minerals, L.P.'s general partner for the year ended December 31, 2024.SECTION 14A SAY-ON-PAY VOTESISSUER1096.0000009100.000000FOR1096.000000FORS000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Approval on a non-binding advisory basis, of the compensation of the executive officers of Black Stone Minerals, L.P.'s general partner for the year ended December 31, 2024.SECTION 14A SAY-ON-PAY VOTESISSUER1096.0000009100.000000FOR1096.000000FOR2S000064728Black Stone Minerals, L.P.09225M101US09225M101806/12/2025Approval of the adoption of the Black Stone Minerals, L.P. 2025 Long-Term Incentive Plan.COMPENSATIONISSUER1096.0000009100.000000FOR1096.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Peter M. CarlinoDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Debra Martin ChaseDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Carol ("Lili") LyntonDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Joseph W. Marshall, IIIDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: James B. PerryDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: Earl C. ShanksDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To elect Peter M. Carlino, Debra Martin Chase, Carol ("Lili") Lynton, Joseph W. Marshall, III, James B. Perry, Earl C. Shanks and E. Scott Urdang as directors to hold office until the Company's 2026 Annual Meeting of Shareholders and until their respective successors have been duly elected and qualified: E. Scott UrdangDIRECTOR ELECTIONSISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the current fiscal year.AUDIT-RELATEDISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To approve, on a non-binding advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3101.0000000FOR3101.000000FORS000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To approve, on a non-binding advisory basis, the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER3101.0000000FOR3101.000000FOR2S000064728Gaming and Leisure Properties, Inc.36467J108US36467J108806/12/2025To approve the Company's Amended and Restated 2013 Long-Term Incentive Compensation Plan.COMPENSATIONISSUER3101.0000000FOR3101.000000FORS000064728Structure Therapeutics Inc.86366E106US86366E106406/23/2025Election of the nominees for Class II director named below to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric DobmeierDIRECTOR ELECTIONSISSUER3875.0000000FOR3875.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025Election of the nominees for Class II director named below to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Joanne Waldstreicher, M.D.DIRECTOR ELECTIONSISSUER3875.0000000FOR3875.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER3875.0000000FOR3875.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3875.0000000FOR3875.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3875.0000000FOR3875.000000FOR2S000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER3875.0000000FOR3875.000000FOR5S000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3875.0000000ONE YEAR3875.000000FORS000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3875.0000000ONE YEAR3875.000000FOR2S000047353Structure Therapeutics Inc.86366E106US86366E106406/23/2025To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER3875.0000000ONE YEAR3875.000000FOR5S000047353CureVac NVN2451R105NL001543603106/24/2025Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Approve Discharge of Management BoardCORPORATE GOVERNANCEISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Approve Discharge of Supervisory BoardCORPORATE GOVERNANCEISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Elect Axel Sven Malkomes to Management BoardCORPORATE GOVERNANCEISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Reelect Jean Stephenne to Supervisory BoardDIRECTOR ELECTIONSISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Elect Mehdi Shahidi to Supervisory BoardDIRECTOR ELECTIONSISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Reelect Debra Barker to Supervisory BoardDIRECTOR ELECTIONSISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Reelect Craig A. Tooman to Supervisory BoardDIRECTOR ELECTIONSISSUER1131.00000034294.000000AGAINST1131.000000AGAINSTS000047353CureVac NVN2451R105NL001543603106/24/2025Reelect Klaus Schollmeier to Supervisory BoardDIRECTOR ELECTIONSISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Reappoint KPMG N.V. as AuditorsAUDIT-RELATEDISSUER1131.00000034294.000000FOR1131.000000FORS000047353CureVac NVN2451R105NL001543603106/24/2025Grant Board Authority to Issue SharesCAPITAL STRUCTUREISSUER1131.00000034294.000000AGAINST1131.000000AGAINSTS000047353CureVac NVN2451R105NL001543603106/24/2025Authorize Board to Exclude Preemptive Rights from Share IssuancesCAPITAL STRUCTUREISSUER1131.00000034294.000000AGAINST1131.000000AGAINSTS000047353CureVac NVN2451R105NL001543603106/24/2025Amend Compensation of Supervisory BoardCOMPENSATIONISSUER1131.00000034294.000000AGAINST1131.000000AGAINSTS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/24/2025To elect the three Class II directors named in the accompanying proxy statement to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Rahul D. Ballal, Ph.D.DIRECTOR ELECTIONSISSUER7110.00000034.000000FOR7110.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/24/2025To elect the three Class II directors named in the accompanying proxy statement to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Jake Bauer, M.B.A.DIRECTOR ELECTIONSISSUER7110.00000034.000000FOR7110.000000FORS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/24/2025To elect the three Class II directors named in the accompanying proxy statement to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Andrew Phillips, Ph.D.DIRECTOR ELECTIONSISSUER7110.00000034.000000WITHHOLD7110.000000AGAINSTS000047353Enliven Therapeutics, Inc.29337E102US29337E102906/24/2025To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7110.00000034.000000FOR7110.000000FORS000047353Erasca, Inc.29479A108US29479A108806/24/2025To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Jonathan E. Lim, M.D.DIRECTOR ELECTIONSISSUER62454.0000000FOR62454.000000FORS000047353Erasca, Inc.29479A108US29479A108806/24/2025To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: James A. Bristol, Ph.D.DIRECTOR ELECTIONSISSUER62454.0000000WITHHOLD62454.000000AGAINSTS000047353Erasca, Inc.29479A108US29479A108806/24/2025To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Valerie Harding - Start, Ph.D.DIRECTOR ELECTIONSISSUER62454.0000000WITHHOLD62454.000000AGAINSTS000047353Erasca, Inc.29479A108US29479A108806/24/2025To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025AUDIT-RELATEDISSUER62454.0000000FOR62454.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/24/2025To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Jeffery L. Stein. Ph.D.DIRECTOR ELECTIONSISSUER6376.0000000FOR6376.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/24/2025To elect two Class III directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Scott W. MorrisonDIRECTOR ELECTIONSISSUER6376.0000000WITHHOLD6376.000000AGAINSTS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/24/2025To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;AUDIT-RELATEDISSUER6376.0000000FOR6376.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/24/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.SECTION 14A SAY-ON-PAY VOTESISSUER6376.0000000FOR6376.000000FORS000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/24/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.SECTION 14A SAY-ON-PAY VOTESISSUER6376.0000000FOR6376.000000FOR2S000047353IDEAYA Biosciences, Inc.45166A102US45166A102506/24/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.SECTION 14A SAY-ON-PAY VOTESISSUER6376.0000000FOR6376.000000FOR5S000047353Arvinas, Inc.04335A105US04335A105106/25/2025Election of three Class I directors: Linda BainDIRECTOR ELECTIONSISSUER8323.0000000WITHHOLD8323.000000AGAINSTS000047353Arvinas, Inc.04335A105US04335A105106/25/2025Election of three Class I directors: John Houston, Ph.D.DIRECTOR ELECTIONSISSUER8323.0000000WITHHOLD8323.000000AGAINSTS000047353Arvinas, Inc.04335A105US04335A105106/25/2025Election of three Class I directors: Laurie Smaldone Alsup, M.D.DIRECTOR ELECTIONSISSUER8323.0000000WITHHOLD8323.000000AGAINSTS000047353Arvinas, Inc.04335A105US04335A105106/25/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8323.0000000FOR8323.000000FORS000047353Arvinas, Inc.04335A105US04335A105106/25/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8323.0000000FOR8323.000000FOR2S000047353Arvinas, Inc.04335A105US04335A105106/25/2025To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER8323.0000000FOR8323.000000FOR5S000047353Arvinas, Inc.04335A105US04335A105106/25/2025Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER8323.0000000FOR8323.000000FORS000047353Kymera Therapeutics, Inc.501575104US501575104406/25/2025To elect two class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Jeffrey Albers, J.D., MBADIRECTOR ELECTIONSISSUER1.0000003891.000000WITHHOLD1.000000AGAINSTS000047353Kymera Therapeutics, Inc.501575104US501575104406/25/2025To elect two class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Shareholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Felix J. Baker, Ph.D.DIRECTOR ELECTIONSISSUER1.0000003891.000000WITHHOLD1.000000AGAINSTS000047353Kymera Therapeutics, Inc.501575104US501575104406/25/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003891.000000FOR1.000000FORS000047353Kymera Therapeutics, Inc.501575104US501575104406/25/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003891.000000FOR1.000000FOR2S000047353Kymera Therapeutics, Inc.501575104US501575104406/25/2025To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1.0000003891.000000FOR1.000000FOR5S000047353Kymera Therapeutics, Inc.501575104US501575104406/25/2025To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER1.0000003891.000000FOR1.000000FORS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Accept Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER42141.0000000FOR42141.000000FORS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Approve Remuneration ReportCOMPENSATIONISSUER42141.0000000FOR42141.000000FORS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Approve Remuneration PolicyCOMPENSATIONISSUER42141.0000000AGAINST42141.000000AGAINSTS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Reappoint Ernst & Young LLP as Auditors and Authorize Their RemunerationAUDIT-RELATEDISSUER42141.0000000FOR42141.000000FORS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Elect Director Robert IannoneDIRECTOR ELECTIONSISSUER42141.0000000AGAINST42141.000000AGAINSTS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Elect Director Ravi RaoDIRECTOR ELECTIONSISSUER42141.0000000FOR42141.000000FORS000047353Autolus Therapeutics Plc05280R100US05280R100506/26/2025Approve Qualified Employee Stock Purchase PlanCOMPENSATIONISSUER42141.0000000FOR42141.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/26/2025To elect the Class II Directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Jeffrey Chodakewitz, M.D.DIRECTOR ELECTIONSISSUER2316.0000000WITHHOLD2316.000000AGAINSTS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/26/2025To elect the Class II Directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Merit Cudkowicz, M.D.DIRECTOR ELECTIONSISSUER2316.0000000FOR2316.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/26/2025To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER2316.0000000FOR2316.000000FORS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/26/2025To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER2316.0000000AGAINST2316.000000AGAINSTS000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/26/2025To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER2316.0000000AGAINST2316.000000AGAINST2S000047353Praxis Precision Medicines, Inc.74006W207US74006W207006/26/2025To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.SECTION 14A SAY-ON-PAY VOTESISSUER2316.0000000AGAINST2316.000000AGAINST5S000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Frank K. Clyburn, Jr.DIRECTOR ELECTIONSISSUER3653.0000000FOR3653.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Sandra J. Horning, M.D.DIRECTOR ELECTIONSISSUER3653.0000000WITHHOLD3653.000000AGAINSTS000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Sushil Patel, Ph.D.DIRECTOR ELECTIONSISSUER3653.0000000WITHHOLD3653.000000AGAINSTS000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To elect four Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until his or her successor is elected: Thilo Schroeder, Ph.D.DIRECTOR ELECTIONSISSUER3653.0000000WITHHOLD3653.000000AGAINSTS000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025; andAUDIT-RELATEDISSUER3653.0000000FOR3653.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER3653.0000000FOR3653.000000FORS000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER3653.0000000FOR3653.000000FOR2S000047353Revolution Medicines, Inc.76155X100US76155X100006/26/2025To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTESISSUER3653.0000000FOR3653.000000FOR5S000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To re-appoint as a director Dave Lemus, who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To re-appoint as a director Tim McInerney, who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To re-appoint as a director Iain Ross, who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To re-appoint as a director Craig Tooman, who retires in accordance with the articles of association.DIRECTOR ELECTIONSISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER24888.0000000FOR24888.000000FOR2S000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER24888.0000000FOR24888.000000FOR5S000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER24888.0000000ONE YEAR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER24888.0000000ONE YEAR24888.000000FOR2S000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER24888.0000000ONE YEAR24888.000000FOR5S000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025AUDIT-RELATEDISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.AUDIT-RELATEDISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To authorize the Audit & Risk Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2025.AUDIT-RELATEDISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. Annual Report").CORPORATE GOVERNANCEISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025To approve our directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the proxy statement and on pages 32 to 56 (inclusive) of the 2024 U.K. Annual Report.COMPENSATIONISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025That, in accordance with Article 159.13(b) of the articles of association, Article 159 of the articles of association shall apply with effect from the conclusion of this AGM to the conclusion of the next annual general meeting of the Company.CORPORATE GOVERNANCEISSUER24888.0000000FOR24888.000000FORS000047353Silence Therapeutics Plc82686Q101US82686Q101306/26/2025That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of association of the Company in substitution for, and to the exclusion of, the Company's existing articles of association.CORPORATE GOVERNANCEISSUER24888.0000000FOR24888.000000FORS000047353Omeros Corporation682143102US682143102906/27/2025Election of Directors: Arnold C. HanishDIRECTOR ELECTIONSISSUER96.00000013256.000000FOR96.000000FORS000047353Omeros Corporation682143102US682143102906/27/2025Election of Directors: Rajiv Shah, M.D.DIRECTOR ELECTIONSISSUER96.00000013256.000000FOR96.000000FORS000047353Omeros Corporation682143102US682143102906/27/2025Approval of advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER96.00000013256.000000FOR96.000000FORS000047353Omeros Corporation682143102US682143102906/27/2025Approval of advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER96.00000013256.000000FOR96.000000FOR2S000047353Omeros Corporation682143102US682143102906/27/2025Approval of advisory resolution on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER96.00000013256.000000FOR96.000000FOR5S000047353Omeros Corporation682143102US682143102906/27/2025Ratification of Ernst & Young LLP as independent registered public accounting firm for 2025AUDIT-RELATEDISSUER96.00000013256.000000FOR96.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Adopt Financial Statements and Statutory ReportsCORPORATE GOVERNANCEISSUER5960.0000000FOR5960.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Ratify PricewaterhouseCoopers Accountants N.V. as AuditorsAUDIT-RELATEDISSUER5960.0000000FOR5960.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Approve Discharge of DirectorsCORPORATE GOVERNANCEISSUER5960.0000000FOR5960.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Authorize Repurchase of Ordinary Shares or Depositary ReceiptsCAPITAL STRUCTUREISSUER5960.0000000FOR5960.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Reelect David Meeker as Non-Executive DirectorDIRECTOR ELECTIONSISSUER5960.0000000AGAINST5960.000000AGAINSTS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Reelect Robert Glassman as Non-Executive DirectorDIRECTOR ELECTIONSISSUER5960.0000000FOR5960.000000FORS000047353Pharvaris NVN69605108NL00150005Y406/27/2025Reelect Viviane Monges as Non-Executive DirectorDIRECTOR ELECTIONSISSUER5960.0000000FOR5960.000000FORS000047353Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Election of the Class II directors, each to serve for a three year term until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jennifer GoodDIRECTOR ELECTIONSISSUER7371.0000000FOR7371.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Election of the Class II directors, each to serve for a three year term until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Edward T. MathersDIRECTOR ELECTIONSISSUER7371.0000000WITHHOLD7371.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER7371.0000000FOR7371.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER7371.0000000AGAINST7371.000000AGAINSTS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER7371.0000000AGAINST7371.000000AGAINST2S000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTESISSUER7371.0000000AGAINST7371.000000AGAINST5S000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Approval of an amendment to our Amended and Restated Certificate of Incorporation to provide for exculpation of officers from breaches of fiduciary duty to the fullest extent permitted by the General Corporation Law of the State of Delaware (the "Officer Exculpation Proposal").CORPORATE GOVERNANCEISSUER7371.0000000FOR7371.000000FORS000047354Rhythm Pharmaceuticals, Inc.76243J105US76243J105106/24/2025Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve the Officer Exculpation Amendment.CORPORATE GOVERNANCEISSUER7371.0000000FOR7371.000000FORS000047354Springworks Therapeutics, Inc.85205L107US85205L107006/26/2025A proposal to adopt the Agreement and Plan of Merger, dated as of April 27, 2025 (the "Merger Agreement"), by and among Merck KGaA, Darmstadt, Germany, a German corporation with general partners ("Parent"), EMD Holdings Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), and SpringWorks Therapeutics, Inc. (the "Company"), pursuant to which Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the "Merger").EXTRAORDINARY TRANSACTIONSISSUER10611.0000000FOR10611.000000FORS000047354Springworks Therapeutics, Inc.85205L107US85205L107006/26/2025A proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting.CORPORATE GOVERNANCEISSUER10611.0000000FOR10611.000000FORS000047354Springworks Therapeutics, Inc.85205L107US85205L107006/26/2025A proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER10611.0000000FOR10611.000000FORS000047354Springworks Therapeutics, Inc.85205L107US85205L107006/26/2025A proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER10611.0000000FOR10611.000000FOR2S000047354Springworks Therapeutics, Inc.85205L107US85205L107006/26/2025A proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger.SECTION 14A SAY-ON-PAY VOTESISSUER10611.0000000FOR10611.000000FOR5S000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Christopher CauseyDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Raymond DwekDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Richard GiltnerDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Ray KurzweilDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Jan MalcolmDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Linda MaxwellDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Nilda MesaDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Judy OlianDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Christopher PatuskyDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Martine RothblattDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Louis SullivanDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Election of Directors: Tommy ThompsonDIRECTOR ELECTIONSISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1137.0000000FOR1137.000000FOR2S000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER1137.0000000FOR1137.000000FOR5S000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan.COMPENSATIONISSUER1137.0000000FOR1137.000000FORS000047354United Therapeutics Corporation91307C102US91307C102706/26/2025Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025.AUDIT-RELATEDISSUER1137.0000000FOR1137.000000FORS000047354MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Noriyuki HaraDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Yasuzo KanasugiDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Shinichiro FunabikiDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Shigeo KudoDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Keisuke NiiroDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Junichi TobimatsuDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Rochelle KoppDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Akemi IshiwataDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Jun SuzukiDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Atsuko OkajimaDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Hideki KawatsuDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Taisei KuniiDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Yukari Murayama @ Yukari HagiwaraDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Ryoichi HayashiDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Elect Eizo ChiyaDIRECTOR ELECTIONSISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Non-Audit Committee Directors' FeesCOMPENSATIONISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Audit Committee Directors' FeesCOMPENSATIONISSUER1714.0000000.000000FOR1714.000000FORS000058304MS&AD Insurance Group Holdings, Inc.JP389031000006/23/2025Amendment to the Restricted Stock PlanCOMPENSATIONISSUER1714.0000000.000000FOR1714.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Satoru KomiyaDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Kenji OkadaDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Kichiichiro YamamotoDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Keiko FujitaDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Hiroaki ShirotaDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Takashi MitachiDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Nobuhiro EndoDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Shinya KatanozakaDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Emi OsonoDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Kosei ShindoDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Robert Alan FeldmanDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Haruka Matsuyama @ Haruka KatoDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304Tokio Marine Holdings, Inc.JP391066000406/23/2025Elect Masahiro KoikeDIRECTOR ELECTIONSISSUER1701.0000000.000000FOR1701.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Kazuma SekiyaDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Noboru YoshinagaDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Takao TamuraDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Kazuyoshi TokimaruDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Noriko OkiDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Akiko MatsuoDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Etsuko Kobayashi @ Etsuko MasamuneDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Christina L. AhmadjianDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304DISCO CORPORATIONJP354860000006/24/2025Elect Atsushi MurakamiDIRECTOR ELECTIONSISSUER157.0000000.000000FOR157.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Tatsuro KosakaDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Hiroyuki YanagiDIRECTOR ELECTIONSISSUER623.0000000.000000AGAINST623.000000AGAINSTS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Masako EgawaDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Haruka Matsuyama @ Haruka KatoDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Kunihito MinakawaDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Peter D. PedersenDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Kei UrumaDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Atsuhiro YabuDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Noriyuki TakazawaDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mitsubishi Electric CorporationJP390240000506/24/2025Elect Kenichiro FujimotoDIRECTOR ELECTIONSISSUER623.0000000.000000FOR623.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Yoshimitsu KobayashiDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Takashi TsukiokaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Kotaro OnoDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Hiromichi ShinoharaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Yumiko NodaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Takakazu UchidaDIRECTOR ELECTIONSISSUER2530.0000000.000000AGAINST2530.000000AGAINSTS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Masahiko TezukaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Yuki Ikuno @ Yuki KanzakiDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Seiji ImaiDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Hisaaki HiramaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Masahiro KiharaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Hidekatsu TakeDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Mitsuhiro KanazawaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Elect Takefumi YonezawaDIRECTOR ELECTIONSISSUER2530.0000000.000000FOR2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Shareholder Proposal Regarding Assessment of RiskCORPORATE GOVERNANCESECURITY HOLDER2530.0000000.000000AGAINST2530.000000FORS000058304Mizuho Financial Group, Inc.JP388578000106/24/2025Shareholder Proposal Regarding Customers' Climate Change Transition PlansENVIRONMENT OR CLIMATESECURITY HOLDER2530.0000000.000000AGAINST2530.000000FORS000058304SCSK CorporationJP340040000206/24/2025Amendments to ArticlesCORPORATE GOVERNANCEISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Masaki NakajimaDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Takaaki TomaDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Takafumi TakeshitaDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Shinichi KatoDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Tetsuya KuboDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Sadayo HirataDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Shoei YamanaDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Hiromichi JitsunoDIRECTOR ELECTIONSISSUER3895.0000000.000000AGAINST3895.000000AGAINSTS000058304SCSK CorporationJP340040000206/24/2025Elect Hidetaka MatsuishiDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Elect Yumiko WasedaDIRECTOR ELECTIONSISSUER3895.0000000.000000FOR3895.000000FORS000058304SCSK CorporationJP340040000206/24/2025Amendments to Director's Fee and Equity Compensation PlanCOMPENSATIONISSUER3895.0000000.000000FOR3895.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Atsushi OsakiDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Fumiaki HayataDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Tomomi NakamuraDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Tetsuo FujinukiDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Shinsuke TodaDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Miwako DoiDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Fuminao HachiumaDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Shigeru YamashitaDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Jinya Shoji as Statutory AuditorCORPORATE GOVERNANCEISSUER810.0000000.000000FOR810.000000FORS000058304SUBARU CORPORATIONJP381480000306/25/2025Elect Hirohisa Ryu as Alternate Statutory AuditorDIRECTOR ELECTIONSISSUER810.0000000.000000FOR810.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Christophe WeberDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Milano FurutaDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Andrew PlumpDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Masami IijimaDIRECTOR ELECTIONSISSUER3737.0000000.000000AGAINST3737.000000AGAINSTS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Ian T. ClarkDIRECTOR ELECTIONSISSUER3737.0000000.000000AGAINST3737.000000AGAINSTS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Steven GillisDIRECTOR ELECTIONSISSUER3737.0000000.000000AGAINST3737.000000AGAINSTS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Emiko HigashiDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect John M. MaraganoreDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Michel OrsingerDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025Elect Miki TsusakaDIRECTOR ELECTIONSISSUER3737.0000000.000000FOR3737.000000FORS000058304Takeda Pharmaceutical Company LimitedJP346300000406/25/2025BonusCOMPENSATIONISSUER3737.0000000.000000FOR3737.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Accounts and ReportsCORPORATE GOVERNANCEISSUER14165.0000000.000000FOR14165.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER14165.0000000.000000FOR14165.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Elect ZHANG HuiDIRECTOR ELECTIONSISSUER14165.0000000.000000FOR14165.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Elect Anita FUNG Yuen MeiDIRECTOR ELECTIONSISSUER14165.0000000.000000FOR14165.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Appointment of Auditor and Authority to Set FeesAUDIT-RELATEDISSUER14165.0000000.000000FOR14165.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Authority to Issue Shares w/o Preemptive RightsCAPITAL STRUCTUREISSUER14165.0000000.000000FOR14165.000000FORS000058304BOC Hong Kong (Holdings) LtdHK238801119206/26/2025Authority to Repurchase SharesCAPITAL STRUCTUREISSUER14165.0000000.000000FOR14165.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Kei TakeuchiDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Yoshihiro MoriDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Tsukasa OkamotoDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Yutaka AmanoDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Yoshimasa TanakaDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Yutaka TakahashiDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Atsushi IritaniDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Junko OwadaDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Koichi AbeDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Kyoko AsakawaDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Masa MatsushitaDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Shuji KawaiDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Kenji KobayashiDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Elect Chieko OuchiDIRECTOR ELECTIONSISSUER429.0000000.000000FOR429.000000FORS000058304DAITO TRUST CONSTRUCTION CO., LTDJP348680000006/26/2025Amendment to the Trust Type Equity Compensation PlanCOMPENSATIONISSUER429.0000000.000000FOR429.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Masanori KatayamaDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Shinsuke MinamiDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Shinichi TakahashiDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Naohiro YamaguchiDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Shun FujimoriDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Mitsuyoshi ShibataDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Machiko MiyaiDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Tetsuya NakanoDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Masao WatanabeDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Kimie SakuragiDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Masato KawanamiDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Hirotomo AbeDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304ISUZU MOTORS LIMITEDJP313720000606/26/2025Elect Yumiko Hosoi @ Yumiko AndoDIRECTOR ELECTIONSISSUER5081.0000000.000000FOR5081.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Amendment to ArticlesCORPORATE GOVERNANCEISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Goro YamaguchiDIRECTOR ELECTIONSISSUER2111.0000000.000000AGAINST2111.000000AGAINSTS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Hideo TanimotoDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Norihiko InaDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Shiro SakushimaDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Koichi KanoDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Michinori YamadaDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Hiroaki ChidaDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Eiji KakiuchiDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Shigenobu MaekawaDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Junko Sunaga @ Junko InoueDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Noriko OiDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Shoichi Aoki as Statutory AuditorCORPORATE GOVERNANCEISSUER2111.0000000.000000FOR2111.000000FORS000058304KYOCERA CORPORATIONJP324960000206/26/2025Elect Yusuke Nakano as Alternate Statutory AuditorDIRECTOR ELECTIONSISSUER2111.0000000.000000FOR2111.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Takeo ObayashiDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Toshimi SatoDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Atsushi SasagawaDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Yoshihito SasakiDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Masako OriiDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Hiroyuki KatoDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Yukiko Kuroda @ Yukiko MatsumotoDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Hiroyuki ShimeDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304OBAYASHI CORPORATIONJP319000000406/26/2025Elect Yoshihiro IkegawaDIRECTOR ELECTIONSISSUER1965.0000000.000000FOR1965.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Keiko HondaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Satoko Kuwabara @ Satoko OtaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Hirofumi NomotoDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Mari Elka PangestuDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Hiroshi ShimizuDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect David SneiderDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Miyuki SuzukiDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Koichi TsujiDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Teruhisa UedaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Ryoichi ShinkeDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Takayuki YasudaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Kanetsugu MikeDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Hironori KamezawaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Junichi HanzawaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Makoto KobayashiDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Elect Hiroshi KubotaDIRECTOR ELECTIONSISSUER3009.0000000.000000FOR3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Assessment of RiskCORPORATE GOVERNANCESECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Customers' Climate Change Transition PlansENVIRONMENT OR CLIMATESECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Engaging in Transparent Capital MarketOTHER SOCIAL ISSUESSECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Company Name ChangeCORPORATE GOVERNANCESECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Addition to Code of ConductCORPORATE GOVERNANCESECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Acquisition of Treasury SharesCAPITAL STRUCTURESECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Election of Takafumi HorieDIRECTOR ELECTIONSSECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Election of Takashi TachibanaDIRECTOR ELECTIONSSECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Mitsubishi UFJ Financial Group, Inc.JP390290000406/27/2025Shareholder Proposal Regarding Election of Yuta MisakiDIRECTOR ELECTIONSSECURITY HOLDER3009.0000000.000000AGAINST3009.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Norio NakajimaDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Hiroshi IwatsuboDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Masanori MinamideDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Hiroshi IzumitaniDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Takaki MurataDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Yuko YasudaDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Takashi NishijimaDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Elect Hiroyuki InaDIRECTOR ELECTIONSISSUER816.0000000.000000FOR816.000000FORS000058304Murata Manufacturing Co., Ltd.JP391440000106/27/2025Adoption of the Performance Share Unit PlanCOMPENSATIONISSUER816.0000000.000000FOR816.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Shuntaro FurukawaDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Shigeru MiyamotoDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Shinya TakahashiDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Satoru ShibataDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Ko ShiotaDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Yusuke BeppuDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Chris MeledandriDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Miyoko DemayDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304Nintendo Co., Ltd.JP375660000706/27/2025Elect Kazuhiko HachiyaDIRECTOR ELECTIONSISSUER680.0000000.000000FOR680.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Yoshitaka KitaoDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Masato TakamuraDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Tomoya AsakuraDIRECTOR ELECTIONSISSUER1877.0000000.000000AGAINST1877.000000AGAINSTS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Satoe KusakabeDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Shinji MatsuiDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Motoaki ShiinoDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Heizo TakenakaDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Yasuhiro SuzukiDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Hiroshi ItoDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Kanae Takeuchi @ Kanae KusakariDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Junichi FukudaDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Hiroyuki SuematsuDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Masashi OkuyamaDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Yasuo NishikawaDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Takao OchiDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Masayuki YamadaCORPORATE GOVERNANCEISSUER1877.0000000.000000AGAINST1877.000000AGAINSTS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Tetsutaro WakatsukiCORPORATE GOVERNANCEISSUER1877.0000000.000000FOR1877.000000FORS000058304SBI Holdings, Inc.JP343612000406/27/2025Elect Tadayuki Sawada as Alternate Statutory AuditorDIRECTOR ELECTIONSISSUER1877.0000000.000000FOR1877.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Allocation of Profits/DividendsCAPITAL STRUCTUREISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Makoto TakashimaDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Toru NakashimaDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Teiko KudoDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Kazuyuki AnchiDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Toshihiro IsshikiDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Honami MatsugasakiDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Sonosuke KadonagaDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Jun SawadaDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Yoriko GotoDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Isao TeshirogiDIRECTOR ELECTIONSISSUER3793.0000000.000000AGAINST3793.000000AGAINSTS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Norimitsu TakashimaDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Charles D. Lake IIDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Elect Jenifer S. RogersDIRECTOR ELECTIONSISSUER3793.0000000.000000FOR3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Shareholder Proposal Regarding Assessment of RiskCORPORATE GOVERNANCESECURITY HOLDER3793.0000000.000000AGAINST3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Shareholder Proposal Regarding Customers' Climate Change Transition PlansENVIRONMENT OR CLIMATESECURITY HOLDER3793.0000000.000000AGAINST3793.000000FORS000058304Sumitomo Mitsui Financial Group, Inc.JP389035000606/27/2025Shareholder Proposal Regarding Appropriation of SurplusCAPITAL STRUCTURESECURITY HOLDER3793.0000000.000000AGAINST3793.000000FORS000058304Portman Ridge Finance Corporation73688F201US73688F201106/24/2025To elect as directors three nominees, each for a term of three years and until his successor is duly elected and qualified: George GrunebaumDIRECTOR ELECTIONSISSUER32468.0000002100.000000WITHHOLD32468.000000AGAINSTS000064727Portman Ridge Finance Corporation73688F201US73688F201106/24/2025To elect as directors three nominees, each for a term of three years and until his successor is duly elected and qualified: Dean KehlerDIRECTOR ELECTIONSISSUER32468.0000002100.000000FOR32468.000000FORS000064727Portman Ridge Finance Corporation73688F201US73688F201106/24/2025To elect as directors three nominees, each for a term of three years and until his successor is duly elected and qualified: Matthew WestwoodDIRECTOR ELECTIONSISSUER32468.0000002100.000000FOR32468.000000FORS000064727Portman Ridge Finance Corporation73688F201US73688F201106/24/2025To ratify the selection of Deloitte & Touche LLP as the independent registered public accountant of the Company for the fiscal year ending December 31, 2025.AUDIT-RELATEDISSUER32468.0000002100.000000FOR32468.000000FORS000064727Portman Ridge Finance Corporation73688F201US73688F201106/27/2025To approve the issuance of shares of common stock, par value $0.01 per share, of Portman Ridge Finance Corporation ("PTMN") pursuant to the merger of Portman Ridge Merger Sub, Inc., a Maryland corporation and a direct wholly-owned subsidiary of PTMN, with and into Logan Ridge Finance Corporation, a Maryland corporation ("LRFC"), with LRFC continuing as the surviving company and as a wholly-owned subsidiary of PTMN, in accordance with the NASDAQ Global Select Market listing rule requirements.EXTRAORDINARY TRANSACTIONSISSUER32468.0000002100.000000FOR32468.000000FORS000064727Portman Ridge Finance Corporation73688F201US73688F201106/27/2025To approve one or more adjournments of the Special Meeting of Stockholders if necessary to solicit additional proxies in favor of Proposal 1 if there are insufficient votes at the time of the Special Meeting of Stockholders to approve Proposal 1.CORPORATE GOVERNANCEISSUER32468.0000002100.000000FOR32468.000000FORS000064727